{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/descartesmbogning/immune-checkpoint-therapy-patent-analysis/blob/main/Patent_TopicModeling_immune_checkpoint.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# data import and preprocessing"
      ],
      "metadata": {
        "id": "1vQjaSbabo1E"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "j7nUM_BMRY1D",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "a069baf2-d508-49cc-e749-9bef2c0d448e"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "WB6fu6cKfE7t"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "kYgcPNdUluRk",
        "outputId": "583486af-3fe3-4b8d-f759-c26f2097b99e"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting pyLDAvis==3.4.0\n",
            "  Downloading pyLDAvis-3.4.0-py3-none-any.whl (2.6 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.6/2.6 MB\u001b[0m \u001b[31m12.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: numpy>=1.22.0 in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (1.23.5)\n",
            "Requirement already satisfied: scipy in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (1.11.4)\n",
            "Requirement already satisfied: pandas>=1.3.4 in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (1.5.3)\n",
            "Requirement already satisfied: joblib>=1.2.0 in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (1.3.2)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (3.1.3)\n",
            "Requirement already satisfied: numexpr in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (2.9.0)\n",
            "Collecting funcy (from pyLDAvis==3.4.0)\n",
            "  Downloading funcy-2.0-py2.py3-none-any.whl (30 kB)\n",
            "Requirement already satisfied: scikit-learn>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (1.2.2)\n",
            "Requirement already satisfied: gensim in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (4.3.2)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from pyLDAvis==3.4.0) (67.7.2)\n",
            "Requirement already satisfied: python-dateutil>=2.8.1 in /usr/local/lib/python3.10/dist-packages (from pandas>=1.3.4->pyLDAvis==3.4.0) (2.8.2)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.10/dist-packages (from pandas>=1.3.4->pyLDAvis==3.4.0) (2023.4)\n",
            "Requirement already satisfied: threadpoolctl>=2.0.0 in /usr/local/lib/python3.10/dist-packages (from scikit-learn>=1.0.0->pyLDAvis==3.4.0) (3.2.0)\n",
            "Requirement already satisfied: smart-open>=1.8.1 in /usr/local/lib/python3.10/dist-packages (from gensim->pyLDAvis==3.4.0) (6.4.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->pyLDAvis==3.4.0) (2.1.4)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.10/dist-packages (from python-dateutil>=2.8.1->pandas>=1.3.4->pyLDAvis==3.4.0) (1.16.0)\n",
            "Installing collected packages: funcy, pyLDAvis\n",
            "Successfully installed funcy-2.0 pyLDAvis-3.4.0\n"
          ]
        }
      ],
      "source": [
        "!pip install pyLDAvis==3.4.0"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "zn6zDCOzluTB"
      },
      "outputs": [],
      "source": [
        "import pyLDAvis\n",
        "import pyLDAvis.sklearn"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "1yKVOLGJc04l"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Gdy8NI_lSZEb",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "43da5f8b-76a8-4977-d524-3d0bf2b08f8f"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "\n",
        "import spacy\n",
        "import codecs\n",
        "import re\n",
        "from wordcloud import STOPWORDS\n",
        "\n",
        "import nltk\n",
        "from nltk.corpus import stopwords\n",
        "from nltk.stem import WordNetLemmatizer\n",
        "\n",
        "from sklearn.feature_extraction.text import TfidfVectorizer, CountVectorizer\n",
        "from sklearn import decomposition\n",
        "from nltk.stem.porter import PorterStemmer"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "3m_8ZWnbL0Et",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "d6fd9a69-efba-4a36-dc45-12c5a87c163f"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
          ]
        }
      ],
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 748
        },
        "id": "_yRRTyNvSZFv",
        "outputId": "a6b5998b-8642-496c-c30f-dab6386be4e7"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "3439\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   # Jurisdiction Kind        Display Key              Lens ID  \\\n",
              "0  1           TW    A     TW 202114659 A  197-733-628-711-768   \n",
              "1  2           WO   A1  WO 2022/056572 A1  023-616-950-865-48X   \n",
              "2  3           CN    A     CN 112512579 A  094-569-953-648-612   \n",
              "3  4           CN    A     CN 112512580 A  143-969-408-220-424   \n",
              "4  5           WO   A8  WO 2019/156568 A8  194-887-353-832-386   \n",
              "\n",
              "  Publication Date  Publication Year Application Number Application Date  \\\n",
              "0       2021-04-16              2021     TW 109133847 A       2020-09-29   \n",
              "1       2022-03-24              2022   AU 2020/050994 W       2020-09-18   \n",
              "2       2021-03-16              2021  CN 201980049832 A       2019-09-27   \n",
              "3       2021-03-16              2021  CN 201980049896 A       2019-09-27   \n",
              "4       2019-10-03              2019    NL 2019050092 W       2019-02-12   \n",
              "\n",
              "                                    Priority Numbers Earliest Priority Date  \\\n",
              "0                                      EP 19201152 A             2019-10-02   \n",
              "1                                   AU 2020/050994 W             2020-09-18   \n",
              "2  CN 201811147946 A;;CN 201910467950 A;;CN 20191...             2018-09-29   \n",
              "3  CN 201811149357 A;;CN 201811547685 A;;CN 20191...             2018-09-29   \n",
              "4                                       NL 2020422 A             2018-02-12   \n",
              "\n",
              "                                               Title  \\\n",
              "0  Combination comprising HDAC inhibitor, CTLA-4 ...   \n",
              "1                         TREATMENT OF SOLID TUMOURS   \n",
              "2  USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...   \n",
              "3  USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...   \n",
              "4  METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...   \n",
              "\n",
              "                                            Abstract  \\\n",
              "0  The invention relates to medical uses of an HD...   \n",
              "1  The present invention relates to a method for ...   \n",
              "2  Use of a combination of a TLR agonist and an i...   \n",
              "3  Disclosed is the use of an EZH2 inhibitor in c...   \n",
              "4  The present invention relates to the field of ...   \n",
              "\n",
              "                                          Applicants  \\\n",
              "0                                             4SC AG   \n",
              "1            OLIVIA NEWTON JOHN CANCER RES INSTITUTE   \n",
              "2  JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "3  JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "4  STICHTING HET NEDERLANDS KANKER INST ANTONI VA...   \n",
              "\n",
              "                                           Inventors Owners  \\\n",
              "0                       HAMM SVETLANA;;HERMANN FRANK    NaN   \n",
              "1  POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER    NaN   \n",
              "2  JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...    NaN   \n",
              "3  ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...    NaN   \n",
              "4  SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...    NaN   \n",
              "\n",
              "                                    URL        Document Type Has Full Text  \\\n",
              "0  https://lens.org/197-733-628-711-768   Patent of Addition            no   \n",
              "1  https://lens.org/023-616-950-865-48X   Patent Application           yes   \n",
              "2  https://lens.org/094-569-953-648-612   Patent Application            no   \n",
              "3  https://lens.org/143-969-408-220-424   Patent Application            no   \n",
              "4  https://lens.org/194-887-353-832-386  Amended Application           yes   \n",
              "\n",
              "   Cites Patent Count  Cited by Patent Count  Simple Family Size  \\\n",
              "0                   0                      0                   2   \n",
              "1                   3                      0                   1   \n",
              "2                   3                      0                   3   \n",
              "3                   2                      1                   3   \n",
              "4                   0                      0                   3   \n",
              "\n",
              "   Extended Family Size  Sequence Count  \\\n",
              "0                     2               0   \n",
              "1                     2               0   \n",
              "2                     3               0   \n",
              "3                     3               0   \n",
              "4                     3               0   \n",
              "\n",
              "                                 CPC Classifications  \\\n",
              "0                  A61K45/06;;A61P35/00;;A61K31/4155   \n",
              "1  A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...   \n",
              "2      A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04   \n",
              "3  A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...   \n",
              "4                       G01N33/57423;;G01N2333/70532   \n",
              "\n",
              "                                IPCR Classifications US Classifications  \\\n",
              "0      A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00                NaN   \n",
              "1  A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...                NaN   \n",
              "2      A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04                NaN   \n",
              "3  A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...                NaN   \n",
              "4                                         G01N33/574                NaN   \n",
              "\n",
              "   NPL Citation Count  NPL Resolved Citation Count  \\\n",
              "0                   0                            0   \n",
              "1                   2                            2   \n",
              "2                   0                            0   \n",
              "3                   0                            0   \n",
              "4                   0                            0   \n",
              "\n",
              "                    NPL Resolved Lens ID(s)  \\\n",
              "0                                       NaN   \n",
              "1  011-457-792-548-92X;;048-229-382-653-004   \n",
              "2                                       NaN   \n",
              "3                                       NaN   \n",
              "4                                       NaN   \n",
              "\n",
              "                         NPL Resolved External ID(s)  \\\n",
              "0                                                NaN   \n",
              "1  29955905;;10.1007/s00018-018-2863-3;;pmc638240...   \n",
              "2                                                NaN   \n",
              "3                                                NaN   \n",
              "4                                                NaN   \n",
              "\n",
              "                                       NPL Citations Legal Status  \n",
              "0                                                NaN      PENDING  \n",
              "1  YU, G.-T. ET AL.: \"Inhibition of SRC family ki...      PENDING  \n",
              "2                                                NaN      PENDING  \n",
              "3                                                NaN      PENDING  \n",
              "4                                                NaN      PENDING  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-3bf78b76-5c67-4f12-bbe2-5733d44ab77a\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>#</th>\n",
              "      <th>Jurisdiction</th>\n",
              "      <th>Kind</th>\n",
              "      <th>Display Key</th>\n",
              "      <th>Lens ID</th>\n",
              "      <th>Publication Date</th>\n",
              "      <th>Publication Year</th>\n",
              "      <th>Application Number</th>\n",
              "      <th>Application Date</th>\n",
              "      <th>Priority Numbers</th>\n",
              "      <th>Earliest Priority Date</th>\n",
              "      <th>Title</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Applicants</th>\n",
              "      <th>Inventors</th>\n",
              "      <th>Owners</th>\n",
              "      <th>URL</th>\n",
              "      <th>Document Type</th>\n",
              "      <th>Has Full Text</th>\n",
              "      <th>Cites Patent Count</th>\n",
              "      <th>Cited by Patent Count</th>\n",
              "      <th>Simple Family Size</th>\n",
              "      <th>Extended Family Size</th>\n",
              "      <th>Sequence Count</th>\n",
              "      <th>CPC Classifications</th>\n",
              "      <th>IPCR Classifications</th>\n",
              "      <th>US Classifications</th>\n",
              "      <th>NPL Citation Count</th>\n",
              "      <th>NPL Resolved Citation Count</th>\n",
              "      <th>NPL Resolved Lens ID(s)</th>\n",
              "      <th>NPL Resolved External ID(s)</th>\n",
              "      <th>NPL Citations</th>\n",
              "      <th>Legal Status</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>1</td>\n",
              "      <td>TW</td>\n",
              "      <td>A</td>\n",
              "      <td>TW 202114659 A</td>\n",
              "      <td>197-733-628-711-768</td>\n",
              "      <td>2021-04-16</td>\n",
              "      <td>2021</td>\n",
              "      <td>TW 109133847 A</td>\n",
              "      <td>2020-09-29</td>\n",
              "      <td>EP 19201152 A</td>\n",
              "      <td>2019-10-02</td>\n",
              "      <td>Combination comprising HDAC inhibitor, CTLA-4 ...</td>\n",
              "      <td>The invention relates to medical uses of an HD...</td>\n",
              "      <td>4SC AG</td>\n",
              "      <td>HAMM SVETLANA;;HERMANN FRANK</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/197-733-628-711-768</td>\n",
              "      <td>Patent of Addition</td>\n",
              "      <td>no</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K45/06;;A61P35/00;;A61K31/4155</td>\n",
              "      <td>A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>2</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2022/056572 A1</td>\n",
              "      <td>023-616-950-865-48X</td>\n",
              "      <td>2022-03-24</td>\n",
              "      <td>2022</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>TREATMENT OF SOLID TUMOURS</td>\n",
              "      <td>The present invention relates to a method for ...</td>\n",
              "      <td>OLIVIA NEWTON JOHN CANCER RES INSTITUTE</td>\n",
              "      <td>POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/023-616-950-865-48X</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...</td>\n",
              "      <td>A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>011-457-792-548-92X;;048-229-382-653-004</td>\n",
              "      <td>29955905;;10.1007/s00018-018-2863-3;;pmc638240...</td>\n",
              "      <td>YU, G.-T. ET AL.: \"Inhibition of SRC family ki...</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>3</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512579 A</td>\n",
              "      <td>094-569-953-648-612</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>2021</td>\n",
              "      <td>CN 201980049832 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811147946 A;;CN 201910467950 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...</td>\n",
              "      <td>Use of a combination of a TLR agonist and an i...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/094-569-953-648-612</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04</td>\n",
              "      <td>A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>4</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512580 A</td>\n",
              "      <td>143-969-408-220-424</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>2021</td>\n",
              "      <td>CN 201980049896 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811149357 A;;CN 201811547685 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...</td>\n",
              "      <td>Disclosed is the use of an EZH2 inhibitor in c...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/143-969-408-220-424</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...</td>\n",
              "      <td>A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>5</td>\n",
              "      <td>WO</td>\n",
              "      <td>A8</td>\n",
              "      <td>WO 2019/156568 A8</td>\n",
              "      <td>194-887-353-832-386</td>\n",
              "      <td>2019-10-03</td>\n",
              "      <td>2019</td>\n",
              "      <td>NL 2019050092 W</td>\n",
              "      <td>2019-02-12</td>\n",
              "      <td>NL 2020422 A</td>\n",
              "      <td>2018-02-12</td>\n",
              "      <td>METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...</td>\n",
              "      <td>The present invention relates to the field of ...</td>\n",
              "      <td>STICHTING HET NEDERLANDS KANKER INST ANTONI VA...</td>\n",
              "      <td>SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/194-887-353-832-386</td>\n",
              "      <td>Amended Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>G01N33/57423;;G01N2333/70532</td>\n",
              "      <td>G01N33/574</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-3bf78b76-5c67-4f12-bbe2-5733d44ab77a')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-3bf78b76-5c67-4f12-bbe2-5733d44ab77a button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-3bf78b76-5c67-4f12-bbe2-5733d44ab77a');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-31040763-b8e7-4073-9c89-bd0066f292c0\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-31040763-b8e7-4073-9c89-bd0066f292c0')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-31040763-b8e7-4073-9c89-bd0066f292c0 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 83
        }
      ],
      "source": [
        "df = pd.read_csv ('/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /DATA/LENS.ORG/immune-checkpoint-petent-lensorg-28012024.csv')\n",
        "pd.set_option('display.max_columns', None)\n",
        "print(len(df))\n",
        "df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GYfiUBxrStTX",
        "outputId": "adc0fdce-e830-437c-da56-a12d1a1e595f"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "3439"
            ]
          },
          "metadata": {},
          "execution_count": 84
        }
      ],
      "source": [
        "## Convert 'Publication Year' to integers\n",
        "df['Publication Year'] = df['Publication Year'].astype(int)\n",
        "\n",
        "# Filter based on 'Publication Year' column\n",
        "#df = df[df['Publication Year'] >= 2003]\n",
        "len(df)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "WBPCsGRMKnto",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "69a5fad7-c871-4f2c-9393-c4c425e1d31e"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "bN_vhjVQfN47",
        "outputId": "33d99d7a-2f5b-44ad-c53b-bf4343c67f8c"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "3378"
            ]
          },
          "metadata": {},
          "execution_count": 85
        }
      ],
      "source": [
        "df = df[(~pd.isnull(df['Abstract'])) & (~pd.isnull(df['Title']))]\n",
        "len(df)"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "taAS0BuOLE4B",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "e6cc5554-ecc0-48a5-ef36-7c0b8dd39bd9"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df = df.set_index(['Lens ID','Publication Year'])\n",
        "df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "QZW6MAnWJb-U",
        "outputId": "5557aeb1-895a-466a-b399-df2b4693f5b2"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                         # Jurisdiction Kind  \\\n",
              "Lens ID             Publication Year                           \n",
              "197-733-628-711-768 2021                 1           TW    A   \n",
              "023-616-950-865-48X 2022                 2           WO   A1   \n",
              "094-569-953-648-612 2021                 3           CN    A   \n",
              "143-969-408-220-424 2021                 4           CN    A   \n",
              "194-887-353-832-386 2019                 5           WO   A8   \n",
              "...                                    ...          ...  ...   \n",
              "042-723-456-628-924 2023              3433           US   A1   \n",
              "166-510-410-954-06X 2023              3436           WO   A1   \n",
              "120-354-976-671-738 2021              3437           AU   A4   \n",
              "183-320-641-365-157 2020              3438           WO   A1   \n",
              "085-567-628-784-332 2021              3439           WO   A1   \n",
              "\n",
              "                                             Display Key Publication Date  \\\n",
              "Lens ID             Publication Year                                        \n",
              "197-733-628-711-768 2021                  TW 202114659 A       2021-04-16   \n",
              "023-616-950-865-48X 2022               WO 2022/056572 A1       2022-03-24   \n",
              "094-569-953-648-612 2021                  CN 112512579 A       2021-03-16   \n",
              "143-969-408-220-424 2021                  CN 112512580 A       2021-03-16   \n",
              "194-887-353-832-386 2019               WO 2019/156568 A8       2019-10-03   \n",
              "...                                                  ...              ...   \n",
              "042-723-456-628-924 2023              US 2023/0070723 A1       2023-03-09   \n",
              "166-510-410-954-06X 2023               WO 2023/224912 A1       2023-11-23   \n",
              "120-354-976-671-738 2021               AU 2021/102091 A4       2021-06-10   \n",
              "183-320-641-365-157 2020               WO 2020/163222 A1       2020-08-13   \n",
              "085-567-628-784-332 2021               WO 2021/122745 A1       2021-06-24   \n",
              "\n",
              "                                     Application Number Application Date  \\\n",
              "Lens ID             Publication Year                                       \n",
              "197-733-628-711-768 2021                 TW 109133847 A       2020-09-29   \n",
              "023-616-950-865-48X 2022               AU 2020/050994 W       2020-09-18   \n",
              "094-569-953-648-612 2021              CN 201980049832 A       2019-09-27   \n",
              "143-969-408-220-424 2021              CN 201980049896 A       2019-09-27   \n",
              "194-887-353-832-386 2019                NL 2019050092 W       2019-02-12   \n",
              "...                                                 ...              ...   \n",
              "042-723-456-628-924 2023              US 202217819401 A       2022-08-12   \n",
              "166-510-410-954-06X 2023              US 2023/0022243 W       2023-05-15   \n",
              "120-354-976-671-738 2021               AU 2021/102091 A       2021-04-20   \n",
              "183-320-641-365-157 2020              US 2020/0016375 W       2020-02-03   \n",
              "085-567-628-784-332 2021                EP 2020086419 W       2020-12-16   \n",
              "\n",
              "                                                                       Priority Numbers  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                  EP 19201152 A   \n",
              "023-616-950-865-48X 2022                                               AU 2020/050994 W   \n",
              "094-569-953-648-612 2021              CN 201811147946 A;;CN 201910467950 A;;CN 20191...   \n",
              "143-969-408-220-424 2021              CN 201811149357 A;;CN 201811547685 A;;CN 20191...   \n",
              "194-887-353-832-386 2019                                                   NL 2020422 A   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                           US 202217819401 A;;US 202163232966 P   \n",
              "166-510-410-954-06X 2023                                              US 202263342548 P   \n",
              "120-354-976-671-738 2021                                               AU 2021/102091 A   \n",
              "183-320-641-365-157 2020                                              US 201962800972 P   \n",
              "085-567-628-784-332 2021                                                 GB 201918541 A   \n",
              "\n",
              "                                     Earliest Priority Date  \\\n",
              "Lens ID             Publication Year                          \n",
              "197-733-628-711-768 2021                         2019-10-02   \n",
              "023-616-950-865-48X 2022                         2020-09-18   \n",
              "094-569-953-648-612 2021                         2018-09-29   \n",
              "143-969-408-220-424 2021                         2018-09-29   \n",
              "194-887-353-832-386 2019                         2018-02-12   \n",
              "...                                                     ...   \n",
              "042-723-456-628-924 2023                         2021-08-13   \n",
              "166-510-410-954-06X 2023                         2022-05-16   \n",
              "120-354-976-671-738 2021                         2021-04-20   \n",
              "183-320-641-365-157 2020                         2019-02-04   \n",
              "085-567-628-784-332 2021                         2019-12-16   \n",
              "\n",
              "                                                                                  Title  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              Combination comprising HDAC inhibitor, CTLA-4 ...   \n",
              "023-616-950-865-48X 2022                                     TREATMENT OF SOLID TUMOURS   \n",
              "094-569-953-648-612 2021              USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...   \n",
              "143-969-408-220-424 2021              USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...   \n",
              "194-887-353-832-386 2019              METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                      COMBINATION THERAPY TO TREAT BRAIN CANCER   \n",
              "166-510-410-954-06X 2023              METHODS OF TREATING METASTATIC CASTRATION-RESI...   \n",
              "120-354-976-671-738 2021              A METHOD FOR CONFIRMING CONSTITUTIONAL MISMATC...   \n",
              "183-320-641-365-157 2020              NUCLEIC ACID SEQUENCE ENCODING CHIMERIC ANTIGE...   \n",
              "085-567-628-784-332 2021              4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMIN...   \n",
              "\n",
              "                                                                               Abstract  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              The invention relates to medical uses of an HD...   \n",
              "023-616-950-865-48X 2022              The present invention relates to a method for ...   \n",
              "094-569-953-648-612 2021              Use of a combination of a TLR agonist and an i...   \n",
              "143-969-408-220-424 2021              Disclosed is the use of an EZH2 inhibitor in c...   \n",
              "194-887-353-832-386 2019              The present invention relates to the field of ...   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023              Provided herein are methods of treating brain ...   \n",
              "166-510-410-954-06X 2023              The present disclosure provides methods for tr...   \n",
              "120-354-976-671-738 2021              The present disclosure relates to a method for...   \n",
              "183-320-641-365-157 2020              The present invention is directed to a nucleic...   \n",
              "085-567-628-784-332 2021              The present invention pertains generally to th...   \n",
              "\n",
              "                                                                             Applicants  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                         4SC AG   \n",
              "023-616-950-865-48X 2022                        OLIVIA NEWTON JOHN CANCER RES INSTITUTE   \n",
              "094-569-953-648-612 2021              JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "143-969-408-220-424 2021              JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "194-887-353-832-386 2019              STICHTING HET NEDERLANDS KANKER INST ANTONI VA...   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                   INOVIO PHARMACEUTICALS INC;;REGENERON PHARMA   \n",
              "166-510-410-954-06X 2023                                               REGENERON PHARMA   \n",
              "120-354-976-671-738 2021                         CHAKRABORTY SARIT;;PAUL CHANDRAMALLIKA   \n",
              "183-320-641-365-157 2020              PROMAB BIOTECHNOLOGIES INC;;FOREVERTEK BIOTECH...   \n",
              "085-567-628-784-332 2021                                       CARRICK THERAPEUTICS LTD   \n",
              "\n",
              "                                                                              Inventors  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                   HAMM SVETLANA;;HERMANN FRANK   \n",
              "023-616-950-865-48X 2022              POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER   \n",
              "094-569-953-648-612 2021              JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...   \n",
              "143-969-408-220-424 2021              ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...   \n",
              "194-887-353-832-386 2019              SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023              BREDLAU AMY-LEE;;LOWY ISRAEL;;SKOLNIK JEFFREY;...   \n",
              "166-510-410-954-06X 2023              MILLER ELIZABETH;;SANDIGURSKY SABINA;;LOWY ISR...   \n",
              "120-354-976-671-738 2021                         PAUL CHANDRAMALLIKA;;CHAKRABORTY SARIT   \n",
              "183-320-641-365-157 2020                                    WU LIJUN;;GOLUBOVSKAYA VITA   \n",
              "085-567-628-784-332 2021              AINSCOW EDWARD;;BAHL ASHWANI;;SUNOSE MIHIRO;;C...   \n",
              "\n",
              "                                     Owners  \\\n",
              "Lens ID             Publication Year          \n",
              "197-733-628-711-768 2021                NaN   \n",
              "023-616-950-865-48X 2022                NaN   \n",
              "094-569-953-648-612 2021                NaN   \n",
              "143-969-408-220-424 2021                NaN   \n",
              "194-887-353-832-386 2019                NaN   \n",
              "...                                     ...   \n",
              "042-723-456-628-924 2023                NaN   \n",
              "166-510-410-954-06X 2023                NaN   \n",
              "120-354-976-671-738 2021                NaN   \n",
              "183-320-641-365-157 2020                NaN   \n",
              "085-567-628-784-332 2021                NaN   \n",
              "\n",
              "                                                                       URL  \\\n",
              "Lens ID             Publication Year                                         \n",
              "197-733-628-711-768 2021              https://lens.org/197-733-628-711-768   \n",
              "023-616-950-865-48X 2022              https://lens.org/023-616-950-865-48X   \n",
              "094-569-953-648-612 2021              https://lens.org/094-569-953-648-612   \n",
              "143-969-408-220-424 2021              https://lens.org/143-969-408-220-424   \n",
              "194-887-353-832-386 2019              https://lens.org/194-887-353-832-386   \n",
              "...                                                                    ...   \n",
              "042-723-456-628-924 2023              https://lens.org/042-723-456-628-924   \n",
              "166-510-410-954-06X 2023              https://lens.org/166-510-410-954-06X   \n",
              "120-354-976-671-738 2021              https://lens.org/120-354-976-671-738   \n",
              "183-320-641-365-157 2020              https://lens.org/183-320-641-365-157   \n",
              "085-567-628-784-332 2021              https://lens.org/085-567-628-784-332   \n",
              "\n",
              "                                            Document Type Has Full Text  \\\n",
              "Lens ID             Publication Year                                      \n",
              "197-733-628-711-768 2021               Patent of Addition            no   \n",
              "023-616-950-865-48X 2022               Patent Application           yes   \n",
              "094-569-953-648-612 2021               Patent Application            no   \n",
              "143-969-408-220-424 2021               Patent Application            no   \n",
              "194-887-353-832-386 2019              Amended Application           yes   \n",
              "...                                                   ...           ...   \n",
              "042-723-456-628-924 2023               Patent Application           yes   \n",
              "166-510-410-954-06X 2023               Patent Application           yes   \n",
              "120-354-976-671-738 2021                   Limited Patent            no   \n",
              "183-320-641-365-157 2020               Patent Application           yes   \n",
              "085-567-628-784-332 2021               Patent Application           yes   \n",
              "\n",
              "                                      Cites Patent Count  \\\n",
              "Lens ID             Publication Year                       \n",
              "197-733-628-711-768 2021                               0   \n",
              "023-616-950-865-48X 2022                               3   \n",
              "094-569-953-648-612 2021                               3   \n",
              "143-969-408-220-424 2021                               2   \n",
              "194-887-353-832-386 2019                               0   \n",
              "...                                                  ...   \n",
              "042-723-456-628-924 2023                               0   \n",
              "166-510-410-954-06X 2023                              19   \n",
              "120-354-976-671-738 2021                               0   \n",
              "183-320-641-365-157 2020                               6   \n",
              "085-567-628-784-332 2021                              10   \n",
              "\n",
              "                                      Cited by Patent Count  \\\n",
              "Lens ID             Publication Year                          \n",
              "197-733-628-711-768 2021                                  0   \n",
              "023-616-950-865-48X 2022                                  0   \n",
              "094-569-953-648-612 2021                                  0   \n",
              "143-969-408-220-424 2021                                  1   \n",
              "194-887-353-832-386 2019                                  0   \n",
              "...                                                     ...   \n",
              "042-723-456-628-924 2023                                  0   \n",
              "166-510-410-954-06X 2023                                  0   \n",
              "120-354-976-671-738 2021                                  0   \n",
              "183-320-641-365-157 2020                                  3   \n",
              "085-567-628-784-332 2021                                  1   \n",
              "\n",
              "                                      Simple Family Size  \\\n",
              "Lens ID             Publication Year                       \n",
              "197-733-628-711-768 2021                               2   \n",
              "023-616-950-865-48X 2022                               1   \n",
              "094-569-953-648-612 2021                               3   \n",
              "143-969-408-220-424 2021                               3   \n",
              "194-887-353-832-386 2019                               3   \n",
              "...                                                  ...   \n",
              "042-723-456-628-924 2023                               3   \n",
              "166-510-410-954-06X 2023                               1   \n",
              "120-354-976-671-738 2021                               1   \n",
              "183-320-641-365-157 2020                               2   \n",
              "085-567-628-784-332 2021                               8   \n",
              "\n",
              "                                      Extended Family Size  Sequence Count  \\\n",
              "Lens ID             Publication Year                                         \n",
              "197-733-628-711-768 2021                                 2               0   \n",
              "023-616-950-865-48X 2022                                 2               0   \n",
              "094-569-953-648-612 2021                                 3               0   \n",
              "143-969-408-220-424 2021                                 3               0   \n",
              "194-887-353-832-386 2019                                 3               0   \n",
              "...                                                    ...             ...   \n",
              "042-723-456-628-924 2023                                 3               0   \n",
              "166-510-410-954-06X 2023                                 1              28   \n",
              "120-354-976-671-738 2021                                 1               0   \n",
              "183-320-641-365-157 2020                                 2              46   \n",
              "085-567-628-784-332 2021                                 8               0   \n",
              "\n",
              "                                                                    CPC Classifications  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                              A61K45/06;;A61P35/00;;A61K31/4155   \n",
              "023-616-950-865-48X 2022              A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...   \n",
              "094-569-953-648-612 2021                  A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04   \n",
              "143-969-408-220-424 2021              A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...   \n",
              "194-887-353-832-386 2019                                   G01N33/57423;;G01N2333/70532   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023              C07K16/2818;;A61K39/001195;;A61K39/001157;;A61...   \n",
              "166-510-410-954-06X 2023              C07K16/3069;;C07K16/2809;;C07K2317/31;;C07K231...   \n",
              "120-354-976-671-738 2021              C12Q1/6827;;C12Q2600/118;;C12Q2600/106;;C12Q26...   \n",
              "183-320-641-365-157 2020              A61K31/713;;A61K35/17;;A61K39/001112;;A61K2039...   \n",
              "085-567-628-784-332 2021              C07D487/04;;C07D519/00;;A61K31/138;;A61K31/167...   \n",
              "\n",
              "                                                                   IPCR Classifications  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                  A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00   \n",
              "023-616-950-865-48X 2022              A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...   \n",
              "094-569-953-648-612 2021                  A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04   \n",
              "143-969-408-220-424 2021              A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...   \n",
              "194-887-353-832-386 2019                                                     G01N33/574   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023              A61K31/495;;A61K38/20;;A61K39/00;;A61K39/395;;...   \n",
              "166-510-410-954-06X 2023                                A61P35/00;;C07K16/28;;C07K16/30   \n",
              "120-354-976-671-738 2021                             C12Q1/6827;;C12Q1/6886;;G01N33/574   \n",
              "183-320-641-365-157 2020              A61K31/713;;A61K35/17;;C07H21/02;;C07K16/28;;C...   \n",
              "085-567-628-784-332 2021                  C07D487/04;;A61K31/519;;A61P35/00;;C07D519/00   \n",
              "\n",
              "                                     US Classifications  NPL Citation Count  \\\n",
              "Lens ID             Publication Year                                          \n",
              "197-733-628-711-768 2021                            NaN                   0   \n",
              "023-616-950-865-48X 2022                            NaN                   2   \n",
              "094-569-953-648-612 2021                            NaN                   0   \n",
              "143-969-408-220-424 2021                            NaN                   0   \n",
              "194-887-353-832-386 2019                            NaN                   0   \n",
              "...                                                 ...                 ...   \n",
              "042-723-456-628-924 2023                            NaN                   0   \n",
              "166-510-410-954-06X 2023                            NaN                  10   \n",
              "120-354-976-671-738 2021                            NaN                   0   \n",
              "183-320-641-365-157 2020                            NaN                   0   \n",
              "085-567-628-784-332 2021                            NaN                  26   \n",
              "\n",
              "                                      NPL Resolved Citation Count  \\\n",
              "Lens ID             Publication Year                                \n",
              "197-733-628-711-768 2021                                        0   \n",
              "023-616-950-865-48X 2022                                        2   \n",
              "094-569-953-648-612 2021                                        0   \n",
              "143-969-408-220-424 2021                                        0   \n",
              "194-887-353-832-386 2019                                        0   \n",
              "...                                                           ...   \n",
              "042-723-456-628-924 2023                                        0   \n",
              "166-510-410-954-06X 2023                                        6   \n",
              "120-354-976-671-738 2021                                        0   \n",
              "183-320-641-365-157 2020                                        0   \n",
              "085-567-628-784-332 2021                                       24   \n",
              "\n",
              "                                                                NPL Resolved Lens ID(s)  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022                       011-457-792-548-92X;;048-229-382-653-004   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                                                            NaN   \n",
              "166-510-410-954-06X 2023              018-820-995-716-872;;103-897-301-868-65X;;071-...   \n",
              "120-354-976-671-738 2021                                                            NaN   \n",
              "183-320-641-365-157 2020                                                            NaN   \n",
              "085-567-628-784-332 2021              007-364-858-655-289;;001-057-233-129-619;;014-...   \n",
              "\n",
              "                                                            NPL Resolved External ID(s)  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022              29955905;;10.1007/s00018-018-2863-3;;pmc638240...   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                                                            NaN   \n",
              "166-510-410-954-06X 2023              10.1158/1078-0432.ccr-20-3725;;33504551;;25482...   \n",
              "120-354-976-671-738 2021                                                            NaN   \n",
              "183-320-641-365-157 2020                                                            NaN   \n",
              "085-567-628-784-332 2021              10.1002/jps.2600660104;;833720;;pmc1430317;;16...   \n",
              "\n",
              "                                                                          NPL Citations  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022              YU, G.-T. ET AL.: \"Inhibition of SRC family ki...   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                                                            NaN   \n",
              "166-510-410-954-06X 2023              DEEGEN PETRA ET AL: \"The PSMA-targeting Half-l...   \n",
              "120-354-976-671-738 2021                                                            NaN   \n",
              "183-320-641-365-157 2020                                                            NaN   \n",
              "085-567-628-784-332 2021              BERGE ET AL.: \"Pharmaceutically Acceptable Sal...   \n",
              "\n",
              "                                     Legal Status  \n",
              "Lens ID             Publication Year               \n",
              "197-733-628-711-768 2021                  PENDING  \n",
              "023-616-950-865-48X 2022                  PENDING  \n",
              "094-569-953-648-612 2021                  PENDING  \n",
              "143-969-408-220-424 2021                  PENDING  \n",
              "194-887-353-832-386 2019                  PENDING  \n",
              "...                                           ...  \n",
              "042-723-456-628-924 2023                  PENDING  \n",
              "166-510-410-954-06X 2023                  PENDING  \n",
              "120-354-976-671-738 2021                 INACTIVE  \n",
              "183-320-641-365-157 2020                  PENDING  \n",
              "085-567-628-784-332 2021                  PENDING  \n",
              "\n",
              "[3378 rows x 31 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-8f1feb4a-cfb2-4bbf-b9c6-61620d9b00a6\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th>#</th>\n",
              "      <th>Jurisdiction</th>\n",
              "      <th>Kind</th>\n",
              "      <th>Display Key</th>\n",
              "      <th>Publication Date</th>\n",
              "      <th>Application Number</th>\n",
              "      <th>Application Date</th>\n",
              "      <th>Priority Numbers</th>\n",
              "      <th>Earliest Priority Date</th>\n",
              "      <th>Title</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Applicants</th>\n",
              "      <th>Inventors</th>\n",
              "      <th>Owners</th>\n",
              "      <th>URL</th>\n",
              "      <th>Document Type</th>\n",
              "      <th>Has Full Text</th>\n",
              "      <th>Cites Patent Count</th>\n",
              "      <th>Cited by Patent Count</th>\n",
              "      <th>Simple Family Size</th>\n",
              "      <th>Extended Family Size</th>\n",
              "      <th>Sequence Count</th>\n",
              "      <th>CPC Classifications</th>\n",
              "      <th>IPCR Classifications</th>\n",
              "      <th>US Classifications</th>\n",
              "      <th>NPL Citation Count</th>\n",
              "      <th>NPL Resolved Citation Count</th>\n",
              "      <th>NPL Resolved Lens ID(s)</th>\n",
              "      <th>NPL Resolved External ID(s)</th>\n",
              "      <th>NPL Citations</th>\n",
              "      <th>Legal Status</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Lens ID</th>\n",
              "      <th>Publication Year</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>197-733-628-711-768</th>\n",
              "      <th>2021</th>\n",
              "      <td>1</td>\n",
              "      <td>TW</td>\n",
              "      <td>A</td>\n",
              "      <td>TW 202114659 A</td>\n",
              "      <td>2021-04-16</td>\n",
              "      <td>TW 109133847 A</td>\n",
              "      <td>2020-09-29</td>\n",
              "      <td>EP 19201152 A</td>\n",
              "      <td>2019-10-02</td>\n",
              "      <td>Combination comprising HDAC inhibitor, CTLA-4 ...</td>\n",
              "      <td>The invention relates to medical uses of an HD...</td>\n",
              "      <td>4SC AG</td>\n",
              "      <td>HAMM SVETLANA;;HERMANN FRANK</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/197-733-628-711-768</td>\n",
              "      <td>Patent of Addition</td>\n",
              "      <td>no</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K45/06;;A61P35/00;;A61K31/4155</td>\n",
              "      <td>A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>023-616-950-865-48X</th>\n",
              "      <th>2022</th>\n",
              "      <td>2</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2022/056572 A1</td>\n",
              "      <td>2022-03-24</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>TREATMENT OF SOLID TUMOURS</td>\n",
              "      <td>The present invention relates to a method for ...</td>\n",
              "      <td>OLIVIA NEWTON JOHN CANCER RES INSTITUTE</td>\n",
              "      <td>POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/023-616-950-865-48X</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...</td>\n",
              "      <td>A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>011-457-792-548-92X;;048-229-382-653-004</td>\n",
              "      <td>29955905;;10.1007/s00018-018-2863-3;;pmc638240...</td>\n",
              "      <td>YU, G.-T. ET AL.: \"Inhibition of SRC family ki...</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>094-569-953-648-612</th>\n",
              "      <th>2021</th>\n",
              "      <td>3</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512579 A</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>CN 201980049832 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811147946 A;;CN 201910467950 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...</td>\n",
              "      <td>Use of a combination of a TLR agonist and an i...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/094-569-953-648-612</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04</td>\n",
              "      <td>A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143-969-408-220-424</th>\n",
              "      <th>2021</th>\n",
              "      <td>4</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512580 A</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>CN 201980049896 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811149357 A;;CN 201811547685 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...</td>\n",
              "      <td>Disclosed is the use of an EZH2 inhibitor in c...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/143-969-408-220-424</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...</td>\n",
              "      <td>A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>194-887-353-832-386</th>\n",
              "      <th>2019</th>\n",
              "      <td>5</td>\n",
              "      <td>WO</td>\n",
              "      <td>A8</td>\n",
              "      <td>WO 2019/156568 A8</td>\n",
              "      <td>2019-10-03</td>\n",
              "      <td>NL 2019050092 W</td>\n",
              "      <td>2019-02-12</td>\n",
              "      <td>NL 2020422 A</td>\n",
              "      <td>2018-02-12</td>\n",
              "      <td>METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...</td>\n",
              "      <td>The present invention relates to the field of ...</td>\n",
              "      <td>STICHTING HET NEDERLANDS KANKER INST ANTONI VA...</td>\n",
              "      <td>SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/194-887-353-832-386</td>\n",
              "      <td>Amended Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>G01N33/57423;;G01N2333/70532</td>\n",
              "      <td>G01N33/574</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>042-723-456-628-924</th>\n",
              "      <th>2023</th>\n",
              "      <td>3433</td>\n",
              "      <td>US</td>\n",
              "      <td>A1</td>\n",
              "      <td>US 2023/0070723 A1</td>\n",
              "      <td>2023-03-09</td>\n",
              "      <td>US 202217819401 A</td>\n",
              "      <td>2022-08-12</td>\n",
              "      <td>US 202217819401 A;;US 202163232966 P</td>\n",
              "      <td>2021-08-13</td>\n",
              "      <td>COMBINATION THERAPY TO TREAT BRAIN CANCER</td>\n",
              "      <td>Provided herein are methods of treating brain ...</td>\n",
              "      <td>INOVIO PHARMACEUTICALS INC;;REGENERON PHARMA</td>\n",
              "      <td>BREDLAU AMY-LEE;;LOWY ISRAEL;;SKOLNIK JEFFREY;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/042-723-456-628-924</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>C07K16/2818;;A61K39/001195;;A61K39/001157;;A61...</td>\n",
              "      <td>A61K31/495;;A61K38/20;;A61K39/00;;A61K39/395;;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>166-510-410-954-06X</th>\n",
              "      <th>2023</th>\n",
              "      <td>3436</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2023/224912 A1</td>\n",
              "      <td>2023-11-23</td>\n",
              "      <td>US 2023/0022243 W</td>\n",
              "      <td>2023-05-15</td>\n",
              "      <td>US 202263342548 P</td>\n",
              "      <td>2022-05-16</td>\n",
              "      <td>METHODS OF TREATING METASTATIC CASTRATION-RESI...</td>\n",
              "      <td>The present disclosure provides methods for tr...</td>\n",
              "      <td>REGENERON PHARMA</td>\n",
              "      <td>MILLER ELIZABETH;;SANDIGURSKY SABINA;;LOWY ISR...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/166-510-410-954-06X</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>19</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>28</td>\n",
              "      <td>C07K16/3069;;C07K16/2809;;C07K2317/31;;C07K231...</td>\n",
              "      <td>A61P35/00;;C07K16/28;;C07K16/30</td>\n",
              "      <td>NaN</td>\n",
              "      <td>10</td>\n",
              "      <td>6</td>\n",
              "      <td>018-820-995-716-872;;103-897-301-868-65X;;071-...</td>\n",
              "      <td>10.1158/1078-0432.ccr-20-3725;;33504551;;25482...</td>\n",
              "      <td>DEEGEN PETRA ET AL: \"The PSMA-targeting Half-l...</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>120-354-976-671-738</th>\n",
              "      <th>2021</th>\n",
              "      <td>3437</td>\n",
              "      <td>AU</td>\n",
              "      <td>A4</td>\n",
              "      <td>AU 2021/102091 A4</td>\n",
              "      <td>2021-06-10</td>\n",
              "      <td>AU 2021/102091 A</td>\n",
              "      <td>2021-04-20</td>\n",
              "      <td>AU 2021/102091 A</td>\n",
              "      <td>2021-04-20</td>\n",
              "      <td>A METHOD FOR CONFIRMING CONSTITUTIONAL MISMATC...</td>\n",
              "      <td>The present disclosure relates to a method for...</td>\n",
              "      <td>CHAKRABORTY SARIT;;PAUL CHANDRAMALLIKA</td>\n",
              "      <td>PAUL CHANDRAMALLIKA;;CHAKRABORTY SARIT</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/120-354-976-671-738</td>\n",
              "      <td>Limited Patent</td>\n",
              "      <td>no</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>C12Q1/6827;;C12Q2600/118;;C12Q2600/106;;C12Q26...</td>\n",
              "      <td>C12Q1/6827;;C12Q1/6886;;G01N33/574</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>INACTIVE</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>183-320-641-365-157</th>\n",
              "      <th>2020</th>\n",
              "      <td>3438</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2020/163222 A1</td>\n",
              "      <td>2020-08-13</td>\n",
              "      <td>US 2020/0016375 W</td>\n",
              "      <td>2020-02-03</td>\n",
              "      <td>US 201962800972 P</td>\n",
              "      <td>2019-02-04</td>\n",
              "      <td>NUCLEIC ACID SEQUENCE ENCODING CHIMERIC ANTIGE...</td>\n",
              "      <td>The present invention is directed to a nucleic...</td>\n",
              "      <td>PROMAB BIOTECHNOLOGIES INC;;FOREVERTEK BIOTECH...</td>\n",
              "      <td>WU LIJUN;;GOLUBOVSKAYA VITA</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/183-320-641-365-157</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>6</td>\n",
              "      <td>3</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>46</td>\n",
              "      <td>A61K31/713;;A61K35/17;;A61K39/001112;;A61K2039...</td>\n",
              "      <td>A61K31/713;;A61K35/17;;C07H21/02;;C07K16/28;;C...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>085-567-628-784-332</th>\n",
              "      <th>2021</th>\n",
              "      <td>3439</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2021/122745 A1</td>\n",
              "      <td>2021-06-24</td>\n",
              "      <td>EP 2020086419 W</td>\n",
              "      <td>2020-12-16</td>\n",
              "      <td>GB 201918541 A</td>\n",
              "      <td>2019-12-16</td>\n",
              "      <td>4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMIN...</td>\n",
              "      <td>The present invention pertains generally to th...</td>\n",
              "      <td>CARRICK THERAPEUTICS LTD</td>\n",
              "      <td>AINSCOW EDWARD;;BAHL ASHWANI;;SUNOSE MIHIRO;;C...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/085-567-628-784-332</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>10</td>\n",
              "      <td>1</td>\n",
              "      <td>8</td>\n",
              "      <td>8</td>\n",
              "      <td>0</td>\n",
              "      <td>C07D487/04;;C07D519/00;;A61K31/138;;A61K31/167...</td>\n",
              "      <td>C07D487/04;;A61K31/519;;A61P35/00;;C07D519/00</td>\n",
              "      <td>NaN</td>\n",
              "      <td>26</td>\n",
              "      <td>24</td>\n",
              "      <td>007-364-858-655-289;;001-057-233-129-619;;014-...</td>\n",
              "      <td>10.1002/jps.2600660104;;833720;;pmc1430317;;16...</td>\n",
              "      <td>BERGE ET AL.: \"Pharmaceutically Acceptable Sal...</td>\n",
              "      <td>PENDING</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>3378 rows × 31 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-8f1feb4a-cfb2-4bbf-b9c6-61620d9b00a6')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-8f1feb4a-cfb2-4bbf-b9c6-61620d9b00a6 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-8f1feb4a-cfb2-4bbf-b9c6-61620d9b00a6');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-32da520b-134c-41fd-a499-8d2c4263bd4e\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-32da520b-134c-41fd-a499-8d2c4263bd4e')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-32da520b-134c-41fd-a499-8d2c4263bd4e button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_386424df-d252-4b67-aa29-446931e0b3e3\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_386424df-d252-4b67-aa29-446931e0b3e3 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 86
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9Ma8jUgsStU2",
        "outputId": "37202840-ce7c-4932-8aed-5d5811f57a18"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "3378"
            ]
          },
          "metadata": {},
          "execution_count": 87
        }
      ],
      "source": [
        "#data = [str(df['Title'][i])+str(df['Abstract'][i]) for i in df.index] #Title and Abstract\n",
        "len(data)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#data"
      ],
      "metadata": {
        "id": "70xjrXWmK_hQ",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "59674086-8fa0-4fbd-8f86-7390f020ef55"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AlFC9BAghud5",
        "outputId": "1fe85d42-90b4-4d48-d46a-9260d089769f"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting en-core-web-md==3.7.1\n",
            "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_md-3.7.1/en_core_web_md-3.7.1-py3-none-any.whl (42.8 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m42.8/42.8 MB\u001b[0m \u001b[31m19.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: spacy<3.8.0,>=3.7.2 in /usr/local/lib/python3.10/dist-packages (from en-core-web-md==3.7.1) (3.7.2)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (1.0.10)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (2.0.8)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.3.0,>=8.1.8 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (8.2.2)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (1.1.2)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (2.4.8)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.4.0,>=0.1.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (0.3.4)\n",
            "Requirement already satisfied: typer<0.10.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (0.9.0)\n",
            "Requirement already satisfied: smart-open<7.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (6.4.0)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (4.66.1)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (2.31.0)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (1.10.14)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (3.1.3)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (67.7.2)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (23.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (3.3.0)\n",
            "Requirement already satisfied: numpy>=1.19.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (1.23.5)\n",
            "Requirement already satisfied: typing-extensions>=4.2.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (4.5.0)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (3.3.2)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (3.6)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (2.0.7)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (2023.11.17)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.1.8->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.1.8->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (0.1.4)\n",
            "Requirement already satisfied: click<9.0.0,>=7.1.1 in /usr/local/lib/python3.10/dist-packages (from typer<0.10.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (8.1.7)\n",
            "Requirement already satisfied: cloudpathlib<0.17.0,>=0.7.0 in /usr/local/lib/python3.10/dist-packages (from weasel<0.4.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (0.16.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy<3.8.0,>=3.7.2->en-core-web-md==3.7.1) (2.1.4)\n",
            "\u001b[38;5;2m✔ Download and installation successful\u001b[0m\n",
            "You can now load the package via spacy.load('en_core_web_md')\n"
          ]
        }
      ],
      "source": [
        "!python -m spacy download en_core_web_md"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ADJ4guaGStYx",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "bd92e3aa-e6aa-4423-f4f0-afaa83a942ec"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "import en_core_web_md\n",
        "nlp = en_core_web_md.load()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AVWSWIUljCxr",
        "outputId": "3735c464-a448-49df-e1f5-4770f3ebfa61"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n",
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Package punkt is already up-to-date!\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "metadata": {},
          "execution_count": 91
        }
      ],
      "source": [
        "import nltk\n",
        "nltk.download('punkt')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "1gZFkHOfStaS",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "154d71d8-2ed8-4517-e8d7-f5c57dc3439c"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "from wordcloud import WordCloud, STOPWORDS\n",
        "import plotly.express as px\n",
        "import nltk\n",
        "from nltk.corpus import stopwords\n",
        "from nltk.stem import WordNetLemmatizer\n",
        "\n",
        "nltk.download('wordnet')\n",
        "nltk.download('stopwords')\n",
        "s = set(STOPWORDS)\n",
        "sw = stopwords.words('english')\n",
        "sw += s\n",
        "sw.append ('amp')"
      ],
      "metadata": {
        "id": "WDveHckVhWIE"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from wordcloud import WordCloud, STOPWORDS\n",
        "import plotly.express as px\n",
        "import nltk\n",
        "from nltk.corpus import stopwords\n",
        "from nltk.stem import WordNetLemmatizer\n",
        "\n",
        "# Downloads\n",
        "nltk.download('wordnet')\n",
        "nltk.download('stopwords')\n",
        "\n",
        "# Initialize your stopwords set with wordcloud's stopwords\n",
        "s = set(STOPWORDS)\n",
        "\n",
        "# Get stopwords for all languages in NLTK\n",
        "languages = stopwords.fileids()\n",
        "for language in languages:\n",
        "    s.update(stopwords.words(language))\n",
        "\n",
        "# Add any additional stopwords if needed\n",
        "s.add('amp')\n",
        "\n",
        "# If you really need the resulting stopwords as a list:\n",
        "sw = list(s)\n"
      ],
      "metadata": {
        "id": "mVxitGDjVJiW",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "0450d121-ac1e-4120-a430-471f8f539cdd"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n",
            "[nltk_data] Downloading package wordnet to /root/nltk_data...\n",
            "[nltk_data]   Package wordnet is already up-to-date!\n",
            "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]   Package stopwords is already up-to-date!\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "fJaHnuR7hc6i",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "01a37952-3fc6-4543-e0ee-1af8a8687ac0"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "waTKGoC0SZJM",
        "outputId": "b33578c5-9104-46a9-8830-d54bf06368c5"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "3320"
            ]
          },
          "metadata": {},
          "execution_count": 93
        }
      ],
      "source": [
        "# Read the texts and remove the stopwords :\n",
        "#Build the text list:\n",
        "txt = []\n",
        "idx = []\n",
        "t1 = ''\n",
        "t2 = []\n",
        "for i in range(len(data)):\n",
        "        t1 = str(data[i]).lower()\n",
        " #       t1 = re.sub ('#','',t1)\n",
        "        #t1 = re.sub ('.','',t1)\n",
        " #       t1 = re.sub (',','',t1)\n",
        " #       t1 = re.sub (\"'\",'',t1)\n",
        "#        t1 = t1.replace('.','')\n",
        "        t2 = t1.split()\n",
        "        t1 = ''\n",
        "        for item2 in t2:\n",
        "            if item2 not in sw:\n",
        "                t1 += item2\n",
        "                t1 += ' '\n",
        "        if t1[:-1] not in txt and t1[:-1] != '':\n",
        "            txt.append (t1[:-1])\n",
        "            idx.append (i)\n",
        "len (txt)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#pip install --upgrade ipykernel"
      ],
      "metadata": {
        "id": "GHGm9Kvb4Zv-",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "33dc85fd-3da1-4368-cbd4-14c2bf064ea6"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "KSzxkRcL4Z0S",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "fb02e6e4-47b9-47cf-a963-02bea04ec53f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "idx"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "3ooeVJ8u3VzQ",
        "outputId": "aa0839e8-e507-49fb-fd70-6248086ba8a2"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[0,\n",
              " 1,\n",
              " 2,\n",
              " 3,\n",
              " 4,\n",
              " 5,\n",
              " 6,\n",
              " 7,\n",
              " 8,\n",
              " 9,\n",
              " 10,\n",
              " 11,\n",
              " 12,\n",
              " 13,\n",
              " 14,\n",
              " 15,\n",
              " 16,\n",
              " 17,\n",
              " 18,\n",
              " 19,\n",
              " 20,\n",
              " 21,\n",
              " 22,\n",
              " 23,\n",
              " 24,\n",
              " 25,\n",
              " 26,\n",
              " 27,\n",
              " 28,\n",
              " 29,\n",
              " 30,\n",
              " 31,\n",
              " 32,\n",
              " 33,\n",
              " 34,\n",
              " 35,\n",
              " 36,\n",
              " 37,\n",
              " 38,\n",
              " 39,\n",
              " 40,\n",
              " 41,\n",
              " 42,\n",
              " 43,\n",
              " 44,\n",
              " 45,\n",
              " 46,\n",
              " 47,\n",
              " 48,\n",
              " 49,\n",
              " 50,\n",
              " 51,\n",
              " 52,\n",
              " 53,\n",
              " 54,\n",
              " 55,\n",
              " 56,\n",
              " 57,\n",
              " 58,\n",
              " 59,\n",
              " 60,\n",
              " 61,\n",
              " 62,\n",
              " 63,\n",
              " 64,\n",
              " 65,\n",
              " 66,\n",
              " 67,\n",
              " 68,\n",
              " 69,\n",
              " 70,\n",
              " 71,\n",
              " 72,\n",
              " 73,\n",
              " 74,\n",
              " 75,\n",
              " 76,\n",
              " 77,\n",
              " 78,\n",
              " 79,\n",
              " 80,\n",
              " 81,\n",
              " 82,\n",
              " 83,\n",
              " 84,\n",
              " 86,\n",
              " 87,\n",
              " 88,\n",
              " 89,\n",
              " 90,\n",
              " 91,\n",
              " 92,\n",
              " 93,\n",
              " 94,\n",
              " 95,\n",
              " 96,\n",
              " 97,\n",
              " 98,\n",
              " 99,\n",
              " 100,\n",
              " 101,\n",
              " 102,\n",
              " 103,\n",
              " 104,\n",
              " 105,\n",
              " 106,\n",
              " 107,\n",
              " 108,\n",
              " 109,\n",
              " 110,\n",
              " 111,\n",
              " 112,\n",
              " 113,\n",
              " 114,\n",
              " 115,\n",
              " 116,\n",
              " 117,\n",
              " 118,\n",
              " 119,\n",
              " 120,\n",
              " 121,\n",
              " 122,\n",
              " 123,\n",
              " 124,\n",
              " 125,\n",
              " 126,\n",
              " 127,\n",
              " 128,\n",
              " 129,\n",
              " 130,\n",
              " 131,\n",
              " 132,\n",
              " 133,\n",
              " 134,\n",
              " 135,\n",
              " 136,\n",
              " 137,\n",
              " 138,\n",
              " 139,\n",
              " 140,\n",
              " 141,\n",
              " 142,\n",
              " 143,\n",
              " 144,\n",
              " 145,\n",
              " 146,\n",
              " 147,\n",
              " 148,\n",
              " 149,\n",
              " 150,\n",
              " 151,\n",
              " 152,\n",
              " 153,\n",
              " 154,\n",
              " 155,\n",
              " 156,\n",
              " 157,\n",
              " 158,\n",
              " 159,\n",
              " 160,\n",
              " 161,\n",
              " 162,\n",
              " 163,\n",
              " 164,\n",
              " 165,\n",
              " 166,\n",
              " 167,\n",
              " 168,\n",
              " 169,\n",
              " 170,\n",
              " 171,\n",
              " 172,\n",
              " 173,\n",
              " 174,\n",
              " 175,\n",
              " 176,\n",
              " 177,\n",
              " 178,\n",
              " 179,\n",
              " 180,\n",
              " 181,\n",
              " 182,\n",
              " 183,\n",
              " 184,\n",
              " 185,\n",
              " 186,\n",
              " 187,\n",
              " 188,\n",
              " 189,\n",
              " 190,\n",
              " 191,\n",
              " 192,\n",
              " 193,\n",
              " 194,\n",
              " 195,\n",
              " 196,\n",
              " 197,\n",
              " 198,\n",
              " 199,\n",
              " 200,\n",
              " 201,\n",
              " 202,\n",
              " 203,\n",
              " 204,\n",
              " 205,\n",
              " 206,\n",
              " 207,\n",
              " 208,\n",
              " 209,\n",
              " 210,\n",
              " 211,\n",
              " 212,\n",
              " 213,\n",
              " 214,\n",
              " 215,\n",
              " 216,\n",
              " 217,\n",
              " 218,\n",
              " 219,\n",
              " 220,\n",
              " 221,\n",
              " 222,\n",
              " 223,\n",
              " 224,\n",
              " 225,\n",
              " 226,\n",
              " 227,\n",
              " 228,\n",
              " 229,\n",
              " 230,\n",
              " 231,\n",
              " 232,\n",
              " 233,\n",
              " 234,\n",
              " 235,\n",
              " 236,\n",
              " 237,\n",
              " 238,\n",
              " 239,\n",
              " 240,\n",
              " 241,\n",
              " 242,\n",
              " 243,\n",
              " 244,\n",
              " 245,\n",
              " 246,\n",
              " 247,\n",
              " 248,\n",
              " 249,\n",
              " 250,\n",
              " 251,\n",
              " 252,\n",
              " 253,\n",
              " 254,\n",
              " 255,\n",
              " 256,\n",
              " 257,\n",
              " 258,\n",
              " 259,\n",
              " 260,\n",
              " 261,\n",
              " 262,\n",
              " 263,\n",
              " 264,\n",
              " 265,\n",
              " 266,\n",
              " 267,\n",
              " 268,\n",
              " 269,\n",
              " 270,\n",
              " 271,\n",
              " 272,\n",
              " 273,\n",
              " 274,\n",
              " 275,\n",
              " 276,\n",
              " 277,\n",
              " 278,\n",
              " 279,\n",
              " 280,\n",
              " 281,\n",
              " 282,\n",
              " 283,\n",
              " 284,\n",
              " 285,\n",
              " 286,\n",
              " 287,\n",
              " 288,\n",
              " 289,\n",
              " 290,\n",
              " 291,\n",
              " 292,\n",
              " 293,\n",
              " 294,\n",
              " 295,\n",
              " 296,\n",
              " 297,\n",
              " 298,\n",
              " 299,\n",
              " 300,\n",
              " 301,\n",
              " 302,\n",
              " 303,\n",
              " 304,\n",
              " 305,\n",
              " 306,\n",
              " 307,\n",
              " 308,\n",
              " 309,\n",
              " 310,\n",
              " 311,\n",
              " 312,\n",
              " 313,\n",
              " 314,\n",
              " 315,\n",
              " 316,\n",
              " 317,\n",
              " 318,\n",
              " 319,\n",
              " 320,\n",
              " 321,\n",
              " 322,\n",
              " 323,\n",
              " 324,\n",
              " 325,\n",
              " 326,\n",
              " 327,\n",
              " 328,\n",
              " 329,\n",
              " 330,\n",
              " 331,\n",
              " 332,\n",
              " 333,\n",
              " 334,\n",
              " 335,\n",
              " 336,\n",
              " 337,\n",
              " 338,\n",
              " 339,\n",
              " 340,\n",
              " 341,\n",
              " 342,\n",
              " 343,\n",
              " 344,\n",
              " 345,\n",
              " 346,\n",
              " 347,\n",
              " 348,\n",
              " 349,\n",
              " 350,\n",
              " 351,\n",
              " 352,\n",
              " 353,\n",
              " 354,\n",
              " 355,\n",
              " 356,\n",
              " 357,\n",
              " 358,\n",
              " 359,\n",
              " 360,\n",
              " 361,\n",
              " 362,\n",
              " 363,\n",
              " 364,\n",
              " 365,\n",
              " 366,\n",
              " 367,\n",
              " 368,\n",
              " 369,\n",
              " 370,\n",
              " 371,\n",
              " 372,\n",
              " 373,\n",
              " 374,\n",
              " 375,\n",
              " 376,\n",
              " 377,\n",
              " 378,\n",
              " 379,\n",
              " 380,\n",
              " 381,\n",
              " 382,\n",
              " 383,\n",
              " 384,\n",
              " 385,\n",
              " 386,\n",
              " 387,\n",
              " 388,\n",
              " 389,\n",
              " 391,\n",
              " 392,\n",
              " 393,\n",
              " 395,\n",
              " 396,\n",
              " 397,\n",
              " 398,\n",
              " 399,\n",
              " 400,\n",
              " 401,\n",
              " 403,\n",
              " 404,\n",
              " 405,\n",
              " 407,\n",
              " 408,\n",
              " 409,\n",
              " 410,\n",
              " 411,\n",
              " 412,\n",
              " 413,\n",
              " 414,\n",
              " 415,\n",
              " 416,\n",
              " 417,\n",
              " 418,\n",
              " 419,\n",
              " 420,\n",
              " 421,\n",
              " 422,\n",
              " 423,\n",
              " 424,\n",
              " 425,\n",
              " 426,\n",
              " 427,\n",
              " 428,\n",
              " 429,\n",
              " 430,\n",
              " 431,\n",
              " 432,\n",
              " 433,\n",
              " 434,\n",
              " 435,\n",
              " 436,\n",
              " 437,\n",
              " 439,\n",
              " 440,\n",
              " 441,\n",
              " 442,\n",
              " 443,\n",
              " 444,\n",
              " 445,\n",
              " 446,\n",
              " 447,\n",
              " 448,\n",
              " 449,\n",
              " 450,\n",
              " 451,\n",
              " 452,\n",
              " 453,\n",
              " 454,\n",
              " 455,\n",
              " 456,\n",
              " 457,\n",
              " 458,\n",
              " 459,\n",
              " 460,\n",
              " 461,\n",
              " 462,\n",
              " 463,\n",
              " 464,\n",
              " 465,\n",
              " 466,\n",
              " 467,\n",
              " 468,\n",
              " 469,\n",
              " 470,\n",
              " 471,\n",
              " 472,\n",
              " 473,\n",
              " 474,\n",
              " 475,\n",
              " 476,\n",
              " 477,\n",
              " 478,\n",
              " 479,\n",
              " 480,\n",
              " 481,\n",
              " 482,\n",
              " 483,\n",
              " 484,\n",
              " 485,\n",
              " 486,\n",
              " 487,\n",
              " 488,\n",
              " 489,\n",
              " 490,\n",
              " 491,\n",
              " 492,\n",
              " 493,\n",
              " 494,\n",
              " 495,\n",
              " 496,\n",
              " 497,\n",
              " 498,\n",
              " 499,\n",
              " 500,\n",
              " 501,\n",
              " 502,\n",
              " 503,\n",
              " 504,\n",
              " 505,\n",
              " 506,\n",
              " 507,\n",
              " 508,\n",
              " 509,\n",
              " 510,\n",
              " 511,\n",
              " 512,\n",
              " 513,\n",
              " 514,\n",
              " 515,\n",
              " 516,\n",
              " 517,\n",
              " 518,\n",
              " 519,\n",
              " 520,\n",
              " 521,\n",
              " 522,\n",
              " 523,\n",
              " 524,\n",
              " 525,\n",
              " 526,\n",
              " 527,\n",
              " 528,\n",
              " 529,\n",
              " 530,\n",
              " 531,\n",
              " 532,\n",
              " 533,\n",
              " 534,\n",
              " 535,\n",
              " 536,\n",
              " 537,\n",
              " 538,\n",
              " 539,\n",
              " 540,\n",
              " 541,\n",
              " 542,\n",
              " 543,\n",
              " 544,\n",
              " 545,\n",
              " 546,\n",
              " 547,\n",
              " 548,\n",
              " 549,\n",
              " 550,\n",
              " 551,\n",
              " 552,\n",
              " 553,\n",
              " 554,\n",
              " 555,\n",
              " 556,\n",
              " 557,\n",
              " 558,\n",
              " 559,\n",
              " 560,\n",
              " 561,\n",
              " 562,\n",
              " 563,\n",
              " 564,\n",
              " 565,\n",
              " 566,\n",
              " 567,\n",
              " 568,\n",
              " 569,\n",
              " 570,\n",
              " 571,\n",
              " 572,\n",
              " 573,\n",
              " 574,\n",
              " 575,\n",
              " 576,\n",
              " 577,\n",
              " 578,\n",
              " 579,\n",
              " 580,\n",
              " 581,\n",
              " 582,\n",
              " 583,\n",
              " 584,\n",
              " 585,\n",
              " 586,\n",
              " 587,\n",
              " 588,\n",
              " 589,\n",
              " 590,\n",
              " 591,\n",
              " 592,\n",
              " 593,\n",
              " 594,\n",
              " 595,\n",
              " 596,\n",
              " 597,\n",
              " 598,\n",
              " 599,\n",
              " 600,\n",
              " 601,\n",
              " 602,\n",
              " 603,\n",
              " 604,\n",
              " 605,\n",
              " 606,\n",
              " 607,\n",
              " 608,\n",
              " 609,\n",
              " 610,\n",
              " 611,\n",
              " 612,\n",
              " 613,\n",
              " 614,\n",
              " 615,\n",
              " 616,\n",
              " 617,\n",
              " 618,\n",
              " 619,\n",
              " 620,\n",
              " 621,\n",
              " 622,\n",
              " 623,\n",
              " 624,\n",
              " 625,\n",
              " 626,\n",
              " 627,\n",
              " 628,\n",
              " 629,\n",
              " 630,\n",
              " 631,\n",
              " 632,\n",
              " 633,\n",
              " 634,\n",
              " 635,\n",
              " 636,\n",
              " 637,\n",
              " 638,\n",
              " 639,\n",
              " 640,\n",
              " 641,\n",
              " 642,\n",
              " 643,\n",
              " 644,\n",
              " 645,\n",
              " 646,\n",
              " 647,\n",
              " 648,\n",
              " 649,\n",
              " 650,\n",
              " 651,\n",
              " 652,\n",
              " 653,\n",
              " 654,\n",
              " 655,\n",
              " 656,\n",
              " 657,\n",
              " 658,\n",
              " 659,\n",
              " 660,\n",
              " 661,\n",
              " 662,\n",
              " 663,\n",
              " 664,\n",
              " 665,\n",
              " 666,\n",
              " 667,\n",
              " 668,\n",
              " 669,\n",
              " 670,\n",
              " 671,\n",
              " 672,\n",
              " 673,\n",
              " 674,\n",
              " 675,\n",
              " 676,\n",
              " 677,\n",
              " 678,\n",
              " 679,\n",
              " 680,\n",
              " 681,\n",
              " 682,\n",
              " 683,\n",
              " 684,\n",
              " 685,\n",
              " 686,\n",
              " 687,\n",
              " 688,\n",
              " 689,\n",
              " 690,\n",
              " 691,\n",
              " 692,\n",
              " 693,\n",
              " 694,\n",
              " 695,\n",
              " 696,\n",
              " 697,\n",
              " 698,\n",
              " 699,\n",
              " 700,\n",
              " 701,\n",
              " 702,\n",
              " 703,\n",
              " 704,\n",
              " 705,\n",
              " 706,\n",
              " 707,\n",
              " 708,\n",
              " 709,\n",
              " 710,\n",
              " 711,\n",
              " 712,\n",
              " 713,\n",
              " 714,\n",
              " 715,\n",
              " 716,\n",
              " 717,\n",
              " 718,\n",
              " 719,\n",
              " 720,\n",
              " 721,\n",
              " 722,\n",
              " 723,\n",
              " 725,\n",
              " 726,\n",
              " 727,\n",
              " 728,\n",
              " 729,\n",
              " 730,\n",
              " 731,\n",
              " 732,\n",
              " 733,\n",
              " 734,\n",
              " 735,\n",
              " 736,\n",
              " 737,\n",
              " 738,\n",
              " 739,\n",
              " 740,\n",
              " 741,\n",
              " 742,\n",
              " 743,\n",
              " 744,\n",
              " 745,\n",
              " 746,\n",
              " 747,\n",
              " 748,\n",
              " 749,\n",
              " 750,\n",
              " 751,\n",
              " 752,\n",
              " 753,\n",
              " 754,\n",
              " 755,\n",
              " 756,\n",
              " 757,\n",
              " 758,\n",
              " 759,\n",
              " 760,\n",
              " 761,\n",
              " 762,\n",
              " 763,\n",
              " 764,\n",
              " 765,\n",
              " 766,\n",
              " 767,\n",
              " 768,\n",
              " 769,\n",
              " 770,\n",
              " 771,\n",
              " 772,\n",
              " 773,\n",
              " 774,\n",
              " 775,\n",
              " 776,\n",
              " 777,\n",
              " 778,\n",
              " 779,\n",
              " 780,\n",
              " 781,\n",
              " 782,\n",
              " 783,\n",
              " 784,\n",
              " 785,\n",
              " 786,\n",
              " 788,\n",
              " 789,\n",
              " 790,\n",
              " 791,\n",
              " 792,\n",
              " 794,\n",
              " 795,\n",
              " 796,\n",
              " 797,\n",
              " 798,\n",
              " 799,\n",
              " 800,\n",
              " 801,\n",
              " 802,\n",
              " 803,\n",
              " 804,\n",
              " 805,\n",
              " 806,\n",
              " 807,\n",
              " 808,\n",
              " 809,\n",
              " 810,\n",
              " 811,\n",
              " 812,\n",
              " 813,\n",
              " 814,\n",
              " 815,\n",
              " 816,\n",
              " 817,\n",
              " 818,\n",
              " 819,\n",
              " 820,\n",
              " 821,\n",
              " 822,\n",
              " 823,\n",
              " 824,\n",
              " 825,\n",
              " 826,\n",
              " 827,\n",
              " 828,\n",
              " 829,\n",
              " 830,\n",
              " 831,\n",
              " 832,\n",
              " 833,\n",
              " 834,\n",
              " 835,\n",
              " 836,\n",
              " 837,\n",
              " 838,\n",
              " 839,\n",
              " 840,\n",
              " 841,\n",
              " 842,\n",
              " 843,\n",
              " 844,\n",
              " 845,\n",
              " 846,\n",
              " 847,\n",
              " 848,\n",
              " 849,\n",
              " 850,\n",
              " 851,\n",
              " 852,\n",
              " 854,\n",
              " 856,\n",
              " 857,\n",
              " 858,\n",
              " 859,\n",
              " 860,\n",
              " 861,\n",
              " 862,\n",
              " 863,\n",
              " 864,\n",
              " 865,\n",
              " 866,\n",
              " 867,\n",
              " 868,\n",
              " 869,\n",
              " 870,\n",
              " 871,\n",
              " 872,\n",
              " 873,\n",
              " 874,\n",
              " 875,\n",
              " 876,\n",
              " 877,\n",
              " 878,\n",
              " 879,\n",
              " 880,\n",
              " 882,\n",
              " 883,\n",
              " 884,\n",
              " 885,\n",
              " 886,\n",
              " 887,\n",
              " 888,\n",
              " 889,\n",
              " 890,\n",
              " 891,\n",
              " 892,\n",
              " 893,\n",
              " 894,\n",
              " 895,\n",
              " 896,\n",
              " 897,\n",
              " 898,\n",
              " 899,\n",
              " 900,\n",
              " 901,\n",
              " 902,\n",
              " 903,\n",
              " 904,\n",
              " 905,\n",
              " 906,\n",
              " 908,\n",
              " 909,\n",
              " 910,\n",
              " 911,\n",
              " 912,\n",
              " 914,\n",
              " 915,\n",
              " 916,\n",
              " 917,\n",
              " 918,\n",
              " 919,\n",
              " 920,\n",
              " 921,\n",
              " 922,\n",
              " 923,\n",
              " 924,\n",
              " 925,\n",
              " 926,\n",
              " 927,\n",
              " 928,\n",
              " 929,\n",
              " 930,\n",
              " 931,\n",
              " 932,\n",
              " 933,\n",
              " 934,\n",
              " 935,\n",
              " 936,\n",
              " 937,\n",
              " 938,\n",
              " 939,\n",
              " 940,\n",
              " 941,\n",
              " 942,\n",
              " 943,\n",
              " 944,\n",
              " 945,\n",
              " 946,\n",
              " 947,\n",
              " 948,\n",
              " 949,\n",
              " 950,\n",
              " 951,\n",
              " 952,\n",
              " 953,\n",
              " 954,\n",
              " 955,\n",
              " 956,\n",
              " 957,\n",
              " 958,\n",
              " 959,\n",
              " 960,\n",
              " 961,\n",
              " 962,\n",
              " 963,\n",
              " 964,\n",
              " 965,\n",
              " 966,\n",
              " 967,\n",
              " 968,\n",
              " 969,\n",
              " 970,\n",
              " 971,\n",
              " 972,\n",
              " 973,\n",
              " 974,\n",
              " 975,\n",
              " 976,\n",
              " 977,\n",
              " 978,\n",
              " 979,\n",
              " 980,\n",
              " 981,\n",
              " 982,\n",
              " 983,\n",
              " 984,\n",
              " 985,\n",
              " 986,\n",
              " 987,\n",
              " 988,\n",
              " 989,\n",
              " 990,\n",
              " 991,\n",
              " 992,\n",
              " 994,\n",
              " 995,\n",
              " 996,\n",
              " 997,\n",
              " 999,\n",
              " 1000,\n",
              " 1001,\n",
              " 1002,\n",
              " 1003,\n",
              " 1004,\n",
              " 1005,\n",
              " 1006,\n",
              " 1007,\n",
              " 1008,\n",
              " 1009,\n",
              " 1010,\n",
              " 1012,\n",
              " 1013,\n",
              " 1014,\n",
              " 1015,\n",
              " 1016,\n",
              " ...]"
            ]
          },
          "metadata": {},
          "execution_count": 95
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#txt"
      ],
      "metadata": {
        "id": "mbAVUEHnbFFL",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "fa17fb3b-ed1e-4729-a502-7ef097a1d4a8"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(type(txt))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "qUEXbtbaaZQL",
        "outputId": "ca011050-c016-43f6-d376-ca7acd2e5a52"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<class 'list'>\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "import nltk\n",
        "from nltk.corpus import stopwords\n",
        "from wordcloud import WordCloud, STOPWORDS\n",
        "\n",
        "# Assume df is your original DataFrame\n",
        "# Remove rows where either 'Abstract' or 'Title' is null\n",
        "df = df.dropna(subset=['Abstract', 'Title'])\n",
        "\n",
        "# Generate the data list combining 'Title' and 'Abstract'\n",
        "data = [str(df['Title'].iloc[i]) + str(df['Abstract'].iloc[i]) for i in range(len(df))]\n",
        "\n",
        "## Download necessary NLTK resources\n",
        "#nltk.download('wordnet')\n",
        "#nltk.download('stopwords')\n",
        "\n",
        "## Generate a list of stopwords\n",
        "#s = set(STOPWORDS)\n",
        "#sw = set(stopwords.words('english'))\n",
        "#sw |= s\n",
        "#sw.add('amp')\n",
        "\n",
        "# Initialize a list to store cleaned texts\n",
        "cleaned_texts = []\n",
        "\n",
        "# Text preprocessing\n",
        "for text in data:\n",
        "    words = text.lower().split()\n",
        "    cleaned_words = [word for word in words if word not in sw]\n",
        "    cleaned_text = ' '.join(cleaned_words)\n",
        "    cleaned_texts.append(cleaned_text)\n",
        "\n",
        "# Add the cleaned texts back to the original DataFrame\n",
        "df['Cleaned_Text'] = cleaned_texts\n",
        "len(df)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "SZrOjwN1VKti",
        "outputId": "4f7d4998-a8b1-450c-eb4f-4719d70472cc"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "3378"
            ]
          },
          "metadata": {},
          "execution_count": 98
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Drop rows where 'Cleaned_Text' is null\n",
        "df_filtered = df.dropna(subset=['Cleaned_Text'])\n",
        "\n",
        "# Keep only the rows with unique 'Cleaned_Text'\n",
        "df_filtered = df_filtered.drop_duplicates(subset=['Cleaned_Text'])\n",
        "df_filtered"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "aTZ_q8UqVMaG",
        "outputId": "8c5060b4-4ced-4352-c566-de7e680c7bb2"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                         # Jurisdiction Kind  \\\n",
              "Lens ID             Publication Year                           \n",
              "197-733-628-711-768 2021                 1           TW    A   \n",
              "023-616-950-865-48X 2022                 2           WO   A1   \n",
              "094-569-953-648-612 2021                 3           CN    A   \n",
              "143-969-408-220-424 2021                 4           CN    A   \n",
              "194-887-353-832-386 2019                 5           WO   A8   \n",
              "...                                    ...          ...  ...   \n",
              "042-723-456-628-924 2023              3433           US   A1   \n",
              "166-510-410-954-06X 2023              3436           WO   A1   \n",
              "120-354-976-671-738 2021              3437           AU   A4   \n",
              "183-320-641-365-157 2020              3438           WO   A1   \n",
              "085-567-628-784-332 2021              3439           WO   A1   \n",
              "\n",
              "                                             Display Key Publication Date  \\\n",
              "Lens ID             Publication Year                                        \n",
              "197-733-628-711-768 2021                  TW 202114659 A       2021-04-16   \n",
              "023-616-950-865-48X 2022               WO 2022/056572 A1       2022-03-24   \n",
              "094-569-953-648-612 2021                  CN 112512579 A       2021-03-16   \n",
              "143-969-408-220-424 2021                  CN 112512580 A       2021-03-16   \n",
              "194-887-353-832-386 2019               WO 2019/156568 A8       2019-10-03   \n",
              "...                                                  ...              ...   \n",
              "042-723-456-628-924 2023              US 2023/0070723 A1       2023-03-09   \n",
              "166-510-410-954-06X 2023               WO 2023/224912 A1       2023-11-23   \n",
              "120-354-976-671-738 2021               AU 2021/102091 A4       2021-06-10   \n",
              "183-320-641-365-157 2020               WO 2020/163222 A1       2020-08-13   \n",
              "085-567-628-784-332 2021               WO 2021/122745 A1       2021-06-24   \n",
              "\n",
              "                                     Application Number Application Date  \\\n",
              "Lens ID             Publication Year                                       \n",
              "197-733-628-711-768 2021                 TW 109133847 A       2020-09-29   \n",
              "023-616-950-865-48X 2022               AU 2020/050994 W       2020-09-18   \n",
              "094-569-953-648-612 2021              CN 201980049832 A       2019-09-27   \n",
              "143-969-408-220-424 2021              CN 201980049896 A       2019-09-27   \n",
              "194-887-353-832-386 2019                NL 2019050092 W       2019-02-12   \n",
              "...                                                 ...              ...   \n",
              "042-723-456-628-924 2023              US 202217819401 A       2022-08-12   \n",
              "166-510-410-954-06X 2023              US 2023/0022243 W       2023-05-15   \n",
              "120-354-976-671-738 2021               AU 2021/102091 A       2021-04-20   \n",
              "183-320-641-365-157 2020              US 2020/0016375 W       2020-02-03   \n",
              "085-567-628-784-332 2021                EP 2020086419 W       2020-12-16   \n",
              "\n",
              "                                                                       Priority Numbers  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                  EP 19201152 A   \n",
              "023-616-950-865-48X 2022                                               AU 2020/050994 W   \n",
              "094-569-953-648-612 2021              CN 201811147946 A;;CN 201910467950 A;;CN 20191...   \n",
              "143-969-408-220-424 2021              CN 201811149357 A;;CN 201811547685 A;;CN 20191...   \n",
              "194-887-353-832-386 2019                                                   NL 2020422 A   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                           US 202217819401 A;;US 202163232966 P   \n",
              "166-510-410-954-06X 2023                                              US 202263342548 P   \n",
              "120-354-976-671-738 2021                                               AU 2021/102091 A   \n",
              "183-320-641-365-157 2020                                              US 201962800972 P   \n",
              "085-567-628-784-332 2021                                                 GB 201918541 A   \n",
              "\n",
              "                                     Earliest Priority Date  \\\n",
              "Lens ID             Publication Year                          \n",
              "197-733-628-711-768 2021                         2019-10-02   \n",
              "023-616-950-865-48X 2022                         2020-09-18   \n",
              "094-569-953-648-612 2021                         2018-09-29   \n",
              "143-969-408-220-424 2021                         2018-09-29   \n",
              "194-887-353-832-386 2019                         2018-02-12   \n",
              "...                                                     ...   \n",
              "042-723-456-628-924 2023                         2021-08-13   \n",
              "166-510-410-954-06X 2023                         2022-05-16   \n",
              "120-354-976-671-738 2021                         2021-04-20   \n",
              "183-320-641-365-157 2020                         2019-02-04   \n",
              "085-567-628-784-332 2021                         2019-12-16   \n",
              "\n",
              "                                                                                  Title  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              Combination comprising HDAC inhibitor, CTLA-4 ...   \n",
              "023-616-950-865-48X 2022                                     TREATMENT OF SOLID TUMOURS   \n",
              "094-569-953-648-612 2021              USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...   \n",
              "143-969-408-220-424 2021              USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...   \n",
              "194-887-353-832-386 2019              METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                      COMBINATION THERAPY TO TREAT BRAIN CANCER   \n",
              "166-510-410-954-06X 2023              METHODS OF TREATING METASTATIC CASTRATION-RESI...   \n",
              "120-354-976-671-738 2021              A METHOD FOR CONFIRMING CONSTITUTIONAL MISMATC...   \n",
              "183-320-641-365-157 2020              NUCLEIC ACID SEQUENCE ENCODING CHIMERIC ANTIGE...   \n",
              "085-567-628-784-332 2021              4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMIN...   \n",
              "\n",
              "                                                                               Abstract  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              The invention relates to medical uses of an HD...   \n",
              "023-616-950-865-48X 2022              The present invention relates to a method for ...   \n",
              "094-569-953-648-612 2021              Use of a combination of a TLR agonist and an i...   \n",
              "143-969-408-220-424 2021              Disclosed is the use of an EZH2 inhibitor in c...   \n",
              "194-887-353-832-386 2019              The present invention relates to the field of ...   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023              Provided herein are methods of treating brain ...   \n",
              "166-510-410-954-06X 2023              The present disclosure provides methods for tr...   \n",
              "120-354-976-671-738 2021              The present disclosure relates to a method for...   \n",
              "183-320-641-365-157 2020              The present invention is directed to a nucleic...   \n",
              "085-567-628-784-332 2021              The present invention pertains generally to th...   \n",
              "\n",
              "                                                                             Applicants  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                         4SC AG   \n",
              "023-616-950-865-48X 2022                        OLIVIA NEWTON JOHN CANCER RES INSTITUTE   \n",
              "094-569-953-648-612 2021              JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "143-969-408-220-424 2021              JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "194-887-353-832-386 2019              STICHTING HET NEDERLANDS KANKER INST ANTONI VA...   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                   INOVIO PHARMACEUTICALS INC;;REGENERON PHARMA   \n",
              "166-510-410-954-06X 2023                                               REGENERON PHARMA   \n",
              "120-354-976-671-738 2021                         CHAKRABORTY SARIT;;PAUL CHANDRAMALLIKA   \n",
              "183-320-641-365-157 2020              PROMAB BIOTECHNOLOGIES INC;;FOREVERTEK BIOTECH...   \n",
              "085-567-628-784-332 2021                                       CARRICK THERAPEUTICS LTD   \n",
              "\n",
              "                                                                              Inventors  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                   HAMM SVETLANA;;HERMANN FRANK   \n",
              "023-616-950-865-48X 2022              POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER   \n",
              "094-569-953-648-612 2021              JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...   \n",
              "143-969-408-220-424 2021              ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...   \n",
              "194-887-353-832-386 2019              SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023              BREDLAU AMY-LEE;;LOWY ISRAEL;;SKOLNIK JEFFREY;...   \n",
              "166-510-410-954-06X 2023              MILLER ELIZABETH;;SANDIGURSKY SABINA;;LOWY ISR...   \n",
              "120-354-976-671-738 2021                         PAUL CHANDRAMALLIKA;;CHAKRABORTY SARIT   \n",
              "183-320-641-365-157 2020                                    WU LIJUN;;GOLUBOVSKAYA VITA   \n",
              "085-567-628-784-332 2021              AINSCOW EDWARD;;BAHL ASHWANI;;SUNOSE MIHIRO;;C...   \n",
              "\n",
              "                                     Owners  \\\n",
              "Lens ID             Publication Year          \n",
              "197-733-628-711-768 2021                NaN   \n",
              "023-616-950-865-48X 2022                NaN   \n",
              "094-569-953-648-612 2021                NaN   \n",
              "143-969-408-220-424 2021                NaN   \n",
              "194-887-353-832-386 2019                NaN   \n",
              "...                                     ...   \n",
              "042-723-456-628-924 2023                NaN   \n",
              "166-510-410-954-06X 2023                NaN   \n",
              "120-354-976-671-738 2021                NaN   \n",
              "183-320-641-365-157 2020                NaN   \n",
              "085-567-628-784-332 2021                NaN   \n",
              "\n",
              "                                                                       URL  \\\n",
              "Lens ID             Publication Year                                         \n",
              "197-733-628-711-768 2021              https://lens.org/197-733-628-711-768   \n",
              "023-616-950-865-48X 2022              https://lens.org/023-616-950-865-48X   \n",
              "094-569-953-648-612 2021              https://lens.org/094-569-953-648-612   \n",
              "143-969-408-220-424 2021              https://lens.org/143-969-408-220-424   \n",
              "194-887-353-832-386 2019              https://lens.org/194-887-353-832-386   \n",
              "...                                                                    ...   \n",
              "042-723-456-628-924 2023              https://lens.org/042-723-456-628-924   \n",
              "166-510-410-954-06X 2023              https://lens.org/166-510-410-954-06X   \n",
              "120-354-976-671-738 2021              https://lens.org/120-354-976-671-738   \n",
              "183-320-641-365-157 2020              https://lens.org/183-320-641-365-157   \n",
              "085-567-628-784-332 2021              https://lens.org/085-567-628-784-332   \n",
              "\n",
              "                                            Document Type Has Full Text  \\\n",
              "Lens ID             Publication Year                                      \n",
              "197-733-628-711-768 2021               Patent of Addition            no   \n",
              "023-616-950-865-48X 2022               Patent Application           yes   \n",
              "094-569-953-648-612 2021               Patent Application            no   \n",
              "143-969-408-220-424 2021               Patent Application            no   \n",
              "194-887-353-832-386 2019              Amended Application           yes   \n",
              "...                                                   ...           ...   \n",
              "042-723-456-628-924 2023               Patent Application           yes   \n",
              "166-510-410-954-06X 2023               Patent Application           yes   \n",
              "120-354-976-671-738 2021                   Limited Patent            no   \n",
              "183-320-641-365-157 2020               Patent Application           yes   \n",
              "085-567-628-784-332 2021               Patent Application           yes   \n",
              "\n",
              "                                      Cites Patent Count  \\\n",
              "Lens ID             Publication Year                       \n",
              "197-733-628-711-768 2021                               0   \n",
              "023-616-950-865-48X 2022                               3   \n",
              "094-569-953-648-612 2021                               3   \n",
              "143-969-408-220-424 2021                               2   \n",
              "194-887-353-832-386 2019                               0   \n",
              "...                                                  ...   \n",
              "042-723-456-628-924 2023                               0   \n",
              "166-510-410-954-06X 2023                              19   \n",
              "120-354-976-671-738 2021                               0   \n",
              "183-320-641-365-157 2020                               6   \n",
              "085-567-628-784-332 2021                              10   \n",
              "\n",
              "                                      Cited by Patent Count  \\\n",
              "Lens ID             Publication Year                          \n",
              "197-733-628-711-768 2021                                  0   \n",
              "023-616-950-865-48X 2022                                  0   \n",
              "094-569-953-648-612 2021                                  0   \n",
              "143-969-408-220-424 2021                                  1   \n",
              "194-887-353-832-386 2019                                  0   \n",
              "...                                                     ...   \n",
              "042-723-456-628-924 2023                                  0   \n",
              "166-510-410-954-06X 2023                                  0   \n",
              "120-354-976-671-738 2021                                  0   \n",
              "183-320-641-365-157 2020                                  3   \n",
              "085-567-628-784-332 2021                                  1   \n",
              "\n",
              "                                      Simple Family Size  \\\n",
              "Lens ID             Publication Year                       \n",
              "197-733-628-711-768 2021                               2   \n",
              "023-616-950-865-48X 2022                               1   \n",
              "094-569-953-648-612 2021                               3   \n",
              "143-969-408-220-424 2021                               3   \n",
              "194-887-353-832-386 2019                               3   \n",
              "...                                                  ...   \n",
              "042-723-456-628-924 2023                               3   \n",
              "166-510-410-954-06X 2023                               1   \n",
              "120-354-976-671-738 2021                               1   \n",
              "183-320-641-365-157 2020                               2   \n",
              "085-567-628-784-332 2021                               8   \n",
              "\n",
              "                                      Extended Family Size  Sequence Count  \\\n",
              "Lens ID             Publication Year                                         \n",
              "197-733-628-711-768 2021                                 2               0   \n",
              "023-616-950-865-48X 2022                                 2               0   \n",
              "094-569-953-648-612 2021                                 3               0   \n",
              "143-969-408-220-424 2021                                 3               0   \n",
              "194-887-353-832-386 2019                                 3               0   \n",
              "...                                                    ...             ...   \n",
              "042-723-456-628-924 2023                                 3               0   \n",
              "166-510-410-954-06X 2023                                 1              28   \n",
              "120-354-976-671-738 2021                                 1               0   \n",
              "183-320-641-365-157 2020                                 2              46   \n",
              "085-567-628-784-332 2021                                 8               0   \n",
              "\n",
              "                                                                    CPC Classifications  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                              A61K45/06;;A61P35/00;;A61K31/4155   \n",
              "023-616-950-865-48X 2022              A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...   \n",
              "094-569-953-648-612 2021                  A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04   \n",
              "143-969-408-220-424 2021              A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...   \n",
              "194-887-353-832-386 2019                                   G01N33/57423;;G01N2333/70532   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023              C07K16/2818;;A61K39/001195;;A61K39/001157;;A61...   \n",
              "166-510-410-954-06X 2023              C07K16/3069;;C07K16/2809;;C07K2317/31;;C07K231...   \n",
              "120-354-976-671-738 2021              C12Q1/6827;;C12Q2600/118;;C12Q2600/106;;C12Q26...   \n",
              "183-320-641-365-157 2020              A61K31/713;;A61K35/17;;A61K39/001112;;A61K2039...   \n",
              "085-567-628-784-332 2021              C07D487/04;;C07D519/00;;A61K31/138;;A61K31/167...   \n",
              "\n",
              "                                                                   IPCR Classifications  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                  A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00   \n",
              "023-616-950-865-48X 2022              A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...   \n",
              "094-569-953-648-612 2021                  A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04   \n",
              "143-969-408-220-424 2021              A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...   \n",
              "194-887-353-832-386 2019                                                     G01N33/574   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023              A61K31/495;;A61K38/20;;A61K39/00;;A61K39/395;;...   \n",
              "166-510-410-954-06X 2023                                A61P35/00;;C07K16/28;;C07K16/30   \n",
              "120-354-976-671-738 2021                             C12Q1/6827;;C12Q1/6886;;G01N33/574   \n",
              "183-320-641-365-157 2020              A61K31/713;;A61K35/17;;C07H21/02;;C07K16/28;;C...   \n",
              "085-567-628-784-332 2021                  C07D487/04;;A61K31/519;;A61P35/00;;C07D519/00   \n",
              "\n",
              "                                     US Classifications  NPL Citation Count  \\\n",
              "Lens ID             Publication Year                                          \n",
              "197-733-628-711-768 2021                            NaN                   0   \n",
              "023-616-950-865-48X 2022                            NaN                   2   \n",
              "094-569-953-648-612 2021                            NaN                   0   \n",
              "143-969-408-220-424 2021                            NaN                   0   \n",
              "194-887-353-832-386 2019                            NaN                   0   \n",
              "...                                                 ...                 ...   \n",
              "042-723-456-628-924 2023                            NaN                   0   \n",
              "166-510-410-954-06X 2023                            NaN                  10   \n",
              "120-354-976-671-738 2021                            NaN                   0   \n",
              "183-320-641-365-157 2020                            NaN                   0   \n",
              "085-567-628-784-332 2021                            NaN                  26   \n",
              "\n",
              "                                      NPL Resolved Citation Count  \\\n",
              "Lens ID             Publication Year                                \n",
              "197-733-628-711-768 2021                                        0   \n",
              "023-616-950-865-48X 2022                                        2   \n",
              "094-569-953-648-612 2021                                        0   \n",
              "143-969-408-220-424 2021                                        0   \n",
              "194-887-353-832-386 2019                                        0   \n",
              "...                                                           ...   \n",
              "042-723-456-628-924 2023                                        0   \n",
              "166-510-410-954-06X 2023                                        6   \n",
              "120-354-976-671-738 2021                                        0   \n",
              "183-320-641-365-157 2020                                        0   \n",
              "085-567-628-784-332 2021                                       24   \n",
              "\n",
              "                                                                NPL Resolved Lens ID(s)  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022                       011-457-792-548-92X;;048-229-382-653-004   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                                                            NaN   \n",
              "166-510-410-954-06X 2023              018-820-995-716-872;;103-897-301-868-65X;;071-...   \n",
              "120-354-976-671-738 2021                                                            NaN   \n",
              "183-320-641-365-157 2020                                                            NaN   \n",
              "085-567-628-784-332 2021              007-364-858-655-289;;001-057-233-129-619;;014-...   \n",
              "\n",
              "                                                            NPL Resolved External ID(s)  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022              29955905;;10.1007/s00018-018-2863-3;;pmc638240...   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                                                            NaN   \n",
              "166-510-410-954-06X 2023              10.1158/1078-0432.ccr-20-3725;;33504551;;25482...   \n",
              "120-354-976-671-738 2021                                                            NaN   \n",
              "183-320-641-365-157 2020                                                            NaN   \n",
              "085-567-628-784-332 2021              10.1002/jps.2600660104;;833720;;pmc1430317;;16...   \n",
              "\n",
              "                                                                          NPL Citations  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022              YU, G.-T. ET AL.: \"Inhibition of SRC family ki...   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "...                                                                                 ...   \n",
              "042-723-456-628-924 2023                                                            NaN   \n",
              "166-510-410-954-06X 2023              DEEGEN PETRA ET AL: \"The PSMA-targeting Half-l...   \n",
              "120-354-976-671-738 2021                                                            NaN   \n",
              "183-320-641-365-157 2020                                                            NaN   \n",
              "085-567-628-784-332 2021              BERGE ET AL.: \"Pharmaceutically Acceptable Sal...   \n",
              "\n",
              "                                     Legal Status  \\\n",
              "Lens ID             Publication Year                \n",
              "197-733-628-711-768 2021                  PENDING   \n",
              "023-616-950-865-48X 2022                  PENDING   \n",
              "094-569-953-648-612 2021                  PENDING   \n",
              "143-969-408-220-424 2021                  PENDING   \n",
              "194-887-353-832-386 2019                  PENDING   \n",
              "...                                           ...   \n",
              "042-723-456-628-924 2023                  PENDING   \n",
              "166-510-410-954-06X 2023                  PENDING   \n",
              "120-354-976-671-738 2021                 INACTIVE   \n",
              "183-320-641-365-157 2020                  PENDING   \n",
              "085-567-628-784-332 2021                  PENDING   \n",
              "\n",
              "                                                                           Cleaned_Text  \n",
              "Lens ID             Publication Year                                                     \n",
              "197-733-628-711-768 2021              combination comprising hdac inhibitor, ctla-4 ...  \n",
              "023-616-950-865-48X 2022              treatment solid tumoursthe present invention r...  \n",
              "094-569-953-648-612 2021              combination tlr agonist immune checkpoint inhi...  \n",
              "143-969-408-220-424 2021              ezh2 inhibitor combination immune checkpoint i...  \n",
              "194-887-353-832-386 2019              methods predicting treatment outcome and/or se...  \n",
              "...                                                                                 ...  \n",
              "042-723-456-628-924 2023              combination therapy treat brain cancerprovided...  \n",
              "166-510-410-954-06X 2023              methods treating metastatic castration-resista...  \n",
              "120-354-976-671-738 2021              method confirming constitutional mismatch repa...  \n",
              "183-320-641-365-157 2020              nucleic acid sequence encoding chimeric antige...  \n",
              "085-567-628-784-332 2021              4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amin...  \n",
              "\n",
              "[3320 rows x 32 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-5a47968a-4229-4d6e-815c-59c0691d96cc\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th>#</th>\n",
              "      <th>Jurisdiction</th>\n",
              "      <th>Kind</th>\n",
              "      <th>Display Key</th>\n",
              "      <th>Publication Date</th>\n",
              "      <th>Application Number</th>\n",
              "      <th>Application Date</th>\n",
              "      <th>Priority Numbers</th>\n",
              "      <th>Earliest Priority Date</th>\n",
              "      <th>Title</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Applicants</th>\n",
              "      <th>Inventors</th>\n",
              "      <th>Owners</th>\n",
              "      <th>URL</th>\n",
              "      <th>Document Type</th>\n",
              "      <th>Has Full Text</th>\n",
              "      <th>Cites Patent Count</th>\n",
              "      <th>Cited by Patent Count</th>\n",
              "      <th>Simple Family Size</th>\n",
              "      <th>Extended Family Size</th>\n",
              "      <th>Sequence Count</th>\n",
              "      <th>CPC Classifications</th>\n",
              "      <th>IPCR Classifications</th>\n",
              "      <th>US Classifications</th>\n",
              "      <th>NPL Citation Count</th>\n",
              "      <th>NPL Resolved Citation Count</th>\n",
              "      <th>NPL Resolved Lens ID(s)</th>\n",
              "      <th>NPL Resolved External ID(s)</th>\n",
              "      <th>NPL Citations</th>\n",
              "      <th>Legal Status</th>\n",
              "      <th>Cleaned_Text</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Lens ID</th>\n",
              "      <th>Publication Year</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>197-733-628-711-768</th>\n",
              "      <th>2021</th>\n",
              "      <td>1</td>\n",
              "      <td>TW</td>\n",
              "      <td>A</td>\n",
              "      <td>TW 202114659 A</td>\n",
              "      <td>2021-04-16</td>\n",
              "      <td>TW 109133847 A</td>\n",
              "      <td>2020-09-29</td>\n",
              "      <td>EP 19201152 A</td>\n",
              "      <td>2019-10-02</td>\n",
              "      <td>Combination comprising HDAC inhibitor, CTLA-4 ...</td>\n",
              "      <td>The invention relates to medical uses of an HD...</td>\n",
              "      <td>4SC AG</td>\n",
              "      <td>HAMM SVETLANA;;HERMANN FRANK</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/197-733-628-711-768</td>\n",
              "      <td>Patent of Addition</td>\n",
              "      <td>no</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K45/06;;A61P35/00;;A61K31/4155</td>\n",
              "      <td>A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>combination comprising hdac inhibitor, ctla-4 ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>023-616-950-865-48X</th>\n",
              "      <th>2022</th>\n",
              "      <td>2</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2022/056572 A1</td>\n",
              "      <td>2022-03-24</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>TREATMENT OF SOLID TUMOURS</td>\n",
              "      <td>The present invention relates to a method for ...</td>\n",
              "      <td>OLIVIA NEWTON JOHN CANCER RES INSTITUTE</td>\n",
              "      <td>POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/023-616-950-865-48X</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...</td>\n",
              "      <td>A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>011-457-792-548-92X;;048-229-382-653-004</td>\n",
              "      <td>29955905;;10.1007/s00018-018-2863-3;;pmc638240...</td>\n",
              "      <td>YU, G.-T. ET AL.: \"Inhibition of SRC family ki...</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>treatment solid tumoursthe present invention r...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>094-569-953-648-612</th>\n",
              "      <th>2021</th>\n",
              "      <td>3</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512579 A</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>CN 201980049832 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811147946 A;;CN 201910467950 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...</td>\n",
              "      <td>Use of a combination of a TLR agonist and an i...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/094-569-953-648-612</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04</td>\n",
              "      <td>A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>combination tlr agonist immune checkpoint inhi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143-969-408-220-424</th>\n",
              "      <th>2021</th>\n",
              "      <td>4</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512580 A</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>CN 201980049896 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811149357 A;;CN 201811547685 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...</td>\n",
              "      <td>Disclosed is the use of an EZH2 inhibitor in c...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/143-969-408-220-424</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...</td>\n",
              "      <td>A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>ezh2 inhibitor combination immune checkpoint i...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>194-887-353-832-386</th>\n",
              "      <th>2019</th>\n",
              "      <td>5</td>\n",
              "      <td>WO</td>\n",
              "      <td>A8</td>\n",
              "      <td>WO 2019/156568 A8</td>\n",
              "      <td>2019-10-03</td>\n",
              "      <td>NL 2019050092 W</td>\n",
              "      <td>2019-02-12</td>\n",
              "      <td>NL 2020422 A</td>\n",
              "      <td>2018-02-12</td>\n",
              "      <td>METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...</td>\n",
              "      <td>The present invention relates to the field of ...</td>\n",
              "      <td>STICHTING HET NEDERLANDS KANKER INST ANTONI VA...</td>\n",
              "      <td>SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/194-887-353-832-386</td>\n",
              "      <td>Amended Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>G01N33/57423;;G01N2333/70532</td>\n",
              "      <td>G01N33/574</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>methods predicting treatment outcome and/or se...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>042-723-456-628-924</th>\n",
              "      <th>2023</th>\n",
              "      <td>3433</td>\n",
              "      <td>US</td>\n",
              "      <td>A1</td>\n",
              "      <td>US 2023/0070723 A1</td>\n",
              "      <td>2023-03-09</td>\n",
              "      <td>US 202217819401 A</td>\n",
              "      <td>2022-08-12</td>\n",
              "      <td>US 202217819401 A;;US 202163232966 P</td>\n",
              "      <td>2021-08-13</td>\n",
              "      <td>COMBINATION THERAPY TO TREAT BRAIN CANCER</td>\n",
              "      <td>Provided herein are methods of treating brain ...</td>\n",
              "      <td>INOVIO PHARMACEUTICALS INC;;REGENERON PHARMA</td>\n",
              "      <td>BREDLAU AMY-LEE;;LOWY ISRAEL;;SKOLNIK JEFFREY;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/042-723-456-628-924</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>C07K16/2818;;A61K39/001195;;A61K39/001157;;A61...</td>\n",
              "      <td>A61K31/495;;A61K38/20;;A61K39/00;;A61K39/395;;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>combination therapy treat brain cancerprovided...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>166-510-410-954-06X</th>\n",
              "      <th>2023</th>\n",
              "      <td>3436</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2023/224912 A1</td>\n",
              "      <td>2023-11-23</td>\n",
              "      <td>US 2023/0022243 W</td>\n",
              "      <td>2023-05-15</td>\n",
              "      <td>US 202263342548 P</td>\n",
              "      <td>2022-05-16</td>\n",
              "      <td>METHODS OF TREATING METASTATIC CASTRATION-RESI...</td>\n",
              "      <td>The present disclosure provides methods for tr...</td>\n",
              "      <td>REGENERON PHARMA</td>\n",
              "      <td>MILLER ELIZABETH;;SANDIGURSKY SABINA;;LOWY ISR...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/166-510-410-954-06X</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>19</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>28</td>\n",
              "      <td>C07K16/3069;;C07K16/2809;;C07K2317/31;;C07K231...</td>\n",
              "      <td>A61P35/00;;C07K16/28;;C07K16/30</td>\n",
              "      <td>NaN</td>\n",
              "      <td>10</td>\n",
              "      <td>6</td>\n",
              "      <td>018-820-995-716-872;;103-897-301-868-65X;;071-...</td>\n",
              "      <td>10.1158/1078-0432.ccr-20-3725;;33504551;;25482...</td>\n",
              "      <td>DEEGEN PETRA ET AL: \"The PSMA-targeting Half-l...</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>methods treating metastatic castration-resista...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>120-354-976-671-738</th>\n",
              "      <th>2021</th>\n",
              "      <td>3437</td>\n",
              "      <td>AU</td>\n",
              "      <td>A4</td>\n",
              "      <td>AU 2021/102091 A4</td>\n",
              "      <td>2021-06-10</td>\n",
              "      <td>AU 2021/102091 A</td>\n",
              "      <td>2021-04-20</td>\n",
              "      <td>AU 2021/102091 A</td>\n",
              "      <td>2021-04-20</td>\n",
              "      <td>A METHOD FOR CONFIRMING CONSTITUTIONAL MISMATC...</td>\n",
              "      <td>The present disclosure relates to a method for...</td>\n",
              "      <td>CHAKRABORTY SARIT;;PAUL CHANDRAMALLIKA</td>\n",
              "      <td>PAUL CHANDRAMALLIKA;;CHAKRABORTY SARIT</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/120-354-976-671-738</td>\n",
              "      <td>Limited Patent</td>\n",
              "      <td>no</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>C12Q1/6827;;C12Q2600/118;;C12Q2600/106;;C12Q26...</td>\n",
              "      <td>C12Q1/6827;;C12Q1/6886;;G01N33/574</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>INACTIVE</td>\n",
              "      <td>method confirming constitutional mismatch repa...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>183-320-641-365-157</th>\n",
              "      <th>2020</th>\n",
              "      <td>3438</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2020/163222 A1</td>\n",
              "      <td>2020-08-13</td>\n",
              "      <td>US 2020/0016375 W</td>\n",
              "      <td>2020-02-03</td>\n",
              "      <td>US 201962800972 P</td>\n",
              "      <td>2019-02-04</td>\n",
              "      <td>NUCLEIC ACID SEQUENCE ENCODING CHIMERIC ANTIGE...</td>\n",
              "      <td>The present invention is directed to a nucleic...</td>\n",
              "      <td>PROMAB BIOTECHNOLOGIES INC;;FOREVERTEK BIOTECH...</td>\n",
              "      <td>WU LIJUN;;GOLUBOVSKAYA VITA</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/183-320-641-365-157</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>6</td>\n",
              "      <td>3</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>46</td>\n",
              "      <td>A61K31/713;;A61K35/17;;A61K39/001112;;A61K2039...</td>\n",
              "      <td>A61K31/713;;A61K35/17;;C07H21/02;;C07K16/28;;C...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>nucleic acid sequence encoding chimeric antige...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>085-567-628-784-332</th>\n",
              "      <th>2021</th>\n",
              "      <td>3439</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2021/122745 A1</td>\n",
              "      <td>2021-06-24</td>\n",
              "      <td>EP 2020086419 W</td>\n",
              "      <td>2020-12-16</td>\n",
              "      <td>GB 201918541 A</td>\n",
              "      <td>2019-12-16</td>\n",
              "      <td>4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMIN...</td>\n",
              "      <td>The present invention pertains generally to th...</td>\n",
              "      <td>CARRICK THERAPEUTICS LTD</td>\n",
              "      <td>AINSCOW EDWARD;;BAHL ASHWANI;;SUNOSE MIHIRO;;C...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/085-567-628-784-332</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>10</td>\n",
              "      <td>1</td>\n",
              "      <td>8</td>\n",
              "      <td>8</td>\n",
              "      <td>0</td>\n",
              "      <td>C07D487/04;;C07D519/00;;A61K31/138;;A61K31/167...</td>\n",
              "      <td>C07D487/04;;A61K31/519;;A61P35/00;;C07D519/00</td>\n",
              "      <td>NaN</td>\n",
              "      <td>26</td>\n",
              "      <td>24</td>\n",
              "      <td>007-364-858-655-289;;001-057-233-129-619;;014-...</td>\n",
              "      <td>10.1002/jps.2600660104;;833720;;pmc1430317;;16...</td>\n",
              "      <td>BERGE ET AL.: \"Pharmaceutically Acceptable Sal...</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amin...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>3320 rows × 32 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-5a47968a-4229-4d6e-815c-59c0691d96cc')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-5a47968a-4229-4d6e-815c-59c0691d96cc button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-5a47968a-4229-4d6e-815c-59c0691d96cc');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-a733571a-2c79-4de4-8e53-e255eca603ef\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-a733571a-2c79-4de4-8e53-e255eca603ef')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-a733571a-2c79-4de4-8e53-e255eca603ef button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_70e1c1c4-a7a2-448c-926f-70a36ff45b06\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df_filtered')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_70e1c1c4-a7a2-448c-926f-70a36ff45b06 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df_filtered');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 99
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "8xYgoohpa7W8",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "376ae67f-b070-46a9-cfdf-29d918fe155f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "text = df['Cleaned_Text'].tolist()\n",
        "text"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MTJ6RbJHa7fM",
        "outputId": "944a55c6-df66-42db-82d2-1177fa21fd46"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['combination comprising hdac inhibitor, ctla-4 inhibitor pd-1 inhibitor pd-l1 inhibitor cancer treatmentthe invention relates medical hdac inhibitor general formula i, r1 r7 described herein, salt solvate thereof combination ctla-4 inhibitor pd-1 inhibitor pd-l1 inhibitor treatment cancer.',\n",
              " 'treatment solid tumoursthe present invention relates method treatment cancer, particular colorectal cancer (colon cancer), comprising administering effective amount dasatinib subject; administering effective amount immune checkpoint inhibitor subject. preferably immune checkpoint inhibitor selected group consisting pd-1 inhibitor, pd-l1 inhibitor ctla-4 inhibitor, pembrolizumab, nivolumab, cemiplimab, atezolizumab, avelumab, durvalumab ipilimumab.',\n",
              " 'combination tlr agonist immune checkpoint inhibitor preparation drugs treating tumorsuse combination tlr agonist immune checkpoint inhibitor preparation drugs treating tumors. specifically, tlr agonist compound formula (i) pharmacologicallyacceptable salt thereof, immune checkpoint inhibitor selected group consisting pd-1 inhibitor, pd-l1 inhibitor, ctla-4 inhibitor.',\n",
              " 'ezh2 inhibitor combination immune checkpoint inhibitor preparation treating tumorsdisclosed ezh2 inhibitor combination immune checkpoint inhibitor preparation treating tumors. particular, ezh2 inhibitor compound shownin formula (i) pharmaceutically acceptable salt thereof, immune checkpoint inhibitor selected pd-1 inhibitor, pd-l1 inhibitor ctla-4 inhibitor.',\n",
              " 'methods predicting treatment outcome and/or selecting subject suitable immune checkpoint therapythe present invention relates field biomarker development cancer immunotherapy pd-1 inhibitor compounds and/or pd-l1 inhibitor compounds. provided assays quantifying pd-1 expression (i.e. immunostaining intensity) cells present tumor sample (i.e. intratumoral cells), advantageously identify unique sub-population intratumoral cells referred pd-1 cells, serves biomarker cancer immunotherapy pd-1 inhibitor compounds and/or pd-l1 inhibitor compounds combination therapeutic agents (e.g. ctla-4 inhibitor compound, e.g. ipilimumab). present invention methods selecting human subject diagnosed cancer (e.g. non-small cell lung cancer (nsclc)) suitable immune checkpoint therapy agents pd-1 inhibitors (e.g. nivolumab) and/or pd-l1 inhibitors (e.g. atezolizumab) combination therapeutic agents (e.g. ctla- 4 inhibitor compound, e.g. ipilimumab), methods predicting responsiveness immune checkpoint therapy agents pd-1 inhibitors and/or pd-l1 inhibitors, method treatment human subject diagnosed cancer pd-1 inhibitors and/or pd-l1 inhibitors combination therapeutic agents (e.g. ctla-4 inhibitor compound, e.g. ipilimumab).',\n",
              " 'antitumor compositionthe invention antitumor composition comprises (a) bifidobacterium longum; (b) immune checkpoint inhibitor pd-1 inhibitor, pd-l1 inhibitor ctla-4 inhibitor.',\n",
              " 'anti-tumor compositionthe invention anti-tumor composition. anti-tumor composition comprises: (a) akkermansia; (b) immune checkpoint inhibitor, pd-1 inhibitor, pd-l1 inhibitor ctla-4 inhibitor.',\n",
              " 'application combination tlr agonist, immune checkpoint inhibitor vegfr inhibitor preparation tumor treatment drugthe invention relates application combination tlr agonist, immune checkpoint inhibitor vegfr inhibitor preparation tumor treatment drug. particular, tlr agonist acompound shown formula (i) compound pharmaceutically acceptable salt thereof, immune checkpoint inhibitor selected pd-1 inhibitor, pd-l1 inhibitor ctla-4 inhibitor, vegfr inhibitor apatinib pharmaceutically acceptable salt thereof.',\n",
              " 'triplet therapies hdac inhibitors, pd-l1 and/or pd-1 inhibitors, ctla-4 inhibitorsprovided combination therapy comprising hdac inhibitor (hdaci) pd-l1 and/or pd-1 inhibitor, ctla-4 inhibitor. combination therapy provided kit composition pharmaceutical composition. also, provided method treating cancer combination therapy.',\n",
              " 'combination comprising hdac inhibitor, lag-3 inhibitor pd-1 inhibitor pd-l1 inhibitor cancer treatmentthe invention relates medical hdac inhibitor general formula i, r1 r7 described herein, salt solvate thereof combination lag-3 inhibitor pd-1 inhibitor pd-l1 inhibitor treatment cancer.',\n",
              " 'reducing tumor burden administering ccr1 antagonists combination pd-1 inhibitors pd-l1 inhibitorsthe present invention methods reducing tumor burden, tumor growth, tumor progression, and/or metastasis subject suffering solid tumor cancer triple negative breast cancer. methods include administering subject thereof therapeutically effective amount pd-l1 inhibitor pd-1 inhibitor combination small molecule chemokine receptor antagonist blocks ccr1.',\n",
              " 'anti-tumor compositionthe invention anti-tumor composition. anti-tumor composition comprises (a) triple living bacteria preparation (b) immune checkpoint inhibitors, programmed death-1 (pd-1)inhibitors, programmed cell death-ligand 1 (pd-l1) inhibitors, cytotoxic t-lymphocyte antigen 4 (ctla-4) inhibitors, etc., triple living bacteria preparation includes bifidobacterium, lactobacillus acidophilus enterococcus faecalis.',\n",
              " 'inhibitors prc1 treatment cancerdisclosed compounds methods inhibition rnf1 rnf2 subunit polycomb repressive complex 1 (prc1) treatment metastatic cancer, metastatic castration-resistant prostate cancer. inhibitors combined checkpoint inhibitors pd-1 inhibitors, pd-l1 inhibitors, ctla-4 inhibitors.',\n",
              " 'combination therapies hdac inhibitors pd-l1 inhibitorsprovided combinations include hdaci pd-l1 inhibitor treating cancer, including cancer resistant pd-1 inhibitors.',\n",
              " 'application baicalin preparation medicine treating tumors responded immune checkpoint inhibitor super-progressed immune checkpoint inhibitorthe invention discloses application baicalin preparation medicine treating tumors response/super-progression immune checkpoint inhibitor, tumors response/super-progression immune checkpoint inhibitor caused excessive foxp3 + treg cells. tumor melanoma, non-small cell lung cancer, renal cell carcinoma, liver cancer, colorectal cancer, urinary tract epithelium bladder cancer pancreatic cancer, immune checkpoint inhibitor comprises mixture pd-1 inhibitor, pd-l1 inhibitor ctla-4 inhibitor. baicalin cooperates immune checkpoint inhibitor inhibit number foxp3 + treg cells tumors, anti-tumor sensibilization effect achieved, phenomena multiple tumor-bearing tumors respond immune checkpoint inhibitor tumor-bearing tumors super-progressed due excessive foxp3 + treg cells effectively treated, obvious adverse reaction found, safety good, application prospect wide.',\n",
              " 'anti-cd40 antibodies combination methods usethe present invention methods utilize agonistic anti-cd40 antibody combination immune modulating agent, immune checkpoint inhibitor (e.g., pd-1 inhibitor, pd-l1 inhibitor, ctla-4 inhibitor, vista inhibitor) and/or innate immunity activator (e.g., tlr-4 agonist) related compositions. high affinity anti-cd40 antibody combinations variety therapeutic methods treatment cancer diseases. particular, combinations anti-cd40 antibody apx005m immune checkpoint inhibitor innate immunity activator disclosed.',\n",
              " \"application baicalin preparation pharmaceutical composition treating inapplicable tumors immune checkpoint inhibitorthe invention discloses application baicalin preparation pharmaceutical composition treating inapplicable tumors immune checkpoint inhibitor. immune checkpoint inhibitor comprises mixture pd-1 inhibitor, pd-l1 inhibitor ctla-4 inhibitor. specific expression of'inapplicability immune checkpoint inhibitors' tumor recommended diagnosis treatment guide due poor effect, tumor mss type (microsatellite stable type) colorectal cancer subtype. pharmaceutical composition promote secretion cytokines increasing cd8 + cell infiltration, effectively improves tumor immunosuppression microenvironment mss type colorectal cancer subtype, treating type tumors. pharmaceutical composition remarkable anti-tumor sensibilization effect, changes current situation immune checkpoint inhibitor treating mss type colorectal cancer subtype conventionally, obvious adverse reaction, safety wide application prospect.\",\n",
              " \"therapeutic combinations btk inhibitor, pi3k inhibitor, jak-2 inhibitor, pd-1 inhibitor and/or pd-l1 inhibitortherapeutic compositions methods compositions, including combinations bruton's tyrosine kinase (btk) inhibitor, phosphoinositide 3-kinase (pi3k) inhibitor, including pi3k inhibitors selective γ- δ-isoforms selective γ- δ-isoforms (pi3k-γ,δ, pi3k-γ, pi3k-δ, programmed death 1 (pd-1) programmed death ligand 1 (pd-l1) inhibitor, and/or janus kinase-2 (jak- 2) inhibitor described. embodiments, invention includes therapeutic methods pd-1 monoclonal antibody btk inhibitor. embodiments, invention includes therapeutic methods pd-l1 monoclonal antibody btk inhibitor. embodiments, invention includes therapeutic methods pd-1 inhibitor, btk inhibitor, pi3k-δ inhibitor. embodiments, invention includes therapeutic methods pd-l1 inhibitor, btk inhibitor, pi3k-δ inhibitor.\",\n",
              " \"therapeutic combinations btk inhibitor, pi3k inhibitor, jak-2 inhibitor, pd-1 inhibitor, and/or pd-l1 inhibitortherapeutic compositions methods compositions, including combinations bruton's tyrosine kinase (btk) inhibitor, phosphoinositide 3-kinase (pi3k) inhibitor, including pi3k inhibitors selective γ- δ-isoforms selective γ- δ-isoforms (pi3k-γ,δ, pi3k-γ, pi3k-δ, programmed death 1 (pd-1) programmed death ligand 1 (pd-l1) inhibitor, and/or janus kinase-2 (jak- 2) inhibitor described. embodiments, invention includes therapeutic methods pd-1 monoclonal antibody btk inhibitor. embodiments, invention includes therapeutic methods pd-l1 monoclonal antibody btk inhibitor. embodiments, invention includes therapeutic methods pd-1 inhibitor, btk inhibitor, pi3k-δ inhibitor. embodiments, invention includes therapeutic methods pd-l1 inhibitor, btk inhibitor, pi3k-δ inhibitor.\",\n",
              " 'combinations stat-inhibitors immune checkpoint inhibitors treatment and/or management cancerprovided methods treating cancer subject thereof, comprising administering subject effective amount stat inhibitor effective amount immune checkpoint inhibitor (e.g., pd-1 inhibitor pd-l1 inhibitor).',\n",
              " 'combination therapies hdac inhibitors pd-1 inhibitorsprovided combinations include hdaci pd-1 inhibitor treating cancer, including reducing and/or preventing cancer metastasis. combination treating cancer previously treated pd-l1 inhibitor.',\n",
              " 'marker combination predicting curative effect gastrointestinal tumor immune checkpoint inhibitor application thereofthe invention marker combination predicting treatment effect gastrointestinal tumor immune checkpoint inhibitor application marker combination. marker combination comprises hla-b62 supertypes. marker combination provided embodiment invention, treatment effect gastrointestinal tumor immune checkpoint inhibitor object accurately predicted, example, pd-1/pd-l1 inhibitor singly combined ctla-4 inhibitor, response rate treatment gastrointestinal tumor immune checkpoint inhibitor improved.',\n",
              " 'combination immunotherapy treating cancermethods disclosed treating cancer subject. embodiments methods include administering subject therapeutically effective amount combination therapy comprising tlr4 agonist (such hmgn1), tlr2/6 agonist (such fsl-1), checkpoint inhibitor. optionally, combination therapy administered subject include sting agonist (such cgamp c-di-gmp). embodiments, checkpoint inhibitor pd-l1 inhibitor, pd-1 inhibitor, tnfr-2 inhibitor, ctla-4 inhibitor. embodiments, cancer colorectal cancer, kidney cancer, melanoma.',\n",
              " 'combination chromene compound active agentthe present disclosure provide combination chromene compound structure formula (i), pharmaceutically acceptable salts, compound selected pd-1 inhibitor, pd-l1 inhibitor, ctla-4 inhibitor, ox-40 agonist, cd137 agonist, lag-3 inhibitor, ido inhibitor, bi-specific protein, egfr inhibitor, her2 inhibitor, immune stimulating therapy method combination treating preventing cancer.',\n",
              " 'pd-l1 inhibitorthe present invention relates means methods determining patient pd-l1 inhibitor cotherapy. patient determined pd-l1 inhibitor cotherapy low absent expression level expression level programmed death ligand 1 (pd-l1) increased comparison control measured vitro sample patient. patient undergoing therapy comprising modulator her2/neu (erbb2) signaling pathway (like trastuzumab) chemotherapeutic agent (like dodetaxel) therapy contemplated patient. provided means methods treating cancer cancer patient therapy comprising modulator her2/neu (erbb2) signaling pathway (like trastuzumab) chemotherapeutic agent (like dodetaxel) contemplated, patient receive pd-l1 inhibitor cotherapy.',\n",
              " 'engineered oncolytic viruses expressing pd-l1 inhibitors thereofoncolytic viruses offer situ vaccination approach activate tumor-specific cell responses. however, upregulation pd-l1 expression tumor cells immune cells leads tumor resistance oncolytic immunotherapy. herein, generate engineered oncolytic virus coexpresses pd-l1 inhibitor gm-csf. oncolytic virus capable secreting pd-l1 inhibitor systemically binds inhibits pd-l1 tumor cells immune cells. intratumoral injection oncolytic virus overcomes pd-l1-mediated immunosuppression priming effector phases, provokes systemic cell responses dominant subdominant neoantigen epitopes derived mutations, leads effective rejection virus-injected distant tumors. engineered oncolytic virus activation tumor neoantigen-specific cell responses, providing potent, individual tumor-specific oncolytic immunotherapy cancer patients, especially resistant pd-1/pd-l1 blockade therapy.',\n",
              " 'treatment tumor infiltrating lymphocyte therapies combination ctla-4 pd-1 inhibitorsthe present invention improved and/or shortened processes methods preparing tils order prepare therapeutic populations tils increased therapeutic efficacy treatment cancer tils combination ctla-4 pd-1 inhibitors and/or pd-l1 inhibitors described herein.',\n",
              " 'treatment tumor-infiltrating lymphocyte therapy combination ctla-4 pd-1 inhibitorsthe present invention improved and/or shortened processes methods preparation tils prepare population therapeutic tils increased therapeutic efficacy treatment cancer tils described combination ctla-4 pd-1 inhibitor and/or pd-l1 inhibitor.',\n",
              " 'combination therapies inhibition polo-like kinase 4provided methods treating triple negative breast cancer effective amount compound (i) represented formula: pharmaceutically acceptable salt thereof effective amount immune checkpoint inhibitor, checkpoint inhibitor pd-1 inhibitor pd-l1 inhibitor. effective amount compound [i] effective amount immune checkpoint inhibitor, checkpoint inhibitor pd-1inhibitor pd-l1 inhibitor treating triple negative breast cancer provided herein.',\n",
              " 'methods treating psma-expressing cancersthe present invention relates combinations methods treating cancers expressing prostate specific membrane antigen (psma). particular, present invention therapies based combination psma therapeutic agent (e.g., radiolabeled compound i) immunooncology (i-o) therapeutic agent, i-o therapeutic agent selected group consisting lag-3 inhibitor, tim-3 inhibitor, gitr agonist, tgf-beta inhibitor, il15/il-15ra complex, pd-1 inhibitor, pd-l1 inhibitor, ctla-4 inhibitor.',\n",
              " 'method treating psma-expressing cancersthe present invention relates combinations methods treating cancers express prostate specific membrane antigen (psma). particular, invention therapies based combination psma therapeutic agent, radiolabeled compound i, immuno-oncology (i-o) therapeutic agents, i-o therapeutic agents selected group consisting lag-3 inhibitors, tim-3 inhibitors, gitr agonists, tgf-β inhibitors, il15/il-15ra, pd-1 inhibitors, pd-l1 inhibitors, ctla-4 inhibitors.',\n",
              " 'plant lignan enterolactone pd-1/pd-l1 inhibitor combined pharmaceutical composition application thereofthe invention relates plant lignan enterolactone pd-1/pd-l1 inhibitor combined pharmaceutical composition application thereof, belongs technical field biological medicine. order solve problem malignant tumor patients insensitive immunotherapy, invention plant lignan enterolactone pd-1/pd-l1 inhibitor combined pharmaceutical composition comprises effective dose plant lignan preparation enterolactone preparation effective dose pd-1/pd-l1 inhibitor. combined pharmaceutical composition disclosed invention increase proportion immune cells anti-cancer function inhibit immune escape cancer cells. proportion cd4 cd8 positive cells up-regulated combined medication, effect inhibiting growth mouse breast cancer superior independent medication plant lignans, enterolactone pd-l1/pd-1 inhibitors. invention unprecedented effective auxiliary synergistic treatment strategy immunotherapy malignant tumors.',\n",
              " 'method treating psma-expressing cancersthe present invention relates combinations methods treating cancers express prostate specific membrane antigen (psma). particular, invention therapies based combination psma therapeutic agent, radiolabeled compound formula i, immuno-oncology (i-o) therapeutic agents, i-o therapeutic agents selected group consisting lag-3 inhibitors, tim-3 inhibitors, gitr agonists, tgf-β inhibitors, il15/il-15ra complex, pd-1 inhibitors, pd-l1 inhibitors, ctla-4 inhibitors.',\n",
              " 'polysubstituted benzene pd-l1 inhibitor, composition application polysubstituted benzene pd-l1 inhibitor compositionthe invention discloses polysubstituted benzene pd-l1 inhibitor, composition application polysubstituted benzene pd-l1 inhibitor composition. polysubstituted benzene pd-l1 inhibitor structure shown general formula (i). experiments prove compound disclosed invention shows strong pd-1/pd-l1 blocking activity remarkable pd-l1 occupying activity, reverse cell functions inhibited pd-l1 time. meanwhile, compound provided invention absorbed oral administration, pharmacokinetic properties, anti-tumor inhibitory activity vivo. therefore, compounds present invention treatment diseases, disorders conditions benefit inhibition pd1 pd-l1 activity, including infectious diseases, immune diseases, inflammatory diseases cancers, combination drugs.',\n",
              " 'combination therapy notch pd-1 pd-l1 inhibitorsthe present invention medicaments treating methods treating t-cell acute lymphoblastic leukemia, acute lymphoblastic leukemia, chronic lymphoblastic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, erythroleukemia, triple negative breast cancer, breast cancer, ovarian cancer, melanoma, sung cancer, small-cell lung cancer, pancreatic cancer, glioblastoma, colorectal cancer, head neck cancer, cervical cancer, prostate cancer, liver cancer, oral squamous cell carcinoma, skin cancer, medul!ob!astoma, hepatocellular carcinoma, intrahepatic extrahepatic cholangiocarcinoma, desmoid tumor, soft tissue sarcoma, adenoid cystic carcinoma patient comprising combination therapy 4,4,4-tri-fluoro-n-[(1s)-2˜[[(7s)-5-(2-hydroxyemyl)-6-oxo-7h-pyrido[23-d][3]benzazepin-7-yl]amino]-1-methyl-2-oxo-ethyljbutanamide, pharmaceutically acceptable salt hydrate thereof, pd-1 pd-l1 inhibitor selected pembrolizumab, nivolumab, atezolizumab, durvalumab, avelumab.',\n",
              " \"application anti-pd-1 antibody and/or anti-pd-l1 antibody preparation medicine treating parkinson's diseasethe invention relates technical field medicines, particular application anti-pd-1 antibody and/or anti-pd-l1 antibody preparation medicine treating parkinson's disease. found anti-pd-1 antibody and/or anti-pd-l1 antibody reduce alpha synuclein aggregation, anti-pd-1/pd-l1 antibodies, namely, pembrolizumab, nivolumab, cemiplimab, toripalimab, sintilimab, camrelizumab, tirelizumab, atezolizumab, durvalumab avenlimab reduce alpha synuclein aggregation. specific clinical application cases, found intravenous injection oral administration anti-pd-1/pd-l1 antibody, parkinson's disease improved, development disease condition effectively prevented.\",\n",
              " 'pd-1/pd-l1 inhibitorsabstract compounds pd-1/pd-l1 inhibitors methods compounds singly combination additional agents compositions compounds treatment cancer disclosed.',\n",
              " 'pharmaceutical combination application thereofa pharmaceutical combination application thereof. pharmaceutical combination comprises pi3k inhibitor immune checkpoint inhibitor, pi3k inhibitor selected compound represented formula (i), linperlisib, samotolisib, copanlisib, shc014748m, pilaralisib, buparlisib, taselisib, yzj-0673, gedatolisib, omipalisib, bimiralisib, voxtalisib, al58805, hec68498, pharmaceutically acceptable salts thereof, immune checkpoint inhibitor pd-1/pd-l1 inhibitor. compound represented formula (ia) high inhibitory effect pi3kδ pi3kγ kinases, pharmaceutical combination pi3k inhibitor pd-1 inhibitor combination, effectively improving inhibitory effect tumors, solving problem resistance pd-1/pd-l1 inhibitors.',\n",
              " 'application pd-l1 inhibitor preparation drugs kitsthe invention relates technical field biology, particularly relates application pd-l1 inhibitor preparation drugs kits. invention application pd-l1 inhibitor preparation drugs kits. drugs kits treating tumors, and/or adjusting expression level stat3 protein, and/or adjusting phosphorylation level stat3 protein. application pd-l1 inhibitor, condition cells exist, tumor cell apoptosis effectively promoted, proliferation tumor cells inhibited, tumor tissue growth inhibited, obvious tissue damage inflammatory reaction caused, efficient high-specificity immunotherapy strategy inhibit expression checkpoint protein source depend cells provided, application industrialization prospects.',\n",
              " 'small molecule pd-1/pd-l1 inhibitor, pharmaceutical composition small molecule pd-1/pd-l1 inhibitor pd-l1 antibody, application pharmaceutical compositionthe present invention discloses small molecule pd-1/pd-l1 inhibitor, pharmaceutical composition small molecule pd-1/pd-l1 inhibitor pd-l1 antibody, application pharmaceutical composition. small molecule pd-1/pd-l1 inhibitor, aromatic vinyl aromatic ethyl derivatives represented general formula (i), treat cancers.',\n",
              " 'process preparing pd-1/pd-l1 inhibitorthe present invention relates processes preparing pd-1/pd-l1 inhibitor (r)-1-((7-cyano-2-(3′-(3-(((r)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-ylamino)-2,2′-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid, salts thereof, related synthetic intermediates, salts intermediates, pd-1/pd-l1 inhibitor treatment diseases including infectious diseases cancer.',\n",
              " 'application steroid compound preparation pd-1/pd-l1 inhibitorthe invention discloses application steroid compound preparation pd-1/pd-l1 inhibitor. pd-1/pd-l1 inhibitor steroid compound, general formula shown formula i. invention, htrf method employed vitro inhibition pd-1/pd-l1 binding activity test steroid compounds 1-25, test result shows part compounds show significant inhibitory activity pd-1/pd-l1 binding, pd-1/pd-l1 inhibitor, preparation pd-1/pd-l1 small molecule inhibitor.',\n",
              " 'heterocyclic compounds pd-l1 inhibitorsthe invention belongs field medicinal chemistry, relates class heterocyclic compounds pd-l1 inhibitors application heterocyclic compounds, specifically relates compounds shown formula isomers thereof, pharmaceutically acceptable salt, solvates prodrugs, preparation method compounds, pharmaceutical compositions containing compounds, compounds compositions treating cancer infectious diseases.',\n",
              " 'pharmaceutical composition comprising cd47 antibody pd-1/pd-l1 inhibitorprovided method treating disorder subject thereof, comprising administrating anti-cd47 antibody pd-1/pd-l1 inhibitor subject, provided pharmaceutical composition includes anti-cd47 antibody pd-1/pd-l1 inhibitor.',\n",
              " 'application oroxylin pd-1/pd-l1 inhibitor preparation medicine treating liver cancerthe invention discloses application oroxylin pd-1/pd-l1 inhibitor preparation medicine treating liver cancer, belongs technical field medicines. application disclosed invention, experiment treating mouse liver cancer cell h22 subcutaneous transplantation tumor combining oroxylin pd-1/pd-l1 inhibitor proves combination oroxylin pd-1/pd-l1 small-molecule inhibitor pd-1 monoclonal antibody improve anti-tumor effect independent oroxylin, pd-1/pd-l1 small-molecule inhibitor pd-1 monoclonal antibody, obvious inhibition effect weight experimental animal generated, importantly, survival time tumor-bearing mice prolonged. therefore, oroxylin promote curative effect immune checkpoint inhibitor liver cancer, combined medication play great role future liver cancer treatment.',\n",
              " 'combination hepatitis b virus (hbv) vaccines pd-l1 inhibitorstherapeutic combinations hepatitis b virus (hbv) vaccines pd-l1 inhibitors described. methods inducing immune response hbv treating hbv-induced disease, particularly individuals chronic hbv infection, disclosed therapeutic combinations hbv vaccines pd-l1 inhibitors described. kits comprising disclosed therapeutic combinations described.',\n",
              " 'treatment human papillomavirus-associated cancers pd-l1 inhibitorsthe present disclosure relates treatment hpv-associated cancers small molecule pd-l1 inhibitors.',\n",
              " 'immunosuppressant mrna dosage form application immunosuppressant preparation tumor treatment medicinethe invention mrna (messenger ribonucleic acid) immunosuppressant application thereof preparation medicine treating tumors, belongs technical field tumor treatment, mrna immunosuppressant comprises mrna coding ctla-4 inhibitor, mrna coding pd-1 inhibitor mrna coding pd-l1 inhibitor; cells transfected immunosuppressor mrna dosage form, corresponding inhibitors ctla-4, pd-1 pd-l1 proteins expressed, effects corresponding protein inhibitors exerted; mrna dosage form immunosuppressor significantly reduce tumor volume significantly improve proportion cd8 + tumor infiltration cells, compared protein dosage form immunosuppressor, mrna dosage form immunosuppressor advantages low immunogenicity, long in-vivo half-life period low cost.',\n",
              " 'immunosuppressant mrna dosage form application thereof preparation medicament treating tumorsan immunosuppressant mrna dosage form application thereof preparation medicament treating tumors, belonging technical field tumor treatment. immunosuppressant mrna dosage form comprises mrna encodes ctla-4 inhibitor, mrna encodes pd-1 inhibitor, mrna encodes pd-l1 inhibitor; immunosuppressant mrna dosage form transfected cells, transfected cells express corresponding inhibitors ctla-4, pd-1 pd-l1 proteins, function corresponding protein inhibitors; immunosuppressant mrna dosage form significantly reduce tumor sizes, significantly increase proportion cd8+ tumor-infiltrating cells. compared immunosuppressants protein dosage form, immunosuppressant mrna dosage form advantages low immunogenicity, long vivo half-life, low costs.',\n",
              " 'method treating cancer associated ras mutationin accordance purpose(s) present disclosure, described methods treating cancer associated ras mutation subject treatment comprising administering subject effective amount compound formula described pharmaceutically acceptable salt thereof. compounds described improved efficacy compared benchmark bet inhibitor jq-1 comparable efficacy high dose jq-1 respect treatment pdac. aspect, compounds administered combination effective amount immune checkpoint inhibitor as, example, pd-1/pd-l1 inhibitor, ctla-4 inhibitor, combination thereof.',\n",
              " 'combinations checkpoint inhibitors oncolytic virus treating cancerthe present disclosure relates methods inhibiting growth tumor patient thereof. methods comprise administering patient oncolytic virus combination therapeutically effective amount pd-1 inhibitor (e.g., cemiplimab bioequivalent thereof) optionally, therapeutically effective amount ctla-4 inhibitor (e.g., ipilimumab bioequivalent thereof). embodiments, administration combination results enhanced tumor inhibition compared administration antibody virus alone. embodiments, oncolytic virus recombinant vesicular stomatitis virus (vsv), vv1.',\n",
              " 'pd-l1 ccl-2 biomarker diagnosis pd-l1 inhibitor ccl-2 inhibitor resistant cancer thereofthe present invention relates biomarker diagnosing pd-l1 inhibitor ccl-2 inhibitor-resistant cancer, thereof. specifically, present invention relates biomarker diagnosing pd-l1 inhibitor ccl-2 inhibitor-resistant cancer including transglutaminase 2 (tg2), composition diagnosing pd-l1 inhibitor ccl-2 inhibitor-resistant cancer same, kit, method providing information diagnosing pd-l1 inhibitor ccl-2 inhibitor-resistant cancer. present invention, confirmed pd-1/pd-l1 inhibitor resistance induced tg2 triple-negative breast cancer cells, confirmed pd-l1 ccl2 expression increased tg2. is, pd-l1 upregulated tg2 blocked pd-1/pd-l1 inhibitor, confirmed ccl2 induced tg2 generate pd-1/pd-l1 inhibitor resistance. confirmed tg2 present invention applied marker diagnosing resistance pd-l1 inhibitors ccl-2 inhibitors. furthermore, present invention, confirmed tg2 inhibitor dual inhibition pd-l1 ccl2 restores cell-mediated killing effect pd-1/pd-l1 inhibitor resistance. thus, possible provide information administer tg2 inhibitor treatment pd-1/pd-l1 inhibitor-resistant cancer.',\n",
              " 'pd-1/pd-l1 inhibitor application thereofthe invention relates field molecular immunology, particularly discloses pd-1/pd-l1 inhibitor application thereof. pd-1/pd-l1 inhibitor comprises s-cyanomethyl-l-cysteine, activation lymphocytes promoted releasing h2s, pd-1 gene expression down-regulated, pd-l1 gene expression liver cancer cells down-regulated, pd-1/pd-l1 pathway inhibited, cancer cell immune escape reaction blocked, immune response capacity lymphocytes hepg2 cells enhanced, inhibition effect lymphocytes liver cancer cells enhanced, immune function mice enhanced, cancer inhibition effect quinoline derivatives tumor targeted isostere tectoridin effectively enhanced.',\n",
              " 'heterocyclic compound serving pd-l1 inhibitorthe invention belongs field medical chemistry, relates heterocyclic compound serving pd-l1 inhibitor application thereof, particular compound shown formula isomer, pharmaceutically-acceptable salt, solvate prodrug thereof, preparation methods thereof, pharmaceutical compositions containing compounds application compounds compositions treatment cancers infectious diseases.',\n",
              " 'method predicting therapeutic effect pd-1/pd-l1 inhibitor abnormality pd-l1(cd274) indexthe purpose present invention provide effective method predicting therapeutic effect pd-1/pd-l1 inhibitor. method, pd-1/pd-l1 inhibitor effective treating subject malignant tumor predicted, comprises detecting abnormality genome relating effectiveness pd-1/pd-l1 inhibitor tumor cell collected subject and, abnormality present, evaluating pd-1/pd-l1 inhibitor effective treating subject.',\n",
              " 'pd-1 / pd-l1 inhibitors treatment cancerpd-1 / pd-l1 inhibitors treatment cancer invention relates methods treating cancer subject, comprising administering subject therapeutically effective amount inhibitor interaction pd-1 receptor ligand pd-l1. ( figure )',\n",
              " 'treatment glycolysis-low glycolysis-high tumors ctla-4 inhibitorsa method treating subject tumor susceptible treatment ctla-4 blockade, comprising administering ctla-4 inhibitor subject, tumor susceptible treatment ctla-4 blockade tumor glycolysis-low tumor. addition, method treating tumor subject, comprising administering ctla-4 inhibitor inhibitor tumor glycolysis subject, tumor glycolysis-high tumor.',\n",
              " 'application autologous lymphocyte reinfusion preparation pd-1/pd-l1 inhibitor preparation tumor treatment productthe invention discloses application autologous lymphocyte reinfusion preparation pd-1/pd-l1 inhibitor preparation tumor treatment product. invention applications autologous lymphocyte reinfusion preparation pd-1/pd-l1 inhibitor: 1) preparing tumor treatment product; 2) preparing product inhibiting tumor cell growth; 3) preparing product prolonging lifetime tumor patient; 4) preparing reconstruction product promoting body immunity; experiments prove autologous lymphocyte reinfusion preparation pd-1/pd-l1 inhibitor remarkable anti-tumor effect human liver cancer qgy7703 subcutaneous transplantation tumor model human liver cancer hepg2 orthotopic transplantation tumor model, survival time mice effectively prolonged, indicated autologous lymphocyte reinfusion preparation pd-1/pd-l1 inhibitor combined treating liver cancer, application autologous lymphocyte reinfusion preparation pd-1/pd-l1 inhibitor treating liver cancer promoted. pd-1/pd-l1 inhibitor assists autologous lymphocyte reinfusion preparation promote immune reconstruction activated lymphocytes organism.',\n",
              " 'combination tasquinimod pharmaceutically acceptable salt thereof pd-1 and/or pd-l1 inhibitor, medicamentthe present invention concerns combination comprising tasquinimod, pharmaceutically acceptable salt thereof, pd-1 and/or pd-l1 inhibitor, medicament. concerns pharmaceutical composition comprising tasquinimod, pharmaceutically acceptable salt thereof, pd-1 and/or pd-l1 inhibitor.',\n",
              " 'small molecule pd-1/pd-l1 inhibitor thereof drugsa small molecule pd-1/pd-l1 inhibitor thereof drugs. specifically, provided small molecule pd-1/pd-l1 inhibitor chemical compound represented formula (i), stereoisomer, geometric isomer, tautomer, oxynitride, hydrate, solvate, metabolic product, ester, pharmaceutically acceptable salt, prodrug thereof. provided preparation method compound represented formula (i), pharmaceutical composition, thereof preparation drugs prevention treatment diseases relating pd-1/pd-l1 signaling pathways.',\n",
              " 'methods materials assessing treating cancerthis document methods materials involved assessing cancer (e.g., breast cancer). example, methods materials determining cancer patient (e.g., breast cancer patient) er−/pgr−/her2− cancer cells favorable unfavorable outcome and/or respond cancer treatment includes pd-1 inhibitor and/or pd-l1 inhibitor combination jak2 inhibitor provided. methods materials involved treating mammals er−/pgr−/her2− cancer (e.g., er−/pgr−/her2− breast cancer) administering pd-1 inhibitor and/or pd-l1 inhibitor combination jak2 inhibitor provided.',\n",
              " 'combination therapy comprising a2a/a2b pd-1/pd-l1 inhibitorsthe present application methods treating cancer combination a2a and/or a2b inhibitor pd-1 and/or pd-l1 inhibitor.',\n",
              " 'salts pd-1/pd-l1 inhibitorthe present invention relates salt forms pd-1/pd-l1 inhibitor (r)-1-((7-cyano-2-(3′-(3-(((r)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-ylamino)-2,2′-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid, including methods preparation thereof, compound treatment diseases including infectious diseases cancer.',\n",
              " 'marker predicting curative effect pd-1/pd-l1 inhibitor tumor immunotherapythe invention discloses marker predicting curative effect pd-1/pd-l1 inhibitor tumor immunotherapy. invention, 32 methylation markers scarf2 screened out. methylation marker combination methylation marker pd-l1 provided invention high consistency curative effect prediction clinical evaluation standard patient non-small cell lung cancer pd-1/pd-l1; sensitivity, specificity accuracy pd-1/pd-l1 inhibitor tumor immunotherapy effect prediction marker superior existing marker pd-l1. based marker prediction, invention constructs corresponding prediction model, prediction model effectively predict tumor immunotherapy effect pd-1/pd-l1 inhibitor, high sensitivity specificity, beneficial clinically formulating personalized therapeutic schedules patients providing precise therapy.',\n",
              " 'pd-l1 inhibitor preparation method application thereofthe invention compound serving pd-1/pd-l1 inhibitor preparation method application compound. invention discloses application compound pharmaceutical composition thereof preparation drugs. drugs preventing treating diseases related pd-1/pd-l1.',\n",
              " 'application bruceol pd-l1 inhibitorthe invention discloses application brucea javanica pd-l1 inhibitor. invention discovers effect brucea javanica activating body immunity treat cancers time. experimental results prove brucea javanica improve immunity body play role treatment hepatocellular carcinoma: pd-l1 promote growth tumor cells inhibiting immune system body, brucea javanica treatment, expression condition pd-l1 tumor tissues reduced, effect treating hepatocellular carcinoma achieved. infiltration condition immune cells tumor tissues improved, apoptosis condition tumor cells increased, tumor growth inhibited.',\n",
              " 'application brucea javanica picrol combined 17-aag pd-l1 inhibitorthe invention discloses application brucea javanica picrol combined 17-aag pd-l1 inhibitor. invention discloses application composition brucea javanica 17-aag preparation pd-l1 inhibitor, application composition brucea javanica 17-aag preparation tumor treatment drug, application composition brucea javanica 17-aag preparation tumor immunotherapy drug. invention relates application brucea javanica bitter alcohol preparation antitumor effect enhancer 17-aag. invention, found time bru cooperate 17-aag activate body immunity play role treatment hepatocellular carcinoma.',\n",
              " 'data processing system method poor prognosis pd-1/pd-l1 inhibitorsthe invention data processing system poor prognosis pd-1/pd-l1 inhibitor. data processing system comprises data acquisition unit data processing unit, data acquisition unit acquiring expression level biomarker signal path activity scoring data; data analysis unit analyzing expression level biomarker activity scoring data signal channel obtain activation information interleukin 1 signal channel; data determination unit determining prognosis information pd-1/pd-l1 inhibitor activation information interleukin 1 signal channel. method method capable predicting poor prognosis receiving pd-1/pd-l1 inhibitor present, integrates traditional rna protein detection, bioinformatics analysis like, simple clear discrimination standard, high speed high accuracy, easy implement clinical application, beneficial selection proper treatment scheme.',\n",
              " 'double negative cells pd-1 blockade treatment cancermethods treatment cancer double negative cells (dnts) pd-1 pd-l1 inhibitor described. tumors treated dnts pd-1 inhibitor exhibited increased dnt cell infiltration increased cytotoxicity non-small cell lung cancer (nsclc) cells. described compositions kits comprising dnts pd-1 pd-l1 inhibitor treatment cancer.',\n",
              " \"process making pd-1/pd-l1 inhibitor salts crystalline forms thereofthis application relates processes intermediates preparation pd-1/pd-l1 inhibitor (r)-1-((7-cyano-2-(3'-((2-(difluoromethyl)-7-((3-hydroxypyrrolidin-1-yl)methyl)pyrido[3,2-d]pyrimidin-4-yl)amino)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)benzo[d]oxazol-5-yl)methyl)piperidine-4-carboxylic acid, salts crystalline forms thereof, pd-1/pd-l1 inhibitor solid forms salt forms thereof treatment diseases including infectious diseases cancer.\",\n",
              " 'process making pd-1/pd-l1 inhibitor salts crystalline forms thereofthis application relates processes intermediates preparation pd-1/pd-l1 inhibitor (r)-1-((7-cyano-2-(3′-((2-(difluoromethyl)-7-((3-hydroxypyrrolidin-1-yl)methyl)pyrido[3,2-d]pyrimidin-4-yl)amino)-2,2′-dimethyl-[1,1′-biphenyl]-3-yl)benzo[d]oxazol-5-yl)methyl)piperidine-4-carboxylic acid, salts crystalline forms thereof, pd-1/pd-l1 inhibitor solid forms salt forms thereof treatment diseases including infectious diseases cancer.',\n",
              " 'small molecule pd-1/pd-l1 inhibitor, pharmaceutical composition thereof pd-l1 antibody application thereofthe present invention discloses small molecule pd-1/pd-l1 inhibitor, pharmaceutical composition thereof pd-l1 antibody, applications thereof; small molecule pd-1/pd-l1 inhibitor is, example, aromatic vinyl aromatic ethyl derivative represented formula (i), applied cancer treatment.',\n",
              " 'pd-1/pd-l1 inhibitor, preparation method therefor, thereofprovided compound pd-l1 inhibitor, preparation method therefor, thereof. provided compound pharmaceutical composition thereof preparation medicine, medicine preventing treating pd-l1-related disease.',\n",
              " \"crystalline form pd-1/pd-l1 inhibitorthe present invention relates crystalline forms pd-1/pd-l1 inhibitor (r)-1-((7-cyano-2-(3'-(3-(((r)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-ylamino)-2,2'-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid, including methods preparation thereof, related synthetic intermediates, compound treatment diseases including infectious diseases cancer.\",\n",
              " 'application babaodan enhancing anti-liver cancer effect pd-1 inhibitor and/or relieving toxic side effects pd-1 inhibitorthe invention relates application babaodan enhancing anti-liver cancer effect pd-1 inhibitor and/or relieving toxic side effects pd-1 inhibitor. invention pharmaceutical composition, comprises babaodan pd-1 inhibitor. tests prove babaodan enhance anti-liver cancer effect pd-1 inhibitor reduce visceral toxicity pd-1 inhibitor.',\n",
              " 'pd-1/pd-l1 inhibitor preparation method application thereofthe invention compound serving pd-l1 inhibitor preparation method application compound. invention discloses application compound pharmaceutical composition thereof preparation drugs, drugs preventing treating pd-l1 related diseases.',\n",
              " 'combination therapy comprising a2a/a2b inhibitors, pd-1/pd-l1 inhibitors, anti-cd73 antibodiesdisclosed combination therapies comprising administration cd73 inhibitor, adenosine a2a a2b receptor inhibitor, pd-1/pd-l1 inhibitor. disclosed combination therapies treatment diseases related activity adenosine receptors and/or cd73 and/or pd-1/pd-l1 including, 5 example, cancer, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases. anti-cd73 antibodies, pd-1/pd-l1 inhibitors, a2a/a2b inhibitors disclosed.',\n",
              " 'pdl-1 inhibitors treatment pulmonary vascular diseasesthe disclosure therapies prevention pulmonary vascular remodeling treatment vascular conditions. particular, disclosure methods treatment pulmonary vascular diseases comprising administration inhibitor programmed cell death protein 1 (pd-1) corresponding programmed death-ligand 1 (pd-l1). methods comprise administering subject pd-1 pd-l1 inhibitor monoclonal antibody. provided diagnostic methods assessing patient sensitivity therapies. methods identifying subject pulmonary hypertension sensitive treatment pd-l1 inhibitor pd-1 inhibitor provided. subjects identified pulmonary hypertension sensitive anti-pd-l1 treatment subsequently administered pd-l1 inhibition treatment.',\n",
              " 'combination pd-1/pd-l1 inhibitors targeted thorium conjugatesthe present invention relates combinations components, component component b, component pd-1/pd-l1 inhibitor, component b targeted thorium conjugate. aspect present invention relates combinations described preparation medicament treatment prophylaxis disease, particularly treatment breast prostate cancer.',\n",
              " 'combination therapy chemokine receptor 2 (ccr2) antagonist pd-1/pd-l1 inhibitor.the present disclosure drawn combination therapy chemokine receptor 2 (ccr2) antagonist pd-1 and/or pd-l1 inhibitor treatment cancer.',\n",
              " 'combination therapy chemokine receptor 2 (ccr2) antagonist pd-1/pd-l1 inhibitorthe present disclosure drawn combination therapy chemokine receptor 2 (ccr2) antagonist pd-1 and/or pd-l1 inhibitor treatment cancer.',\n",
              " 'methods treating cervical cancer administering pd-1 inhibitor antibody cemiplimabthe present disclosure methods treating, reducing severity of, inhibiting growth tumor improving survival cervical cancer patient, method includes selecting patient cervical cancer thereof administering patient therapeutically effective amount programmed death 1 (pd-1) inhibitor ( e.g ., anti-pd-1 antibody antigen-binding fragment thereof cemiplimab bioequivalent thereof). embodiments, patient recurrent metastatic cervical cancer disease progression chemotherapy.',\n",
              " 'administration pd-1 inhibitor treating skin cancerthe disclosure relates methods treating inhibiting growth tumor patient skin cancer, including administering patient therapeutically effective amount programmed death 1 (pd-1) inhibitor (e.g., antibody antigen-binding fragment thereof specifically binds pd-1, pd-l1, and/or pd-l2). embodiments, method includes administering pd-1 inhibitor adjuvant treatment patient completed surgery optionally radiation therapy skin cancer, cscc, high risk disease recurrence. embodiments, method includes administering pd-1 inhibitor neoadjuvant treatment planned surgery skin cancer. embodiments, method includes administering pd-1 inhibitor neoadjuvant treatment planned surgery skin cancer subsequently administering patient pd-1 inhibitor adjuvant therapy surgery.',\n",
              " 'combination therapy chemokine receptor 2 (ccr2) antagonist pd-1 and/or pd-l1 inhibitorthe present disclosure drawn combination therapy chemokine receptor 2 (ccr2) antagonist pd-1 and/or pd-l1 inhibitor treatment central nervous system cancer.',\n",
              " 'application pd-l1 inhibitor tumor antigen binding peptide-engineered immune cell combination prostatic cancer treatmentthe invention discloses application combination pd-l1 inhibitor tumor antigen binding peptide-engineered immune cell treatment prostatic cancer, combination pd-l1 inhibitor tumor antigen binding peptide-engineered immune cell applied treatment prostatic cancer time, treatment effect shown. invention applied preparation targeted anti-prostatic cancer drugs targeted therapy assisting prostatic cancer, clinical application prospect.',\n",
              " 'combination therapy chemokine receptor 2 (ccr2) antagonist pd-1 and/or pd-l1 inhibitorthe present disclosure drawn combination therapy chemokine receptor 2 (ccr2) antagonist pd-1 and/or pd-l1 inhibitor treatment central nervous system cancer.',\n",
              " 'combination therapy pi3k inhibitor pd-1 inhibitorprovided methods treating proliferative diseases disorders (e.g., cancer) patient thereof combination therapy compound (i) pharmaceutically acceptable salt thereof pd-1 inhibitor (e.g., pembrolizumab).',\n",
              " 'application compound pgg preparation sensitizer pd-1 inhibitorthe invention belongs field medicines, particularly relates application compound pgg sensitizer pd-1 inhibitor. firstly, found pgg combined pd-1 inhibitor significantly inhibit growth pancreatic cancer tumors; pgg combined pd-1 inhibitor treatment, survival time pancreatic cancer remarkably prolonged, tumor microenvironment pancreatic cancer remarkably improved; pgg sensitize pd-1 inhibitor, treatment effect pd-1 inhibitor pancreatic cancer enhanced, pgg wide application prospect.',\n",
              " \"salts crystalline forms pd-1/pd-l1 inhibitorthis application relates solid forms salt forms pd-1/pd-l1 inhibitor 4,4'-(((((2,2'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis(azanediyl))bis(carbonyl))bis(1-methyl-1,4,6,7-tetrahydro-5h-imidazo[4,5-c]pyridine-2,5-diyl))bis(ethane-2,1-diyl))bis(bicyclo[2.2.1]heptane-1-carboxylic acid), including processes preparation thereof, solid forms salt forms treatment diseases including infectious diseases cancer.\",\n",
              " 'salts crystalline forms pd-1/pd-l1 inhibitorthis application relates solid forms salt forms pd-1/pd-l1 inhibitor 4,4′-(((((2,2′-dichloro-[1,1′-biphenyl]-3,3′-diyl)bis(azanediyl))bis(carbonyl))bis(1-methyl-1,4,6,7-tetrahydro-5h-imidazo[4,5-c]pyridine-2,5-diyl))bis(ethane-2,1-diyl))bis(bicyclo[2.2.1]heptane-1-carboxylic acid), including processes preparation thereof, solid forms salt forms treatment diseases including infectious diseases cancer.',\n",
              " 'methods treating cancer immunosuppressed immunocompromised patients administering pd-1 inhibitorthe present disclosure methods treating inhibiting growth tumor, including selecting patient cancer, patient immunosuppressed immunocompromised, administering patient therapeutically effective amount programmed death 1 (pd-1) inhibitor (e.g., anti-pd-1 antibody, cemiplimab bioequivalent thereof). embodiments, cancer skin cancer, cutaneous squamous cell carcinoma.',\n",
              " 'methods treating cancer administering neoadjuvant pd-1 inhibitorthe present disclosure methods treating, reducing severity of, inhibiting growth tumor, inducing necrosis tumor, method includes selecting patient cancer (e.g., liver cancer, lung cancer, head neck cancer) thereof administering patient therapeutically effective amount programmed death 1 (pd-1) inhibitor (e.g., cemiplimab bioequivalent thereof) neoadjuvant therapy surgical resection optional administration programmed death 1 (pd-1) inhibitor (e.g., cemiplimab bioequivalent thereof) post-surgery adjuvant therapy. embodiments, liver cancer hepatocellular carcinoma (hcc), lung cancer non-small cell lung cancer (nsclc), head neck cancer head neck squamous cell carcinoma (hnscc).',\n",
              " 'methods compositions genetic modulation tumor microenvironmentsprovided therapy comprising hdac inhibitor (hdaci), and/or pd-l1 and/or pd-1 inhibitor, and/or ctla-4 inhibitor. combination therapy provided kit composition pharmaceutical composition. also, provided method treating cancer combination therapy.',\n",
              " 'marker predicting curative effect lung cancer immune checkpoint inhibitor application thereofthe invention marker predicting treatment effect immune checkpoint inhibitor lung cancer object application marker. marker combination comprises genes shown table 1. marker disclosed embodiment invention, treatment effect lung cancer immune checkpoint inhibitor object, pd-1/pd-l1 inhibitor, accurately predicted, object shows remarkable clinical benefit treated immune checkpoint inhibitor distinguished; therefore, response rate lung cancer immune checkpoint inhibitor treatment improved.',\n",
              " 'mesothelin chimeric antigen receptor (car) antibody pd-l1 inhibitor combined anticancer therapyprovided compositions methods treating diseases associated expression mesothelin comprising administering cell expresses chimeric antigen receptor (car) specific mesothelin combination pd-l1 inhibitor.',\n",
              " 'combination treatments directed programmed death ligand-1 (pd-l1) positive cancersprovided methods treating cancers sugar analog, including methods sensitizing cancers egf inhibitor-, pd-1 inhibitor-, and/or pd-l1 inhibitor-based therapies administering sugar analog, as, example, 2-deoxy-d-glucose (2-dg), f-fucose, 2-f-peracetyl-fucose.',\n",
              " 'anti-cancer combination therapy methods ctla-4 inhibitors non-the invention anticancer combined treatment method ctla-4 inhibitor non-steroid anti-inflammatory drug, particularly product combination, comprises (i) pharmaceutical composition containing (a) active component ctla-4 inhibitor pharmaceutically acceptable carrier, (ii) pharmaceutical composition containing (a) active component non-steroid anti-inflammatory non-steroid anti-inflammatory non-steroid anti-inflammatory non-steroid anti-inflammatory non-steroid anti-inflammatory non-steroid anti-inflammatory drug, (ii) pharmaceutical composition, pharmaceutical composition containing (b) active ingredient, active ingredient non-steroid anti-inflammatory drug, pharmaceutically acceptable carrier; pharmaceutical composition pharmaceutical composition different pharmaceutical compositions pharmaceutical composition. product composition disclosed invention synergistically treating tumors.',\n",
              " 'application notch family gene mutation predicting sensitivity patient suffering solid tumor immune checkpoint inhibitor therapyprovided detection agent predicting sensitivity subject suffering solid tumor immune checkpoint inhibitor therapy kit comprises detection agent. detection agent detection agent detecting notch gene mutation; notch gene selected notch1, notch2, notch3 notch4; immune checkpoint inhibitor pd1 inhibitor and/or pd-l1 inhibitor.',\n",
              " 'method intelligently predicting curative effect pd-l1 inhibitor gastric cancer h&e staining imagethe present invention gastric cancer hamp; invention discloses method intelligently predicting curative effect pd-l1 inhibitor dyeing image, method comprises steps: proposing cancerization region segmentation model based semi-supervised learning, segmenting hamp; e, dyeing canceration areas image; secondly, taking image blocks containing canceration areas, obtaining category label image block pd-l1 inhibitor curative effect label marked clinician, performing image block level prediction applying image classification model based multi-instance learning; finally, generating hamp based prediction result image block layer. e, dyeing curative effect discrimination matrix image, performing curative effect prediction slice level image classification model based deep convolutional neural network. applying technical scheme, prediction result curative effect gastric cancer patient pd-l1 inhibitor obtained, doctors assisted make clinical decisions.',\n",
              " 'combination ctla4 pd1/pdl1 antibodies treating cancerthe invention anti-ctla4 binding proteins (e.g., antibodies, bispecific antibodies, chimeric receptors) combination pd-1 signaling agents (e.g., pd-1 inhibitors pd-l1 inhibitors) treating preventing cancer, compositions kits comprising anti-ctla4 binding proteins pd-1 signaling agents.',\n",
              " 'treating cancer cck receptor inhibitor immune checkpoint inhibitorprovided methods treating cholecystokinin (cck) receptor-expressing cancerous tumor subject. methods comprising administering subject effective amount cck receptor inhibitor effective amount immune checkpoint inhibitor, cck receptor inhibitor inhibits cck receptors selected group consisting cck-a receptor, cck-b receptor cck-c receptor, immune checkpoint inhibitor programmed cell death protein 1 (pd1) inhibitor cytotoxic t-lymphocyte-associated antigen 4 (ctla-4) inhibitor.',\n",
              " 'combinational anti-cancer therapy ctla-4 inhibitor non-steroidal anti-inflammatory drugthe present invention combinational anti-cancer therapy ctla-4 inhibitor non-steroidal anti-inflammatory drug. specifically, present invention product combination comprising: (i) pharmaceutical composition, pharmaceutical composition comprises (a) active ingredient, active ingredient ctla-4 inhibitor, pharmaceutically acceptable carrier; (ii) pharmaceutical composition, pharmaceutical composition comprises (b) active ingredient, active ingredient non-steroidal anti-inflammatory drug, pharmaceutically acceptable carrier; wherein, pharmaceutical composition pharmaceutical composition different pharmaceutical compositions pharmaceutical composition. product combination present invention synergistically treat tumors.',\n",
              " 'rna-containing composition treatment cancer diseasesto provide compositions cancer immunotherapy effective treatment prophylaxis tumor and/or cancer diseases, particular compositions cancer vaccine.solution: present invention discloses rna containing composition, comprising non-coding immunostimulating rna, treatment prophylaxis tumor and/or cancer diseases. rna containing composition administered tumor injection tumor tissue. treatment prophylaxis includes administering pd-1 pd-l1 inhibitor. pd-1 inhibitor antagonistic antibody pd-1 pd-l1 inhibitor antagonistic antibody pd-l1. rna preferably complexed cationic polycationic compounds.selected drawing:',\n",
              " 'combination masked ctla4 pd1/pdl1 antibodies treating cancerthe invention activatable masked anti-ctla4 binding proteins (e.g., antibodies, bispecific antibodies, chimeric receptors) combination pd-1 signaling agents (e.g., pd-1 inhibitors pd-l1 inhibitors) treating cancer, compositions kits comprising activatable masked anti- ctla4 binding proteins pd-1 signaling agents.',\n",
              " 'combined application nk cell pd1/pd-l1 inhibitorthe invention relates field cell therapy antibody therapy, particular combined application nk cells pd1/pd-l1 inhibitor. nk cell prepared steps: 1) preparing mononuclear cell; (2) pretreating cell culture container cd137, cd28 cd3; 3) inoculating product obtained step 1) product obtained step 2), performing cell culture culture medium containing il-2, il-15, il-12, cd137 plasma; 4) supplementing culture medium containing plasma, il-2, il-15 il-12; (5) supplementing culture medium containing il-2, il-15 il-21.',\n",
              " 'pd-l1 inhibitor preparation method thereofthe invention discloses preparation inhibiting pd-l1 protein expression quantity tumor cells reducing positioning distribution pd-l1 proteins cell membranes. preparation comprises 2-bromine palmitate molar concentration 10-100 micromoles, fetal calf serum culture medium. preparation method includes steps: preparing 2-bromine palmitate concentrated solution culture medium containing fetal calf serum; adding 2-bromine palmitate concentrated solution culture medium containing fetal calf serum. preparationfor inhibiting pd-l1 protein expression quantity tumor cells reducing positioning distribution pd-l1 proteins cell membranes, expression pd-l1 proteins tumor cells reduced, positioning pd-l1 tumor cell membranes reduced, preparation double pd-l1 inhibiting effects, immune response cells activated, tumor immunity improved, preparation widely applied pd-l1 regulation biomedicine pharmaceutical research.',\n",
              " 'method treatment disease anti-tigit antibody combination pd-1 inhibitor pharmaceutical combinationthe present disclosure relates method treatment disease anti-tigit antibody combination pd-1 inhibitor pharmaceutical combinations. further, present disclosure relates treatment human tigit-related diseases (e.g., tumors) combination pd-1 inhibitor (e.g., anti-pd-1 antibody) anti-tigit antibody antigen-binding fragment thereof.',\n",
              " 'combination therapy cancerto provide methods treating cancer.solution: invention antibodies bind colony stimulating factor 1 receptor (csf1r) combination pd-1/pd-l1 inhibitors. pd-1/pd-l1 inhibitors anti-pd-1 antibodies antibodies comprising heavy chain comprising specific sequence light chain comprising specific sequence. preferably, anti-pd-1 antibodies comprise heavy chain light chain antibody selected nivolumab pembrolizumab. anti-pd-1 antibodies selected nivolumab pembrolizumab.selected drawing:',\n",
              " 'methods treating cancer pain administering pd-1 inhibitorthe present disclosure methods treating inhibiting cancer pain patient thereof, including selecting patient cancer, administering patient therapeutically effective amount programmed death 1 (pd-1) inhibitor. present disclosure methods reducing analgesic patient thereof, including selecting patient cancer, administering patient therapeutically effective amount pd-1 inhibitor, patient treated background analgesic therapy prior administration pd-1 inhibitor. embodiments, disclosed methods concurrently lead tumor regression, pain reduction, reduced analgesic therapy.',\n",
              " 'application ginsenoside rf preparation enhancer pd-1 inhibitor antitumor drugthe invention discloses application ginsenoside rf preparation pd-1 inhibitor anti-tumor enhancer, ginsenoside rf effects improving anti-tumor reaction rate pd-1 inhibitor, prolonging lifetime reducing toxicity, significant advantages enhancing pd-1 inhibitor treating tumors.',\n",
              " 'combination atr kinase inhibitors pd-1/pd-l1 inhibitorsthe present invention covers combinations components, component component b, comprising component inhibitor atr kinase, particularly inhibitor atr kinase selected vx-803, vx-970, azd-6738, compound general formula (i) described herein, compound general formula (ib) described compound described infra, component b pd-1/pd-l1 inhibitor described herein. aspect present invention covers combinations described preparation medicament treatment prophylaxis disease, particurlarly treatment hyper-proliferative disease.',\n",
              " 'combination pd-1 inhibitors lag-3 inhibitors enhanced efficacy treating cancerthe present disclosure methods treating inhibiting growth cancer comprising selecting patient cancer administering therapeutically effective amount lag-3 inhibitor combination therapeutically effective amount pd-1 inhibitor (e.g., anti-pd-1 antibody antigen-binding fragment thereof). embodiments, administration pd-1 inhibitor enhances efficacy lag-3 inhibitor (e.g., anti-lag-3 antibody antigen-binding fragment thereof) inhibiting growth cancer.',\n",
              " 'combination therapies comprising shp2 inhibitors pd-1 inhibitorsprovided combinations comprising shp2 inhibitor pd-1 inhibitor methods treating cancer. shp2 inhibitor pyrazine derivative. combination comprise pharmaceutical composition comprising shp2 inhibitor pharmaceutical composition comprising pd-1 inhibitor, co-packaged kit, include instructions.',\n",
              " 'pd-1 inhibitor preparation method application thereofthe invention discloses pd-1 inhibitor preparation method application thereof. inhibitor comprises extract, extract obtained extracting composition containing raw materials: semen coicis, semen benincasae, semen pruni persicae rhizoma phragmitis. prepared pd-1 inhibitor disclosed invention effectively act pd-1 target spot tumor cells, solves problem pd-1 target spot lost treatment process, reactivate immune cell function recover enhance tumor cell killing capacity.',\n",
              " 'application combination pd-1 inhibitor sting agonist tumor treatmentthe invention application pd-1 inhibitor combined sting agonist tumor treatment, belongs technical field medicines. application disclosed invention, research finds pd-1 inhibitor (bms1166) sting agonist (dmxaa) effectively inhibiting proliferation dlbcl cells. dmxaa induces activation cgas/sting pathway, promotes dlbcl cells highly express sting. expression pd-l1 promoted increasing expression sting, inhibition bms1166 cell viability enhanced. therefore, bms1166 dmxaa combined use, synergistic effect generated, remarkable anti-tumor effect achieved. invention technical support enhancing treatment reaction pd-1 inhibitor dlbcl optimizing treatment scheme pd-1 inhibitor.',\n",
              " 'suppression bone marrow-derived suppressor cells immune checkpoint blockingthe invention inhibition bone marrow-derived suppressor cells immune checkpoint blocking. unusual response observed patient treated checkpoint inhibition anti-pd-1 antibody anti-ctla-4 antibody. however, immunotherapy poorly immunogenic cancers challenging. treatment anti-pd-1 antibody anti-ctla-4 antibody eradicate appropriate immunogenic large tumor ct26 metastatic tumor 4t1. however, co-treatment epigenetic modulation checkpoint inhibitor significantly improves therapeutic outcome, 80% cured. functional studies reveal major target epigenetic modulators bone marrow-derived suppressor cells (mdsc). combined immune checkpoint inhibitor, pi 3k inhibitor reduces circulating mdsc cures 80% mice metastatic 4t1 tumors. therefore, cancer resistant immune checkpoint blocking cured eliminating mdsc.',\n",
              " 'application pseudo-ginseng pd-1 inhibitor preparation medicine treating cancerthe invention application pseudo-ginseng combined pd-1 inhibitor preparation medicine treating cancers. dosage range pseudo-ginseng 3-9g/d, dosage range pd-1 inhibitor 1-200mg weeks, pseudo-ginseng pd-1 inhibitor play synergistic effect, composition effect preventing treating lung cancer diseases regulating intestinal flora mice time.',\n",
              " 'combination therapies based pd-1 inhibitors sik3 inhibitorsthe invention relates combinations pd-1 inhibitor therapy kinase inhibitors, particular inhibitors protein kinases including sik-family, csf1r, abl/bcr-abl, src, hck, pdgfr, kit and/or mutants, overcome resistance pd-1/pdl1 inhibitor therapy tumours. preferred tumour disease treatable accordance invention squamous cell lung cancer pd-1 inhibitor therapy resistance phenotype.',\n",
              " 'methods treating cancer administering pd-1 inhibitorthe present disclosure methods treating inhibiting growth tumor, including selecting patient cancer, patient tumor threshold levels tumor mutation burden expression major histocompatibility complex, administering patient therapeutically effective amount programmed death 1 (pd-1) inhibitor (e.g., anti-pd-1 antibody antigen-binding fragment thereof). embodiments, cancer skin cancer, basal cell carcinoma cutaneous squamous cell carcinoma.',\n",
              " 'cd47 blockade therapycd47+ disease cells, cancers, treated combination cd47 blockade cell checkpoint inhibition. preferred embodiments sirpαfc combination pd-1 pathway inhibitor nivolumab and/or ctla-4 inhibitor ipilimumab.',\n",
              " 'combination therapy pyrimidone derivative ptpn11 inhibitor pd-1/pd-l1 inhibitor treatment cancerthe present disclosure method treating disease disorder (e.g., cancer) subject. method including administering subject: a) therapeutically effective amount ptpn11 inhibitor; b) therapeutically effective amount pd-1/pd-l1 inhibitor, ptpn11 inhibitor represent formula (i) pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, conformational isomer, tautomer, combination thereof, subscripts b, 1 , 2 , 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 13 provided herein. particular, present disclosure method treating solid tumor (e.g., advanced non-small cell lung cancer) therapeutically effective amount compound formula (10b) (i.e., 6-((3 ,4j )-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(r )-(2,3- dichlorophenyl)-2, 5 -dimethyl-4(3 )-pyrimidinone) combination pd-1/pd-l1 inhibitor (except nivolumab) subject, subject mutations kras.',\n",
              " 'methods treating lung cancer administering pd-1 inhibitorthe present disclosure methods treating inhibiting growth tumor, method includes selecting patient lung cancer brain metastasis thereof administering patient therapeutically effective amount programmed death 1 (pd-1) inhibitor (e.g., cemiplimab bioequivalent thereof). embodiments, lung cancer non-small cell lung cancer (nsclc) pd-l1 expressed ≥50% tumor cells. embodiments, methods lead improvements functioning quality life.',\n",
              " 'pharmaceutical combination anti-ceacam6 anti-pd-1 anti-pd-l1 antibodies treatment cancerpharmaceutical combination treatment cancer present invention relates combinations components, component component b treatment cancer, component anti-ceacam6 antibody component b anti-pd-1 antibody, preferentially nivolumab, pembrolizumab, anti-pd-l1 antibody, preferentially atezolizumab, avelumab, durvalumab.',\n",
              " 'ox-40 agonist, pd-1 pathway inhibitor ctla-4 inhibitor combination method treating cancer solid tumorprovided methods clinical treatment malignant tumors ( e.g. , advanced solid tumors) combination ox40 agonist, pd-1 pathway inhibitor, ctla-4 inhibitor.',\n",
              " 'combination lurbinectedin immune checkpoint inhibitordescribed combination therapies treatment solid tumours, therapies comprising lurbinectedin immune checkpoint inhibitor, example, anti-pd-1, anti-pd-l1 anti-ctla-4 antibodies.',\n",
              " 'intralesional administration pd-1 inhibitors treating skin cancerthe disclosure relates methods treating inhibiting growth tumor, methods include selecting subject skin cancer intralesionally administering tumor subject thereof therapeutically effective amount programmed death 1 (pd-1) inhibitor (e.g., antibody antigen-binding fragment thereof specifically binds pd-1, pd-l1, and/or pd-l2). embodiments, skin cancer cutaneous squamous cell carcinoma. embodiments, pd-1 inhibitor administered multiple locations tumor lesion.',\n",
              " 'method producing pd-1/pd-l1 inhibitor delphinium grandiflorumthe invention discloses active component extracted natural plant delphinium grandiflorum extraction method active component extracted natural plant delphinium grandiflorum, particularly relates fact active component extracted delphinium grandiflorum effectively block bonding pd1 pdl1, eliminates, inhibits, reduces orblocks interaction pd1 pdl1 subsequent action pd1 pdl1. medicine composition active component medicinal carrier effectively pd-1/pd-l1 inhibitor medicine composition active component medicinal carrier applied resistance tumor-related disease, reference provided clinical treatment schemes.',\n",
              " 'bacteroides fragilis immune checkpoint inhibitorthe present invention relates bacteroides fragilis immune checkpoint inhibitor. combination bacteroides fragilis immune checkpoint inhibitor preparation preventing treating lymphoma, deposit number bacteroides fragilis cgmcc no. 10685. compared prior art, present invention beneficial effects: large number experiments prove bacteroides fragilis zy-312 deposit number cgmcc no. 10685 combination immune checkpoint inhibitor, especially combination pd-1 inhibitor, synergistic effect lymphoma.',\n",
              " 'methods compositions tumor therapythe present invention compositions methods treatment cancer, cancers resistant immune checkpoint blockade and/or resistant treatment pd-1, pd-l1 ctla-4 inhibitors. embodiments present invention compositions comprising cd40 agonists (e.g. cd40 agonist antibodies), tlr agonists, and/or il10 receptor inhibitors il10 inhibitors, and/or combinations thereof, optionally immune checkpoint inhibitors, compositions treatment tumors.',\n",
              " 'pharmaceutical combinations comprising histone deacetylase inhibitor programmed death-ligand 1 (pd-l1) inhibitor methods thereofthe present disclosure relates pharmaceutical combination comprising (a) histone deacetylase 6 inhibitor (b) programmed death ligand 1 (pd-l1) inhibitor, including combined preparations pharmaceutical compositions thereof; combination treatment prevention cancer; methods treating preventing cancer subject comprising administering therapeutically effective amount combination.',\n",
              " 'pharmaceutical composition application thereofthe invention discloses pharmaceutical composition application thereof. pharmaceutical composition comprises pi3k inhibitor immune checkpoint inhibitor, pi3k inhibitor selected compound shown formula (i), linperlisib, samotolisib, copanilisb, shc014748m, pilaralisib, buparlisib, taseelisib, yzj-0673, gedatalisib, omipalisib, bimilisib, voxtalisib, al58805 hec68498 pharmaceutically acceptable salt compound shown formula (i), pi3k inhibitor selected compound shown formula (i) pharmaceutically acceptable salt pi3k inhibitor pharmaceutically acceptable salt pi3k inhibitor pharmaceutically acceptable salt pi3k inhibitor hec68498. immune checkpoint inhibitor pd-1 (programmed death-1)/pd-l1 (programmed death-l1) inhibitor. compound disclosed invention shown formula (ia) relatively high inhibition effect pi3k delta pi3k gamma kinase; addition, pharmaceutical composition, pi3k inhibitor pd-1 inhibitor combined, tumor inhibition effect effectively improved, problem resistance pd-1/pd-l1 inhibitor solved, pharmaceutical composition clinical application prospects.',\n",
              " 'application sirt1 inhibitors side effects caused combined vegfr inhibitors immune checkpoint inhibitorsthe invention belongs technical field medicines, relates application sirt1 inhibitors side effects caused combined vegfr inhibitors immune checkpoint inhibitors, particularly refers application sirt1 inhibitors prevention and/or treatment side effects caused combined vegfr inhibitors pd-1/pd-l1 inhibitordrugs. compared prior art, side effects caused combined vegfr inhibitors pd-1/pd-l1 inhibitor drugs cured.',\n",
              " 'pharmaceutical composition treating tumors application thereofthe invention discloses pharmaceutical composition treating tumors application medicine composition. pharmaceutical composition provided invention comprises compound shown formula pharmaceutically acceptable salt thereof, pd-1 inhibitor and/or pd-l1 inhibitor. components pharmaceutical composition combined mode, inhibition rate single medicine tumor growth remarkably increased, acute adverse reactions occur mice administration, shown combined therapy safety effectiveness.',\n",
              " 'pharmaceutical combination comprising tno155 pd-1 inhibitorthe present invention relates pharmaceutical combination comprising tno155 pd-1 inhibitor; pharmaceutical compositions comprising same; methods combinations compositions treatment prevention conditions shp2 inhibitor combined pd-1 inhibition beneficial in, example, treatment cancers.',\n",
              " 'application akt/stat3 target immune checkpoint inhibitorthe invention application akt/stat3 target spot immune checkpoint inhibitor, application akt/atat3 inhibitor preparation medicine treating tumors and/or autoimmune diseases preparation pd-1/pd-l1 inhibitor. akt/atat3 inhibitor significantly inhibit expression level pd-l1 inhibiting activity akt/stat3 pathway, blocking combination pd-1 pd-l1 restoring activity cells, enhancing anti-tumor immune response cells, inhibiting in-vitro proliferation tumor cells inducing apoptosis tumor cells, clinical application prospect.',\n",
              " 'application slamf9 tumor immunotherapythe invention discloses application slamf9 tumor immunotherapy, found immunotherapy effect anti-pd-l1 antibody ctla-4 inhibitor melanoma improved inhibiting slamf9 gene expression, slamf9 inhibiting product anti-pd-l1 antibody ctla-4 inhibitor combined mode, cd8 + cell infiltration tumor tissue promoted, immunotherapy effect melanoma improved. treatment effect anti-pd-l1 antibody ctla-4 inhibitor melanoma improved; detecting expression level slamf9 gene, sensitivity tumor patient immunotherapy anti-pd-l1 antibody ctla-4 inhibitor predicted.',\n",
              " 'methods compositions treating cancerprovided methods compositions treating cancer tumor subject administering subject cells reduced rgmb expression activity immune checkpoint inhibitor pd-1 pd-l1 inhibitor.',\n",
              " 'compositions methods treating cancer, overcoming pd-1/pd-l1 blockade resistance, determining resistance checkpoint inhibitor treatmentthe present disclosure relates method treating cancer. method includes obtaining biological sample subject; determining adaptive immunity gene panel expression level sample; determining pro-tumorigenic inflammation gene panel expression level sample; calculating checkpoint inhibitor treatment sensitivity score adaptive immunity gene panel expression level pro-tumorigenic inflammation gene panel expression level; administering anti-cancer treatment subject, anti-cancer treatment comprises checkpoint inhibitor treatment, checkpoint inhibitor sensitivity score critical value. disclosed methods overcoming pd-1/pd-l1 blockade resistance subject methods determining subject resistant checkpoint inhibitor treatment cancer. disclosed checkpoint inhibitor treatment sensitivity score associated checkpoint inhibitor treatment includes adaptive immunity gene panel pro-tumorigenic inflammation gene panel.',\n",
              " 'methods treating myeloproliferative neoplasmstherapeutic methods pharmaceutical compositions treating myeloproliferative neoplasm (mpn), including polycythemia vera (pv), essential thrombocythemia (et), myelofibrosis, described. embodiments, invention includes therapeutic methods treating mpn combination compound formula (i) formula (ii) therapeutic agent selected group consisting jak inhibitor, idh inhibitor, pd-1 inhibitor, pd-l1 inhibitor, pd-l2 inhibitor, interferon, pi3k inhibitor, akt inhibitor, mtor inhibitor, nucleoside analog, combinations thereof.',\n",
              " 'combination ep4 receptor antagonist pd-1 inhibitor cancer treatmentprovided combination ep4 receptor antagonist pd-1 inhibitor treating cancer. specifically, provided product combination comprising: (i) pharmaceutical composition comprising (a) active ingredient, active ingredient comprises ep4 receptor antagonist pharmaceutically acceptable carrier; (ii) pharmaceutical composition comprising (b) active ingredient, active ingredient comprises pd-1 inhibitor pharmaceutically acceptable carrier. pharmaceutical composition pharmaceutical composition different pharmaceutical compositions pharmaceutical composition. product combination present invention synergistically treat malignant tumors.',\n",
              " 'combination therapies chimeric antigen receptors pd-1 inhibitorsprovided compositions methods treating diseases, e.g., cancers, e.g., diseases associated expression antigen, e.g., cd19, comprising administering cell expresses chimeric antigen receptor (car) specific antigen, e.g., cd19, combination pd-1 inhibitor.',\n",
              " 'pharmaceutical composition treatment cancer, comprising immune checkpoint inhibitor antibody fusion protein comprising il-2 mutant cd80 extracellular domaina pharmaceutical composition containing, active ingredients, fusion protein dimer including il-2 protein variant thereof cd80 protein fragment thereof, immune checkpoint inhibitor disclosed. fusion protein containing cd80 fragment, fc domain immunoglobulin, il-2 variant activate immune cells natural killer cells control immune cell regulatory activity regulatory cells. addition, combined administration fusion protein immune checkpoint inhibitor keytruda pd-1 inhibitor effectively inhibit cancer. therefore, pharmaceutical composition containing, active ingredients, fusion protein dimer immune checkpoint inhibitor effectively applied treatment cancer high industrial applicability.',\n",
              " \"immune checkpoint inhibitor related myocarditis mouse model construction methodthe invention relates immune checkpoint inhibitor related myocarditis mouse model construction method, belongs technical field medical animal models. immune checkpoint inhibitor related myocarditis mouse model constructed subcutaneously injecting complete freund's adjuvant mouse cardiac troponin peptide fragment mouse injecting pd-1 inhibitor intraperitoneal cavity mouse. immune checkpoint inhibitor related myocarditis mouse model construction method, success rate modeling effectively improved determining reasonable dosage administration interval, model construction method simple easy implement easy popularize apply, immune checkpoint inhibitor related myocarditis mouse model constructed invention experimental object research clinical immune checkpoint inhibitor related myocarditis pathogenesis screening related myocarditis treatment drugs.\",\n",
              " 'combination therapies egfrviii chimeric antigen receptors pd-1 inhibitorsprovided compositions methods treating diseases, e.g., cancers, e.g., diseases associated expression antigen, e.g., egfrviii, comprising administering cell expresses chimeric antigen receptor (car) specific antigen, e.g., egfrviii, combination pd-1 inhibitor.',\n",
              " 'methods treating malignant glioblastomadisclosed methods identifying subjects, diagnosed glioblastoma (gbm), responders treatment programmed death protein 1 (pd-1) blockade. embodiments, subjects identified determining level phosphorylated extracellular-signal-regulated kinase (p-erk) gbm tumor sample subject. embodiments, gbm recurrent. disclosed methods treating gbm subjects, methods include (1) identifying subject responder pd-1 blockade, (2) administering pd-1 inhibitor and/or programmed death-ligand 1 (pd-l1) inhibitor.',\n",
              " 'treatment prognosis pancreatic cancerthe present invention ccr1 antagonists pharmaceutically acceptable salts, hydrates solvates thereof treatment pancreatic cancer, particular ccr1 antagonists, combination therapeutic agents effective antitumor agents treatment pancreatic cancer. antitumor agent chemotherapeutic agent selected group consisting gemcitabine, fluorouracil (5-fu), capecitabine, folfiriox (calcium folinate, fluorouracil, irinotecan hydrochloride, oxaliplatin), nabtaxol, combinations thereof. immune tumor agents (e.g., pd-1 inhibitors and/or pd-l1 inhibitors) advantageously ccr1 antagonists.',\n",
              " 'dosing cd38-binding fusion proteindisclosed methods treating cancer (e.g., hematologic solid tumor) cd38-binding fusion protein, optionally combination immune checkpoint inhibitor (e.g., pd-1 inhibitor pembrolizumab).',\n",
              " 'medications combination immunotherapyabstract application disclosures medications combination immunotherapy treatments cancers diseases. medications combination immunotherapy comprise kind immunotherapy medication kind immunotherapy medication. kind medication comprises: check point inhibitor. kind medication comprises: immunization vaccine. check point inhibitor selected group of: ctla-4 blockade, pd-1 inhibitor pd-l1 inhibitor. immunization vaccine selected vaccines available market list vaccines tested. 8 3063922 2019-12-04',\n",
              " 'treatment tumors anti-csf-1r antibody combination anti-pd-l1 antibody failure anti-pd-l1/pd1 treatmentthe current disclosure relates combination therapy anti-csf-1r antibody (especially csf-1r dimerization inhibitor) combination anti-pd-l1 antibody pd1/pd-l1 inhibitor treatment failure, corresponding pharmaceutical compositions medicaments combination therapy.',\n",
              " 'combination oncolytic virus, anti-pd-1 inhibitor activator innate immune system treatment prostate cancerthe disclosure relates pharmaceutical combination comprising oncolytic immunotherapeutic agent, programmed cell death-1 (pd-1) inhibitor activator innate immune system treatment cancer.',\n",
              " 'pharmaceutical composition treating cancer, method evaluating sensitivity treatment pd-1 inhibitorproblem solved: provide pharmaceutical composition treating cancer, provide method evaluating sensitivity treatment pd-1 inhibitor.solution: invention pharmaceutical composition treating cancer comprising mir-197, precursor thereof, variant thereof, vector expresses mir-197, precursor thereof, variant thereof. invention method evaluating sensitivity treatment pd-1 inhibitor patient pd-l1 related disease, method comprising (i) measuring mir-197 level organism sample sampled patient, (ii) evaluating patient high sensitivity treatment pd-1 inhibitor, mir-197 level lower standard value.selected drawing:',\n",
              " 'association faecalibacterium prausnitzii strain anti-pd-1, anti-pd-l1 anti-ctla-4 antibodies treatment cancerthe present invention relates association faecalibacterium prausnitzii bacterial strain deposited cncm accession number i-4573; immune checkpoint inhibitor, particular monoclonal antibody selected group consisting anti-pd-1, anti-pd-l1 anti-ctla-4 monoclonal antibodies preventing and/or treating cancer mammal patient. association considered.',\n",
              " 'application pd-1 inhibitor preparation biological agent improving immunization effect hepatitis b vaccine chronic kidney disease suffererthe invention application pd-1 inhibitor preparation biological agent improving immunization effect hepatitis b vaccine chronic kidney disease sufferer belongs technical field biological agents. application, pd-1 inhibitor effectively inhibiting high expression pd-1, improving expression level akt protein, activating pd-1/pd-l1 signal channel promoting secretion cd4+t cells expression il-2 ifn-gamma, immunization effect hepatitis b vaccine chronic kidney disease sufferer improved, immunization effect hepatitis b vaccine improved manner pd-1 inhibitor matched increase number times inoculation hepatitis b vaccine dosage inoculation time. therefore, invention application pd-1 inhibitor improvement immunization effect hepatitis b vaccine chronic kidney disease sufferer.',\n",
              " 'anti-tigit antibodies methods thereofthe present disclosure antibodies specifically bind tigit. antibodies variety therapeutic, diagnostic monitoring applications, described disclosure. example, antibodies treat cancer patient, particular patient receiving received treatment immune checkpoint inhibitor, pd-1/pd-l1 inhibitor.',\n",
              " 'methods treating lung cancer administering pd-1 inhibitorthe present disclosure methods treating tumor inhibiting tumor growth, methods comprise selecting patient suffering lung cancer brain metastasis thereof administering patient therapeutically effective amount programmed death 1 (pd-1) inhibitor (e.g., samiprimab biological equivalent thereof). embodiments, lung cancer non-small cell lung cancer (nsclc) pd-l1 expressed > = 50% tumor cells. embodiments, methods result improvements function quality life.',\n",
              " 'application composition preparation components salvia miltiorrhiza astragalus membranaceus resisting liver cancer cooperation pd-1 inhibitorthe invention relates application composition preparation salvia miltiorrhiza astragalus mongholicus resisting liver cancer cooperation pd-1 inhibitor. composition salvia miltiorrhiza astragalus membranaceus composition formed compatibility tanshinone iia serving active ingredient salvia miltiorrhiza astragaloside serving active ingredient astragalus membranaceus. active ingredient composition disclosed invention effect improving anti-tumor curative effect cooperating pd-1 inhibitor. addition, in-vivo delivery realized preparation form cooperation pharmaceutically acceptable carrier, mof, microemulsion selected carrier, insoluble components, tanshinone iia astragaloside, carried together. carriers significantly improve solubility bioavailability tanshinone iia astragaloside, passively targeted tumor tissues epr effect actively targeted tumor tissues membrane modification. mof carrier advantage high loading capacity, micro-emulsion carrier simple preparation process beneficial industrial production. compounds respectively combined pd-1 inhibitor, anti-tumor curative effect pd-1 inhibitor remarkably improved.',\n",
              " 'compositions methods treating mage-a1-expressing diseasethe present disclosure compositions methods treating diseases disorders associated mage-a1 expression, cancers, including triple negative breast cancer, non-small cell lung cancer, urothelial cancer. embodiments, methods comprise administering population modified immune cells comprise binding protein specific mage-a1 subject negative hla-b*49:01. embodiments, methods comprise administering population modified immune cells comprise binding protein specific mage-a1 subject lymphodepleted undergone lymphodepletion procedure, administered pd-1 inhibitor, and/or pd-l1 inhibitor, and/or negative hla-b*49:01.',\n",
              " 'heterocyclic compounds immunomodulators pd-l1 interactionspd-l1 inhibitors compound formulas, generically specifically disclosed. methods making pd-l1 inhibitor compounds disclosed, generically specifically. methods pd-l1 inhibitor compounds singly combination additional agents compositions pd-l1 inhibitor compounds treatment cancer conditions disclosed.',\n",
              " 'compounds immunomodulators pd-l1 interactionspd-l1 inhibitors compound formulas, generically specifically disclosed. methods making pd-l1 inhibitor compounds disclosed, generically specifically. methods pd-l1 inhibitor compounds singly combination additional agents compositions pd-l1 inhibitor compounds treatment cancer conditions disclosed.',\n",
              " 'compositions methods increasing efficacy anti-pd-1 antibody immunotherapythe present disclosure provides, part, compositions methods increasing efficacy anti-pd-1/pd-l1 antibody immunotherapy subject. compositions methods comprise nlrp3 inhibitor combination pd-1 pd-l1 inhibitor treatment cancer.',\n",
              " 'pharmaceutical composition enhancing antitumor effect immune checkpoint inhibitorfield: medicine; pharmaceutics.substance: object 1 5-aminolevulinic acid salt composite ester enhancing antitumor effect immune checkpoint inhibitor, immune checkpoint inhibitor anti-pd-l1 antibody anti-pd-1 antibody, specified 5-aminolevulinic acid salt composite ester systematically injected subject it. object 2 5-aminolevylinic acid salt composite ester, producing enhancing antitumor effect anti-pd-l1 antibody anti-pd-1 antibody.effect: enhancing antitumor effect immune checkpoint inhibitors, anti-pd-1 antibody anti-pd-l1 antibody, 5-aminolevulinic acid.4 cl, 4 dwg, 2',\n",
              " 'treatment cancer tgf-beta inhibitors pd-1 inhibitorsthe present disclosure relates generally combination therapy treating cancer preventing recurrence cancer disease transforming growth factor beta (tgf beta) inhibitor programmed cell death protein 1 (pd-1) inhibitor, cancer diseases lung cancer, prostate cancer, breast cancer, hepatocellular cancer, esophageal cancer, colorectal cancer, pancreatic cancer, bladder cancer, kidney cancer, ovarian cancer, gastric cancer, fibrotic cancer, glioma melanoma, metastases thereof.',\n",
              " 'kit evaluating occurrence risk immune-related adverse events treatment liver cancer pd-1 inhibitorthe invention relates kit containing ana detection reagent, application kit irae (immune-related adverse events) occurrence risk, irae occurrence time prognosis evaluation liver cancer patient receives pd-1 inhibitor treatment. invention, compared ana-patient, ana + patient easier generate irae; time ana + patient pd-1 inhibitor treatment irae attack shorter ana-patient; ana + important index poor prognosis pfs (progression-free lifetime) (total lifetime).',\n",
              " 'method treating cancer immune checkpoint inhibitorthe invention method treating hpv-positive squamous cell carcinoma head neck comprising administering subject immune checkpoint inhibitor, e.g., anti-pd-1 antibody anti-pd-l1 antibody. disclosure method treating hpv-negative squamous cell carcinoma head neck administering subject immune checkpoint inhibitor,e.g., anti-pd-1 antibody anti-pd-l1 antibody. subject additionally administered anti-cancer agent.',\n",
              " 'traditional chinese medicine component composition application preparation traditional chinese medicine component composition resisting tumors cooperation pd-1 inhibitorthe invention relates application traditional chinese medicine component composition preparation thereof resisting tumors cooperation pd-1 inhibitor. traditional chinese medicine active ingredient composition composition formed compatibility oxymatrine astragaloside, compatibility oxymatrine astragaloside improve anti-tumor curative effect pd-1 inhibitor. addition, in-vivo delivery realized preparation form cooperation pharmaceutically acceptable carrier, iron-based mof, lipidosome selected carrier, co-loading oxymatrine astragaloside different polarities efficient delivery realized. iron-based mof carrier advantages loading capacity high, fe ions cooperate astragaloside improve activity tumor infiltrating cells, tumor tissues precisely targeted ferromagnetism platelet membrane modification; preparation process liposome mature, industrial production facilitated, clinical transformation prospect wide, anti-tumor curative effect pd-1 inhibitor remarkably improved liposome pd-1 inhibitor respectively combined use.',\n",
              " 'anti-pd-l1 nanobody thereofprovided anti-pd-l1 nanobody thereof. anti-pd-l1 nanobody contains cdr1, cdr2 cdr3, cdr1 contains sequence selected seq id nos: 1, 5 9, cdr2 contains sequence selected seq id nos: 2, 6 10, cdr3 contains sequence selected seq id nos: 3, 7, 11 14. antibody block signaling pathways pd-1/pd-l1 cd-80/pd-l1, inhibit growth tumor cells, exhibit tumor treatment effect.',\n",
              " 'combination therapy hsp90 inhibitors pd-1 inhibitors treating cancera pharmaceutical composition comprising pd-1 inhibitor hsp90 inhibitor, tautomer, pharmaceutically acceptable salt thereof, hsp90 inhibitor 3-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(1-methyl-indol-5-yl)-5-hydroxy-[1,2,4] triazole 5-hydroxy-4-(5-hydroxy-4-(1-methyl-1h-indol-5-yl)-4h-1,2,4-triazol-3-yl)-2-isopropylphenyl dihydrogen phosphate. provided method treating cancer subject thereof, pharmaceutical composition described herein.',\n",
              " 'altered virusthe invention relates oncolytic virus encoding ctla-4 inhibitor, anti-ctla-4 antibody, antigen binding fragment thereof.',\n",
              " 'compositions comprising coformulation anti-pd-l1 anti-ctla-4 antibodiesprovided compositions comprising coformulation anti-pd-l1 anti-ctla-4 antibodies, antigen-binding fragments thereof, methods making compositions. aspects, stable coformulations anti-pd-l1 antibody durvalumab (medi4736) anti-ctla-4 antibody tremelimumab provided.',\n",
              " 'anti-pd-l1 nanobody trifunctional fusion proteinthe present invention relates anti-pd-l1 nanobody trifunctional fusion protein. anti-pd-l1 nanobody fc fusion protein thereof strong specificity, high affinity, weak immunogenicity humans, remarkable anti-tumor effect. trifunctional fusion protein comprises tgf-β inhibitor, vegf inhibitor pd-l1 inhibiting antibody, high affinity human vegf protein tgf-β protein affinity human pd-l1 protein; moreover, trifunctional fusion protein block binding human pd-1/pd-l1 protein.',\n",
              " 'combinations transcription inhibitors immune checkpoint inhibitors treatment disease.provided methods treating patients combination transcription inhibitor (e.g., stat3 inhibitor) immune checkpoint blockade therapy (e.g., anti- pd-1 therapy, anti-pd-l1 therapy, anti-ctla-4 therapy). patient proliferative disease, cancer psoriasis. patient pathogenic infection.',\n",
              " 'improved treatments difficult treat triple negative breast cancer patients advanced and/or metastatic diseasethis invention area improved treatments select group patients advanced/metastatic triple negative breast cancer (tnbc) provide increased survival. particular, improved treatments targeted group patients receiving first-line treatment advanced/metastatic tnbc checkpoint inhibitor treatment-naive or, alternatively, patients advanced/metastatic tnbc prior exposure immune checkpoint inhibitor, example, programmed cell death protein-1 (pd-1) and/or programmed death-ligand-1 (pd-l1) inhibitor, first-line chemotherapeutic setting developed therapeutic resistance immune checkpoint inhibitor leading disease progression initial response.',\n",
              " 'anti-tumor agent containing immunomodulator anti-tumor effect potentiatorprovided dna function inhibitor immunomodulator manufacture antitumor agent treatment cancer, dna function inhibitor combination containing trifluridine tipiracil hydrochloride molar ratio 1 : 0.5; immunomodulator anti-pd-1 antibody anti-pd-l1 antibody combination thereof, anti-pd-1 antibody nivolumab pembrolizumab, anti-pd-l1 antibody atezolizumab, durvalumab, avelumab; cancer targeted gastrointestinal cancer, lung cancer, breast cancer.',\n",
              " 'enhancing anti-tumor immunityprovided treatment method response rate and/or life-extending effectiveness nonhuman mammals cancer. provided are: method treating cancer non-human mammals, method comprising starting treatment pd-1/pd-l1 inhibitor radiation therapy; composition treating cancer non-human mammals, composition comprises pd-1/pd-l1 inhibitor administration composition begun radiation therapy; pd-1/pd-l1 inhibitor method treating cancer nonhuman mammals, method comprises starting treatment pd-1/pd-l1 inhibitor radiation therapy.',\n",
              " 'anti-pd-l1 antibody il-7 fusionsprovided fusion molecule pd-l1 inhibitor fused human il-7 protein fragment thereof peptide linker. fusion molecules exhibit synergistic anti-tumor effects.',\n",
              " 'methods compositions treatment persistent infections inhibiting programmed cell death 1 (pd-1) pathwaydisclosed programmed cell death-1 (pd-1) inhibitor manufacture medicament formulated alleviate prevent persistent infection subject, pd-1 inhibitor antil-pd-1 antibody, anti-pd-l1 antibody, anti-pd-l2 antibody, anti-pd-1 rnai, anti-pd-l1-rnai, anti-pd-l2-rnai, anti-pd-1 antisense rna, anti-pd-l1 antisense rna, anti-pd-l2 antisense rna, dominant negative pd-1 protein, dominant negative pd-l1 protein, dominant negative pd-l2 protein.',\n",
              " 'immune checkpoint inhibitor applicationthe invention belongs technical field medicines, discloses immune checkpoint inhibitor application thereof, zg16 protein lectin oligopeptide immune checkpoint inhibitor preparing medicines related diseases treated anti-pd-l1, anti-pd1, ctla4 cd40 genes, zg16 adopted immune checkpoint inhibitor protein naturally existing gastrointestinal tracts, zg16 lectin oligopeptide preparing medicines related diseases treated anti-pd-l1, anti-pd1, ctla4 cd40 genes. protein naturally present gastrointestinal tract, expected side effects compared conventional treatments; experiments show immune checkpoint inhibitor, zg16 activates cells blocking pd1 ctla4 regulating expression cd40 gene, treatment effect tumor diseases related diseases anti-pd-l1, anti-pd1, anti-ctla4 cd40 gene therapy realized.',\n",
              " 'oncolytic viruses, combination checkpoint inhibitor, treatment cancerthe present invention relates oncolytic viruses (e.g., talimogene laherparepvec), combination immune checkpoint inhibitors (e.g., anti-ctla-4, anti-pd-1, anti-pd-l1 compounds antibodies) treatment types cancer. addition, present invention relates compositions kits relating oncolytic viruses, combination immune checkpoint inhibitors.',\n",
              " 'application pd-1 inhibitor pp2a phosphatase inhibitor bladder cancer treating drugsthe invention discloses combined action pd-1 inhibitor pd-1 antibody pp2a phosphatase inhibitor lb100 effectively inhibit growth bladder cancer tumors mice. specific adopted method comprises mice bladder cancer cells implanted mice subcutaneously make mice bladder cancer cells tumorigenic, drugs administered mice; synergistic effect pd-1 antibody lb100 found enhance killing activity immune cells tumor cells, effectively inhibit growth mice tumors achieve effect treating bladder cancer.',\n",
              " 'anti-galectin-9 antibodies thereofdisclosed anti-galectin-9 antibodies methods modulating (e.g., increasing) immune responses subject, combination immune checkpoint inhibitor, pd-1 inhibitor.',\n",
              " 'polymeric delivery conjugates methods making thereofdescribed biodegradable delivery conjugates anti-cancer conjugates effectively delivering anti-cancer agents subject. conjugates include single cleavable peptide linker covalently connected polymeric segments, pd-l1 inhibitor covalently bonded polymeric segment (referred \"a pd-l1 inhibitor polymer conjugate\"). described pd-l1 inhibitor polymer conjugates combination anticancer agents treat prevent cancer.',\n",
              " \"pd-1/pd-l1 inhibitorsinternational application published patent cooperation treaty (pct) (19) world intellectual property organization international bureau (43) international publication date 25 october 2018 (25.10.2018) wipo pct omit iil °nolo oimie (10) international publication number 2018/195321 (51) international patent classification: c07d 405/14 (2006.01) co7d 519/00 (2006.01) a61k 31/497 (2006.01) a61p 35/00 (2006.01) co7d 403/14 (2006.01) co7d 401/14 (2006.01) co7d 241/18 (2006.01) co7d 401/04 (2006.01) co7d 241/20 (2006.01) co7d 498/04 (2006.01) co7d 487/08 (2006.01) co7d 213/61 (2006.01) co7d 487/10 (2006.01) co7d 213/64 (2006.01) co7d 491/107 (2006.01) (21) international application number: pct/us2018/028382 (22) international filing date: 19 april 2018 (19.04.2018) (25) filing language: english (26) publication language: english (30) priority data: 62/488,017 20 april 2017 (20.04.2017) 62/507,678 17 2017 (17.05.2017) (71) applicant: gilead sciences, inc. [us/us]; 333 lakeside drive, foster city, california 94404 (us). (72) inventors: aktoudianakis, evangelos; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). appleby, todd; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). cho, aesop; c/o gilead sciences, inc., 333 lakeside dri- ve, foster city, california 94404 (us). du, zhimin; c/ gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). graupe, michael; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). guerrero, juan a.; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). jabri, salman y.; 870 harrison st., unit 404, san francisco, california 94107 (us). lad, lateshku- thakorlal; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). machicao tello, paulo a.; c/o gilead sciences, inc., 333 lake- side drive, foster city, california 94404 (us). medley, jonathan william; c/o gilead sciences, inc., 333 lake- side drive, foster city, california 94404 (us). meto- bo, samuel e.; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). mukherjee, declarations rule 4.17: prasenjit kumar; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). nadutham- 1-1 bi, devan; c/o gilead sciences, inc., 333 lakeside dri- ve, foster city, california 94404 (us). notte, grego- ry; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). parkhill, eric q.; c/o gilead sciences, inc., 333 lakeside drive, foster city, cal- (54) title: pd-1/pd-l1 inhibitors ifornia 94404 (us). phillips, barton w.; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). simonovich, scott preston; c/o gilead sciences, inc., 333 lakeside drive, foster city, califor- nia 94404 (us). squires, neil h.; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). venkataramani, chandrasekar; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). wang, peiyuan; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). watkins, william j.; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). xu, jie; c/o gilead sciences, inc., 333 lakeside drive, foster city, california 94404 (us). yang, shing; c/o gilead sciences, inc., 333 lakeside drive, foster city, califor- nia 94404 (us). ziebenhaus, christopher allen; c/o gilead sciences, inc., 333 lakeside drive, foster city, cal- ifornia 94404 (us). (74) agent: tanner, lorna l. al.; sheppard mullin richter & hampton, 379 lytton avenue, palo alto, california 94301-1479 (us). (81) designated states (unless indicated, kind national protection available): ae, ag, al, am, ao, at, au, az, ba, bb, bg, bh, bn, br, bw, by, bz, ca, ch, cl, cn, co, cr, cu, cz, de, dj, dk, dm, do, dz, ec, ee, eg, es, fi, gb, gd, ge, gh, gm, gt, hn, hr, hu, id, il, in, ir, is, jo, jp, ke, kg, kh, kn, kp, kr, kw, kz, la, lc, lk, lr, ls, lu, ly, ma, md, me, mg, mk, mn, mw, mx, my, mz, na, ng, ni, no, nz, om, pa, pe, pg, ph, pl, pt, qa, ro, rs, ru, rw, sa, sc, sd, se, sg, sk, sl, sm, st, sv, sy, th, tj, tm, tn, tr, tt, tz, ua, ug, us, uz, vc, vn, za, zm, zw. (84) designated states (unless indicated, kind regional protection available): aripo (bw, gh, gm, ke, lr, ls, mw, mz, na, rw, sd, sl, st, sz, tz, ug, zm, zw), eurasian (am, az, by, kg, kz, ru, tj, tm), european (al, at, be, bg, ch, cy, cz, de, dk, ee, es, fi, fr, gb, gr, hr, hu, ie, is, it, lt, lu, lv, mc, mk, mt, nl, no, pl, pt, ro, rs, se, si, sk, sm, tr), oapi (bf, bj, cf, cg, ci, cm, ga, gn, gq, gw, km, ml, mr, ne, sn, td, tg). applicant's entitlement claim priority earlier application (rule 4.17(iii)) 1-1 © (57) : compounds formula (i), methods compounds singly combination additional agents compositions compounds treatment cancer disclosed. [continued page] 2018/195321 iimedimom0101011efiederimeiiimovoillii0voimie published: international search report (art. 21(3)) expiration time limit amending claims republished event receipt amendments (rule 48.2(h))\",\n",
              " 'bacteroides fragilis combined immune checkpoint inhibitor treatment skin tumorsdisclosed bacteroides fragilis combined immune checkpoint inhibitor treatment skin tumors, particular combination bacteroides fragilis zy-312 deposit number cgmcc no. 10685 pd-1 inhibitor, significantly improve comprehensive efficacy treating skin tumors. means reducing levels proinflammatory factors il-1, il-6, il-8 vegf, increasing migration cd8+ effector cells reducing recruitment treg cells, bacteroides fragilis reduce weight in-situ tumors increase cancer inhibition rate effectively prevent treat occurrence, development, recurrence metastasis melanoma, reduce harm radiotherapy chemotherapy body, improve quality life patients.',\n",
              " '3- 1 pharmaceutical composition combination radiotherapy treating triple negative breast cancer comprising phosphatidylinositol 3-kinase inhibitor programmed cell death protein 1 inhibitorthe present invention pharmaceutical composition combination radiation therapy treating triple negative breast cancer. specifically, pharmaceutical composition comprises pd-1 inhibitor pi3kγδ inhibitor, pd-1 inhibitor pi3kγδ inhibitor combination radiation therapy, pharmaceutical composition superior tumor suppression immunity enhancing effects compared monotherapy therapeutic agent.',\n",
              " 'combined ubenimex immune checkpoint inhibitorsthe purpose present invention provide effective treatment method cancer treatment utilizes tumor immune system. purpose present invention provide, effective tumor immunotherapy, enhances antitumor, pro-inflammatory anti-inflammatory cytokine production. purpose present invention provide, effective tumor immunotherapy, increases tumor-infiltrating lymphocytes. anti-tumor agent ubenimex active component, dosed combination anti-pd-1 antibodies, anti-pd-l1 antibodies and/or anti-ctla-4 antibodies, immune checkpoint inhibitors (icis). ubenimex ici combination therapy brings improvement tumor immune system compared alone, brings benefits treatment malignant tumors.',\n",
              " 'biomarkers predicting response checkpoint inhibitorsthe present invention biomarkers predicting response checkpoint inhibitors. inventor proves pd-1/pd-l1 inhibitor anti-tumor activity tumors low expression pd-l1 immune desert phenotype blocking pd-l1 lymph nodes. present invention combinations intratumoral markers antigen cross-presenting cells cell chemokines, expected efficacy predictive biomarkers compared existing methods.',\n",
              " 'application metformin preparation antitumor enhancing effect immune checkpoint inhibitorthe invention discloses application metformin preparation antitumor enhancing effect immune checkpoint inhibitor. metformin adopted carry in-vitro pretreatment tumor bearing mouse-derived tumor cells, intraperitoneal injection in-vivo administration carried out, ampk transient/continuous activated tumor model constructed, pd-l1 antibody contrast igg treatment, determined metformin immune checkpoint inhibitor synergistic effect, immune checkpoint inhibitor immune checkpoint inhibitor. synergistic effect depends nk cells. invention discloses application metformin synergistic immune checkpoint inhibitor preparation anti-tumor drugs anti-tumor composition based immune checkpoint blocking. anti-tumor pharmaceutical composition comprises immune checkpoint inhibitor metformin.',\n",
              " 'anti-tumor combined pharmaceutical composition application thereofthe invention relates technical field medicines, discloses anti-tumor combined pharmaceutical composition application thereof. anti-tumor combined pharmaceutical composition prepared cis-platinum nano-drug pd1/pd-l1 inhibitor. found cis-platinum nano-drug induce high expression tumor pd-l1 dose time dependence; intravenous administration, high expression tumor pd-l1 continuously induced, pd1/pd-l1 inhibitor opportunities block pd1/pd-l1 signal channel, killer cells activated; combination pd1/pd-l1 inhibitor, achieve synergistic effect, inhibition tumors enhanced. cis-platinum nano-drug pd1/pd-l1 inhibitor combined synergistically enhance inhibition effect tumor growth, wide application prospect achieved field cancer treatment.',\n",
              " 'synergistic anti-tumor drugthe invention belongs field biological medicines, relates synergistic anti-tumor drug, particular application composition containing vesicular stomatitis virus, pi3k inhibitor pd-1 inhibitor preparation anti-glioma drugs. found time three-drug combination vesicular stomatitis virus, pi3k inhibitor pd-1 inhibitor greatly improves reactivity immunotherapy improves treatment effectiveness immune checkpoint inhibitor anti-tumor drug. anti-tumor extremely important meaning treating tumors resisted immunotherapy.',\n",
              " 'therapy methods introducing immature dendritic cells and/or cytoxic lymphocyte anti pd-1 / pd-l1 antibody treatment tumorsthe invention relates therapy methods applying therapy patient. invention includes introduction immature dendritic cells patient introduction pd-1 and/or pd-l1 inhibitor patient. immature dendritic cells introduced intratumorally and/or vessel pd-1 and/or pd-l1 inhibitor introduced intratumorally and/or vessel and/or subcutaneously. immature dendritic cells formed collecting monocyte cells patient culturing cells culture medium. invention effective regress, reduce eliminate tumor cells tumor tissue patients, including metastasized tumors. further, treatment invention effective absence conventional therapy, radiotherapy chemotherapy.',\n",
              " 'therapy methods introducing immature dendritic cells and/or cytotoxic lymphocyte anti pd-1 / pd-l1 antibody treatment tumorsthe invention relates therapy methods applying therapy patient. invention includes introduction immature dendritic cells patient introduction pd-1 and/or pd-l1 inhibitor patient. immature dendritic cells introduced intratumorally and/or vessel pd-1 and/or pd-l1 inhibitor introduced intratumorally and/or vessel and/or subcutaneously. immature dendritic cells formed collecting monocyte cells patient culturing cells culture medium. invention effective regress, reduce eliminate tumor cells tumor tissue patients, including metastasized tumors. further, treatment invention effective absence conventional therapy, radiotherapy chemotherapy.',\n",
              " 'pharmaceutical combination thereofa pharmaceutical combination thereof. pharmaceutical combination comprises pd-1 inhibitor and/or pd-l1 immune checkpoint inhibitor; sting pathway agonist. pharmaceutical combination antitumor efficacy immune checkpoint inhibitor sting pathway agonist alone, realizes treatment innate immune pathway activation organisms immune escape prevention, efficient low-toxicity clinical application prospects.',\n",
              " 'method treating tumor combination il-7 protein immune checkpoint inhibitorthe present disclosure relates methods treating cancer (or tumor) il-7 protein combination immune checkpoint inhibitor, pd-1 antagonist (e.g., anti-pd-1 antibody) ctla-4 antagonist (e.g., anti-ctla-4 antibody).',\n",
              " 'human monoclonal anti-pd-l1 antibodies methods usethe present invention includes human monoclonal antibodies bind pd-l1 (also referred programmed death ligand 1 b7h1). binding antibodies invention pd-l1 inhibits binding receptor pd1 (programmed death 1) ligand-mediated activity treatment cancer chronic viral infections.',\n",
              " 'methods enhancing immune checkpoint blocking therapy modulation microbiomeprovided methods compositions treating cancer modulating microbiome enhance efficacy immune checkpoint blocking. microbiome modulated administration butyrate and/or butyrate-producing bacteria. provided methods determining response immune checkpoint inhibitor identifying subject favorable microbiological profile.',\n",
              " 'ampk composition preventing treating cancer disease comprising immune checkpoint blockade amp-activated protein kinase activatorthe present invention relates composition preventing treating cancer, containing immune checkpoint inhibitor amp-activated protein kinase (ampk) activator active ingredients. specifically, result co-treatment ampk activator anti-pd-1 antibody anti-ctla-4 antibody immune checkpoint inhibitors melanoma mouse animal model, confirmed tumor reduction effect experimental group co-treated immune checkpoint inhibitor, anti-pd-1 antibody anti-ctla-4 antibody, ampk activator excellent compared control group ampk activator administered alone. accordingly, composition containing immune checkpoint inhibitor ampk activator active ingredients provided composition preventing treating cancer immuno-cancer agent.',\n",
              " 'immunotherapy combination treating solid tumorsthe present invention relates technical field biological medicines, particular relates immunotherapy combination treating solid tumors. provided immunotherapy combination immune combination therapy treating solid tumors. immunotherapy combination composed pd-1/pd-l1 inhibitor toxoplasma vaccine, toxoplasma non-toxic toxoplasma or/and attenuated toxoplasma, solid tumors immune-tolerant solid tumors. provided immunotherapy combination immune combination therapy treating solid tumors. found non-toxic toxoplasma or/and attenuated toxoplasma combination pd-1/pd-l1 inhibitor effectively treat immune-tolerant solid tumors, curative effect application range pd-1/pd-l1 inhibitor expanded.',\n",
              " 'lurbinectedin combinationsdescribed combination therapies treatment solid tumours, therapies comprising lurbinectedin immune checkpoint inhibitor, example, anti-pd-1, anti-pd-l1 anti-ctla-4 antibodies.',\n",
              " 'application bacteroides fragilis capsular polysaccharide combination pd-1 inhibitor preparation pharmaceutical treating skin tumorsan application bacteroides fragilis capsular polysaccharide combination pd-1 inhibitor preparation pharmaceutical treating skin tumors; particular, capsular polysaccharide bacteroides fragilis zy-312 preservation number cgmcc no. 10685 achieve synergistic effect pd-1 antibody, immune factor regulated, state immune cell improved, anti-tumor immune response organism enhanced, growth proliferation rate skin tumor remarkably inhibited, malignant melanoma squamous cell carcinoma; capsular polysaccharide active ingredient, prepared biological agent pharmaceutical formulation pharmaceutical composition.',\n",
              " 'method device accurately predicting curative effect deb-tace combined pd-1 inhibitor liver cancer based multi-omics dataa liver cancer deb-tace combined pd-1 inhibitor curative effect accurate prediction method based multi-omics data characterized prediction model generated steps: step 1, obtaining preoperative ct/mri image liver cancer patient, carrying image preprocessing tumor region segmentation, extracting radiomics conventional features depth features, carrying feature screening; step 2, acquiring genomics data, performing correlation analysis radiomics features genomics features, clustering large number radiomics features small number feature modules specific biological basis; 3, quantifying expression level protein marker sample, generating data, obtaining proteomics characteristics adopting deep learning method, performing characteristic screening; step 4, splicing image omics features, proteomics features clinical features form feature matrix, accessing feature matrix full-connection neural network form deep feed-forward network, training network, outputting deb-tace combined pd-1 inhibitor curative effect prediction result liver cancer patient.',\n",
              " 'pharmaceutical combination thereofa pharmaceutical combination thereof. pharmaceutical combination comprises pd-1 inhibitor and/or pd-l1 immune checkpoint inhibitor, toll-like receptor agonist. present pharmaceutical combination medicinal effect immune checkpoint inhibitor toll-like receptor agonist, treatment two-pronged approach activation innate immune pathway prevention immune escape implemented, present invention clinical application prospects highly effective low toxicity.',\n",
              " 'immune checkpoint inhibitor combination therapy treating cancerthe present invention relates combination therapy immune checkpoint inhibitor treatment cancer. specifically, present invention exhibits significant synergy anticancer compound chemical formula 1 pharmaceutically acceptable salt thereof administered triple combination anticancer agents (for example, anti-pd-1 antibody, anti-pd-l1 antibody, anti-ctla4 antibody), effect usefully cancer treatment.',\n",
              " 'application combination quinoline derivative immunomodulator preparation antitumor drugsto provide combination quinoline derivative immunomodulator preparation antitumor drugs.solution: composition comprises compound illustrated cominbed immunomodulator treat tumor. immunomodulator pd-1 antibody. tumor selected group consisting selected colon cancer, hepatoma, renal cell carcinoma, gastric cancer, non-small-cell lung cancer. pd-1 antibody selected sintilimab, toripalimab, rmp1-14, camrelizumab, tislelizumab cemiplimab.selected drawing:',\n",
              " 'bi-specific activators tumor therapythe present invention compositions methods treatment cancer, including, limited to, cancers resistant immune checkpoint blockade and/or resistant treatment pd-1, pd-l1 ctla-4 inhibitors. embodiments present invention compositions comprising \"bi-specific activators\" - nanoparticles cd40 agonist antibody antibody specific tumor-associated antigen surface. embodiments nanoparticles comprise vaccine adjuvants, inside nanoparticles. present invention relates compositions treatment tumors.',\n",
              " 'nitrophenyl ether compound, preparation method therefor, pharmaceutical composition thereof, thereofthe present invention relates field drugs, particularly relates nitrophenyl ether compound structural characteristics general formula (i), stereoisomer, metabolite, metabolic precursor, prodrug, solvate, crystal, pharmaceutically acceptable salt thereof, preparation method therefor, thereof pd-1/pd-l1 inhibitors. pharmacological experiment results show compound present invention remarkable inhibition activity pd-1/pd-l1 protein-protein interaction effectively inhibit pd-1/pd-l1 mediated tumor immune escape, compound preparing inhibitor activity inhibiting pd-1/pd-l1 immune checkpoint inhibitor immunotherapy tumors.',\n",
              " 'conjoint therapy glutaminase inhibitorsthe invention relates methods treating cancer heterocyclic glutaminase inhibitor compounds conjointly pd1 pd-l1 inhibitor.',\n",
              " 'vinylpyridine carboxamide compound pd-l1 immunomodulatordisclosed pd-l1 inhibitor, specifically disclosed compound formula (i) pd-l1 immunomodulator, pharmaceutically acceptable salt isomer thereof.',\n",
              " 'combined medicine treating and/or preventing lung cancer applicationthe invention belongs technical field medicines, particularly relates combined medicine treating and/or preventing lung cancer application. combined medicine disclosed invention combined medicine honokiol liposome immune checkpoint inhibitor respectively simultaneously administered. immune checkpoint inhibitor pd-1 antibody. experiments prove compared singly immune checkpoint inhibitor, combined medicine disclosed invention effectively inhibit lung cancer synergistic interaction honokiol liposome pd-1 antibody. honokiol liposome reduce infiltration lung bone marrow-derived immunosuppressive cells tumor-promoting m2 type macrophages, honokiol liposome pd-1 inhibitor combined achieve obvious synergistic treatment effect.',\n",
              " 'macrocyclic compound inhibiting pd-1/pd-l1 application macrocyclic compoundthe invention discloses macrocyclic compound application thereof. macrocyclic compound pharmaceutically acceptable salts, solvates, prodrugs, racemates isomers thereof usedfor preparing pd-1/pd-l1 inhibitor influence inhibit generation growth factors cell proliferation, macrocyclic compound application prospect preparation drugsfor treating tumors. compared monoclonal antibody research development, peptide inhibitors field pd-1/pd-l1 inhibitors slow progress, research development inhibitors inhibiting pd-1/pd-l1 interaction important clinical significance.',\n",
              " 'biphenyl compound preparation method medical application thereofthe invention discloses biphenyl compound preparation method medical application thereof, structure biphenyl compound shown formula (i) formula (ii), thebiphenyl compound pharmaceutically acceptable salt, tautomer, meso-isomer, raceme, stereoisomer, metabolite, metabolite precursor, prodrug solvate thereof pd-l1 inhibitor. compound hasa remarkable inhibiting effect interaction pd-1 pd-l1 protein, compound applied preparation pd-l1 inhibitors immunomodulator drugs preventing treating tumors, autoimmune diseases, organ transplant rejection, infectious diseases inflammatory diseases.',\n",
              " '(+)-biotin derivative, preparation method applicationthe invention discloses (+)-biotin derivative, belonging technical field organic compounds, derivative compounds: sws1-sws24; invention discloses preparation method (+)-biotin derivative. invention discloses application (+)-biotin derivative preparation pd-1/pd-l1 inhibitor. compound inhibit mutual combination programmed cell death receptor 1/a programmed cell death ligand 1 (pd-1/pd-l1), preparing pd-1/pd-l1 inhibitor, remarkable inhibition effect.',\n",
              " 'combination therapy mek inhibitor, pd-1 axis inhibitor, taxanea combination therapy comprising mek inhibitor, pd-1 pd-l1 inhibitor, taxane provided treatment cancer, triple negative breast cancer.',\n",
              " 'trpv6 inhibitors combination therapies treating cancersprovided trpv6 inhibitor treating cancer combination immune checkpoint modulators, pd-1 pd-l1 inhibitors, related compositions kits.',\n",
              " 'cyclic polypeptide compounds thereofcyclic polypeptide compounds thereof. cyclic polypeptide compounds shown formula (i), compounds pd-1/pd-l1 inhibitors.',\n",
              " 'combination therapy cancer anti-endoglin antibodies anti-programmed death receptor agentsthe present application relates anti-endoglin antibody combination anti-pd-1 antibody. present application relates anti-endoglin antibody combination anti-pd-l1 antibody. present application relates anti-endoglin antibody combination anti-pd-1 antibody anti-pd-l1 antibody. present application relates anti-endoglin antibody combination nivolumab, pidilizumab pdr001, pembrolizumab, bms-936559, avelumab atezolizumab. aspect relates combinations antibodies treating cancers metastases thereof.',\n",
              " \"therapeutic combinations antifolate btk inhibitortherapeutic combinations antifolate compound bruton's tyrosine kinase (btk) inhibitor described. embodiments, invention pharmaceutical compositions comprising combinations antifolate compound btk inhibitor, methods treating disease antifolate compound btk inhibitor, particular cancer immune, autoimmune, inflammatory disease. embodiments, invention pharmaceutical compositions comprising combinations antifolate compound, pd-1 pd-l1 inhibitor, btk inhibitor, methods treating disease antifolate compound, pd-1 pd-l1 inhibitor, btk inhibitor, particular cancer immune, autoimmune, inflammatory disease.\",\n",
              " 'immune checkpoint inhibitorthe present invention pertains to: immune checkpoint inhibitor containing clec4a function inhibitor clec4a function inhibiting antibody, etc.; application immune checkpoint inhibitor.',\n",
              " 'isomelanin bionic nanoparticles, preparation method application isomelanin bionic nanoparticles in-situ glioblastoma photothermal immunotherapythe invention relates technical field nano-drug delivery systems, particular isomelanin bionic nanoparticles, preparation method application isomelanin bionic nanoparticles in-situ glioblastoma photothermal immunotherapy. isomelanin bionic nanoparticle comprises isomelanin nanoparticle cancer cell membrane, pd-l1 inhibitor loaded isomelanin nanoparticle. nanoparticle treatment, due homing effect cancer cell membrane, nanoparticle penetrate blood brain barrier deliver inhibitor glioblastoma; local temperature isopropyl melanin nanoparticles increased photothermal therapy, blood-brain barrier penetrating power nanoparticles improved; photothermal therapy effectively stimulate death immunogenic cells, up-regulate pd-l1 level, promote infiltration lymphocytes amplify inhibitor-mediated immune checkpoint blocking treatment effect. therefore, nanoparticles scheme huge potential photo-thermal immune checkpoint blocking synergistic treatment in-situ glioblastoma.',\n",
              " 'agent treatment malignant tumorsprovided are: agent treatment malignant tumors, agent characterized containing immune checkpoint inhibitor combination boron neutron capture therapy; (i) immune checkpoint inhibitor selected group consisting anti-pd-1 antibody, anti-pd-l1 antibody, anti-ctla-4 antibody, anti-lag-3 antibody, anti-tim-3 antibody, anti-tigit antibody, anti-kir antibody, pd-l1/tgfβ trap inhibition fusion protein, anti-pd-1/ctla-4 bispecific antibody; (ii) combination treatment malignant tumors, patients respond treatments immune checkpoint inhibitors containing boron compound boron neutron capture therapy.',\n",
              " 'oral formulation pd-l1 inhibitordisclosed oral formulations compound modulates pd-1/pd-l1 protein/protein interaction, pharmaceutically acceptable salt thereof, require cold chain storage.',\n",
              " 'pd-1/pd-l1 inhibitorscompounds methods compounds singly combination additional agents compositions compounds treatment cancer disclosed formula (i)',\n",
              " 'pd-1/pd-l1 inhibitors.compounds formula (i), methods compounds singly combination additional agents compositions compounds treatment cancer disclosed.',\n",
              " 'pd-1 and/or pd-l1 inhibitorto provide low-molecular-weight compound antitumor shows excellent inhibitory action pd-1 and/or pd-l1.solution: present invention discloses compound formula (i) illustrated below, r1 selected group consisting c1-8 perfluoroalkyl group, c1-8 perfluoroalkoxy group, c2-8 perfluoroalkenyl group c2-8 perfluoroalkenyloxy group, r2 substituted/unsubstituted heterocyclyl group, x s.selected drawing: figure 1',\n",
              " 'gm-csf/cd40l vaccine checkpoint inhibitor combination therapya method disclosed treating cancer subject. method comprises administering subject composition comprising therapeutically effective amount checkpoint inhibitor therapeutically effective amount tumor vaccine. embodiments, tumor vaccine comprises radiated autologous tumor cells cell line engineered express gm-csf cd40 ligand. embodiments, checkpoint inhibitor comprises anti-pd-1 antibody (e.g., bms 936558), anti-pd-l1 antibody (e.g., clonem1h1), anti-ctla-4 antibody (e.g., ipilimumab, bms), combination thereof.',\n",
              " 'pentoxifylline immune checkpoint-blockade therapies treatment melanomamethods treating pd-1-resistant cancer provided comprise administering subject thereof therapeutically effective amount c-rel inhibitor therapeutically effective amount pd-1 inhibitor. pharmaceutical combination comprising therapeutically effective amount c-rel inhibitor, therapeutically effective amount pd-1 inhibitor provided. finally, methods treating cancer ctla-4-resistant cancer, cd137-resistant cancer, ox-4-resistant cancer provided comprise administering subject thereof therapeutically effective amount c-rel inhibitor therapeutically effective amount clta-4, cd137 ox-4 inhibitor, respectively.',\n",
              " 'sarna application thereofthe invention discloses sarna. sarna comprises nucleotide sequence complementary -3000 -200 locus area ptpro gene promoter region. invention discloses application sarna preparing medicines treating tumors. sarna targeting ptpro gene, provided invention, reduce phosphorylation level tyr123 site pd-l1, block pd-1/pd-l1 viae, inhibit growth tumor cells, restore activity cells; meanwhile, sarna provided invention pd-l1 inhibitor play synergistic effect treatment tumors, thetreatment effect pd-l1 inhibitor improved. therefore, sarna provided invention preparing antitumor drugs.',\n",
              " 'composition promoting immune checkpoint inhibition therapythe present invention addresses problem providing composition promoting immune checkpoint inhibition therapy. provided composition promoting immune checkpoint inhibition therapy,the composition including extracellular polysaccharides lactic acid bacteria. preferred lactic acid bacterium bacterium genus lactobacillus (lactobacillus delbrueckii subsp. bulgaricus oll1073 r-1).',\n",
              " 'dosing schedule combination ceritinib anti-pd-1 antibody molecule.the present disclosure relates field pharmacy, particularly ceritinib pd-1 inhibitor treatment cancer. specifically, disclosure relates pharmaceutical combination comprising ceritinib, pharmaceutically acceptable salt thereof, pd-1 inhibitor, pharmaceutically acceptable salt thereof, treatment cancer, method treatment cancer involves administering combination combination manufacture medicament treatment cancer.',\n",
              " 'cyclic polypeptide compound application thereofthe invention discloses cyclic polypeptide compound application thereof, cyclic polypeptide compound shown formula (i), definition group shown specification. compound pd-1/pd-l1 inhibitor.',\n",
              " 'methods detecting treating cancers adenosine pathway activationthe present disclosure relates methods detecting expression levels genes subject suspected cancer optionally treating subject adenosine pathway antagonist (e.g., adenosine a2a receptor (adora2a) antagonist) combination pd-1 inhibitor and/or pd-l1 inhibitor treat cancer. genes comprise, limited to, cd68, cd163, lbp, ccl2, ccl3,ccl7,ccl24,ccne1,cd14,cd300e,cd86,cd93,clec5a, csf3,cxcl1,cxcl2,cxcl3,cxcl5,cxcl6,cxcl8,dfna5,ecel1,epb41l3,ehf,fut7,galm,gbp6,gpr157,has1,il1a,il-1beta,il23,il24,il5,il6,il8,inhba,lap3,layn,loc100505585,mrpl11,nid1,ost4,padi2,pid1,plaur,ppbp,ptgs2,rhcg,serpinb2,slc11a1,slc7a7,spon1,st6galnac2,tbx21,thbs1,c1r,c1s,c4bpa,ccl11,ccl20,cxcl16,cxcl2,hamp,hsd11b1,itgam,lif,saa1,tfrc,tlr5,tnfsf14,trem2,app,atg10,bcl2,ccl15,cd24,cd46,cd59,creb5,cx3cl1,cxcl14,cyfip2,defb1,dpp4,ecsit,epcam,ifit1,igf1r,itga6,itgb3,map2k4,mapk1,masp1,pparg,rorc,spa17,stat5b,tollip,akt3,bmi1,cd164,cd34,cdh5,creb1,dock9,eng,hmgb1,itga1,jam3,maf,mapk3,mapk8,mcam,mfge8,notch1,nrp1,prkce,smad2,tal1, thy1, tnfsf12,traf6, txnip,vegfa,s100a8 and/or wdr83os.',\n",
              " 'combination tlr8 modulating compound anti-hbv sirna therapeuticsthe present disclosure treatment and/or prevention hepatitis b viral infection administering subject combination therapy regimen including toll-like receptor 8 (tlr8) modulator, dsrna, pd-1/pd-l1 inhibitor.',\n",
              " 'binding agents capable binding cd27 combination therapythe present invention combination therapy binding agent comprises binding region binding cd27 combination pd1/pd-l1 inhibitor reduce progression prevent progression tumor treating cancer.',\n",
              " 'immune checkpoint blocking bispecific moleculesthe invention tumor targeting, immune checkpoint-blocking bispecific molecules. bispecific molecules contain anti-pd-l1 antibody antigen-binding fragment, peptide agent specifically binds surface antigen cellular marker solid tumor. provided invention methods specific molecules therapeutic applications.',\n",
              " 'dosing schedule wnt inhibitor anti-pd-1 antibody molecule combinationthe present disclosure relates field pharmacy, particularly wnt inhibitor pd-1 inhibitor treatment cancer. specifically, disclosure relates pharmaceutical combination comprising wnt inhibitor, pharmaceutically acceptable salt thereof, pd-1 inhibitor, pharmaceutically acceptable salt thereof, treatment cancer, method treatment cancer involves administering combination combination manufacture medicament treatment cancer.',\n",
              " 'combined pharmaceutical preparation treating melanoma, lung cancers colorectal cancersthe present invention discloses combined pharmaceutical preparation treating melanoma, lung cancers colorectal cancers. pharmaceutical preparation comprises effective amount antibody programmed death receptor ligand 1 (pd-l1) cilengitide. combined pharmaceutical preparation combines integrin inhibitor cilengitide pd-l1 inhibitor inhibit tumor cellproliferation inhibiting formation blood vessels tumor microenvironment enhancing infiltration activation cells improve immune microenvironment. compared single use, inhibition effects cilengitide pd-l1 inhibitors relatively clear, side effects relatively low, risks relatively low. combined use, objective remission rate tumors higher single use, total survival time increased lethal side effects observed.',\n",
              " 'small-molecule immunoregulation inhibitor pharmaceutical composition application thereofthe invention relates field medicines, particular small-molecule immunoregulation inhibitor pharmaceutical composition application thereof, particularly, small-molecule compound pd-l1 inhibitor anti-tumor application.',\n",
              " 'methods sensitizing tumors treatment immune checkpoint inhibitorsthe present disclosure methods increasing sensitivity tumor treatment immune checkpoint inhibitor (ici) subject methods treating subject immune checkpoint inhibitor (ici)-resistant tumor. methods comprise administering subject composition comprising liposome comprising cationic lipid mrna molecules, liposome systemically administered subject. provided methods increasing number activated plasmacytoid dendritic cells (pdcs) subject thereof, comprising administering subject composition comprising liposome comprising cationic lipid mrna molecules, liposome systemically administered subject. combination therapy anti-pd-l1 mab. related methods treatment methods preparing dendritic cell vaccine additionally provided.',\n",
              " 'compositions comprising chemotherapeutic agents checkpoint inhibitors methods usedisclosed methods treating/inhibiting/reducing non-immunogenic cancer subject inducing blockade inhibitor susceptibility (such as, example, pd-1/pdli, ctla-4/b7-1/2, and/or cd47/sirpa inhibitor susceptibility) tumor subject cancer, methods comprising administering subject hydrogel matrix comprising chemotherapeutic agent (including, limited gemcitabine) blockade inhibitor (including, limited apd-1/pd-li blockade inhibitor, as, nivolumab, pembrolizumab, pidilizumab, atezolizumab, avelumab, durvalumab, bms-936559; ctla-4/b7-1/2 inhibitor as, example, ipilimumab; and/or cd47/sirpa inhibitor as, hu5f9-g4, cvi, b6h12, 2d3, cc-90002, tti-621).',\n",
              " 'axl-specific antibodies cancer treatmentthe disclosure relates anti-axl antibodies, immunoconjugates, compositions treatment cancer, resistant predicted resistant treatment programmed cell death-1/programmed cell death-1 ligand (pd-1/pd-l1) inhibitor.',\n",
              " 'combination therapyprovided methods treating diseases, cancer, combination therapy. embodiments, methods comprise administering effective amount phosphoinositide-3-kinase (pi3k) inhibitor effective amount pd-1 pd-l1 inhibitor patient.',\n",
              " 'cd80 extracellular domain polypeptides cancer treatmentthe application relates cd80 (b7-1) extracellular domain (ecd) polypeptides cd80-ecd fusion molecules treatment cancer, combination therapeuticagents, immune stimulating agents pd-1/pd-l1 inhibitors.',\n",
              " 'dosage regimes anti-m-csf antibodies thereofthe invention generally relates dosage regimes anti-macrophage colony stimulating factor 1 (m-csf) antibodies, lacnotuzumab, methods treatment cancer subject, dosage regimes anti-m-csf antibodies, lacnotuzumab, treating cancer. invention generally relates dosage regimes combinations agents, combinations comprising anti-m-csf antibodies, lacnotuzumab, gemcitabine, nab-paclitaxel pd-1 inhibitor (such spartalizumab).',\n",
              " 'methods compositions blocking interaction non-glycosylated pd-1 polypeptidesprovided methods compositions activating immune response patient hosting tumor. instances, method described comprises administering patient non-glycosylated pd-1 inhibitor optionally glycosylated pd-1 inhibitor, non-glycosylated pd-1 inhibitor optionally combination glycosylated pd-1 inhibitor results activation immune response.',\n",
              " 'crystal form biphenyl derivative inhibitor preparation method therefora crystal form compound general formula (i), preparation method therefor, pharmaceutical composition containing therapeutically effective amount crystal form, thereof pd-1/pd-l1 inhibitor treatment cancers, infectious diseases autoimmune diseases.',\n",
              " 'indoline immunoregulation inhibitor pharmaceutical composition application thereofthe invention relates field medicines, particular indoline immunoregulation inhibitor pharmaceutical composition application thereof, particularly, indoline immunoregulation inhibitor applied related diseases mediated pd-l1 inhibitor anti-tumor application.',\n",
              " 'method screening immune checkpoint inhibitorthe present specification method screening immune checkpoint inhibitor, comprises steps: firstly culturing biological sample isolated individual cells enriched; treating enriched cells immune checkpoint inhibitor; mixing cells treated immune checkpoint inhibitor cancer cell line gene immune checkpoint ligand knocked out, culturing cells; measuring amount cytokine secretion cultured cells. method screening immune checkpoint inhibitor present invention identify difference amount cytokine secretion modified knockout cancer cell line cells, effect immune checkpoint inhibitor intuitively evaluated.',\n",
              " 'immune checkpoint inhibitor composition application thereofthe invention immune checkpoint inhibitor composition application thereof, belongs technical field biological medicine, solve technical problem existing immune checkpoint inhibitor ideal tumor effect. immune checkpoint inhibitor composition comprises active component active component, active component cytokine improving tumor response rate, active component immune checkpoint inhibitors; cell factor improving tumor response rate human interleukin 12, immune checkpoint inhibitors pd-1 antibody ctla4 antibody. immune checkpoint inhibitor composition applied preparation tumor treatment preparations drugs.',\n",
              " 'predictive index tumor immunotherapythe invention discloses method system predicting immunotherapy effect pd-1/pd-l1 inhibitor. method comprises steps acquiring types abundance cell receptors tumor infiltrating lymphocytes subject types cell receptors cd8+pd1+t cells baseline peripheral blood; counting types common cell receptors tumor infiltrating lymphocytes cd8+pd1+t cells subject, calculating average proportion tumor infiltrating lymphocytes common cell receptors tumor infiltrating lymphocytes serve ir index; judging immunotherapy effect pd-1/pd-l1 inhibitor ir index. method provided invention provide predictive index ofthe tumor immunotherapy effect prognosis, effectively screen immunotherapy response patient groups.',\n",
              " 'method kit treating cancer combination therapya method treating subject suffering cancer comprising administering effective amount polysaccharide extract effective amount pd-1 inhibitor subject, polysaccharide extract comprises ginseng polysaccharides. method increasing amount tumor-infiltrating leukocytes cancer cells subject; kit comprising polysaccharide extract pd-1 inhibitor. -. votcle(po$) 1500 .anibpd.i(1*rqftc) fig. 1 vehicle(pbs) anti-pd-i anti-pd-1+gp fig. 2',\n",
              " 'pharmaceutical composition treating liver cancer application thereofthe invention discloses application combined regorafenib pd-1/pd-l1 inhibitor preparation medicine treating liver cancer. pharmaceutical composition (regorafenib andthe pd-1/pd-l1 inhibitor) provided invention generate synergistic anti-liver cancer effect; scheme combined administration two, sensitivity liver cancercells regorafenib improved, inhibition effect liver cancer cells improved, dosage regorafenib reduced, treatment cost liver cancer patient isdirectly reduced, liver cancer patients benefited; pharmaceutical composition low price, high safety affirmative curative effect; pharmaceutical composition disclosed invention convenient produce, convenient large-scale production, curative effect low cost, beneficial social public interests.',\n",
              " 'immune checkpoint inhibitorprovided immune checkpoint inhibitor. present invention immune checkpoint inhibitor active ingredient selected peptide fragment n-end region caveolin 1, peptide fragment scaffolding domain sequence caveolin 1, peptide fragment scaffolding domain deleted n-end region caveolin 1, peptide fragment caveolin 1 binding region cd26, fusion proteins peptide fragments immunoglobulin constant region.',\n",
              " 'methods treating cancer (r)-n-(3-fluoro-4-((3-((1-hydroxypropyl-2-yl) amino)-1h-pyrazolo [3, 4-b] pyridin-4-yl) oxy) phenyl)-3-(4-fluorophenyl)-1-isopropyl-2, 4-dioxo-1, 2, 3, 4-tetrahydropyrimidine-5-carboxamidethe present invention relates method treating cancer administering therapeutic agent comprising compound 1 pharmaceutically acceptable salt thereof, combination pd-1 pd-l1 inhibitor, patient thereof intermittent administration schedule period time.',\n",
              " 'panels methods diagnosing treating lung cancerthe invention molecular classifiers characterization diagnosis lung cancer methods selecting treating subjects appropriate personalized cancer treatments, including limited cdk4/6 inhibitors, c-met inhibitors, pd-1/pd-l1 inhibitors combinations thereof.',\n",
              " 'tumor treatment composition including mesenchymal stem cell preparations immune checkpoint inhibitors kit application thereofthe invention relates tumor treatment composition including mesenchymal stem cell preparations immune checkpoint inhibitors kit application thereof. tumor treatment composition specifically comprises pharmacologically effective quantity mesenchymal stem cells immune checkpoint inhibitors. mesenchymal stem cells improve treatment effect immune checkpoint inhibitors monoclonal antibody (keytruda) resistance pd-1 non-small cell lung cancer.',\n",
              " 'methods treating cancer combination therapythe present application directed therapeutic regimens methods treating cancer, regimens methods comprising administering subject programmed death-ligand 1 (pd-l1) inhibitor recombinant vesicular stomatitis virus engineered expresses interferon beta (vsv-ifnβ-nis).',\n",
              " '3-hydroxy-8-tigloyloxy-110-dehydroariglovin composition comprising extract jerusalem artichoke leaves 3-hydroxy-8-tigloyloxy-110-dehydroariglovin compounds isolated preventing treating immune checkpoint inhibitorthe present invention relates pharmaceutical immune checkpoint inhibitor composition including extract jerusalem artichoke top part 3-hydroxy-8β-tigloyloxy-1,10-dehydroariglovin compound isolated therefrom active ingredient. present invention pharmaceutical composition treatment immune checkpoint inhibitor, interrupts interaction anti-programmed cell death protein 1 (anti-pd-1) anti-programmed death-ligand 1 (anti-pd-l1) enhances activity cells, attacks human infected tissue, positive tumors, deformed tissue, like, assist immunity boosting.',\n",
              " 'pd-l1 inhibitory peptide cancer immunotherapyan immune checkpoint (pd-l1) inhibitor oligopeptide comprising sequence gtrlkpliicvqwpgl (seq id no:1), nucleic acids encoding oligopeptide, vectors cells delivery nucleic acids encoding oligopeptide disclosed. methods treating cancer enhancing anti-tumor immunity disclosed.',\n",
              " 'method predicting benefit immune checkpoint inhibition therapythe present invention relates method identifying patient suffering cancer benefiting benefiting immune checkpoint inhibition therapy comprising steps measuring expression level preselected markers cancerous biological sample obtained patient, identifying differentially expressed alternative promoter based expression level preselected markers, calculating alternative promoter usage score identifying patient benefiting benefiting immune checkpoint inhibition therapy alternative promoter usage score. present invention relates biomarker excluding patient suffering cancer immune checkpoint inhibition therapy.',\n",
              " 'application polypeptide inhibiting tumor immune escapethe invention application polypeptide inhibiting tumor immune escape. a11 polypeptide peptide derived 20 30 sites amino acids amino terminal annexin a1 (anxa1) (eyvqtvksskg). series experiments prove a11 polypeptide enters tumor cells means cell-penetrating peptide cpp (ygrkkrrqrrr), competitively combined deubiquitination enzyme usp7 pd-l1, increases ubiquitination degradation pd-l1, remarkably reduces level breast cancer, lung cancer melanoma cells pd-l1, inhibits tumor immune escape, plays anti-tumor role vitro vivo mice. addition, a11 monoclonal antibody pd-1 monoclonal antibody (mab) jointly applied mouse body synergistic anti-tumor immune escape effect. therefore, a11 polypeptide strategy immune checkpoint blocking treatment, tumor immunotherapy, important clinical application value.',\n",
              " 'combination comprising ep4 antagonist immune checkpoint inhibitora medicament comprising combination compound represented formula (i), salt thereof, solvate thereof, n-oxide thereof, prodrug immune checkpoint inhibitor (such anti-pd-1 antibody), exhibits strong anti-tumor effect treatment cancer.',\n",
              " 'vinflunine pd1 and/or pdl1 inhibitor pharmaceutical combinationthe present invention relates pharmaceutical combination comprising: (a) vinflunine pharmaceutically acceptable salt thereof, (b) pd1-inhibitor and/or pd-l1-inhibitor pharmaceutically acceptable salt thereof. pharmaceutical combination drug, notably treatment proliferative disease, cancer.',\n",
              " 'methods enhancing potency immune checkpoint inhibitorsthe present invention relates methods enhancing potency immune checkpoint inhibitors. particular, present invention relates method enhancing potency immune checkpoint inhibitor administered subject part treatment regimen, method comprising administering pharmaceutically effective amount sk1 inhibitor subject combination immune checkpoint inhibitor.',\n",
              " 'benzamide compound preparation method application thereofthe invention discloses benzamide compound structure shown formula i, preparation method application thereof, compound pd-l1 inhibitor, obvious effect blocking pd-1/pd-l1 signal channel, effectively relieve treat related diseases cancers like.',\n",
              " 'biomarker predicting response immune checkpoint inhibitorthe purpose present invention provide method predicting response immune checkpoint inhibitor method predicting prognosis cancer patient treated immune checkpoint inhibitor. present invention method predicting response immune checkpoint inhibitor amount il-1 signaling pathway molecules subject, cancer treatment, indicator. present invention method predicting prognosis cancer patient treated immune checkpoint inhibitor, prognosis predicted amount il-1 signaling pathway molecules aforesaid subject indicator.',\n",
              " 'plinabulin combination immune checkpoint inhibitorsto provide compositions comprising plinabulin immune checkpoint inhibitors treating cancer.solution: disclosed compositions comprising plinabulin immune checkpoint inhibitors treating cancer. disclosed methods treating cancer co-administering plinabulin immune checkpoint inhibitors subject thereof.selected drawing: figure 1a',\n",
              " 'anti-tumor pharmaceutical composition based pkc inhibition application thereofthe invention discloses anti-tumor medicine composition based pkc inhibition application anti-tumor medicine composition, belongs technical field biological medicine. anti-tumor pharmaceutical composition composed pkc inhibitor immune checkpoint inhibitor, pkc inhibitor comprises pkc alpha inhibitor, pkc beta inhibitor pkc theta inhibitor, immune checkpoint inhibitor inhibitor programmed death receptor pd-1 programmed death receptor ligand pd-l1. experiments prove pkc inhibitor reduce pkc expression inhibit kinase activity pkc, pkc inhibitor combined pd-1/pd-1 inhibitor generate synergistic effect, pkc downstream signal down-regulated, killer cells collected, killing ability killer cells enhanced, reactivity tumor cells pd-1/pd-l1 drugs enhanced, tumor growth effectively inhibited.',\n",
              " 'immune checkpoint inhibitor therapeutic usethe present invention immune checkpoint inhibitor therapeutic use, immune checkpoint inhibitor bispecific antibody; bispecific antibody comprises antigen binding functional region capable specifically bound cd274 antigen binding functional region capable specifically bound tim-3, immune checkpoint inhibitor providedby invention humanized igg form, bispecific antibody bound target molecules time, effect aspect treating complex diseases, easily generate off-target effect.',\n",
              " 'combination therapy treating pik3ca mutant cancersa composition therapy treatment pik3ca mutant cancer comprising administering subject thereof pi3k inhibitor, prostaglandin receptor (pge2) inhibitor, pd-1 inhibitor. antitumor activity brought combination methods activity pi3k inhibitor, pd-1 inhibitor prostaglandin receptor (pge2) pd-1 inhibitor.',\n",
              " 'ezh2 inhibitor combination immune checkpoint inhibitor preparation medicament treating tumor diseasesthe disclosure relates ezh2 inhibitor immune checkpoint inhibitor combination tyrosine kinase inhibitor preparation medicament treating tumor diseases. specifically, ezh2 inhibitor compound formula (i) pharmaceutical salt, immune checkpoint inhibitor anti-pd-1 antibody antigen binding fragment, tyrosine kinase inhibitor compound formula (ii) pharmaceutical salt.',\n",
              " 'substituted phenylpropenylpyridine derivative, preparation method therefor medical thereofdisclosed substituted phenylpropenylpyridine derivative, preparation method therefor thereof pd-1/pd-l1 inhibitor. particular, disclosed compound formula (i) pharmaceutically acceptable salt, stereoisomer, solvate, prodrug thereof, preparation method therefor thereof. definition group formula detailed description claims.',\n",
              " 'application combination ezh2 inhibitor, immune checkpoint inhibitor vegfr inhibitor preparation drugs treating tumorsthe invention relates application combination ezh2 inhibitor, immune checkpoint inhibitor vegfr inhibitor preparation drugs treating tumors. specifically, ezh2 inhibitor compound shown formula (i) complex pharmaceutically acceptable salt thereof, immune checkpoint inhibitor anti-pd-1 antibody antigen binding fragment thereof, vegfr inhibitor apatinib pharmaceutically acceptable salt thereof.',\n",
              " 'cancer treatment combination ep4 antagonist immune checkpoint inhibitorthe object present invention provide effective method treating cancer. provided method treating cancer including combination standard therapy, ep 4 antagonist immune checkpoint inhibitor (for example, anti-pd-1 antibody). therapeutic method present invention cancer treatment.',\n",
              " 'immunomodulator preparation method medical thereofthe present invention relates immunomodulator, preparation method thereof, application pd-1/pd-l1 inhibitor. particular, disclosed compound formula (i) pharmaceutically acceptable salt, stereoisomer, solvate, prodrug thereof preparation method application thereof. definition substituent formula described detail specification claims.',\n",
              " 'combination drugs treatment cancerthe present invention relates methods treating cancer comprising administering subject thereof effective amount (i) anti-cancer agent, (ii) agent sensitizing and/or potentiating cancer anti-cancer agent, (iii) anti-cancer agent comprise pd-1 and/or pd-l1 inhibitor.',\n",
              " 'application aplnr combined pd-l1 antibody preparation preparation treating nasopharynx cancerthe invention discloses application aplnr combined pd-l1 antibody preparation preparation treating nasopharynx cancer. researches find overexpression aplnr inhibit expression pd-l1, inhibit growth nasopharyngeal carcinoma cells inhibit immune escape; present invention, application pd-l1 monoclonal antibody (atezolizumab), interaction immune check point pd-1 immune check point pd-l1 blocked, disability apoptosis cells inhibited; combined overexpressed aplnr pd-l1 antibody brings news patients nasopharyngeal carcinoma.',\n",
              " 'fgfr2 inhibitors combination immune stimulating agents cancer treatment.provided fibroblast growth factor receptor 2 (fgfr2) inhibitors cancer treatment, cases combination immune stimulating agents, inhibitors pd-1 pd-l1. embodiments, fgfr2 inhibitors comprise fgfr2 antibodies fgfr2 extracellular domain (ecd) polypeptides, fgfr2 ecd fusion molecules comprising fgfr2 ecd fusion partner. embodiments, pd-1/pd-l1 inhibitors comprise anti-pd-1 antibodies antibodies bind pd-1 pd-l1 inhibit interactions proteins, pd-1 fusion proteins polypeptides.',\n",
              " 'anti-tumor combined medicinal preparation application thereofthe invention belongs technical field anti-tumor drugs, particularly relates anti-tumor combined medicinal preparation application thereof. anti-tumor combined pharmaceutical preparation comprises effective amount brd4 inhibitor effective amount pd-1/pd-l1 inhibitor, brd4 inhibitor comprises azd5153. targeted therapy immunotherapy combined, azd5153 inducing tumor cells generate dna mismatch repair deletion, increase mutation characteristics activate body immunity, pd-1/pd-l1 inhibitor relieving immunosuppression state, immune system comprehensively activated, stronger anti-tumor specific immunoreaction induced, growth in-vivo tumors effectively inhibited, anti-tumor activity tumor cells improved. combined medicinal preparation synergistic effect continuous immunotherapy targeted therapy, dosage targeted medicine remarkably reduced, toxic side effects greatly reduced, biological safety high.',\n",
              " 'method testing susceptibility immune checkpoint inhibitorthe present invention addresses problems providing biomarker serves indicator susceptibility immune checkpoint inhibitor liver cancer providing suitable treatments individual liver cancer patients. liver cancer patients stratified prognosis tumor immune microenvironment, relationship clarified fatty liver cancer tumor immune microenvironment immunopotentiating immunodepleting. furthermore, fatty liver cancer patients discovered susceptible immunotherapy immune checkpoint inhibitors. employing fat content liver cancer tissue indicator susceptibility immune checkpoint inhibitors makes possible predict success immune checkpoint inhibitor provide suitable treatments individual liver cancer patients. fat content calculated image liver cancer tissue signal image display.',\n",
              " 'methods compositions treatment pancreatic cancerthe present invention compositions methods treatment pancreatic cancer, pancreatic ductal adenocarcinoma (pd ac), methods activating pancreatic tissue-specific anti-tumor cell immunity. embodiments methods involve administration il33. embodiments methods involve administration pd-1 and/or pd-l1 inhibitor.',\n",
              " 'method determining responsiveness cancer patient immune checkpoint inhibitorto provide method determining responsiveness cancer patient immune checkpoint inhibitor, provide cancer treatment method.solution: method determining responsiveness cancer patient immune checkpoint inhibitor comprises determining responsiveness cancer patient immune checkpoint inhibitor based level short-chain fatty acid sample patient. addition, cancer treatment method comprises administering immune checkpoint inhibitor cancer patient determined responsiveness immune checkpoint inhibitor determination method.selected drawing: figure 17',\n",
              " 'method treating melanoma herpes simplex virus immune checkpoint inhibitorto provide methods treating stages iiib iv melanoma.solution: combination treatment uses: herpes simplex virus lacks functional icp34.5 genes, lacks functional icp47 gene comprises gene encoding human gm-csf; immune checkpoint inhibitor anti-ctla-4 (cytotoxic t-lymphocyte associated antigen 4) antibody.selected drawing:',\n",
              " 'combination p2y6 inhibitors immune checkpoint inhibitorsthe invention situated field cancer treatment. particular relates treatments comprising combining inhibitor pyrimidinergic receptor p2y6 immune checkpoint inhibitor. particular, treatment benefit cancers poorly responding immune checkpoint inhibitor therapy.',\n",
              " 'harnessing power microbiota metabolites treatment cancerdisclosed method treatment subject having, suspected having, cancer, particular colorectal cancer, immune checkpoint inhibitor combination bacteria selected bifidobacterium pseudolongum, lactobacillus johnsonii, olsenella species, immune checkpoint inhibitor anti-ctla-4 antibody anti- pd-1 antibody, antibiotic therapy precede immune checkpoint inhibitor bacteria.',\n",
              " 'fullerene nanoparticles enhancing antitumor immunotherapythe invention relates application fullerene nanoparticles preparation tumor immunotherapy. fullerene nanoparticles comprise amino acid modified fullerene water-solublemodifier; activate immune cells, polarize tumor-associated macrophages and/or improve lymphocyte infiltration tumor site; treatment effect antitumor immunity pd-l1 inhibitor enhanced.',\n",
              " 'gdf-15 diagnostic marker predict clinical outcome treatment immune checkpoint blockersthe present invention relates methods predicting probability treatment response human cancer patient immune checkpoint blocker treatment e.g. anti pd-1, methods predicting probability survival human cancer patient immune checkpoint blocker treatment, apparatuses kits methods.',\n",
              " 'combination therapiescombination therapies comprising pd-1 inhibitors therapeutic agents treat prevent cancerous conditions disorders follow. combination therapies agents pd-1 inhibitor, cxcr2 inhibitor csf-1/1r binding agent treating pancreatic cancer colorectal cancer. combination therapies agents pd-1 inhibitor, cxcr2 inhibitor inhibitor tim-3, c-met a2ar treating pancreatic cancer colorectal cancer. combination therapies agents pd-1 inhibitor, lag -3 inhibitor (i) inhibitor tgf-beta, tim-3, c-met, il-lb mek (ii) gitr agonist (iii) a2ar antagonist (iv) csf-1/1r binding agent treating breast cancer. combination therapies agents pd-1 inhibitor cxcr2 inhibitor treating pancreatic cancer, colorectal cancer, lung cancer breast cancer.',\n",
              " 'cancer therapy 3,5-disubstituted benzene alkynyl compound immune checkpoint inhibitorthe problem solved present disclosure provide combination therapy (s)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one salt thereof, combination therapy exhibiting excellent antitumor effect cancer patients resistance immune checkpoint inhibitors. present disclosure antitumor agent comprising (s)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one salt thereof active ingredient, antitumor agent administered combination immune checkpoint inhibitor, pembrolizumab, cancer patient resistance immune checkpoint inhibitors.',\n",
              " 'monitoring immune checkpoint inhibitors blood patient stratification methodto provide: method predicting therapeutic efficacy immune checkpoint inhibitor detecting quantifying bspd-l1 biological sample; method monitoring biological response immune checkpoint inhibitor; method stratifying patients susceptibility treatment immune checkpoint inhibitor; system, kit, etc. implementing aforementioned methods.solution: disclosed includes method predicting therapeutic efficacy immune checkpoint inhibitor, method comprising measuring bspd-l1 concentration biological sample(s) obtained subject and/or treatment.selected drawing:',\n",
              " 'attenuated salmonella immune checkpoint inhibitor combined application thereofthe invention discloses attenuated salmonella immune checkpoint inhibitor combined application thereof. attenuated salmonella immune checkpoint inhibitor combined disclosed invention, attenuated salmonella immune checkpoint inhibitor combined formed combining attenuated salmonella typhimurium immune checkpoint inhibitor. attenuated salmonella disclosed invention, effects resisting malignant tumor growth inhibiting tumor metastasis tumor immune checkpoint inhibitor improved synergistic effect mode, treatment effectiveness immune checkpoint inhibitor antitumor greatly improved. combined preparation method disclosed invention simple easy operate, application prospect.',\n",
              " 'combination vegf antibodies immune checkpoint inhibitorthe invention relates combination vegf antibodies immune checkpoint inhibitor antibody, particular application vegf antibodies immune checkpoint inhibitor preparation drugs treating cancers tumors, drugs prepared application treatment method, improvement treatment effect vegf antibody increase patient benefits facilitated.',\n",
              " 'combination anti-cd20 antibody, pi3 kinase-delta inhibitor, anti-pd-1 anti-pd-l1 antibody treating hematological cancersthe present disclosure methods kits treating slowing progression hematological malignancy, administering subject thereof therapeutically effective amount of: (i) inhibitor pi3 kinase (pi3k)-delta (e.g., tgr-1202); (ii) anti-cd20 antibody (e.g., ublituximab); (iii) anti-pd-1 antibody (e.g., pembrolizumab) anti-pd-l1 antibody (e.g., atezolizumab). treatment regimens provided.',\n",
              " 'combination tlr7 agonist immune checkpoint inhibitorthe present invention agent inducing effector memory cell mhc class treating preventing cancer, comprising tlr7 agonist combination immune checkpoint inhibitor. and, present invention medicament treating preventing cancer, comprising tlr7 agonist combination immune checkpoint inhibitor.',\n",
              " 'thymidine kinase marker immune checkpoint inhibitor efficacythe invention method determining prognosis individual cancer considered treatment with, currently treated with, immune checkpoint inhibitors, method comprising consisting steps of: a) providing sample obtained individual prior treatment immune checkpoint inhibitors; b) measuring activity and/or concentration thymidine kinase (tk) sample; c) providing sample obtained individual 1-4 weeks treatment immune checkpoint inhibitors; d) measuring activity and/or concentration thymidine kinase (tk) sample provided step (c); activity and/or concentration thymidine kinase (tk) measured steps (b) (d) indicative prognosis individual treated immune checkpoint inhibitors.',\n",
              " 'compositions methods potentiating immune checkpoint inhibitor therapythe present invention compositions methods treating patient cancer, methods potentiating immune checkpoint inhibitor therapy. methods comprise administering larazotide derivative thereof subject need, including subjects undergoing checkpoint inhibitor therapy, subjects scheduled undergo immune checkpoint inhibitor therapy.',\n",
              " 'combinations pfkfb3 inhibitors immune checkpoint inhibitors treat cancerprovided method treating cancer stimulating anti-tumor immunity subject thereof, method including administering subject synergistic, therapeutically effective amount pfkfb3 inhibitor, pfk-158, combination immune checkpoint inhibitor. provided method synergistically increasing activity immune checkpoint inhibitor, method including administering subject thereof combination therapy including pfk-158 immune checkpoint inhibitor. pharmaceutical composition including pfk-158, immune checkpoint inhibitor; pharmaceutically-acceptable carrier provided.',\n",
              " 'immune checkpoint inhibitors conjugated ultrasonic sensitizers thereofthe invention relates immune checkpoint inhibitor conjugated ultrasonic sensitive agent, application immune checkpoint inhibitor like. immune checkpoint inhibitor conjugate conjugated ultrasonic sensitive agent present invention tumor selectivity respect targeted therapy, specifically responds ultrasonic waves, produce diagnosing treating cancer. particular, conjugate present invention exhibits excellent solubility stability aqueous solution, excellent anti-cancer effect compared simple immune checkpoint inhibitor, expected treatment cancer.',\n",
              " 'bacterium preparation synergist immune checkpoint inhibitorsthe bacterium preparation synergist immune checkpoint inhibitors. means single-bacterium oral preparation human endogenous intestinal bacterium combination immune checkpoint inhibitors, antitumor immune protective response generated means stimulation endogenous intestinal bacterium significantly enhances efficacy immune checkpoint inhibitors multiple tumor species, safety better, survival time cancer patients prolonged, response rate cancer immunotherapy population improved, number cancer patients benefiting cancer immunotherapy increased.',\n",
              " 'marker identifying tumor sensitive immune checkpoint inhibitorthe invention discloses marker identifying tumors sensitive immune checkpoint inhibitors, biomarker, application reagent detecting expression level biomarker and/or hla classi preparation product identifying tumors sensitive immune checkpoint inhibitors/cold hot tumors. experiments prove screened biomarker effectively identify tumors/cold hot tumors sensitive immune checkpoint inhibitor therapy, high diagnostic efficiency, beneficial personalized treatment endometrial cancer patients, wide application prospects.',\n",
              " 'method treating immune toxicities induced immune checkpoint inhibitorsthe invention relates jak inhibitor treating preventing adverse events patient treated immune checkpoint inhibitor, treating cancer combination immune checkpoint inhibitor.',\n",
              " 'combination therapy treating cancerthe present application method treating and/or generating memory immune response tumor/cancer subject thereof, comprising administering subject effective amount pi3k inhibitor, oncolytic virus, pd-1 inhibitor pi3k inhibitor, oncolytic virus, pd-1 inhibitor administered simultaneously, separately, sequentially. present application pharmaceutical composition comprising pi3k inhibitor, oncolytic virus pd-1 inhibitor, pharmaceutically acceptable carrier, kit comprising pharmaceutical composition instructions use.',\n",
              " 'salt biphenyl derivative inhibitor crystal form preparation method thereofthe invention relates salt biphenyl derivative inhibitor, crystal form preparation method thereof. invention specifically relates salt crystal form compound general formula (i), preparation method, pharmaceutical composition containing therapeutically effective amount salt crystal form, application pharmaceutical composition pd-1/pd-l1 inhibitor treatment cancers, infectious diseases autoimmune diseases.',\n",
              " 'cancer biomarkers immune checkpoint inhibitorsdisclosed methods identifying treating cancer patients benefit immune checkpoint inhibitor therapies.',\n",
              " 'compositions methods potentiating immune checkpoint inhibitor therapythe present invention compositions methods treating patient cancer, methods potentiating immune checkpoint inhibitor therapy. methods comprise administering larazotide derivative thereof (d)-larazotide subject need, including subjects undergoing checkpoint inhibitor therapy, subjects scheduled undergo immune checkpoint inhibitor therapy.',\n",
              " 'combination stat3 targeting oligonucleotides pd-l1 inhibitorsthe subject matter disclosed directed modulating gene expression sirna compositions methods directed affecting key cell populations supporting growth metastasis cancer affect beneficial treatment, remission removal underlying tumor patient.',\n",
              " 'predicting responders anti-pd-1/pd-l1 immune checkpoint inhibitors non-small cell lung cancerthis disclosure systems methods creating machine learning model generate outputs corresponding individual subjects diagnosed non-small cell lung cancer fare provided anti-pd-1/pd-l1 immune checkpoint inhibitors second-line monotherapy. prognostic model identify particular prognostic factors and/or transform values prognostic factors outputs representing predicted responsiveness particular treatment (e.g., survivorship likelihood).',\n",
              " 'compounds pd1/pd-l1 inhibitors methods thereofthe present invention relates general, field pharmaceutical compounds, particularly compounds formula (i) acts inhibitors pd1/pd-l1 interaction. present invention relates method preparation compounds formula (i). present invention relates composition compounds formula (i).',\n",
              " 'pd-1/pd-l1 inhibitors treating cancerfield: immunology.substance: invention relates immunology. disclosed method treating urothelial carcinoma involves introduction subject therapeutically effective quantity inhibitor interaction receptor pd-1 ligand pd-l1 thereof, inhibitor antibody pd-l1, avelumab.effect: invention enables effective treatment urothelial carcinoma.13 cl, 2 dwg, 17',\n",
              " 'composition predicting response cancer patient immune checkpoint inhibitorone aspect relates composition predicting response cancer patient immune checkpoint inhibitor method predicting same. aspect, confirmed rt-qpcr results cd274 mrna cancer cells cancer patients treated immune checkpoint inhibitor significant correlation pd-l1 immunohistochemistry (ihc) results superior pd-l1 ihc results terms sensitivity, specificity, positive predictive value, negative predictive value, accuracy. accordingly, composition predicting response cancer patient immune checkpoint inhibitor, aspect, superior pd-l1 ihc terms ability predict response immune checkpoint inhibitor cancer patient (in particular, patient gastric cancer urothelial carcinoma), composition, measuring expression level cd274 mrna means rt-qpcr, advantages reducing time needed predict response immune checkpoint inhibitor enabling cancer diagnosis early stage.',\n",
              " 'application bacteria preparation synergist immune checkpoint inhibitorthe invention discloses application bacteria preparation synergist immune checkpoint inhibitor. bacteria active bacteria inactive whole-cell gut microbiota. monobacterial oral preparation human endogenous gut microbiota alistipes combined immune checkpoint inhibitor, anti-tumor immune protective response effect remodeling gut microbiota generated stimulation oral administration active human commensal gut microbiota inactive whole-cell human commensal gut microbiota, significantly enhances efficacy immune checkpoint inhibitor multiple tumor species, enhances anti-tumor immune function, conducive improving response rate cancer immunotherapy populations, safety, prolongs survival time cancer patients, expands cancer patient population benefited cancer immunotherapy (immunotherapy checkpoint inhibitors), combination therapy regimens therapeutic drugs treat immune checkpoint inhibitor-refractory tumor patients, expands patient benefited cancer immunotherapy.',\n",
              " 'combination anti-il10 anti-pd1 antibodies cancer treatmentthe present disclosure relates field oncology, particularly immune oncology combination therapies treatment malignant melanoma. particular, present invention relates interleukin 10 (il-10) neutralizing antibody fragment thereof combination pd-1 inhibitor treatment melanoma mammal, particular human. provided interleukin 10 (il-10) neutralizing antibody fragment thereof treatment melanoma mammal undergoing treatment pd-1 inhibitor. similarly, present disclosure relates pd-1 inhibitor combination interleukin 10 (il-10) neutralizing antibody fragment thereof treatment melanoma mammal. disclosed pd-1 inhibitor treatment melanoma mammal undergoing treatment interleukin 10 (il-10) neutralizing antibody fragment thereof.',\n",
              " 'benzopyrazolo ring derivative application thereof antitumor drugsthe invention belongs technical field medicines, benzopyrazolo ring derivative shown general formula preparation method thereof. invention disclosesthe benzene bipyrazolo ring derivative inhibit mutual combination programmed cell death receptor 1/a programmed cell death ligand 1 (pd-1/pd-l1) preparing pd-1/pd-l1 inhibitor.',\n",
              " 'resorcinol dianisole derivative thereofthe present invention relates resorcinol dianisole derivative, chemical structure compound represented formula (i). compound present invention inhibit binding programmed cell death receptor 1/programmed cell death ligand 1 (pd-1/pd-l1), preparing pd-1/pd-l1 inhibitor. inhibitor significant anti-tumor effect.',\n",
              " 'phenyl-1h-pyrazole derivative application thereof antitumor drugsthe invention belongs technical field medicines, phenyl-1h-pyrazole derivative shown general formula preparation method thereof. invention discloses phenyl-1h-pyrazole derivative inhibit mutual combination programmed cell death receptor 1/a programmed cell death ligand 1 (pd-1/pd-l1) preparing pd-1/pd-l1 inhibitor.',\n",
              " 'heterocycle-substituted styryl-4-phenylpyridine derivative preparation method medical application thereofthe invention relates heterocycle-substituted styryl-4-phenylpyridine derivative, preparation method thereof application heterocycle-substituted styryl-4-phenylpyridine derivativeas pd-1/pd-l1 inhibitor. specifically, invention discloses compound shown formula (i) pharmaceutically acceptable salt, stereoisomer, solvate prodrug thereof, preparation method application thereof, definition group formula shown specification claims detail.',\n",
              " 'microtubule-targeting drugs immune checkpoint inhibitors methods screening immune checkpoint inhibitors treatment cancers infectious diseasesthe invention based discovery mrna encoding checkpoint proteins pd-1 interact dynamic microtubules surface expression proteins. inhibitor interaction putative immune checkpoint inhibitor suitable treatment cancers infectious diseases. accordingly, present invention relates microtubule-targeting drugs immune checkpoint inhibitor, method screening immune checkpoint inhibitor comprising a) determining ability test compound inhibit interaction mrna sequence encoding immune checkpoint protein polymerized-tubulin moiety b) positively selecting test compound inhibits binding.',\n",
              " 'composition enhancing effect antibody drugprovided composition capable enhancing effect antibody immune checkpoint inhibitor, etc. β-glucan active ingredient composition enhancing effect antibody drug. composition suitably antibody drugs effect suppressing growth cancer immune checkpoint inhibition; e.g., antibody drugs including monoclonal antibody pd-l1.',\n",
              " 'application bacteroides fragilis capsular polysaccharide immune checkpoint inhibitorthe invention relates application bacteroides fragilis capsular polysaccharide immune checkpoint inhibitor, relates application bacteroides fragilis capsular polysaccharide immune checkpoint inhibitor preparation drugs preventing treating lymphoma. large number experiments prove capsular polysaccharide bacteroides fragilis immune checkpoint inhibitor combined use, synergistic effect lymphoma achieved.',\n",
              " 'lag-3 antagonist therapy melanomathe disclosure method treating unresectable metastatic melanoma human patient lymphocyte activation gene-3 (lag-3) antagonist. aspects, method includes combination lag-3 antagonist cytotoxic t-lymphocyte antigen-4 (ctla-4) inhibitor. aspects, method includes additional therapeutic agents and/or anti-cancer therapies.',\n",
              " 'immunosuppressant, preparation method therefor thereofan immunosuppressant structure formula (i), preparation method therefor thereof. series compounds present invention widely preparation drugs preventing and/or treating cancers tumors, immune-related diseases disorders, communicable diseases, infectious diseases metabolic diseases mediated pd-1/pd-l1 signal pathways, drugs expected developed generation pd-1/pd-l1 inhibitors.',\n",
              " 'method selecting individuals administered immune checkpoint inhibitor(problem solved) object provide method selecting individuals administration immune checkpoint inhibitor effective collecting tumor tissue individuals suffering tumors determining expression levels b7-h3 collected tumor tissue. (solution) method selecting individual candidate administration immune checkpoint inhibitor treatment tumor, comprising: (1) step collecting tumor tissue individual, (2) step determining extent b7-h3 expression tumor tissue collected step (1), (3) step selecting individual individual candidate administration immune checkpoint inhibitor b7-h3 expression level considered negative, provided.',\n",
              " 'biomarker immune checkpoint inhibitor sensitive cancerthe invention relates methods diagnosing, predicting disease development, disease progression and/or disease outcome, predicting susceptibility treatment and/or classification context immune checkpoint inhibitor treatable cancer, combination biomarkers table 1 determined. invention relates pharmaceutical products patients stratified methods invention compositions comprising reagents detection combination biomarkers table 1 diagnosis immune checkpoint inhibitor treatable cancer.',\n",
              " 'complexes comprising platinum compound immune checkpoint inhibitor related methodscomplexes comprising platinum compound immune checkpoint inhibitor, related methods, generally provided. embodiments, immune checkpoint inhibitor inhibitor indoleamine-2,3-dioxygenase.',\n",
              " \"method classifying patient's responsiveness immune checkpoint inhibitor therapythe present invention relates method vivo classifying patient non-responder responder immune checkpoint inhibitor therapy, gene set classifying patient non-responder responder immune checkpoint inhibitor therapy.\",\n",
              " 'biopharmaceutical formulation anti-pd-1, anti-pd-l1, anti-vegfr therapeutic monoclonal antibodies method treating nsclc inhalationthis invention relates pharmaceutical formulations therapeutic monoclonal antibody drugs pharmaceutically acceptable excipients therapeutic strategy treatment lung cancers including metastatic nsclc administration formulations soft mist inhaler and/or nebulizer. pharmaceutical formulations comprise (a) therapeutic monoclonal antibody selected group consisting pembrolizumab, atezolizumab, nivolumab, durvalumab, bevacizumab, (b) water, (c) buffer. pharmaceutical formulations delivered locally lungs inhalation treatment cancer.',\n",
              " \"sting agonist combination therapy thereof treatment cancerthe present invention relates methods treatment cancer comprising administering patient thereof (a) compound (dithio-rp,rp-cyclic-[a(2',5')pa(3'5')p]), pharmaceutically acceptable salt thereof, optionally (b) 5 pd-1 ctla-4 checkpoint inhibitors, suitably preferably selected group consisting nivolumab, spartalizumab ipilimumab.\",\n",
              " 'biomarker predicting efficacy immune checkpoint inhibitorthe purpose present invention utilize blood pd-1 concentration biomarker predicting therapeutic effect immune checkpoint inhibitor cancer, evaluating cancer progression, predicting cancer recurrence. present invention pertains agent arresting cancer progression, suppressing cancer recurrence, and/or cancer treatment, agent characterized containing immune checkpoint inhibitor active ingredient administered cancer patients blood pd-1 concentration level predetermined cutoff value.',\n",
              " 'methods treating skin cancer administering pd-1 inhibitor.the present disclosure methods treating, reducing severity, inhibiting growth cancer (e.g., skin cancer). methods present disclosure comprise administering subject thereof therapeutically effective amount programmed death 1 (pd-1) antagonist (e.g., anti-pd-1 antibody). embodiments, skin cancer cutaneous squamous cell carcinoma basal cell carcinoma.',\n",
              " 'neutrophil bionic vesicle nano preparation, preparation method thereof application nano preparation preparation gastric cancer targeted drugsthe invention neutrophil bionic vesicle nano preparation, preparation method thereof application neutrophil bionic vesicle nano preparation preparation gastric cancer targeted drugs, belongs technical field biological drugs. rgd cyclopeptide modifying neutrophil bionic vesicle, rgd cyclopeptide tumor targeting peptide, combined alpha beta 3 receptor efficient selective inhibitor alpha beta 3 integrin receptor, rgd cyclopeptide modified neutrophil bionic vesicle gastric cancer cell targeting performance. drug-loaded photosensitive liposome wrapped rgd cyclopeptide modified neutrophil bionic vesicles, drug-loaded photosensitive liposome contains photosensitizer, photosensitizer corresponding photothermal characteristics, near-infrared second-region laser irradiation, photothermal effect photosensitizer enables drug-loaded photosensitive liposome decompose release active components pd-l1 inhibitor doxorubicin, drug-loaded photosensitive liposome release pd-l1 inhibitor doxorubicin. therefore, gastric cancer cell proliferation inhibited, gastric cancer occurrence development delayed, effect targeted treatment gastric cancer achieved.',\n",
              " \"therapeutic combinations btk inhibitor gitr binding molecule, 4-1bb agonist, ox40 agonisttherapeutic combinations molecule selected group consisting gitr binding molecule, 4-1bb agonist, ox40 agonist, combinations thereof bruton's tyrosine kinase (btk) inhibitor described. embodiments, invention pharmaceutical compositions comprising combinations molecule selected group consisting gitr binding molecule, 4-1bb agonist, ox40 agonist, combinations thereof btk inhibitor, methods treating disease molecule selected group consisting gitr binding molecule, 4-1bb agonist, ox40 agonist, combinations thereof btk inhibitor, particular cancer immune, autoimmune, inflammatory disease. embodiments, invention pharmaceutical compositions comprising combinations molecule selected group consisting gitr binding molecule, 4-1bb agonist, ox40 agonist, combinations thereof, pd-1 pd-l1 inhibitor, btk inhibitor, methods treating disease molecule selected group consisting gitr binding molecule, 4-1bb agonist, ox40 agonist, combinations thereof, pd-1 pd-l1 inhibitor, btk inhibitor, particular cancer immune, autoimmune, inflammatory disease.\",\n",
              " 'methods treating cancer anti-her2 biparatopic antibodiesmethods treating subjects her2-expressing cancer anti-her2 biparatopic antibody 2-tiered fixed dosing regimen based weight subjects treated described. combination therapy chemotherapeutic agents and/or pd-1 inhibitor, anti-pd-1 antibody, described.',\n",
              " 'immunomodulatory il-2 agents combination immune checkpoint inhibitorsthe invention compositions methods treating cancer patient combination therapy comprising fusion protein seq id no: 1 combination immune checkpoint inhibitor. preferably patient failed achieve complete partial response prior ongoing treatment immune checkpoint inhibitor.',\n",
              " 'application s100a7 squamous cell carcinoma immune checkpoint inhibitor treatmentthe invention discloses application s100a7 squamous cell carcinoma immune checkpoint inhibitor treatment. invention finds substance detecting expression quantity s100a7 preparing product functions: (1) predicting assisting predicting curative effect immune checkpoint inhibitor lung squamous cell carcinoma; (2) predicting assisting predicting progression-free survival time immune checkpoint inhibitor treats lung squamous cell carcinoma. experiments prove s100a7 possibly potential predicting curative effect lung squamous cell carcinoma immunotherapy, anti-tumor effect immune checkpoint inhibitor synergistically enhanced jointly inhibiting expression s100a7.',\n",
              " 'method predicting efficacy immune checkpoint inhibitors cancer patientsdisclosed method predicting clinical response cancer patient treatment immune checkpoint inhibitor, combination thereof, combination immune checkpoint inhibitor antitumor drugs, introducing bispecific cell engager (bite) platform lymphocytes containing cells vitro.',\n",
              " 'methods treating cancer anti-her2 biparatopic antibodiesmethods treating subjects haying her2-expressing cancer anti-her2 biparatopic antibody 2-tiered fixed dosing regimen based weight subjects treated described. combination therapy chemotherapeutic agents and/or pd-1 inhibitor, anti-pd-1 antibody, described.',\n",
              " 'immune checkpoint inhibitorsthe present invention relates identification fibrinogen protein 1 (fgl1) prognostic biomarker responsiveness immune checkpoint inhibitor cancer patient. specifically relates methods treating cancer human patient comprising administering immune checkpoint inhibitory antibody specifically inhibiting interaction fibrinogen-like protein 1 (fgl1) lymphocyte-activation gene 3 protein (lag3), cancer fgl1 expressing cancer. further, invention relates methods assessing susceptibility predicting responsiveness treatment immune checkpoint inhibitory antibody specifically inhibiting interaction fgl1 lag3 cancer patient, comprising detecting fgl1 expression sample patient kit selecting cancer patient benefit immune checkpoint inhibitory antibody specifically inhibiting interaction fgl1 lag3. immune checkpoint inhibitory antibody specifically inhibits interaction fgl1 lag3 antibody directed human fgl1 antibody directed human lag3, optionally combination immune checkpoint inhibitory antibodies, anti-pd1 anti-pd-l1 antibody.',\n",
              " 'compound preparation method application thereofthe invention discloses compound preparation method application thereof, structure compound novel, compound selectively act hdac6 pd-l1, hdac6 enzyme pd-l1 protein inhibitory activity shown; preparation method compound mature process, safe pollution-free, advantage industrial popularization; compound widely applied preparation hdac6 inhibitor and/or pd-l1 inhibitor preparation drugs treating and/or preventing cancers.',\n",
              " 'composition combined treatment glioma immune checkpoint inhibitor oncolytic virusthe invention relates technical field tumor treatment, particular composition treating glioma combination immune checkpoint inhibitor oncolytic virus, pharmaceutical composition comprises oncolytic virus immune checkpoint inhibitor, oncolytic virus cytomegalovirus; immune checkpoint inhibitor pdgfr-alpha inhibitor, pd-1 antibody pd-l1 antibody. pdgfr-alpha inhibitor oncolytic virus together, treatment effect glioma achieved, treatment provided glioma treatment.',\n",
              " 'specific bacterial species metabolite improves immune checkpoint inhibitor therapy efficacythe present invention includes compositions methods increasing efficacy immune checkpoint inhibitor comprising: identifying human patient treatment melanoma; providing human patient effective amount immune checkpoint inhibitor; providing human patient of: probiotic bacteria, prebiotic agent, xenobiotic agent, amount effective increase potency immune checkpoint inhibitor melanoma.',\n",
              " 'composition containing pan-hdac immune checkpoint inhibitor applicationthe invention application combination pan-hdac inhibitor n-hydroxy-4-{2-[3-(n, n-dimethylaminomethyl) benzofuran-2-yl carbonylamino] ethyoxyl}-benzamide immune checkpoint inhibitor, pd-1 antibody, preparation medicine preventing recurrent lymphoma, application combination pan-hdac inhibitor n-hydroxy-4-{2-[3-(n, n-dimethylaminomethyl) benzofuran-2-yl carbonylamino] ethyoxyl}-benzamide immune checkpoint inhibitor. n-hydroxy-4-{2-[3-(n, n-dimethylaminomethyl) benzofuran-2-yl carbonyl amino] ethyoxyl}-benzamide salt preferably tosilate, immune checkpoint inhibitor preferably pd-1, content ratio n-hydroxy-4-{2-[3-(n, n-dimethylaminomethyl) benzofuran-2-yl carbonyl amino] ethyoxyl}-benzamide salt immune checkpoint inhibitor preferably (5-10): (1-5). experiments show combination pan-hdac inhibitor n-hydroxy-4-{2-[3-(n, n-dimethylaminomethyl) benzofuran-2-yl carbonylamino] ethyoxyl}-benzamide immune checkpoint inhibitor, pd-1 antibody, effectively prevent recurrent lymphoma.',\n",
              " 'noninvasive multiparameter approach early identification therapeutic benefit immune checkpoint inhibition lung canceran integrated analytic method provided, bayesian framework derive single biomarker circulating tumor dna profiling analysis circulating immune cells generate prognostic patient responsiveness immune checkpoint inhibition. methods robustly identify patients achieve durable clinical benefit immune checkpoint inhibition, embodiments noninvasive blood draws.',\n",
              " 'antiaging effect intradermal administration immune checkpoint inhibitorsthe present invention generally directed compositions methods preventing, ameliorating treating aging effects. aspect, present invention directed method treating effect aging. effect aging selected group consisting loss hair pigmentation, hair loss, increase fine lines, increase skin laxity, increase skin sun spots, loss natural skin color, loss skin elasticity, increase skin pore size loss skin hydration. method comprises steps of: obtaining preparing immune checkpoint inhibitor formulation, formulation comprises immune checkpoint inhibitor water, concentration immune checkpoint inhibitor formation ranges 1 mg/ml 60 mg/ml; intradermally, topically electrophoretically administering portion formula patient experiencing aging effect skin area patient, amount immune checkpoint inhibitor administered formulation ranges 1 mg 750 mg, aging effect lessened percentage ranging 1 percent 50 percent weeks intradermal administration.',\n",
              " 'methods identifying treating immune checkpoint inhibitor-responsive neoplasmsprovided methods identifying subject cancer responsive agents combat immune evasion, immune checkpoint inhibitors. methods treating subject cancer provided. methods include involve identifying cancer responsive immune checkpoint inhibitor and/or immune-evasive cancer administering agent, e.g., immune checkpoint inhibitor and/or myc inhibitor, subject treat cancer. provided methods identifying cancer therapeutics effective myc-regulated immune evasion cancer cell lines transgenic animals methods. kits described methods provided.',\n",
              " 'biomarker judging efficacy immune checkpoint inhibitorthe present invention addresses problem providing: method identifying malignant tumor patient immune checkpoint inhibitor expected effective; agent suppressing advance, suppressing recurrence, and/or treating malignant tumor characterized prescription based method. present invention provides: determination malignant tumor patient immune checkpoint inhibitor expected effective, determination made analyzing evaluation items comprising combination pd-1 expression intensity proportion pd-1 expressing cells, etc., treg cells cd8',\n",
              " 'biphenyl derivatives blocking pd-1/pd-l1 interaction, preparation method therefor thereofbiphenyl derivatives structure formula (i) capable blocking pd-1/pd-l1 interaction, preparation method therefor thereof. series compounds widely preparation medicaments preventing and/or treating cancers tumors, immune-related disease disorders, communicable diseases, infectious diseases metabolic diseases mediated pd-1/pd-l1 signal pathways, expected developed generation pd-1/pd-l1 inhibitors.',\n",
              " 'biomarker panels stratification response immune checkpoint blockade cancerthe present invention describes methods detecting biomarkers tumor tissue, methods improving responsiveness providing survival prognosis subject received of, immune checkpoint inhibitor treatment cancers bladder cancer, lung cancer, leukemia. discoidin domain receptor (ddr)-driven gene signatures identified validated stratify patient response anti-pd-l1 immune checkpoint therapy.',\n",
              " 'cancer treatment cxcl12 signaling inhibitor immune checkpoint inhibitorthe present invention relates methods compositions treating cancer enhancing immune response cancer cells combination inhibitor cxcl12 signaling immune checkpoint inhibitor. invention relates compositions kits parts comprising inhibitor cxcl 12 signaling immune checkpoint inhibitor methods invention.',\n",
              " \"methods improve patient response immune checkpoint inhibitors functional tests predict responsethe present invention methods improve cancer patient's response immune checkpoint inhibitor (ici) therapy, functional test predict likelihood response. specifically, invention methods improve patient's response immune checkpoint inhibitors modulators predict response combination immune checkpoint inhibitors modulators.\",\n",
              " 'biphenyl derivative preparation method medical application thereofthe invention relates field medicinal chemistry, discloses biphenyl derivative pd-1/pd-l1 inhibitory activity preparation method application thereof. invention discloses composition containing biphenyl derivative pd-1/pd-l1 inhibitory activity pharmaceutically acceptable salt biphenyl derivative pharmaceutically acceptable carrier biphenyl derivative, application composition preparation pd-1/pd-l1 inhibitor. compound treating tumors.',\n",
              " 'heterocyclic-substituted nitrogen-containing six-membered heterocyclic derivative preparation method medical application thereofthe invention relates heterocyclic-substituted nitrogen-containing six-membered heterocyclic derivative, preparation method thereof application heterocyclic-substituted nitrogen-containing six-membered heterocyclic derivative pd-1/pd-l1 inhibitor. specifically, invention discloses compound shown formula (i) pharmaceutically acceptable salt, deuterated compound, stereoisomer, solvate prodrug thereof, preparation method application compounds, definition group formula detailed description claims.',\n",
              " 'cyclic compound capable inhibiting programmed death receptor ligand 1, thereofthe present invention proposes cyclic compound capable inhibiting programmed death receptor ligand 1, thereof, compound compound represented formula i, pharmaceutically acceptable salt, hydrate, solvate, metabolite, stereoisomer prodrug thereof, r1, r2, r3 defined specification. present invention, compoundcan small molecule pd-l1 inhibitor, preparing drugs treatment and/or prevention tumors. formula defined specification.',\n",
              " 'biomarker accessing efficacy immune checkpoint inhibitorthe problem solved present invention provide method identifying patient malignant tumor expected benefit immune checkpoint inhibitor, agent suppressing progression of, suppressing recurrence of, and/or treating malignant tumor, prescribed based thereon. present invention agents suppressing progression of, suppressing recurrence of, and/or treating malignant tumor, prescribed based identifying patient malignant tumor expected benefit immune checkpoint inhibitor, based combination sets evaluation items specific condition defined combination thereof.',\n",
              " 'gene combination application thereof preparation reagent predicting prognosis patient treated immune checkpoint inhibitorthe invention gene combination application thereof preparation reagent predicting prognosis patient treated immune checkpoint inhibitor. based combination 55 genes, invention develops tumor mutation score tms32055 method gene combination, tms defined number genes containing non-synonymous mutations specific gene combination. tms 55 divided 3 groups: tms 55 equal 0, tms 55 greater equal 1 equal 5, tms 55 greater 5. compared group tms 55 equal 0, patients groups tms 55 greater equal 1 equal 5 tms 55 greater 5 prognosis longer survival time.the tms55 based 55-gene combination higher prediction efficiency tmb predicting survival immunotherapy, uniform cutoff value. therefore, tms55 beused predicting prognosis patients receiving immune checkpoint inhibition treatment, easier popularize apply clinical practice.',\n",
              " 'microrna-34 immunotherapya method treating pd-l1 expressing cancer individual thereof administering synthetic mir-34 oligonucleotide combination synthetic mir-34 oligonucleotide pd-l1 pd-1 inhibitor. method treating chronic infectious disease individual thereof administering synthetic mir-34 oligonucleotide pd-l1 pd-1 inhibitor.',\n",
              " 'anticancer combination cbp/catenin inhibitor immune checkpoint inhibitorthe present invention aims provide therapeutic cancer superior treatment effect. cancer treatment cbp/catenin inhibitor immune checkpoint inhibitor combination increases treatment effect cancer, enables effective treatment cancer patients showing low sensitivity immune checkpoint inhibitor alone.',\n",
              " 'combination therapy hyaluronan-degrading enzyme immune checkpoint inhibitorprovided combinations hyaluronan-degrading enzyme, hyaluronidase, immune checkpoint inhibitor. combinations improve therapy, particularly anti-tumor therapy, includes administration immune checkpoint inhibitors inhibitors immunosuppressive effects tumors. combination therapy treating cancers, including solid non-solid tumors. methods treating cancers provided.',\n",
              " 'combination mcoln activators immune checkpoint inhibitorsthe present invention relates composition combination comprising activator mucolipin channel (mcoln) immune checkpoint inhibitor thereof, particular treating cancer.',\n",
              " 'oncolytic vaccinia virus expressing immune checkpoint blockade cancer immunotherapydisclosed methods compositions related treatment, prevention, and/or amelioration cancer subject thereof. particular aspects, present technology relates poxviruses, including engineered attenuated vaccinia virus (vacv) strain comprising disruption n-terminal dna binding domain e3l gene (e3l?a83n) deletion thymidine kinase (e3l?83n-tk-) engineered express antibody specifically targeting cytotoxic lymphocyte antigen 4 (e3l?83n-tk--anti- ctla-4), combination immune checkpoint blocking agents immune stimulating agents, oncolytic immunotherapeutic composition. aspects, present technology relates e3l?83n-tk--anti-ctla-4 virus engineered express human fms-like tyrosine kinase 3 ligand (hflt3l) (e3l?83n-tk--hflt3l-anti- ctla-4). embodiments, engineered viruses administered subject combination immune checkpoint blocking agents immune stimulating agents, oncolytic immunotherapeutic composition.',\n",
              " 'fluorobiphenyl methyl resorcinol ether derivative preparation method application thereofthe invention discloses fluorobiphenyl methyl resorcinol ether derivative preparation method application thereof. general formula fluorobiphenyl methyl resorcinol ether derivative shown i, r1 selected groups; r2 selected groups: fluorine, chlorine methoxyl; x selected hydrogen, chlorine, bromine, iodine, c1-c4 alkyl methoxyl; r3 selected groups: r4 selected groups: substituted c1-c8 saturated alkylamino group, substituted c2-c6 unsaturated alkylamino group substituted c2-c6 azacyclo-1-group. fluorobiphenyl methyl resorcinol ether derivative disclosed invention pd-l1 inhibitor, interaction proteins pd-1 pd-l1 remarkably inhibited concentration 10nm, activity fluorobiphenyl methyl resorcinol ether derivative remarkably superior pd-l1 inhibitor bms-202. biphenyl compound disclosed invention high inhibitory activity pd-l1, chemical stability metabolic stability, biphenyl compound druggability.',\n",
              " 'nk cell surface modified immune checkpoint inhibitor application thereofthe invention discloses nk cell surface modified immune checkpoint inhibitor application thereof. structural formula nk cell surface modified immune checkpoint inhibitor shown specification. nk cell surface modified immune checkpoint inhibitor presented surfaces nk cells intracellular metabolism carried out, cis-form interaction siglec-7 interaction, trans-combination siglec-7 tumor cell surface sialic acid inhibited, killing activity nk cells released interaction nk cells tumor cells.',\n",
              " 'methods anti-her2 biparatopic antibody-drug conjugates treatment cancermethods treating her2-expressing cancer anti-her2 biparatopic antibody conjugate (adc) auristatin analogue conjugated antibody average drug-to-antibody ratio (dar) 1.5 2.5. dosing regimens combination therapy pd-1 inhibitor, anti-pd-1 antibody, described.',\n",
              " 'kit predicting efficacy immune checkpoint inhibitor cancer patientsthe invention relates field immunotherapy, particular kit predicting curative effect immune checkpoint inhibitor cancer patient. kit predicting curative effect immune checkpoint inhibitor cancer patient comprises reagent detecting expression level laminin-gamma2, amino acid sequence laminin-gamma2 shown seq id no.1. invention, effective clinical marker laminin lamin gamma2 found predict curative effect immune checkpoint inhibitor cancer patients, cure rate patients improved. meanwhile, animal experiments find curative effect pd1 antibody improved inhibiting tgf-beta1 signal reduce expressionof laminin-gamma2.',\n",
              " 'methods activating dysfunctional immune cells treatment cancermethod activating dysfunctional cells, determining responsiveness subject tumor immune checkpoint inhibition provided. provided agent capable inhibiting target gene expression product thereof treating subject tumor. additionally alternatively provided immune checkpoint inhibitor agent capable inhibiting target gene expression product thereof treating subject tumor.',\n",
              " 'immunosuppressive agent, preparation method therefor pharmaceutical thereofan immunosuppressive agent structure formula (i), preparation method therefor, pharmaceutical thereof. series compounds strong inhibitory activity pd-1/pd-l1 interaction, widely preparing medicaments preventing and/or treating cancers tumors, immune-related diseases disorders, communicable diseases, infectious diseases metabolic diseases mediated pd-1/pd-l1 signaling pathway, expected developed generation pd-1/pd-l1 inhibitors.',\n",
              " 'methods enhancing immune checkpoint inhibitor therapycompositions methods enhancing immune checkpoint inhibitor therapy cancer cotherapy cyclic peptides provided. cyclic peptides naturally occurring synthetic origin.',\n",
              " 'prostate-associated antigens vaccine-based immunotherapy regimensthe present disclosure pharmaceutical product comprising (1) vaccine comprising antigen construct, (2) ctla-4 inhibitor, antigen construct comprises nucleotide sequence encoding immunogenic psma polypeptide selected group consisting of: (i) polypeptide consisting amino acids 15-750 amino acid sequence seq id no: 1; (ii) polypeptide comprising amino acid sequence seq id no: 9.',\n",
              " 'immune checkpoint inhibitor related myocarditis early diagnosis kitthe invention relates early diagnosis kit immune checkpoint inhibitor related myocarditis, belongs technical field biological medicine. invention diagnostic reagent diagnostic kit immune checkpoint inhibitor related myocarditis, detecting resistin level peripheral blood tumor patient receiving icis treatment judging early myocardial injury icis related myocarditis exists not. invention application reagent detecting resistin level preparation diagnostic kit icis-related myocarditis. method diagnostic reagent provided invention high sensitivity, specificity, low cost convenient rapid detection, early diagnosis immune checkpoint inhibitor related myocarditis.',\n",
              " 'prophylactic and/or therapeutic agent diabetesthe present invention aims provide prophylactic and/or therapeutic agent diabetes highly effective diabetes developed side effect immune checkpoint inhibitors effect patients. present invention therapeutic agent diabetes comprising mesenchymal stem cells. prophylactic and/or therapeutic agents diabetes present invention suitably particularly diabetes caused immune checkpoint inhibitors diabetes caused anti-pd-1 antibody anti-pd-l1 antibody.',\n",
              " 'biphenyl compound pd-l1 inhibitory activity application thereofthe invention relates biphenyl compound pd-l1 inhibitory activity, chemical structure compound shown formula (i), formula (i), x selected one; biphenyl compound pd-l1 inhibitory activity inhibit mutual combination programmed cell death receptor 1/a programmed cell death ligand 1 (pd-1/pd-l1), preparing pd-1/pd-l1 inhibitor, anti-tumor effect.',\n",
              " 'method assisting determination efficacy immune checkpoint inhibitordisclosed method assisting determination efficacy immune checkpoint inhibitor, method comprising: measuring free protein marker liquid sample collected subject; determining efficacy immune checkpoint inhibitor subject based result measurement, free protein marker selected free cytotoxic lymphocyte antigen-4 (ctla-4), free programmed cell death-1 (pd-1) free programmed cell death-ligand 1 (pd-l1).',\n",
              " 'biomarkers predicting responsiveness immune checkpoint inhibitor therapythe present disclosure methods identifying subjects respond immune checkpoint inhibitor therapies. example, embodiments, methods comprise: (a) determining genotype biomarker genes biological sample subject afflicted tumor (e.g., cancer); (b) determining genotype biomarker genes biological sample; (c) classifying subject sensitive resistant therapy comprising immune checkpoint inhibitor based genotype biomarker genes biological sample.',\n",
              " 'method system predicting response immune checkpoint inhibitorthe present invention relates method predicting response immune checkpoint inhibitor, executed computing devices. method comprises: step receiving pathological slide image; step detecting subject items pathological slide image; step determining immunity expression type areas pathological slide image information related immunity expression type based results detection subject items; step generating prediction result patient related pathological slide image responds immune checkpoint inhibitor based immunity expression type areas pathological slide image information related immunity expression type. present invention aims provide method predicting response immune checkpoint inhibitor, capable improving prediction rate.',\n",
              " 'immune checkpoint inhibitor combination therapy quinoline carboxamide derivativeprovided method stat3 inhibitor exerts excellent antitumor effect. antitumor agent comprises quinoline carboxamide derivative represented formula (1) salt thereof active ingredient administered combination immune checkpoint inhibitor. antitumor agent administered prior administration immune checkpoint inhibitor.',\n",
              " 'combination ep2 receptor antagonist immune checkpoint inhibitor and/or ep4 receptor antagonistan object present invention provide effective cancer treatment method. solution, provided combination compound represented general formula (ia): (wherein symbols meanings described specification), pharmaceutically acceptable salt thereof, hydrates immune checkpoint inhibitor (eg, anti-pd-1 antibody, etc.) and/or ep4 receptor antagonist. combination present invention exerts strong antitumor effect cancer treatment.',\n",
              " 'application myeloperoxidase inhibitor preparation heart protection medicinethe invention discloses application myeloperoxidase inhibitor preparation heart protection drug, myeloperoxidase inhibitor pf-1355 effectively reduce prevent heart injury induced programmed death protein 1 inhibitor, safety pd-1 inhibitor improved; prognosis tumor patients clinically pd-1 inhibitor improved, method potential clinical development.',\n",
              " 'immune checkpoint inhibitor combination sonodynamic therapythe invention generally relates sonodynamic therapy microbubble-sonosensitiser complexes and, specifically, therapy treatment deeply-sited tumours associated metastatic disease. particular, invention relates combination therapy sonodynamic treatment deeply-sited tumours microbubble-sonosensitiser complexes combined treatment immune checkpoint inhibitors. relates methods sonodynamic therapy sonodynamic-induced abscopal response modulates systemic regression metastatic disease. methods abscopal response enhanced co-administration immune checkpoint inhibitor. invention particularly suitable treatment pancreatic cancer (e.g. pancreatic ductal adenocarcinoma) associated metastasis.',\n",
              " 'cancer treatment combining cd47 inhibitor, immune checkpoint inhibitor standard therapiesan object present invention provide effective cancer treatment. proposed cancer treatment combines cd47 inhibitor, immune checkpoint inhibitor (e.g., anti-pd-1 antibody like) standard therapies (such combined treatment folfox therapy bevacizumab cetuximab unresectable progressive recurrent colon/rectal cancer, folfirinox therapy reduced regimens pancreatic cancer distant metastasis). treatment present invention treating cancer.',\n",
              " 'enhancement anti-tumor effects immune checkpoint inhibitors administration intestinal ruminococcusprovided pharmaceutical composition capable enhancing effect immune checkpoint inhibitor tumor cancer subject. pharmaceutical composition provided administered combination immune checkpoint inhibitor comprises cell, culture supernatant, metabolite, and/or cell extract intestinal ruminococcus.',\n",
              " 'immune checkpoint inhibitor treatment cancerthe invention immune checkpoint inhibitor treatment cancer. particularly, invention monoclonal antibody, monoclonal antibody humanized monoclonal antibody, specifically combined ildr2, effectively inhibit immune effect ildr2, function inhibiting tumor process.',\n",
              " 'application bgn gene predicting treatment effect immune checkpoint inhibitor colon cancer patientthe invention discloses application bgn gene predicting therapeutic effect immune checkpoint inhibitor colon cancer patient, bgn gene effective biomarker predicting therapeutic effect immune checkpoint inhibitor colon cancer patient, patient benefit immune checkpoint inhibitor therapy identified. invention reliable convenient immune checkpoint inhibitor treatment response rate prediction index, positive effect clinical medication guidance precise treatment colon cancer patients.',\n",
              " 'anti-tgf [beta] antibodies checkpoint inhibitors treatment proliferative diseasesdisclosed therapies tgf-beta inhibitor and/or pd-1 inhibitor. drugs treatment prevention proliferative diseases, solid tumors, including pancreatic cancer, doses (including smooth administration) regimens. additional combinations thereof disclosed.',\n",
              " 'combination therapy merestinib anti-pd-l1 anti-pd-1 inhibitors treatment cancerthe present invention relates combination therapy -(3-fluoro-4-(1-methyl- 6-(1 -pyrazol-4-yl)-1 -indazol-5-yloxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide (merestinib, ly2801653), pharmaceutically acceptable salt thereof, antibodies bind human co-inhibitory immune checkpoints programmed death 1 ligand 1 (pd-l1) programmed death 1 (pd-1) treatment cancers.',\n",
              " 'methods treating cancer small molecule pd-l1 inhibitorsthe present disclosure provides, inter alia, methods treating cancer administering effective amount compound formula (i). embodiments, cancer solid cancer. embodiments, cancer melanoma. aspects, present disclosure methods increasing cd8+ cell/cd4+ cell ratio solid tumor microenvironment administering effective amount compound formula (i).',\n",
              " 'biomarkers immune checkpoint inhibitors treatmentthe present invention relates methods determining predicting patient predetermined disease, cancer, particular metastatic urothelial cancer, responsive, respond treatment based immune checkpoint inhibitor. present invention relates computer-implemented methods implementing methods.',\n",
              " 'prophylactic therapeutic agent tumors, pd-l1 inhibitor, screening method prophylactic therapeutic agent tumors, screening method pd-l1 inhibitorthis prophylactic therapeutic agent tumors contains, active ingredient, inhibitor interaction hla-g2 leukocyte ig-like receptor b2 (lilrb2).',\n",
              " 'pd-l1 inhibitor - tgfβ inhibitor bispecific moieties.the present disclosure directed bifunctional proteins including portion τοεβ receptor (τορβκιι) polypeptide sequence capable binding τορβ (a \"τορβ trap\" polypeptide sequence) affimer® polypeptides bind programmed death ligand 1 (pd-l1) inhibit interaction pd-1 (a \"pd-l1 binding affimer®\" polypetide seuquence). bispecific protein agents exhibit synergistic effect cancer treatment, compared effect administering agents separately.',\n",
              " 'pvrig/tigit binding proteins combination immune checkpoint inhibitors treatment cancerthe present disclosure relates pvrig/tigit binding proteins combination immune checkpoint inhibitors treatment cancer. particular, present disclosure relates pvrig/tigit binding proteins combination immune checkpoint inhibitors manufacture medicament treatment cancer.',\n",
              " 'method predicting occurrence risk mace related immune checkpoint inhibitorthe invention relates method predicting occurrence risk mace related immune checkpoint inhibitor, belongs technical field biomedical detection. prediction method comprises steps: acquiring diagnosis treatment information patient treated immune checkpoint inhibitor, extracting risk factors evaluating occurrence risk cardiovascular adverse events diagnosis treatment information; setting data indexes measuring risk factors; risk factors data indexes thereof, establishing risk prediction model related cardiovascular adverse events treatment immune checkpoint inhibitor; counting data indexes risk factors risk prediction model, calculating risk assessment values related cardiovascular adverse events, performing risk stratification risk assessment values. oncology doctor assisted individually evaluate risk cardiovascular adverse events patient applies immune checkpoint inhibitor, individual intervention measures predicted risk, occurrence adverse events reduced.',\n",
              " 'prophylactic and/or therapeutic agent diabetesthe purpose present invention provide prophylactic and/or therapeutic agent diabetes exerts excellent effects diabetes occurring side effect administration immune checkpoint inhibitor achieve effects patients. present invention pertains diabetes therapeutic agent containing mesenchymal stem cells. prophylactic and/or therapeutic agent diabetes present invention appropriately usable particularly diabetes caused immune checkpoint inhibitor diabetes caused anti-pd-1 antibody anti-pd-l1 antibody.',\n",
              " 'method treatment immune checkpoint inhibitor-related immune adverse effectsa method treatment and/or reduction occurrence immune checkpoint inhibitor related immune adverse effects subject thereof, includes administering thymosin alpha 1 subject. immune checkpoint inhibitor related immune adverse effects include colitis, diarrhea, rash, elevated alanine amino transferase (alt), hypothyroidism, hypophysitis.',\n",
              " 'combination therapies comprising dendritic cells-based vaccine immune checkpoint inhibitorthe present disclosure method treating hcc comprising co-administering patient, dendritic cells-based vaccine combination immune checkpoint inhibitor. treatment dc vaccine combination immune checkpoint inhibitor significantly improved survival subjects.',\n",
              " 'combination therapies comprising dendritic cells-based vaccine immune checkpoint inhibitorthe present disclosure method treating hcc comprising co-administering patient, dendritic cells-based vaccine combination immune checkpoint inhibitor. treatment dc vaccine combination immune checkpoint inhibitor significantly improved survival subjects.',\n",
              " 'method predicting response immune checkpoint inhibitorprovided method predicting response immune checkpoint inhibitor subject cancer, method comprising: step (1) determining values presence absence single nucleotide polymorphism (snp), selected group consisting of: (i) abundance microorganisms feces bowel content subject, (ii) genome pathway score feces bowel content subject, (iii) abundance metabolic products blood, serum, plasma subject, (iv) gene expression blood, serum plasma subject, (v) snp genes selected group consisting il6r nlrc5 subject; step (2) predicting response subject immune checkpoint inhibitor basis value obtained step (1).',\n",
              " 'methods combinations treatment cancer immune checkpoint inhibitor antibodiesthe disclosure relates methods, compositions, combinations treatment cancer. specifically, disclosure relates methods comprising administering subject thereof anti-ctla-4 antibody antigen-binding fragment anti-pd- l1 antibody antigen-binding fragment thereof. disclosure relates combinations comprising anti-ctla-4 antibody antigen-binding fragment anti- pd-l1 antibody antigen-binding fragment thereof.',\n",
              " 'chiauranib combination immune checkpoint inhibitor antitumor therapythe present invention relates field medicines, particular relates chiauranib combination immune checkpoint inhibitor antitumor therapy. combination chiauranib derivative thereof immune checkpoint inhibitor preparation medicine treating tumor, pharmaceutical composition kit comprising combination, method treating tumor administering therapeutically effective amount pharmaceutical composition kit tumor patient thereof. combination synergistic effect suitable treating cancer.',\n",
              " 'combination therapies comprising dendritic cells-based vaccine immune checkpoint inhibitorthe present disclosure method treating hcc comprising co-administering patient, dendritic cells-based vaccine combination immune checkpoint inhibitor. treatment dc vaccine combination immune checkpoint inhibitor significantly improved survival subjects.',\n",
              " 'biphenyl fluorine double bond derivative, preparation method therefor, pharmaceutical application thereofa biphenyl fluorine double bond derivative structure represented formula (i), preparation method therefor, pharmaceutical application thereof. biphenyl fluorine double bond derivative structure represented formula (i) widely applied preparation medicaments preventing and/or treating cancers tumors, immune-related diseases disorders, communicable diseases, infectious diseases metabolic diseases mediated pd-1/pd-l1 signal pathways, expected developed generation pd-1/pd-l1 inhibitors.',\n",
              " 'coumarin type derivative application thereofthe invention coumarin type derivative pharmaceutically-acceptable salts thereof. structural formula coumarin type derivative shown formula (which described thespecification). invention discloses pharmaceutically-acceptable salts coumarin type derivative. compound provided invention obvious anti-tumor activity pd-1/pd-l1 inhibiting activity, preparing mediciens treating preventing cancer diseases proliferative diseases, treatment prevention cancer diseases proliferative diseases realized.',\n",
              " 'biaryl derivative, preparation method thereof pharmaceutical application thereofdisclosed biaryl derivative structure represented formula (i) inhibitory activity pd-1/pd-l1 interaction, preparation method thereof, pharmaceutical application thereof. series compounds widely applied preparation medicament preventing and/or treating cancer tumors, immune-related diseases disorders, contagious diseases, infectious diseases metabolic diseases mediated pd-1/pd-l1 signaling pathway, shows promise development generation pd-1/pd-l1 inhibitors.',\n",
              " 'anticancer compositions comprising immune checkpoint inhibitorsthe present invention relates pharmaceutical composition preventing treating cancer comprising: active ingredients, (1) immune checkpoint inhibitor; (2) biguanide-based compound pharmaceutically acceptable salt thereof; (3) 2-deoxy-d-glucose; comprising: (4) inositol hexaphosphate pharmaceutically acceptable salt thereof, inositol, mixture thereof. compositions present invention increase indicants carcinomas immune checkpoint inhibitors limited indicants, exhibit synergistic anti-cancer effect appropriately combining specific drugs, maximizing therapeutic effect killing cancer cells side effects. therefore, compositions present invention usefully anticancer agents preventing treating cancer.',\n",
              " 'kind cyclopeptides compounds pd-1/pd-l1 interaction application cyclopeptides compoundsthe invention discloses kind cyclopeptides compounds application thereof. cyclopeptides compounds, pharmaceutically acceptable salts, ester solvent compounds thereof preparing pd-1/pd-l1 pathway inhibitor, application prospects preparation tumor treatment medicine. compared research development monoclonal antibodies, progress peptide inhibitors field pd-1/pd-l1 inhibitors slow, research development inhibitors inhibiting pd-1/pd-l1 interaction important clinical significance.',\n",
              " 'defibrotide cancer therapy and/or immunotherapydefibrotide nucleotide nucleic acid constituents immunotherapy cancer therapy, ameliorating eliminating side effects, associated administration immune checkpoint receptors (e.g., ctla-4 pd-l1) inhibitors. advantages include regulation restoration state cell tissue functioning respect mapk pathway state hormone-producing organs regulated camp. cytokine release symptoms associated elevated cytokine levels, including immune response adverse events (irae), effectively controlled.',\n",
              " 'method predicting monitoring response immune checkpoint inhibitora method analyzing cell free dna (cfdna) bloodstream cancer patient provided. embodiments, method comprise sequencing part coding sequences tp53 kras sample cfdna, analyzing sequences identify nucleotide transversions coding sequences genes, relative reference sequences genes. embodiments, method comprise counting total number identified nucleotide transversions. presence nucleotide transversions indicates patient responsive immune checkpoint inhibitor, decreased number transversions transversios indicates patient responsive immune checkpoint inhibitor.',\n",
              " 'method predicting monitoring response immune checkpoint inhibitora method analyzing cell free dna (cfdna) bloodstream cancer patient provided. embodiments, method comprise sequencing part coding sequences tp53 kras sample cfdna, analyzing sequences identify nucleotide transversions coding sequences genes, relative reference sequences genes. embodiments, method comprise counting total number identified nucleotide transversions. presence nucleotide transversions indicates patient responsive immune checkpoint inhibitor, decreased number transversions transversios indicates patient responsive immune checkpoint inhibitor.',\n",
              " 'combined treatment netrin-1 interfering immune checkpoint inhibitors drugsthe invention combination combined (i) compound disrupt impede netrin-1 /netrin-1 receptors interaction netrin-1 -mediated receptor dimerization, called ntn1 neutralizing agent, compound antibody binding netrin-1 anti-netrin-1 antibody, (ii) immune checkpoint inhibitor, treatment cancer. composition comprise anti-netrin-1 antibody immune checkpoint inhibitor, anticancerous simultaneous, separate sequential administration anti-netrin-1 antibody immune checkpoint inhibitor patient.',\n",
              " 'immune checkpoint inhibitor treatment related biomarker interpretation system construction method device thereofthe invention discloses guidance system immune checkpoint inhibitor treatment medication. system comprises immune checkpoint inhibitor related biomarker interpretation system construction method thereof, medication guidance adaptation method device storage medium, construction method interpretation system comprises steps: obtaining public dataresources comprise biomarker information related tumor immune checkpoint inhibitor treatment like; screening classifying public data resources, determining key fieldsand attributes information input interpretation system; carrying grade classification immune checkpoint inhibitor related clinical evidence information; establishing structural framework interpretation system; inputting key field information corresponding field position interpretation system structure framework unified standardized input rule. method, problems immune checkpoint inhibitor treatment medication guidance process, scattered data, incomprehensive data collection, tedious query procedures, inaccurate medication guidance caused fact immune checkpoint inhibitor medication recommendation priority, solved.',\n",
              " 'marker predicting curative effect gastrointestinal tumor immune checkpoint inhibitor application thereofthe invention marker predicting therapeutic effect gastrointestinal tumor immune checkpoint inhibitor application marker, marker hla-b heterotropoid evolution index (hla-bhed), hla-b heterotropoid evolution index (hla-bhed) marker predicting therapeutic effect gastrointestinal tumor immune checkpoint inhibitor object. heterotaxis evolution index (hla-bhed) hla-b gene, treatment effect immune checkpoint inhibitor gastrointestinal tumors accurately predicted reflecting sequence diversity hla molecule antigen peptide binding domain organism, object high hla-bhed index, hla-b combined antigen peptides induce immune response cells, immune checkpoint inhibitor treating gastrointestinal tumors. subject shows clinically significant benefit treatment immune checkpoint inhibitor, lifetime disease-free progression period significantly prolonged.',\n",
              " 'method predicting monitoring response immune checkpoint inhibitora method analyzing cell free dna (cfdna) bloodstream cancer patient provided. embodiments, method comprise sequencing part coding sequences tp53 kras sample cfdna, analyzing sequences identify nucleotide transversions coding sequences genes, relative reference sequences genes. embodiments, method comprise counting total number identified nucleotide transversions. presence nucleotide transversions indicates patient responsive immune checkpoint inhibitor, decreased number transversions transversios indicates patient responsive immune checkpoint inhibitor.',\n",
              " 'immune checkpoint inhibitor combinationsabstract present application method treating tumour patient, comprising combined, sequential separate administration patient immune 5 checkpoint inhibitor compound formula: ccllccllc (1) (seq id no. 1); represents cationic amino acid represents amino acid 10 lipophilic group amino acids lipophilic group non-genetically coded amino acid, salt, ester amide thereof, immune checkpoint inhibitor inhibits immune checkpoint pd-1. present invention pharmaceutical compositions packs comprising active agents.',\n",
              " 'cancer therapy characterized axl inhibitor immune checkpoint inhibitor administered combinationa cancer therapy characterized axl inhibitor immune checkpoint inhibitor (for example, anti-pd-1 antibody) administered combination, axl inhibitor compound represented general formula (i): (wherein formula, symbols meanings defined specification), salt thereof, solvate thereof, n-oxide thereof, prodrug thereof, combination exhibits strong anti-tumor effect and, therefore, cancer therapy.',\n",
              " 'methods compositions treating immune checkpoint inhibitor associated colitisdescribed methods compositions treating immune checkpoint inhibitor (ici)-associated colitis subject comprising administering fecal matter healthy donor subject. aspects disclosure relate method treating immune checkpoint inhibitor (ici)-associated colitis subject comprising administering subject composition comprising isolated purified population bacteria belonging genera escherichia, akkermansia, bacteroides, lachnospiraceae, blautia, tyzzerella, bifidobacterium, streptococcus, colinsella, fusicatenibacter.',\n",
              " 'pd-1 related cancer therapyprovided compositions methods identifying individuals cancer benefit pd-1 inhibitor therapy. method comprises determining levels signaling lymphocyte activation molecule-associated protein (sap) individual based levels, determining individual suitable pd-1 inhibitor therapy. provided method treatment x-linked lymphoproliferative disease comprising administering individual pd-1 inhibitory therapy, shp2 inhibitors.',\n",
              " 'combination docetaxel albumin composition immune checkpoint inhibitor applicationthe invention applications docetaxel albumin composition immune checkpoint inhibitor treatment tumors solid tumors, especially treatment colon cancer, liver cancer, melanoma head neck squamous cell carcinoma, including related pharmaceutical uses, pharmaceutical compositions like. docetaxel albumin composition corticosteroid pretreatment clinical use, docetaxel albumin composition efficiently combined immune checkpoint inhibitor generate synergistic anti-tumor effect.',\n",
              " 'combination iap inhibitor immune checkpoint inhibitorthe present invention relates combination compound represented formula (i), isomer thereof pharmaceutically acceptable salt thereof iap inhibitor, immune checkpoint inhibitor; combination preparation cancer treatment drug.',\n",
              " 'methods compositions treatment synthetic nanocarriers immune checkpoint inhibitorsdisclosed synthetic nanocarrier compositions immune checkpoint inhibitor compositions related methods administration subject.',\n",
              " 'method predicting efficacy immune checkpoint inhibitor test subjectthis method predicting efficacy immune checkpoint inhibitor test subject comprises: (a) step collecting cells blood sample test subject; (b1) step bringing cells contact primary antibody capable recognizing pd-l1 bringing cells contact secondary antibody capable recognizing primary antibody labeled fluorescent dye, step bringing cells contact antibody capable recognizing pd-l1 labeled fluorescent dye; (c) step irradiating cells excitation light fluorescent dye detect fluorescence emitted cells, case cells pd-l1-positive cancer cells, immune checkpoint inhibitor determined high efficacy test subject. present invention configured enable predicting efficacy immune checkpoint inhibitor imposing burden test subject.',\n",
              " 'combination cpg-oligodeoxynucleotides immunomodulators cancer immunotherapythe present invention combination cpg-oligodeoxynucleotide immunomodulator cancer immunotherapy enhance efficacy immune checkpoint blocking tumors immunosuppressive microenvironment. specifically, combination therapy relates treatment cancer immune checkpoint inhibitor cpg-oligodeoxynucleotide.',\n",
              " 'pharmaceutical composition treating cancer comprising anticancer virus, immune checkpoint inhibitor hydroxyurea active ingredientsthe present invention relates pharmaceutical composition treating cancer comprising anticancer virus, immune checkpoint inhibitor hydroxyurea active ingredients. pharmaceutical composition treating cancer present invention, comprising anticancer virus, immune checkpoint inhibitor hydroxyurea active ingredients, excellent anticancer effect safety compared conventional case single administration anticancer virus combined administration anticancer virus immune checkpoint inhibitor. accordingly, pharmaceutical composition treating cancer present invention, comprising anticancer virus, immune checkpoint inhibitor hydroxyurea active ingredients, effectively treating cancer.',\n",
              " 'method device assisting prediction occurrence severe adverse event caused immune checkpoint inhibitorone problem solved present invention provide method assisting prediction occurrence severe adverse event tumor immunotherapy immune checkpoint inhibitor. problem solved method assisting prediction occurrence severe adverse event caused immune checkpoint inhibitor, method including step acquiring value reflects number cd4-positive, cd25-positive cd45ra-positive cells relative number cd4-postive cells peripheral blood collected patient candidate administration immune checkpoint inhibitor. method, value falls predetermined standard range, suggested severe adverse event caused immune checkpoint inhibitor patient.',\n",
              " 'anti-tumor composition comprising oncologic adenovirus immune checkpoint inhibitorthe present invention relates anticancer composition containing tumor-specific killing adenovirus immune checkpoint inhibitor. recombinant adenovirus il-12 shvegf introduced present invention exhibits excellent anticancer effect improving immune function, anticancer effect remarkably enhanced combining immune checkpoint inhibitor. therefore, present invention core technique field cancer treatment.',\n",
              " 'combinations lpt-723 immune checkpoint inhibitors methods treatmentto provide compositions methods treating cancer.solution: invention combination comprising compound formula (i) pharmaceutically acceptable salt thereof, optionally combination immune checkpoint inhibitor. provided kit comprising composition, method composition ameliorating treating disease cancer subject. disclosure, general, relates field cancer cancer therapy. specifically, disclosure relates composition comprising combination pi3kγ inhibitor immune checkpoint inhibitor method treating cancer.selected drawing:',\n",
              " 'anti-tumor pharmaceutical composition based blocking pd-1/pd-l1 application anti-tumor pharmaceutical compositionthe invention anti-tumor pharmaceutical composition blocking reducing trib3 expression based immune checkpoints application anti-tumor pharmaceutical composition. thebiological mechanism anti-tumor pharmaceutical composition tumor treatment process clarified. immune checkpoint-based anti-tumor pharmaceutical composition comprises immune checkpoint inhibitor small molecule compound capable reducing trib3 expression. small molecule activate autophagy reducing expression cancer-promoting protein trib3 recruit killer tumor cells increase killing activity killer tumor cells. compound combined pd-l1/pd-1 inhibitor generate synergistic effect, killer tcells collected living killing property enhanced comparison single use, growth tumors effectively inhibited. therefore, pharmaceutical composition clinical application prospect.',\n",
              " 'immune checkpoint inhibiting antibodythe present invention immune checkpoint inhibiting antibody based mechanism activating antitumor immune responses. present invention pertains antibody immune checkpoint inhibitory action specifically binds extracellular domain human clec4a protein antigen-binding fragment antibody, antitumor same, antitumor antibody antigen-binding fragment thereof, comprising employing cell expressed immune checkpoint molecule inhibitor therewith.',\n",
              " 'immune checkpoint inhibitor, therapeuti.provided are: immune checkpoint inhibitor contains active component substance inhibits bonding fibronectin immunosuppressive receptor lilrb4; therapeutic agent immune checkpoint-related disease; immunosuppressant contains active component substance activates immunosuppressive receptor lilrb4; anti-fibronectin antibody derivative thereof; fibronectin analog; kit detecting fibronectin partial protein thereof; method detecting fibronectin partial protein thereof biological sample kit.',\n",
              " 'combination medication containing liposome composition encapsulating immune checkpoint inhibitoran object present invention provide pharmaceutical formulation obtained combining liposome composition liposomes encapsulate immune checkpoint inhibitor. present invention, provided pharmaceutical formulation including (a) liposome composition combination (b) immune checkpoint inhibitor, liposome composition includes, constitutional components liposome membrane, hydrophilic polymer-modified diacylphosphatidylethanolamine; dihydrosphingomyelin; cholesterols, liposome composition includes water phase containing ammonium sulfate, molar ratio sulfate ions water phase entire water phase 0.36 more, liposome composition immune checkpoint inhibitor administered simultaneously sequentially.',\n",
              " 'aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumabthe present invention relates anti-pd-l1 antibody formulation. particular, invention relates aqueous pharmaceutical formulation anti-pd-l1 antibody avelumab.',\n",
              " 'immune checkpoint inhibitor related cardiotoxicity prognosis evaluation model application thereofthe invention relates immune checkpoint inhibitor related cardiotoxicity prognosis evaluation model application thereof, belongs technical field biomedical detection. prognosis evaluation model comprises steps: acquiring diagnosis treatment information patient suffering immune checkpoint inhibitor related cardiotoxicity, extracting prognosis evaluation factor evaluating cardiotoxicity diagnosis treatment information; setting data index measuring prognosis evaluation factor; establishing prognosis evaluation model patient prognosis evaluation factor data index thereof; prognosis evaluation model counts data indexes prognosis evaluation factors calculate prognosis evaluation value patient suffering immune checkpoint inhibitor related cardiotoxicity, corresponding prognosis conclusion obtained prognosis evaluation value. prognosis model provided invention beneficial providing reference information disease outcome prognosis immune checkpoint inhibitor related cardiotoxicity patients, assisting clinically formulating reasonable diagnosis treatment scheme.',\n",
              " 'therapy combination anti-cd26 antibody immune checkpoint inhibitorto provide combination therapy exerts superior antitumor effect compared administration anti-cd26 antibody alone.solution: pharmaceutical composition cancer treatment contains immune checkpoint inhibitor anti-cd26 antibody antigen-binding fragment thereof active ingredient. immune checkpoint inhibitor anti-cd26 antibody antigen-binding fragment separately administered concurrently, continuously, time interval.selected drawing:',\n",
              " 'compositions methods enhancing immune checkpoint inhibitor therapyprovided compositions methods treating cancer, treating colitis associated immune checkpoint inhibitor therapy, colonizing microbiome, and/or restoring microbiome, administering compositions food products subject.',\n",
              " 'antitumor combination immune checkpoint inhibitorthe present invention pertains agent prevention and/or treatment cancer, contains mpges-1 inhibitor active ingredient, combination immune checkpoint inhibitor. present invention industrially applicable.',\n",
              " 'pd-l1&nampt double-target inhibitor applicationthe invention discloses preparation method pd-l1amp; invention discloses nampt double-target inhibitor application thereof. inhibitor compound structural general formula shown formula pharmaceutically acceptable salt, racemate, optical isomer solvent compound compound. double-target inhibitor simultaneously inhibit activity pd-l1 nampt, preparing antitumor drugs, effectively overcome defects single pd-l1 inhibitor poor effect, single nampt inhibitor weak activity like, application prospect.',\n",
              " 'cancer therapeutic combination comprising cancer-targeting trans-splicing ribozyme immune checkpoint inhibitorthe present invention relates cancer therapeutic combination comprising cancer-targeting trans-splicing ribozyme immune checkpoint inhibitor. ribozyme present invention exhibits cancer cell-specific expression, superb terms expression efficiency posttranscriptional level, anticancer activity heterogeneous cancers, stability normal liver tissues, synergistic therapeutic effect cancer administered combination immune checkpoint inhibitor, therapeutic modality cancer resistant immune checkpoint inhibitor.',\n",
              " 'derivatives containing biphenyl medical application thereofthe invention relates field medicinal chemistry, discloses biphenyl derivatives pd-1/pd-l1 inhibitory activity medical application biphenyl derivatives. invention discloses composition containing biphenyl derivative pd-1/pd-l1 inhibitory activity pharmaceutically acceptable salt pharmaceutically acceptable carrier biphenyl derivative application biphenyl derivative preparation pd-1/pd-l1 inhibitor, biphenyl derivative treating cancers tumors related immune checkpoints pd-1/pd-l1 wide applicability.',\n",
              " 'combined pharmaceutical formulation comprising gemcitabine-containing liposome composition immune checkpoint inhibitoran object present invention provide combined pharmaceutical formulation obtained combining liposome composition immune checkpoint inhibitor, gemcitabine encapsulated dissolved state liposomes liposome composition. present invention, provided pharmaceutical formulation including (a) liposome composition combination (b) immune checkpoint inhibitor, liposome composition includes liposomes water phase, aqueous solution constituting outer water phase liposomes dispersed therein, gemcitabine encapsulated dissolved state liposomes, liposome composition immune checkpoint inhibitor administered simultaneously sequentially.',\n",
              " 'application bacillus coagulans preparing antitumor immunity inducing immune checkpoint inhibitor sensitizing agentsthe invention discloses application bacillus coagulans preparing antitumor immunity inducing immune checkpoint inhibitor sensitizing agents. specifically, bacillus coagulans applied major active component preparing biological agents drugs combining immune checkpoint inhibitor treat cancers. prepared antitumor immunity inducing immune checkpointinhibitor sensitizing agents effectively induce antitumor immunity, enhance response treatment effects immune checkpoint inhibitor, reduce side effects prolong survival period.',\n",
              " 'combination cxcr4 antagonist immune checkpoint inhibitorthe invention relates combination cxcr4 antagonist 6-{4-[1 -(propan-2-yl)piperidin-4-yl]-1,4-diazepan-1-yl}-n-(pyridin-4-yl)pyridine-2-carboxamide immune checkpoint inhibitor, treatment tumours and/or cancers.',\n",
              " 'combining cd27 agonists immune checkpoint inhibition immune stimulationthe present invention relates treatments conditions ameliorated stimulation immune response, particular stimulation antigen-specific t-lymphocytes. treatment conditions invention effected combination anti-human cd27 agonistic antibody number immune checkpoint inhibitors.',\n",
              " 'method system predicting response immune checkpoint inhibitorthe present disclosure relates method, performed computing device, predicting response immune checkpoint inhibitor. method includes receiving pathology slide image, detecting target items pathology slide image, determining immune phenotype regions pathology slide image information associated immune phenotype based detection result target items, generating prediction result patient associated pathology slide image responds immune checkpoint inhibitor, based immune phenotype regions pathology slide image information associated immune phenotype.',\n",
              " 'peptides combination immune checkpoint inhibitors treatment cancera wnt5a peptide derivatives thereof combination checkpoint inhibitors treatment cancer subject thereof. furthermore, wnt5a peptides derivatives thereof treatment cancer subject, subject responsive immune checkpoint inhibitors.',\n",
              " 'combined pharmaceutical formulation comprising gemcitabine-containing liposome composition immune checkpoint inhibitoran object present invention provide combined pharmaceutical formulation obtained combining liposome composition immune checkpoint inhibitor, gemcitabine encapsulated dissolved state liposomes liposome composition. present invention, provided pharmaceutical formulation including (a) liposome composition combination (b) immune checkpoint inhibitor, liposome composition includes liposomes water phase, aqueous solution constituting outer water phase liposomes dispersed therein, gemcitabine encapsulated dissolved state liposomes, liposome composition immune checkpoint inhibitor administered simultaneously sequentially.',\n",
              " 'chemotherapy immune checkpoint inhibitor co-delivery micelle preparation method application thereofthe invention discloses chemotherapeutic immune checkpoint inhibitor co-delivery micelle. micelle comprises polymer, chemotherapeutic prodrug immune checkpoint inhibitor, adding mixed solution polymer, solvent buffer solution obtain chemotherapeutic immune checkpoint inhibitor co-delivery micelle. invention, chemotherapeutic immune checkpoint inhibitor co-delivery micelle prepared basis polymer containing dtc chain segment, efficient mouse non-small cell lung cancer chemical immunotherapy effect achieved removing mdsc inhibiting ido1 enzyme activity; intravenous injection atn1-mg/n small particle size active targeting, tumor permeation tumor cell uptake increased; synergy indexes (ci) respectively 0.2 0.1, results confirm chemotherapeutic immune checkpoint inhibitor obvious synergistic effect.',\n",
              " 'immune checkpoint inhibitors cytotoxic cells treatment cancerprovided methods treating cancer comprising conjoint administration immune checkpoint inhibitor composition comprising cytotoxic cells (ctls).',\n",
              " 'biomarkers associated immune checkpoint inhibitor therapy methods thereofthe present disclosure relates biomarkers predict responsiveness cancer patient immune checkpoint inhibitor therapy. embodiments, disclosure diagnostic and/or prognostic methods biomarkers determining cancer patient benefit treatment aryl hydrocarbon receptor antagonist. embodiments, biomarkers described inform provide effective therapeutic methods treatment cancer comprising administering aryl hydrocarbon receptor antagonist, optionally combination immune checkpoint inhibitor therapy.',\n",
              " \"biomarkers related immune checkpoint inhibitor therapy methods samethe disclosure relates biomarkers predictive patient's cancer responsiveness immune checkpoint inhibitor therapy. disclosure provides, embodiments, diagnostic and/or prognostic methods biomarkers determining cancer patient benefit treated aryl hydrocarbon receptor antagonist. embodiments, biomarkers described inform provide effective therapeutic methods treating cancer comprising administering aryl hydrocarbon receptor antagonist, optionally combination immune checkpoint inhibitor therapy.\",\n",
              " \"combination therapies ilt-binding agents pd-1 inhibitorsthe present disclosure methods treating subject cancer binding agent (e.g., antibodies antigen-binding fragments thereof) specifically binds ilt2 ilt4 combination anti-pd-1 antibody antigen-binding fragment thereof comprises light chain complementarity determining regions (cdrs) comprising sequence amino acids set seq id nos: 174, 175 176 heavy chain cdrs comprising sequence amino acids set seq id nos: 179, 180 181. present disclosure methods biomarker predict subject's responsiveness therapy disclosed efficacy therapy.\",\n",
              " 'composition prevention treatment colorectal cancer comprising streptonigrin immune checkpoint inhibitor active ingredientthe present invention relates composition preventing treating colorectal cancer, comprising streptonigrin immune checkpoint inhibitor active ingredients. present inventors confirmed streptonigrin significantly reduces survival rate colorectal cancer cell line, increases expression pd-l1 protein colorectal cancer cell line. present invention shows streptonigrin restore immune sensitivity colorectal cancer cell line, promoting effect anti-pd-1 antibody. therefore, present invention expected enable effective treatment colorectal cancer means co-administration streptonigrin anti-pd-1 antibody.',\n",
              " 'composition preventing treating colorectal cancer, comprising streptonigrin immune checkpoint inhibitor active ingredientsthe present invention relates composition preventing treating colorectal cancer, comprising streptonigrin immune checkpoint inhibitor active ingredients. present inventors confirmed streptonigrin significantly reduces survival rate colorectal cancer cell line, increases expression pd-l1 protein colorectal cancer cell line. result shows streptonigrin restore immune sensitivity colorectal cancer cell line, promoting effect anti-pd-1 antibody, present invention expected enable effective treatment colorectal cancer means co-administration streptonigrin anti-pd-1 antibody.',\n",
              " 'application tea polyphenol immune checkpoint inhibitor preparation antitumor drugsthe present invention application tea polyphenol immune checkpoint inhibitor preparation antitumor drugs.',\n",
              " 'pd-1 inhibitor application thereofthe invention relates steroidal derivative pd-1 blocker application thereof, particular compound shown formula below, medicinal composition containing compound shownas formula below, application compound treatment pd-1 mediated related diseases preparation medicines treating pd-1 mediated related diseases.',\n",
              " 'anti-4-1bb-anti-pd-l1 bispecific antibody, pharmaceutical composition application thereofrelates anti-4bb-anti-pd-l1 bispecific antibody pharmaceutical composition application anti-4bb-anti-pd-l1 bispecific antibody. specifically, invention relates bispecific antibody comprises protein functional region targeting 4-1bb protein functional region targeting pd-l1 pd-1, protein functional region single-domain antibody resisting 4-1bb; protein functional region anti-pd-l1 antibody, anti-pd-1 antibody, anti-ctla-4 antibody anti-her-2 antibody, antigen binding fragment anti-pd-l1 antibody, anti-pd-1 antibody, anti-ctla-4 antibody anti-her-2 antibody. bispecific antibody function blocking combination pd-l1 receptor pd-1, combined 4-1bb immune cells activate activity immune cells tumor microenvironment, effect inhibiting occurrence development tumors effectively improved.',\n",
              " 'combination therapy il-20 antagonist immune checkpoint inhibitormethods compositions relating combination therapy il-20 antagonist immune checkpoint inhibitor provided.',\n",
              " 'combination big-h3 antagonist immune checkpoint inhibitor treatment solid tumorto study mechanism βig-h3 modulation anti-tumoral immune response pancreatic cancer, inventors advantage engineered mouse models spontaneous pancreatic neoplasia cancer evaluate effect depleting βig-h3 modulation anti-tumor immunity subsequent impact tumour growth combination immune checkpoint inhibitor. association proved effective vivo model showing synergic effect therapeutic combination. accordingly, present invention relates combination (i) immune checkpoint inhibitor, (ii) βig-h3 antagonist, simultaneous sequential treatment patient suffering solid tumor, e.g. pancreatic cancer. present invention βig-h3 antagonist, method enhancing sensitivity patient suffering solid tumor immune checkpoint inhibitor.',\n",
              " 'methods compositions enhancing potency superantigen mediated cancer immunotherapyprovided method enhancing potency targeted cancer immunotherapy subject superantigen combination pd-1 inhibitor.',\n",
              " 'application clostridium butyricum preparing preparation inducing antitumor immunity enhancing sensitivity immune checkpoint inhibitorthe invention discloses application clostridium butyricum preparing preparation inducing antitumor immunity enhancing sensitivity immune checkpoint inhibitor. specifically, clostridium butyricum serves active ingredient prepared biological preparations, biological preparations combined immune checkpoint inhibitor treating cancers. means preparation, antitumor immunity effectively induced, response rate treatment effect immune checkpoint inhibitor improved, side effects lowered, lifetime prolonged.',\n",
              " 'kynurenine pathway biomarkers predictive anti-immune checkpoint inhibitor responsethe present invention based identification biomarkers predictive responsiveness anti-immune checkpoint inhibitor therapies.',\n",
              " 'methods compositions treatment cancer combining anti-smic antibody immune checkpoint inhibitorsprovided methods compositions treatment cancer comprising combined administration anti-smic antibody immune checkpoint inhibitor. methods compositions treating colitis antibodies provided. provided methods predicting response anti-smic antibody immune checkpoint inhibitor therapy measuring level serum smic subject.',\n",
              " 'markers methods predicting primary resistance immune checkpoint inhibitor therapythe present invention methods capable predicting resistance tumor patient immune checkpoint inhibitor therapy. invention drug-resistant genes akt1 and/or cdh1, mrna, cdna protein drug-resistant genes akt1 and/or cdh1 detection reagent drug-resistant genes. drug-resistant gene detection reagent thereof predicting resistance tumor patients immunotherapy sensitivity targeted therapy combined combined immunotherapy. akt1 and/or cdh1 gene mutation biomarker predicting primary resistance immune checkpoint inhibitor therapy dmmr/msi-h gastrointestinal tumor patients, drug-resistant accurately predicted, blind avoided, treatment economy immune checkpoint inhibitor therapy improved.',\n",
              " 'compositions methods treating solid tumors anti-btla mono combination therapythe present disclosure relates anti-btla antagonist (including antibodies antigen binding fragments) treatment tumors, mono therapy a. combination therapy immune checkpoint inhibitor therapy anti-pd-1 anti- pd-l1, methods selecting subjects treatment. preferably, solid tumors treated.',\n",
              " \"compositions methods treating cancer il-17 signaling inhibitors immune checkpoint inhibitorsprovided methods treating cancer patients, pancreatic cancer patients, combination il-17 signaling inhibitor immune checkpoint blockade therapy, anti-pdl therapy and/or anti-ctla-4 therapy. provided methods determining therapy efficacious based level lactate patient's cancer and/or serum.\",\n",
              " 'application tofacitinib citrate preparation medicine treating immune checkpoint inhibitor related myocarditisthe invention relates application tofacitinib citrate preparation medicine treating immune checkpoint inhibitor related myocarditis. tofacitinib citrate added medicine treating severe immune checkpoint inhibitor related myocarditis hormone impact applied. compared prior art, safe reliable treatment scheme provided patients severe immunosuppressor-related myocarditis.',\n",
              " 'immune checkpoint blocking polypeptide prodrug nano-micelle, preparation method applicationthe invention discloses immune checkpoint blocking polypeptide prodrug nano-micelle, preparation method application. nano-micelle takes hydrophobic anti-tumor core, core independently connected immune checkpoint blocking polypeptide polyethylene glycol matrix metalloproteinase sensitive connection peptide, immune checkpoint blocking polypeptide polyethylene glycol form shell layer. nano-micelle disclosed invention tumor microenvironment enzyme response, responsively release immune checkpoint blocking polypeptide function matrix metalloproteinase tumor microenvironment, avoids systemic immunity related adverse reaction caused tumor off-target releasing immune checkpoint blocking drug. chemotherapy killing function anti-tumor blocking function immune checkpoint, nano-micelle blood circulation time prolonged, accumulation anti-tumor tumor focus enhanced, bioavailability improved, systemic immunity related adverse reaction caused tumor off-target releasing immune checkpoint blocking avoided, synergetic anti-tumor function chemotherapy killing immune checkpoint blocking realized.',\n",
              " 'holosymmetric biphenyl derivative, preparation method therefor thereofthe present invention relates holosymmetric biphenyl derivative, preparation method therefor thereof. particularly, present invention relates holosymmetric biphenyl derivative structure formula (i), preparation method therefor pharmaceutical composition containing same. series compounds present invention widely preparation preventing and/or treating pd-1/pd-l1 signaling pathway-mediated cancers tumors, immune-related diseases disorders, communicable diseases, infectious diseases metabolic diseases, expected developed generation pd-1/pd-l1 inhibitors.',\n",
              " 'substituted biphenyl containing flavone application thereofthe invention relates substituted biphenyl containing flavone, chemical structure flavone shown formula (i), r1 methoxyl, n-acetyl ethanediamine, ethanediamine,piperazinyl, acetylpiperazine, ethyl piperazine, isopropyl piperazine, t-butyloxycarboryl piperazine cyclopropyl methyl piperazine formula (i), r2 hydrogen, fluorine methyl, r3 ishydrogen 1,4-dioxane. substituted biphenyl containing flavone inhibits mutual combination programmed cell death receptor 1/programmed cell death ligand 1 (pd1/pd-l1), usedto prepare pd1/pd-l1 inhibitor, effect inhibitor obvious.',\n",
              " 'combination therapy tew-7197 specific antibodies treatment cancerthis disclosure pharmaceutical composition preventing treating cancer. pharmaceutical composition includes compound represented formula ii, pharmaceutically acceptable salt, solvate, stereoisomer thereof, combination thereof. pharmaceutical composition includes lymphocyte activating factor. lymphocyte activating factor programmed death-ligand 1 (pd-l1) inhibitor, programmed cell death protein 1 (pd1) inhibitor, cytotoxic t-lymphocyte-associated antigen 4 (ctla4) inhibitor, combination thereof: compound formula preventing treating cancer provided. (see formula ii)',\n",
              " 'application lycium barbarum polysaccharide aspect improving tumor immunotherapy curative effectthe invention discloses application lycium barbarum polysaccharide improving curative effect tumor immunotherapy. method, lycium barbarum polysaccharide immunotherapy combined treating malignant tumors. lycium barbarum polysaccharide composed lycium barbarum polysaccharide fragments molecular weight 40-350 kd, immunotherapy includes limited pd-1/pd-l1 inhibitors adoptive immune cell therapy. experiments prove combined treatment method disclosed invention effect improving inhibition effect immunotherapy tumor growth load, treating malignant tumors.',\n",
              " 'compositions combination therapies preventing treating cancer comprising chemokine inhibitor colony stimulating factor inhibitor immune checkpoint inhibitorthe present invention relates composition combination therapy treating cancer, including chemokine inhibitor, colony stimulating factor inhibitor immune checkpoint inhibitor. particularly, present invention relates pharmaceutical composition preventing treating cancer, including cxcl12 inhibitor, colony stimulating factor 1 (csf1) inhibitor immune checkpoint inhibitor. pharmaceutical composition enhances infiltration activity cd8 cytotoxic cells cancer resistance immune checkpoint inhibitor, particularly pd-1/pd-l1 immune checkpoint inhibitor, reduce size cancer effectively, preventing treating cancer resistant immune checkpoint inhibitor, particularly cancer over-expressing p16^ink4a.',\n",
              " 'cd28/ctla-4 inhibiting peptidomimetics pharmaceutical compositions thereofthe present invention relates peptidomimetics capable inhibiting cd28 and/or ctla-4 interaction cd80 (b7-1) cd86 (b7-2) core amino acid sequence, leumettyrproproprotyrtyr, corresponding residues 2 9 seq id no:1. present invention relates pharmaceutical compositions method treating pathologies disorders improved inhibition cd28 and/or ctla-4 interaction cd80 cd86.',\n",
              " 'immune checkpoint inhibitors preparation medicaments prophylactic treatment cancer subjectsthe invention discloses application immune checkpoint inhibitor. applications application preparation drugs prophylactic treatment cancers subjects. embodiment invention shows immune checkpoint inhibitor applied early cancer stage (high-grade intraepithelial neoplasia stage (hgin) esophageal squamous cell carcinoma, lesion progress esophageal squamous cell carcinoma reversed, recurrence metastasis cancers effectively controlled.',\n",
              " 'method treating cancer immune checkpoint inhibitordisclosed method treating cancer immune checkpoint inhibitor. specifically, disclosed method treating cancer checking expression immune checkpoint protein lymphoid cell- myeloid cell-specific protein circulating tumor cells isolated blood, selecting, patient cancer immunotherapy applicable, patient found positive expression immune checkpoint protein negative expression lymphoid cell- myeloid cell-specific protein, administering immune checkpoint inhibitor patient. method, expression immune checkpoint protein expression lymphoid cell- myeloid cell-specific protein liquid biopsy simultaneously checked, patient selected eliminating false-positive circulating tumor cells. thus, method high accuracy high commercial utility, cancer diagnosis treatment.',\n",
              " 'immune checkpoint inhibitorthe present invention immune checkpoint inhibitor reported before. provided immune checkpoint inhibitor characterized including, active ingredient, plant fermentation product mixture fermentation products (a) (g): (a) koji mold fermentation product beans grains selected group consisting barley, black soybeans, red rice, black rice, adzuki beans, adlay, japanese barnyard millet, foxtail millet, proso millet; (b) yeast and/or lactic acid bacteria fermentation product fruits selected group consisting mandarin oranges, grapes, apples, vitis coignetiae berries, peaches, persimmons, papayas, japanese pears, watermelons, japanese apricots, figs, chinese quince fruit, kabocha squash, kumquats, yuzu, loquat fruit, apricots, jujubes, chestnuts, matatabi fruit, japanese plums; (c) yeast and/or lactic acid bacteria fermentation product root vegetables/potatoes selected group consisting purple sweet potatoes, jerusalem artichokes, carrots, onions, sweet potatoes, taros, japanese wild yam, daikon, red turnips, great burdock, lotus roots, yacón, lily bulbs, arrowhead, ginger, garlic, turmeric; (d) yeast and/or lactic acid bacteria fermentation product flowers/leafy vegetables selected group consisting cabbage, perilla, morus leaves, fish mint, japanese mugwort, sasa veitchii , dandelions; (e) yeast and/or lactic acid bacteria fermentation product types seaweed selected group consisting kelp, wakame, mozuku; (f) yeast and/or lactic acid bacteria fermentation product seeds selected group consisting black sesame, walnuts, ginkgo nuts; (g) yeast and/or lactic acid bacteria fermentation product mushrooms selected group consisting maitake shiitake.',\n",
              " 'therapeutic combinations treating neoplasiathe invention features doxorubicin doxil combination checkpoint inhibitor (e.g., anti-ctla-4 antibody, anti-pd-1 antibody, anti-pd-l1 antibody, gitr ligand, ox40 fusion protein (fp) methods combination enhance anti-tumor activity subject.',\n",
              " 'application splenomegaly determining treatment effect immune checkpoint inhibitor tumor patientthe invention discloses application splenomegaly determining treatment effect immune checkpoint inhibitor tumor patient. invention, splenomegaly found independent prediction factor total lifetime primary liver cancer patient receiving treatment immune checkpoint inhibitor time; curative effect, prognosis total lifetime primary liver cancer patient treated immune checkpoint inhibitor predicted utilizing splenomegaly measured iconography, clinical value achieved, splenomegaly serving immunotherapy predictive factor promote precise medical treatment. moreover, judgment splenomegaly simple accurate, method evaluating splenomegaly combined patient ct mri simple, convenient accurate clinically, patient splenomegaly evaluated selecting ct mri. maximum diameter spleen exceeds 15 cm, patient diagnosed splenomegaly.',\n",
              " 'application baricitinib preparation medicine treating immune checkpoint inhibitor related myocarditisthe invention discloses application baricitinib preparation medicine treating immune checkpoint inhibitor related myocarditis. molecular formula baricitinib c16h17n7o2s, molecular weight 371.42. invention particularly relates application baricitinib regulation macrophage sub-type transformation immune checkpoint inhibitor related myocarditis application baricitinib preparation drugs regulating macrophage sub-type transformation immune checkpoint inhibitor related myocarditis. invention verifies effect baricitinib treating icis-related myocarditis constructing animal model cell model, proves baricitinib effects inhibiting inflammatory factor expression ros (reactive oxygen species) production promoting expression rise m2 type macrophage-related markers. potential icis-related myocarditis, compound advantages low toxicity, small molecular weight small immunogenicity.',\n",
              " 'lactobacillus salivarius application lactobacillus salivarius preparation medicines treating cancersthe invention relates strain combined lactobacillus salivarius application thereof preparation medicines treating cancers, belongs technical field biological medicines. invention strain combined lactobacillus salivarius xa-1416, combined lactobacillus salivarius xa-1416 significantly reduce growth speed colon tumors, significantly increase response efficiency pd-1 inhibitor, reduces growth speed colon tumors presence pd-1 inhibitor, significantly increase infiltration cd8 + cells colon cancer tumor tissues, significantly reduce growth speed colon tumors presence pd-1 inhibitor. lactobacillus salivarius xa-1416 remarkably promote cd8 + cells secrete tnf-alpha, remarkable inhibition effect proliferation gastric cancer cell line ags colon cancer cell line hct116, lactobacillus salivarius xa-1416 great application prospect preparation medicines treating cancers.',\n",
              " 'lactobacillus mucosa application thereof preparation medicines treating cancersthe invention relates lactobacillus mucosa mucus application thereof preparation medicines treating cancers, belongs technical field biological medicines. invention strain lactobacillus mucosa xa-1405, lactobacillus mucosa xa-1405 significantly reduce growth rate colon tumors, significantly increase response efficiency pd-1 inhibitor, reduces growth rate colon tumors presence pd-1 inhibitor, significantly increase infiltration cd8 + cells colon cancer tissues, significantly reduce growth rate colon tumors presence pd-1 inhibitor. lactobacillus mucosa mucus xa-1405 promote cd8 + cells secrete tnf-alpha, obvious inhibition effect proliferation gastric cancer cell line ags colon cancer cell line hct116, lactobacillus mucosa mucus xa-1405 great application prospect preparation medicines treating cancers.',\n",
              " 'androgen deprivation immune checkpoint blockade delays development castration resistant prostate cancerthe inventors found androgen deprivation renders tumor microenvironment prostate cancer tumors immunogenic. combination androgen deprivation administration depleting anti-ctla-4 antibody shown significantly delay development castration resistant prostate cancer. effect observed anti-ctla-4 antibody administered additional checkpoint inhibitor, anti-pd-1 antibody.',\n",
              " 'combination therapy vinca alkaloid n-oxide immune checkpoint inhibitorthe present disclosure therapeutic methods treating cancer patient vinca alkaloide n-oxide immune checkpoint inhibitor.',\n",
              " 'combination curaxins immune checkpoint inhibitors treating cancerthe present disclosure directed, part, curaxin compounds, pharmaceutically acceptable salts thereof, combinations curaxin compounds immune checkpoint inhibitors, pharmaceutically acceptable salts thereof, compositions comprising same, methods preventing treating cancer administering same.',\n",
              " 'biomarker prognosis colorectal cancer patient response efficiency colorectal cancer patient immune checkpoint inhibitor application biomarkerthe invention relates biomarker predicting prognosis colorectal cancer biomarker response efficiency colorectal cancer immune checkpoint inhibitor treatment. biomarker constructed immune related genes: bmp5, nrg1, inhbb hspa1a. addition, invention relates kit predicting prognosis colorectal cancer response efficiency immune checkpoint inhibitor treatment, application bmp5, nrg1, inhbb hspa1a proteins preparation biomarkers prognosis patient colorectal cancer response efficiency immune checkpoint inhibitor. invention discloses application preparation kit predicting colorectal cancer prognosis screening response efficiency immune checkpoint inhibitor treatment.',\n",
              " 'culture system ciks cells dc-ciks cellsthe invention culture system ciks cells. adding pd-1 inhibitor (pd-1in) ciks cell culture system, amplification quantity function ciks cells enhanced; establishing dc-ciks co-culture system adding pd-1in, quantity cultured ciks dc- effect cells greatly improved number culture days reduced; moreover, activity culture system killing tumor cells stronger system free pd-1 inhibitor (pd-1in) (p 0.01).',\n",
              " 'kit predicting curative effect immune checkpoint inhibitor non-small cell lung cancer patientthe invention discloses application saa1 protein, saa2 protein, s100a8 protein s100a9 protein predicting curative effect immune checkpoint inhibitor non-small cell lung cancer patient, kit predicting curative effect immune checkpoint inhibitor non-small cell lung cancer patient. comprising saa1 protein detection reagent, saa2 protein detection reagent, s100a8 protein detection reagent s100a9 protein detection reagent. combination saa1, saa2, s100a8 s100a9 proteins therapeutic effect related biomarker non-small cell lung cancer patient receiving immune checkpoint inhibitor treatment, reliable prediction tool provided non-small cell lung cancer patient subjected immune checkpoint inhibitor treatment not.',\n",
              " 'application nampt preparation kit predicting sensitivity solid tumor patient immune checkpoint inhibitor therapythe invention relates field clinical molecular diagnosis, particular application nampt preparation kit predicting sensitivity solid tumor patient immune checkpoint inhibitor therapy. in-vitro experiments show interferon gamma-induced key indexes, pd-l1 expression, predicting curative effect immune checkpoint inhibitor down-regulated knocking multiple tumor cells nampt; furthermore, in-vivo experiments show nampt normal expression liver cancer model obvious effect anti-pdl1 antibody treatment; nampt knock-down expression liver cancer model insensitive response anti-pdl1 antibody treatment, tumor growth inhibited, indicates nampt low expression tumor tolerant immune checkpoint inhibitor. application prediction index curative effect immune checkpoint inhibitor tumor.',\n",
              " 'pharmaceutical composition comprising foxm1 inhibitor immune checkpoint inhibitor preventing treating cancerthe present invention relates pharmaceutical composition preventing, ameliorating, treating cancer, pharmaceutical composition comprising foxm1 inhibitor immune checkpoint inhibitor active ingredients. foxm1 inhibitor present invention inhibits expression pd-l1 cell membrane inhibits translocation foxm1 nucleus, reducing proliferation survival cancer cells inducing increase cell death, effect preventing, ameliorating, treating cancer. addition, foxm1 inhibitor administered combination immune checkpoint inhibitor, tumor growth inhibited effectively foxm1 inhibitor immune checkpoint inhibitor alone, pharmaceutical composition present invention agent preventing treating cancer.',\n",
              " 'methods testing bioactivity immune checkpoint inhibitors pd-1to provide highly accurate simple methods testing bioactivity immune checkpoint inhibitors.solution: disclosed vitro method testing bioactivity immune checkpoint inhibitor, enhancement cytotoxicity due pd-1/pd-l1 signal inhibition immune checkpoint inhibitor determined effector cell nk activity infected lentivirus introducing pd-1 expression gene lentivirus introducing il-2 expression gene, target cancer cell line infected lentivirus introducing pd-l1 expression gene.selected drawing: figure 1',\n",
              " 'application oncolytic virus vg161 combination oncolytic virus vg161 immune checkpoint inhibitor treatment gastric cancerthe invention discloses application oncolytic virus vg161 combination oncolytic virus vg161 immune checkpoint inhibitor preparation medicine treating and/or relieving gastric cancer. immune checkpoint inhibitor pd-1 monoclonal antibody.',\n",
              " 'application host defense peptide composition thereof preparation drugs treating tumorsthe invention belongs technical field biological medicines, relates host defense peptide composition thereof, invention relates application polypeptide inpreparation tumor treatment drugs, concretely relates application caerin 1.1 mutant, caerin 1.1/1.9 polypeptide, hpv16 e7 polypeptide vaccine immune checkpoint inhibitor preparation antitumor drugs. host defense peptide composition provided invention caerin1.1/1.9 polypeptide composition caerin 1.1 mutant/caerin 1.9 polypeptide composition,and structural formula host defense peptide composition shown specification. weight ratio caerin1.1 peptide caerin1.9 peptide weight ratio caerin1.1 peptide mutant caerin1.9 peptide 1: (0.1 1); caerin 1.1 mutant, caerin 1.1/1.9 polypeptide (or caerin 1.1 mutant/caerin 1.9) disclosed invention, tumor microenvironment treatment vaccine pd-1 inhibitor changed, anti-tumor effect improved.',\n",
              " 'nk (natural killer) cell immune checkpoint inhibitor preparation method thereofthe invention relates nk (natural killer) cell immune checkpoint inhibitor preparation method thereof. structural formula shown specification. nk cell immune checkpoint inhibitor disclosed invention interact siglec-7 surface nk cell trans-interaction, obstruct trans-combination siglec-7 saliva acid surface tumour cell, releasing cytotoxic index nk cells interaction nk cells tumour cells.',\n",
              " 'methods compositions treating cancer enhancing immune checkpoint inhibitor efficacyprovided methods compositions treating tumor increasing anti-cancer effectiveness immune checkpoint inhibitor glycopeptide containing compositions.',\n",
              " 'application ecaf prediction curative effect immune checkpoint blocking therapy treating cancerthe invention discloses application ecaf cancer treatment effect prediction immune checkpoint blocking treatment method, deeply studies influence ecaf subgroups treatment effect cancer immune checkpoint blocking treatment method, finds active degrees ecaf subgroups characteristic genes postn fap thereof cancer related cancer treatment effect immune checkpoint blocking treatment method. therefore, ecaf subgroup characteristic gene thereof potential markers judging cancer treatment effect immune checkpoint blocking treatment method, inhibitor ecaf subgroup characteristic gene thereof enhancer cancer treatment effect immune checkpoint blocking treatment method.',\n",
              " 'combination treatment cancer based icos antibody pd-l1 antibody tgf-beta-receptor fusion proteinthe invention relates method treating cancer, involving combination icos binding protein, pd-1 inhibitor tgf-β inhibitor. particular, invention relates icos binding protein (e.g. anti-icos antibody) fusion protein targeting human protein programmed death ligand 1 (pd-l1) programmed cell death protein 1 (pd-1), transforming growth factor β (tgf-β) (e.g. anti-pd-(l)1(igg):tgfβr fusion protein, comprising, example, anti-pd-l1 antibody tgfβrii fragment capable binding tgf-β).',\n",
              " 'activating jak kinase biomarkers predictive anti-immune checkpoint inhibitor responsethe present invention based identification biomarkers predictive responsiveness anti-immune checkpoint inhibitor therapies.',\n",
              " 'method preparing pd1-pd-l1 inhibitor sophora davidiithe invention discloses active ingredient extracted natural plant sophora davidii extraction method thereof, specifically relates active ingredient extracted sophoradavidii, effectively block pd1-pdl1 combination, eliminating, inhibiting, reducing blocking subsequent interaction pd1-pdl1. active ingredient pharmaceutical composition pharmaceutically acceptable carrier effectively pd1-pdl1 inhibitor, active ingredient applied anti-tumor related diseases, provide referencefor clinical treatment schemes.',\n",
              " 'tumor suppressor oncogene biomarkers predictive anti-immune checkpoint inhibitor responsethe present invention based identification biomarkers predictive responsiveness anti-immune checkpoint inhibitor therapies.',\n",
              " \"therapeutic combinations cd19 inhibitor btk inhibitortherapeutic combinations cd19 inhibitor bruton's tyrosine kinase (btk) inhibitor described. embodiments, invention pharmaceutical compositions comprising combinations cd19 inhibitor btk inhibitor methods pharmaceutical compositions treating disease, particular cancer, hematological malignancy. combination btk inhibitor cd19 inhibitor, cd19-targeted antibody cd19-targeted chimeric antigen receptor expressing cell nk cell, compositions thereof disclosed. combinations btk inhibitor cd19 inhibitor programmed death-1 (pd-1) pd-1 ligand (pd-l1) inhibitor compositions thereof disclosed.\",\n",
              " 'cpg-oligodeoxynucleotide compounds combination immune modulators cancer immunotherapythe present invention discloses combinational therapy enhancing efficacy immune checkpoint blockade tumors immune suppressive microenvironment. specifically, combination therapy involves treatment cancer immune checkpoint inhibitors cpg-oligodeoxynucleotides.',\n",
              " 'application pd-1 antibody ufsp2 covalent inhibitor preparation medicine treating tumorsthe invention discloses application pd-1 antibody ufsp2 covalent inhibitor preparation medicine treating tumors. ufsp2 covalent inhibitor provided invention programmed death pd-1/pd-l1 immunotherapy auxiliary agent, immunotherapy effect programmed death pd-1/pd-l1 remarkably improved, dosage programmed death pd-1/pd-l1 inhibitor greatly reduced, immune resistance tolerance avoided. ufsp2 inhibitor compond-8 provided invention effectively inhibiting tumor growth promoting pd-1 combined therapy.',\n",
              " 'composition treating osteomyelitis application thereofthe invention discloses composition treating osteomyelitis application thereof. composition treating osteomyelitis consists antibiotics pd-1/pd-l1 inhibitor. findings invention, pd-l1/pd-1 neutralizing antibody assist antibiotics treatment acute chronic infectious osteomyelitis. starting activation innate immunity, pd-l1/pd-1 neutralizing antibody applied partially relieving innate immune inhibition state acute chronic infectious osteomyelitis recover sterilization capability macrophages, assisting antibiotics achieve pathogen killing effect reduce infection recurrence improve bone healing.',\n",
              " 'lymphocytes combined immune checkpoint blocking agent application lymphocytes preparing antitumor drugsthe invention discloses lymphocytes combined immune checkpoint blocking agent. lymphocytes combined immune checkpoint blocking agent prepared separating lymphocytes, expanding lymphocytes vitro, combining lymphocytes immune checkpoint blocking agent agonistic antibody vitro. combining immune checkpoint blocking agentwith lymphocytes, ensured immune checkpoint blocking agent quickly enters immune system host lymphocytes, immune checkpoint blocking agent artificially bound surfaces lymphocytes, deficiency immune checkpoint blocking agent secreted lymphocytes natural state insufficient quickly effectivelymade for. lymphocytes combined immune checkpoint blocking agent returned host, growth tumor cells effectively inhibited, cancer recurrence metastasis reduced; lymphocytes anti-tumor effect, tumor-associated antigens, process simple easy implement compared traditional adoptive transfer cell therapy.',\n",
              " 'method improving efficacy melanoma treatmentprovided compositions methods determining individual cancer develop immune-related adverse events (iraes) treatment immune checkpoint inhibitor anti-programmed cell death protein 1 (anti-pd-1) checkpoint inhibitor, and/or anti-cytotoxic t-lymphocyte-associated protein 4 (anti-ctla-4) checkpoint inhibitor. provided methods treating individual cancer checkpoint inhibitor agent reduce risk toxicity checkpoint inhibitor, administering agents prevent reduce risk toxicity treatment.',\n",
              " 'application cordyceps sinensis extract preparation immune checkpoint inhibitorsthe invention application cordyceps sinensis extract preparation immune checkpoint inhibitors. immune checkpoint pd-1, pd-l1 tnfr1. experimental results show cordyceps sinensis extract provided invention stable high-strength binding capacity plurality immunomodulatory targets (pd-1, pd-l1 tnfr1), effectively block binding 293t-h pd-l1 cells pd-1 protein. therefore, cordyceps sinensis extract disclosed invention preparing immune checkpoint inhibitors including pd-1, pd-l1 tnfr1, preparing anti-tumor drugs including esophageal squamous cell carcinoma, urothelial carcinoma squamous non-small cell lung cancer, excellent application prospects.',\n",
              " 'boric acid small molecule compound preparation drugs enhancing curative effect immune checkpoint inhibitor treating leukemiadisclosed boric acid small molecule compound preparation drugs enhancing curative effect immune checkpoint inhibitor treating leukemia. boric acid small molecule compound enhance curative effect immune checkpoint inhibitor, treatment effect leukemia, wide range preparation drugs enhancing curative effect immune checkpoint inhibitor preparation drugs treating leukemia.',\n",
              " 'methods identifying treating patient populations amenable cancer immunotherapymethods identifying cancer patients amenable anti-cancer immunotherapy provided methods monitoring cancer therapy. provided methods treating cancer patients amenable anti-cancer immunotherapy. methods involve determining level cd127<low>pd-1<low>t cells. patients treated immune checkpoint inhibitor, anti-ctla-4 antibody, e.g. ipilimumab.',\n",
              " 'combination urolithin immunotherapy treatmentsthe present invention relates combination urolithin therapeutic agent, particular combination urolithin immunotherapy treatment, immune checkpoint blocking therapy pd-1 antagonist. invention relates pharmaceutical compositions comprising combination, processes preparation pharmaceutical compositions methods compositions treatment diseases. embodiment, immune checkpoint blocking therapy selected group consisting anti-pd-1 antibody, anti-pd-l1 antibody, anti-ctla4 antibody, fusion protein.',\n",
              " 'anti-pd-l1 monoclonal antibody, application thereof preparation anticancer drugsthe invention discloses anti-pd-l1 monoclonal antibody. mouse immunized pd-l1 protein, spleen mouse separated successful immunization determined, total rna extracted, reverse transcription carried obtain cdna, pcr amplification performed obtain antibody light-chain heavy-chain genes, single-chain antibody phage library constructed,and screening performed obtain target antibody. anti-pd-l1 monoclonal antibody screened phage antibody library affinity pd-l1, inhibit combination pd-l1 pd-1. anti-pd-l1 monoclonal antibody immune checkpoint inhibitor humanized, treating cancers infectious diseases.',\n",
              " 'method providing information predicting response patient cancer immune checkpoint inhibitor multiplex immunohistochemistrythe present invention relates method providing information predicting therapeutic responsiveness immune checkpoint inhibitor cancer patient multiple immunohistochemical staining, wherein, performing multiple immunohistochemical staining tumor tissue cancer patient measure expression level immune checkpoint molecules automated method, responsiveness cancer patient immune checkpoint inhibitor therapy accurately quickly predicted. addition, unlike conventional method single immunohistochemical staining, method errors inspectors reduced analyzing markers simultaneously expressed cell evaluating automated method, widely companion diagnostic method immune checkpoint inhibitors.',\n",
              " 'method predict response cancer treatment anti-pd1 immunotherapybiomarkers, vitro methods kit dispositive predicting prognosticating response human subject anti-pd1 and/or anti pd-l1 immune checkpoint inhibition immunotherapy.',\n",
              " 'castalagin analogs thereof anti-cancer efficacy increase response immune checkpoint inhibitorsmethods enhancing restoring antitumor response, antitumor immune mediated immune checkpoint inhibitors, cancer patients, described. methods based administration castalagin analogs thereof, particularly treatment tumors resistant immunotherapy immune checkpoint inhibitor therapy. castalagin analog thereof administered suitable form, crude plant fruit extract myrciaria dubia extract, pharmaceutical composition',\n",
              " 'biomarker predicting effects anti-pd-1 antibody/anti-pd-l1 antibody therapythe purpose present invention provide: marker capable predicting effects anti-pd-1 antibody/anti-pd-l1 antibody therapy high sensitivity; thereof. provided biomarker predicting effects anti-pd-1 antibody/anti-pd-l1 antibody therapy, biomarker comprising immunoglobulin superfamily containing leucine-rich repeat (islr).',\n",
              " 'method predicting efficacy anti-pd-1 antibody anti-pd-l1 antibody therapy, method evaluating cancer grade, method enhancing efficacy anti-pd-1 antibody anti-pd-l1 antibody therapymethods provided predicting response anti-pd-1 antibody anti-pd-l1 antibody therapy based biomarker evaluating malignancy cancer. method predicting response subject anti-pd-1 antibody anti-pd-l1 antibody therapy includes measuring expression level lat1 sample collected cancer tissue subject; predicting response subject anti-pd-1 antibody anti-pd-l1 antibody therapy based expression level lat1. method evaluating malignancy cancer subject includes staining sample collected cancer tissue subject anti-lat1 antibody anti-pd-l1 antibody; evaluating malignancy cancer subject based presence absence lat1-positive pd-l1-positive site.',\n",
              " 'anti-cd27 antibodies thereofthis disclosure isolated antibodies bind specifically cd27 high affinity. disclosure methods treating subject afflicted cancer comprising administeringto subject therapeutically effective amount anti-cd27 antibody monotherapy combination checkpoint inhibitor, anti-pd-1, anti-pd-l1, anti-ctla-4 antibody.',\n",
              " 'synergic combination 2,3-dioxygenase inhibitor immune checkpoint inhibitor treatment cancerthe present invention pharmaceutical composition preventing treating cancer, comprises combination compartment comprising derivative cyclohexyl-ethylene-amino-heteroaryl moiety pharmaceutically acceptable salt thereof active ingredient compartment comprising immune checkpoint inhibitor active ingredient. and, present invention method treating cancer mammal, comprises administering therapeutically effective amount derivative cyclohexyl-ethylene-amino-heteroaryl moiety pharmaceutically acceptable salt thereof combination therapeutically effective amount immune checkpoint inhibitor mammal thereof.',\n",
              " 'combination immunotherapy dosing regimen immune checkpoint blockadethe present disclosure method treating cancer priming dose combination immunotherapy comprising il-2 (e.g., extended-pk il-2), immune checkpoint inhibitor, tumor targeting antibody integrin-binding polypeptide, optional cancer vaccine, administered prior maintenance doses immune checkpoint inhibitor therapy. methods disclosure treat broad range cancer types.',\n",
              " 'anti-tumor immune checkpoint blocking agentthe invention anti-tumor immune checkpoint blocking agent, belongs technical field medicines. tumor targeted anti-tumor immune checkpoint blocking agent gastriccancer. active component blocking agent american cockroach refined product cii-3, american cockroach refined product cii-3 comprises component containing 94.4% peptides,and plays anti-tumor role reducing proportion failure cells derived local tumor tissues failure cells derived peripheral blood, spleen lymph node, blocking expression protein molecules pd-1. blocking agent small side effect treatment effect gastric cancer.',\n",
              " 'treatment cancer combination immune checkpoint inhibitor folfirinox therapya therapeutic method combination immune checkpoint inhibitor folfirinox therapy, modified folfirinox therapy dose-reducing regimen therapies effective treat cancer, particularly cancer difficult treat conventional therapies pancreatic cancer.',\n",
              " 'composition thereofthe present invention relates, inter alia, methods prevention treatment cancer, compositions, combinations kits treatment prevention cancer. embodiment, invention method treating preventing cancer, comprising administering patient thereof immune checkpoint modulator, pd- 1 inhibitor nivolumab, compound formula (i), x so3m h, pharmaceutically acceptable cation; 70% x groups so3m, compound pg-545 (pixatimod).',\n",
              " 'methods treating cancer b-raf inhibitors immune checkpoint inhibitorsprovided therapies including dosage regimens treatment cancer b-raf immune checkpoint inhibitor combination and/or mek inhibitor.',\n",
              " 'method treating individual suffering bladder cancera method treating individual suffering bladder cancer employs crispr system selectively kill reduce numbers pathogenic bacteria individual individual administered immune checkpoint inhibitor. particular embodiments, pathogenic bacteria e. coli, pseudomonas aeruginosa klebsiella bacteria, checkpoint inhibitor selected group consisting nivolumab, pembrolizumab, dostarlimab, pidilizumab, amp-224, amp-514, sti-a1110, tsr-042, rg-7446, bms-936559, medi-4736, msb-0020718c, aur-012 sti-a1010. embodiments include enhancing growth bacteria individual, bacteria including akkermansia, bacteroides, bifidobacterium, clostridium, enterococcus, fusobacterium, coprococcus, lactobacillus, propionibacterium, ruminococcus, veillonella, prevotella, escherichia streptococcus . crispr system include cas9, cpf1 cas3, delivered bacteriophage.',\n",
              " 'combination multi-specific molecule immune checkpoint inhibitorprovided combination medicines treating cancer. pharmaceutical composition treating and/or preventing cancer comprises multi-specific antibody described [i] combination compound described [ii] below: [i] multi-specific antibody antigen-binding fragment thereof; [ii] immune checkpoint inhibitor chemotherapeutic agent.',\n",
              " 'assessment therapeutic effect immune checkpoint inhibitor blood chemokine usedthis method assessing therapeutic effect immune checkpoint inhibitor subject includes assessing scd163 level biological sample collected subject.',\n",
              " 'pharmaceutical composition preventing treating cancer comprising pi3 kinase inhibitor immune checkpoint inhibitorthe present invention provide pharmaceutical composition preventing treating cancer comprising pi3 kinase inhibitor immune checkpoint inhibitor. composition present invention excellent activity preventing treating cancer compared case single therapy compound formula 1 pi3 kinase inhibitor immune checkpoint inhibitor. thus, composition present invention usefully applied preventing, treating improving cancer.',\n",
              " 'application angelica sinensis blood replenishing decoction preparation medicine enhancing curative effect immune checkpoint inhibitorthe invention discloses application angelica sinensis blood replenishing decoction preparation medicine enhancing curative effect immune checkpoint inhibitor, tumor animal model, angelica sinensis blood replenishing decoction promote proliferation activation cd8 + cells tumor tissues drainage lymph nodes promote antigen presentation effect body tumor cells. chinese angelica blood replenishing decoction significantly enhance anti-advanced tumor curative effect immune checkpoint inhibitor, combination chinese angelica blood replenishing decoction immune checkpoint inhibitor shows synergistic interaction achieve treatment effect advanced tumors, chinese angelica blood replenishing decoction applied preparation drugs enhancing curative effect immune checkpoint inhibitor. invention theoretical basis research treatment advanced tumors. angelica sinensis blood replenishing decoction prepared natural traditional chinese medicine components, toxic side effect, wide raw material source low price, reduces tumor treatment cost, solves problem patient suffering advanced tumors prone resistance immune checkpoint inhibitor, application prospect.',\n",
              " 'naphthalene containing substituted biphenyl application naphthalenethe invention relates naphthalene containing substituted biphenyl. chemical structure naphthalene shown formula (i) description, formula (i), r<1> hydrogen 1,4-dioxane, r<2> ethylenediamine, n,n-dimethylethylenediamine, n-t-butyloxycarboryl-1,2-ethylenediamine, hydroxyl, cholamine, acetyl ethylenediamine, d-serine, cis-4-hydroxy-l-proline, l-cysteineand 2-aminoisobutyric acid. naphthalene containing substituted biphenyl inhibit mutual binding programmed cell death receptor 1/programmed cell death ligand 1 (pd1/pd-l1) forpreparing pd1/pd-l1 inhibitor, inhibitor remarkable effect.',\n",
              " 'anti-cancer agent comprising anti pd-1 antibody anti pd-l1 antibodypurpose: anti-cancer containing anti-pd-1 anti-pd-l1 antibody provided suppress anergy induction inkt(invariant natural killer t) cells. constitution: anti-cancer comprises inkt cell ligand anti-cancer anti-pd-1 anti-pd-l1 antibody anti-cancer drug. anti-pc-1 anti-pc-l1 antibody monoclonal polyclonal antibody. reactivity inkt cells recovered treating anti-pd-1 anti-pd-l1 antibody inkt cells anergy induce administering inkt cells ligand. inkt cells ligand alpha-galactosylceramide, alpha-glucuronosylceramide, phosphatidylinositol tetramannoside, isoglobotrihexosylceramide, ganglioside gd3, phosphatidylcholine, lipophosphoglycan.',\n",
              " 'method predicting sensitivity cancer treatment pd-1 immune checkpoint inhibitorthe present invention gene set predicting sensitivity cancer treatment pd-1 immune checkpoint inhibitor. specifically, present invention genes selected group consisting adam8, vcl, lef1-as1, tspan32, ctbp2, rxra, ptgds, itgb1, klrd1, rab11fip5, slc4a8, nin, gcnt2, asb2, hnrpll, ampd3, sirpg, ptpn13, myb, asap1, mboat1, cotl1, icos, st8sia1, pask, sgpp2, pdcd1, tbc1d4, emp3, fam65b, gbp1, fam211b, prr5, c17orf67, fam101b tbl1x, method predicting sensitivity cancer treatment pd-1 immune checkpoint inhibitor genes.',\n",
              " 'combination therapy exosome secretion inhibitor immune checkpoint inhibitora combination, antibody-drug conjugate, polymer-drug conjugate disclosed, combination therapy exosome secretion inhibitor endothelin receptor type (eta) antagonist, immune checkpoint inhibitor.',\n",
              " 'treating cancer immunostimulantsfield: medicine.substance: invention refers treating cancer metastasis subject. method treating melanoma metastasis thereof subject comprises administering composition comprising thymosin-alpha peptide programmed cell death-1 (pd-1) inhibitor, thymosin-alpha peptide administered subject dosage range 0.1 10 mg/day, pd-1 inhibitor administered subject dosage range 0.1 10 mg/kg.effect: invention synergetic effect combined thymosin-alpha pd-1 treating melanoma.22 cl, 23 dwg, 6 tbl, 3',\n",
              " 'method predicting personalized response cancer treatment immune checkpoint inhibitors, method treating cancer, kit therefora method kit provided predicting favorable non-favorable response cancer patient treatment immune checkpoint inhibitor determining biological sample obtained cancer patient, treatment, changes levels factors/biomarkers generated cancer patient response treatment, method treatment cancer patient immune checkpoint inhibitor.',\n",
              " 'combination therapy cancerthe present invention relates combination therapies treatment cancer. particular, present invention relates combination pd-1 inhibitor, tgf [beta] inhibitor mct4 inhibitor treatment cancer.',\n",
              " \"method predicting patient's benefit therapy immune checkpoint inhibitorthe present invention relates method predicting patient's benefit therapy immune checkpoint inhibitor, method predicting cancer patient's probability survival, method determining sample value expression level platelet surface protein.\",\n",
              " 'combination treatment cancerthe present invention relates combination therapies treatment cancer. particular, invention relates combined pd-1 inhibitor, tgfβ inhibitor, adenosine inhibitor treat cancer.',\n",
              " 'combined inhibition pd-1, tgfb tigit treatment cancerthe present invention relates combination therapies treatment cancer. particular, invention relates combined pd-1 inhibitor, tgfβ inhibitor, tigit inhibitor treat cancer.',\n",
              " 'combination treatment cancerthe present disclosure relates combination therapies treatment cancer. particular, disclosure relates combined pd-1 inhibitor, tgfbeta inhibitor, parp inhibitor treat cancer.',\n",
              " 'pd-1, tgfbeta atm combined inhibition combination radiotherapy cancer treatmentthe present invention relates combination therapies treatment cancer. specifically, invention relates combination pd-1 inhibitor, tgf [beta] inhibitor, atm inhibitor radiotherapy treating cancers.',\n",
              " 'therapeutic constructs co-delivery mitotic kinase inhibitor immune checkpoint inhibitordisclosed therapeutic constructs including delivery particle, mitotic kinase inhibitor, immune checkpoint inhibitor. disclosed therapeutic constructs including mitotic kinase inhibitor, immune checkpoint inhibitor, chemical linker. therapeutic constructs cancer death therapeutic immune effects promote targeted delivery therapeutics surviving cancer cells positive feed-back loop. enhance therapeutic index free drugs intratumorally systemically. strategy treat broad cancer types particular cancer obvious receptors cancer-targeted delivery toxic therapeutics.',\n",
              " 'combination treatment cancerthe present invention relates combination therapies treatment cancer. particular, invention relates combined pd-1 inhibitor, tgfβ inhibitor, vegf inhibitor treat cancer.',\n",
              " 'combination therapy il-2 receptor agonist immune checkpoint inhibitorthe present disclosure directed to, inter alia, methods modulating immune response subject thereof il-2 receptor agonist combination immune checkpoint inhibitor.',\n",
              " 'pharmaceutical composition comprising salmonella strain immune checkpoint inhibitor active ingredient prevention treatment cancerthe present invention pertains pharmaceutical composition comprising salmonella strain immune checkpoint inhibitor active ingredients prevention treatment cancer. present invention advantageously prophylactic therapeutic composition configured administer bacterium immune checkpoint inhibitor combination cancer, especially, type resistant cancer difficult treat single anticancer therapy, remarkably inhibit size tumor, improving survival rate.',\n",
              " 'pd-1 antagonist raf inhibitor treatment cancerthe present disclosure relates methods kits treatment cancer. particular, disclosure methods treatment cancers administering pd-1 antagonist pembrolizumab, nivolumab, atezolizumab, durvalumab avelumab combination pan-raf inhibitor (r)-2-(1 -(6-amino-5-chloropyrimidine-4- carboxamide)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide n-{7-cyano-6-[4-fluoro-3-({[3- (trifluoromethyl)-phenyl]acetyl}amino)phenoxy]-1,3-benzothiazol-2-yl}cyclopropanecarboxamide.',\n",
              " 'pharmaceutical composition enhancing anti-cancer effect immune checkpoint inhibitors comprising glutamine transporter inhibitor active ingredientthe present invention relates pharmaceutical composition enhancing anti-cancer effect immune checkpoint inhibitor, including glutamine transporter inhibitor active component. composition present invention increases activity cells anticancer action increases infiltration response cells tumor immune checkpoint inhibitor, significantly enhance anti-cancer effect. therefore, composition present invention usefully pharmaceutical composition treating cancer patients, including cancer patients show therapeutic effect administering conventional immune checkpoint inhibitor alone.',\n",
              " 'composition preventing alleviating treating immune checkpoint inhibitor resistant cancerthe present invention relates composition preventing, alleviating, treating immune checkpoint inhibitor-resistant cancer, includes binding molecule, active ingredient, capable specifically binding leucine-rich immunoglobulin-like domains 1 (lrig-1) protein protein present surface regulatory cells (treg). present invention, binding molecule specific lrig-1 protein inhibits function treg, is, treg activated treg belonging tumor infiltrating lymphocytes (til), lrig-1 protein expressed high level, phenomenon function effector cells inhibited treg effectively prevented, effectively preventing, alleviating, treating immune evasion cancer, is, cancer resistance immune checkpoint inhibitor.',\n",
              " 'biomarker risk prediction immune checkpoint inhibitor-related adverse reactions, kit, model establishment method applicationthe invention discloses biomarker risk prediction immune checkpoint inhibitor related adverse reactions, kit, model establishment method application, belongs technical field tumors. biomarker comprises peripheral blood platelets, lymphocytes, serum albumin serum soluble tumor inhibition factor (sst2). biomarker predict risk immune checkpoint inhibitor related adverse reactions.',\n",
              " 'peptide compatible pd-1, application peptide compatible pd-1the invention specifically relates peptide p1 compatible pd-1, modifying peptide peptide p1. amino acid sequence peptide p1 seqid no.1, modifying peptide alanine scanning peptide, point mutation peptide cutting-off peptide peptide p1. configurations amino acids peptide disclosed invention independently selectedfrom type type. peptide disclosed invention compatible pd-1, block interaction pd-1/pd-l1, peptide precursor peptide fordeveloping pd-1/pd-l1 inhibitor, base provided research development medicines resisting tumors types diseases.',\n",
              " 'anti-pd-l1 antibody treatment bladder cancerprovided methods treating bladder cancer (e.g., urothelial carcinoma, uc) subject bladder cancer, e.g., uc, effective dose regimen anti-pd-l1 antibody, e.g., durvalumab, antigen binding fragment thereof. provided methods anti-pd-l1 antibody combination immunotherapeutic agent, e.g., tremelimumab treat bladder cancer, e.g., uc, subject bladder cancer. cases, subject undergoing treatment identified bladder cancer tumor pd-l1-low/neg, pd-l1-high. methods provided anti-pd-l1 antibody treatment bladder cancer standard first-line therapy subjects progressed therapies relapsed prior treatment regimen.',\n",
              " 'resorcinol diphenyl methyl ether application thereofthe invention relates resorcinol diphenyl methyl ether. chemical structure compound represented formula (i) description, formula (i), r<1> 2-methylalanine, piperazinyl, acetylpiperazinyl, methyl piperazinyl, ethyl piperazinyl, isopropyl piperazinyl, cyclopropyl piperazinyl, t-butyloxycarbonyl piperazinyl, cyclopropyl methyl piperazinyl, n-t-butyloxycarbonyl-1,2-ethylenediamine, n,n-dimethyl ethylenediamine, ethylenediamine 3-hydroxy azetidinyl. resorcinol diphenyl methyl ether inhibit mutual combination programmed cell death receptor 1/programmed cell death ligand 1(pd-1/pd-l1) preparing pd-1/pd-l1 inhibitor, inhibitor remarkable effect.',\n",
              " 'metformin hydrochloride 7-ethyl-10-hydroxycamptothecin self-assembled nano materialthe invention discloses metformin hydrochloride 7-ethyl-10-hydroxycamptothecin self-assembled nano material (mh nps) application thereof synergistic effect tumor immunotherapy chemotherapy. nano material invention uniform granularity dispersibility, preparation method material advantages simple operation, time consumption, lowenergy consumption, mildness, greenness, easy scale like. cell experiment results show prepared nano material synergistic treatment function immunity chemotherapy,has higher safety traditional immunocheckpoint inhibitors pd-l1 inhibitor, easier store cheaoper, important application prospect field future tumor immunotherapy.',\n",
              " 'methods predicting response immune checkpoint inhibitor patient suffering lung cancerthe invention relates prediction responder non-responder immune checkpoint inhibitor patient suffering lung cancer. study interplay malignant cells immune microenvironment, inventors performed lung adenocarcinoma samples integrative analysis incorporated immunochemistry (ihc), gene expression, mutational flow cytometry data. identified tumor immune profiles (tips), found co-occuring genetic alterations, especially tp53, egfr stk11 mutations, major determinants tumor immune composition pd-l1 expression malignant cells. moreover, found distinct combinations tp53, egfr stk11 mutations identify responders pd-l blockers. thus, present invention relates method predicting patient suffering lung cancer achieve response immune checkpoint inhibitor comprising determining notably mutations profile genes tp53, stk11 egfr concluding patient high probability achieve response immune checkpoint inhibitor function mutations profile.',\n",
              " 'biphenyl compound preparation method application thereofthe invention discloses biphenyl compound serving pd-l1 inhibitor, pharmaceutically acceptable salt, racemate, optical isomer solvent compound biphenyl compound preparation method application biphenyl compound. biphenyl compound shown general formula i. biphenyl compound preparing inhibitor inhibitory activity pd-1/pd-l1 signal channel. compound especially preparing anti-tumor anti-infection drugs. pharmacological experiments show biphenyl compound provided invention obvious effect blocking pd1/pd-l1 signal channel, biphenyl compound prospect preparation anti-tumor anti-infection drugs.',\n",
              " 'pd-l1 binding peptides peptide complexes methods thereofdescribed cystine-dense peptides capable binding pd-l1. peptides function pd-l1 inhibitors binding pd-1-binding interface pd-l1 inhibiting interactions pd-l1 pd-1. methods pd-l1-binding peptides treat cancers, autoimmune diseases, conditions described herein. methods include delivering active agents complexed pd-l1-binding peptide pd-l1 positive cell bispecific immune cell engager recruit immune cells pd-l1 positive cells. described chimeric antigen receptors comprising pd-l1-binding peptides.',\n",
              " 'vaccine combination immune checkpoint inhibitor treating cancera polypeptide medicine provided. polypeptide administered simultaneously, separately sequentially immune checkpoint inhibitor. polypeptide comprises polypeptide comprising region 12 amino acids self-antigen sequence 80% identity region. polypeptide 100 amino acids length.',\n",
              " 'pediatric niraparib formulations pediatric treatment methodsthe present invention relates methods treating cancer pediatric subjects comprising administration compound niraparib suitable oral dosage form optionally combination therapeutic agent pd-1 inhibitor.',\n",
              " 'application nicotinamide adenine dinucleotide precursor preparation immune checkpoint inhibitor anti-tumor sensitizing drugthe invention relates technical field medicines, particularly application nicotinamide adenine dinucleotide precursor thereof preparation immune checkpoint inhibitor anti-tumor sensitizing drug. invention, researches aspects in-vitro cell culture in-vivo animal experiments find sensitivity tumors immune checkpoint inhibitor enhanced supplementing nad<+> precursor substances; in-vitro experiments find supplementation nad<+> precursor promote upregulation expression interferon gamma-induced key indicator pd-l1 predicts efficacy immune checkpoint inhibitors; furthermore, in-vivo experiments show growth inhibition effect anti-pdl1 antibody primary secondary immunotherapy tolerant tumors remarkably enhanced supplementing nad<+> precursor; invention application nad<+> precursor; invention treatment tumors tolerant tumor immunotherapy.',\n",
              " 'application combination bacteroides fragilis immune checkpoint inhibitor treatment digestive system tumorsthe invention discloses application combination bacteroides fragilis immune checkpoint inhibitor treatment digestive system tumors, particularly relates combination bacteroides fragilis zy-312 preservation number cgmcc no.10685, inactivated bacteria bacteroides fragilis zy-312 immune checkpoint inhibitor including pd-1 antibody pd-l1 antibody, bacteroides fragilis zy-312, inactivated bacteria bacteroides fragilis zy-312 immune checkpoint inhibitor including pd-1 antibody pd-l1 antibody combined vivo increasing proportion cd4 + cells cd8 + cells. down-regulating level cell factors il-10 tumors up-regulating level inf-gamma, growth transplanted tumors mice effectively inhibited. traditional chinese medicine composition combined treatment means operation, radiotherapy chemotherapy, comprehensive curative effect remarkably improved, harm radiotherapy chemotherapy body relieved, occurrence, development, relapse metastasis tumors effectively prevented, living quality patients improved.',\n",
              " 'multispecific binding agents pd-l1 cd137 combinationthe present invention combination therapy binding agent binds human cd137 human pd-l1 combination pd-1 inhibitor reduce prevent progression tumor treating cancer.',\n",
              " 'assessment adverse events induced administration antitumor and/or immune checkpoint inhibitor disease model mouseaccording present invention, method assessing adverse events induced antitumor and/or immune checkpoint inhibitor comprises: administering antitumor and/or immune checkpoint inhibitor model mouse (i) selected group consisting mxh7/mo/lpr mice, mxh10/mo/lpr mice, mxh28/mo/lpr mice, mxh36/mo/lpr mice, mxh41/mo/lpr mice, mxh43/mo/lpr mice, mxh51/mo/lpr mice, mxh54/mo/lpr mice, (ii) selected group consisting mch/mo/ank.y c3h mice, mch/mo/ank.y mrl mice, mch/mo/lpr/ra1 mice; assessing adverse events induced antitumor and/or immune checkpoint inhibitor.',\n",
              " 'application col24a1 mutation predicting sensitivity lung adenocarcinoma patient immune checkpoint inhibitor therapythe invention relates application col24a1 gene mutation predicting sensitivity lung adenocarcinoma patients immune checkpoint inhibitor therapy.',\n",
              " 'evaluation method, calculation method, evaluation device, calculation device, evaluation program, calculation program, recording medium, evaluation system terminal device relative pharmacological action combination immune checkpoint inhibitor anticancer concomitant compared pharmacological action immune checkpoint inhibitor alonethe present invention addresses problem providing evaluation method, etc., capable providing reliable information reference understanding individual difference expression relative pharmacological action combination immune checkpoint inhibitor anticancer drug, concomitant agent, compared pharmacological action immune checkpoint inhibitor alone. present embodiment evaluates relative pharmacological action combination immune checkpoint inhibitor anticancer drug, concomitant agent, subject evaluated, compared pharmacological action immune checkpoint inhibitor alone, concentration metabolite selected glu, arg, orn, cit, his, val, phe, tyr, met, pro, asn, leu, lys, thr, ile, gln, ala, ser, a-aba, trp, gly, antha, hkyn, htrp, kyn, kyna, np, qa xa blood subject evaluated.',\n",
              " 'pretreatment cell infusion therapy immune-checkpoint inhibitor-resistant tumorto provide technique relating therapy immune checkpoint inhibitor-resistant tumor.solution: problem solved pharmaceutical composition intended administered prior administration cells specific antigen cell infusion therapy immune checkpoint inhibitor-resistant tumor, pharmaceutical composition comprising antigen-loaded nanogel hydrophobized polysaccharide-based nanogel loaded long peptide antigen protein antigen contains cd8-positive cytotoxic cell recognizing epitope(s) and/or cd4-positive helper cell recognizing epitope(s) derived antigen.selected drawing: figure 3',\n",
              " 'macrocyclic peptides pd-l1 inhibitors immunomodulators treatment cancer infectious diseasesaccording present disclosure, macrocyclic compounds bind pd-l1 capable inhibiting interaction pd-l1 pd-1 cd80 found. macrocyclic compounds exhibit vitro immunomodulatory efficacy, making therapeutic candidates treatment diseases, including cancer infectious diseases.',\n",
              " 'combination therapy comprising axl/mer pd-1/pd-l1 inhibitorsthe present disclosure relates methods treating cancer administering compound axl/mer kinase inhibitor combination antibody antibody fragment thereof binds pd-1.',\n",
              " 'method preparing pd-1/pd-l1 inhibitor clematis tanguticathe present invention discloses active ingredient extracted clematis tangutica natural plant extraction method active ingredient. particularly active ingredient extracted clematis tangutica effectively block pd1-pdl1 combination remove, inhibit, reduce block pd1-pdl1 interaction subsequent action; pharmaceutical composition activeingredient pharmaceutical carrier effectively pd1-pdl1 inhibitor; pd1-pdl1 inhibitor applied anti-tumor related diseases, references provided clinical treatment schemes.',\n",
              " 'method preparing pd-1/pd-l1 inhibitor thalictrum elegansthe invention discloses active component extracted natural plant, thalictrum elegans extraction method active component. specifically, active component extracted thalictrum elegans effectively block combination pd1-pdl1, interaction pd1-pdl1 subsequent action pd1-pdl1 eliminated, inhibited, reduced blocked. pharmaceutical composition active component pharmaceutical carrier effectively pd1-pdl1 inhibitor; pd1-pdl1 inhibitor applied resisting tumor related diseases, provide reference clinical treatment scheme.',\n",
              " 'application 4-hydroxyisoleucinethe invention belongs technical field biological medicine, particularly discloses application 4-hydroxyisoleucine. in-vivo in-vitro experiments find 4-hydroxyisoleucine (4-hil) enhance anti-tumor function immune checkpoint inhibitor, relieve immune-related adverse events gastrointestinal tracts, reduce intestinal inflammation level relieve treat gastrointestinal diseases (such ulcerative colitis) time. clinically, treatment cost icb therapy high, 4-hil combined icb therapy effectively reduce dosage immune checkpoint inhibitors, treatment cost reduced, medication burden patients relieved anti-tumor ability enhanced immune-related adverse events gastrointestinal diseases relieved, 4-hil combined icb therapy wide clinical application prospects. invention candidate first-line treatment immune checkpoint blocking therapy, candidate treatment immune checkpoint inhibitor related gastrointestinal diseases.',\n",
              " 'method preparing pd-1/pd-l1 inhibitor thermopsis alpinathe invention discloses active ingredient extracted natural plant thermopsis alpina extraction method active ingredient particularly relates active ingredient isextracted thermopsis alpina effectively block combination pd1-pdl1 eliminate, inhibit, reduce block interaction pd1-pdl1 subsequent effects thereof. active ingredient medicinal composition pharmaceutically carrier effectively pd1-pdl1 inhibitor applied anti-tumor related diseases, reference provided clinical treatment schemes.',\n",
              " 'application combination bacteroides fragilis capsular polysaccharide immune checkpoint inhibitor preparation drugs treating digestive system tumorsaccording application combination bacteroides fragilis capsular polysaccharide immune checkpoint inhibitor preparation drugs treating digestive system tumors, bacteroides fragilis capsular polysaccharide capsular polysaccharide extracted bacteroides fragilis zy-312 method disclosed invention, relative molecular weight 70-90kda, content combined lipid lower 0.02% bacteroides fragilis capsular polysaccharide contain lipid. bacteroides fragilis capsular polysaccharide active component prepared biological preparations pharmaceutical preparation pharmaceutical composition, combined immune checkpoint inhibitor treat digestive system tumors, response rate treatment effect immune checkpoint inhibitor increased, side effects reduced.',\n",
              " 'composition preventing treating cancer comprising manassantin immune checkpoint inhibitorthe present invention relates composition preventing and/or treating cancer comprising manassantin immune checkpoint inhibitor active ingredients. composition present invention expected effectively suppress resistance chemotherapy, recurrence, metastasis proliferation solid cancers combined administration.',\n",
              " 'method preparing pd-1/pd-l1 inhibitor rheum officinalethe invention discloses active ingredient extracted natural plant rheum officinale extraction method active ingredient, particularly relates active ingredient extracted rheum officinale, effectively block combination pd1-pdl1 eliminate, inhibit, reduce block pd1-pdl1 interaction subsequent effects thereof. pharmaceuticalcomposition active ingredient pharmaceutical carrier effectively pd1-pdl1 inhibitor, pd1-pdl1 inhibitor resisting tumor related diseases, provide reference clinical treatment schemes.',\n",
              " 'anti-pd-l1 anti-ctla-4 antibodies treating non-small cell lung cancerprovided methods treating non-small cell lung cancers comprising administering effective amount durvalumab (medi4736) antigen-binding fragment thereof tremelimumab antigen-binding fragment thereof. combination durvalumab tremelimumab effective treating non-small cell lung cancers characterized pd-l1 - high level cd8 + tumor-infiltrating lymphocytes',\n",
              " 'multilamellar rna nanoparticles methods sensitizing tumors treatment immune checkpoint inhibitorsthe present disclosure methods increasing sensitivity tumor treatment immune checkpoint inhibitor (ici) subject methods treating subject immune checkpoint inhibitor (ici)-resistant tumor. methods comprise administering subject composition comprising nanoparticle comprising positively-charged surface interior comprising (i) core (ii) nucleic acid layers, nucleic acid layer positioned cationic lipid bilayer. provided methods increasing number activated plasmacytoid dendritic cells (pdcs) subject thereof, comprising administering subject composition comprising nanoparticle comprising positivelycharged surface interior comprising (i) core (ii) nucleic acid layers, nucleic acid layer positioned cationic lipid bilayer.',\n",
              " 'method predicting clinical response immune checkpoint inhibitor based pretreatment therewiththe present invention relates method predicting clinical response human animal subject suffering risk developing neoplastic disease treatment, method comprising steps of: administering subject initial dose immune checkpoint inhibitor, initial administration, obtaining biological sample subject, determining, sample, expression level gene interest selected rom group consisting pd1, pd-l1, ctla4, cd3, cd4, cd68, cd163 cd8, predicting therapeutic success follow treatment immune checkpoint inhibitor',\n",
              " 'method collecting data predicting administration effectiveness immune checkpoint inhibitor cancer patientto provide technique predicting administration effectiveness immune checkpoint inhibitor.solution: method collecting data predicting administration effectiveness immune checkpoint inhibitor cancer patient, includes process measuring expression level marker gene marker protein biological sample derived cancer patient. method, marker gene marker protein includes nell2 gene protein, amica1 gene protein, clec11a gene protein, clecl1 gene protein cmtm7 gene protein, expression level data predicting effectiveness, fact expression level higher reference value indicates administration immune checkpoint inhibitor cancer patient effective.selected drawing:',\n",
              " 'method sensitizing cancers immunotherapy immunomodulatory agentsthe invention described relates newly discovered ability tumor internalizing arginylglycylaspartic acid (irgd) peptides alter immune cell landscape pancreatic ductal adenocarcinoma (pdac) cancers. irgd peptides sensitize cancer immune checkpoint inhibitors, anti-pd-l1, anti-pd-l1, anti-pd-1, anti-ctla4 monoclonal antibodies specifically deplete tregs tumor, resulting expansion intratumoral cd8+ cells (effector cells). methods treating cancers pdac, preferably synergistic combination chemotherapy immunotherapy, leads reduced tumor burden prolonged survival.',\n",
              " 'pharmaceutical composition thereof preparing treating tumor multi-drug resistancea pharmaceutical composition includes chlorogenic acid coumaroylquinic acid. preparing reversing agent tumor multi-drug resistance pd-1/pd-l1 inhibitor. combined chlorogenic acid coumaroylquinic acid exhibits synergistic effect, effectuating reversing effect resistance tumor cell strain produces multi-drug resistance chemotherapeutic drugs immunotherapeutic drugs, effectively inhibit pd-1/pd-l1 expression drug-resistant b16 melanoma drug-resistant lewis lung cancer mice transplantation tumor tissue, effectively proliferate cd4+t cd8+t cells drug-resistant b16 melanoma mice lewis lung cancer mice.',\n",
              " 'method sensitizing cancers immunotherapy immunomodulatory agentsthe invention described relates newly discovered ability tumor internalizing arginylglycylaspartic acid (irgd) peptides alter immune cell landscape pancreatic ductal adenocarcinoma (pdac) cancers. irgd peptides sensitize cancer immune checkpoint inhibitors, anti-pd-l1, anti-pd-l1. anti-pd-1, anti-ctla4 monoclonal antibodies specifically deplete tregs tumor, resulting expansion intratumoral cd8+ cells (effector cells). methods treating cancers pdac, preferably synergistic combination chemotherapy immunotherapy, leads reduced tumor burden prolonged survival.',\n",
              " 'method preparing pd1-1/pd-l1 inhibitor peganum harmalathe present invention discloses active ingredient extracted peganum harmala natural plant extraction method active ingredient. particularly, active ingredient extracted peganum harmala effectively block pd1-pdl1 combination eliminate, inhibit, reduce block pd1-pdl1 interaction subsequent actions; pharmaceutical composition active ingredient pharmaceutical carrier effectively pd1-pdl1 inhibitor, applied anti-tumor related diseases provide reference clinical treatment scheme.',\n",
              " 'application cdk4/6 inhibitor combined immunotherapy preparation anti-cancer drugsthe invention relates application cdk4/6 inhibitor combined immunotherapy preparation anti-cancer drugs, belongs technical field biological medicines. particular application pirociclib pharmaceutical salt thereof combined pd-1 pd-l1 inhibitor preparation drugs treating cancers lung cancer, melanoma, brain cancer, breast cancer, liver cancer, glioblastoma, gastric cancer, intestinal cancer, pancreatic cancer, kidney cancer, prostatic cancer, ovarian cancer, endometrial cancer, thyroid cancer lymphoma. combined therapy provided invention synergistic effect, improves survival rate median lifetime transplanted tumor mice, clinical application prospect inhibition tumor growth metastasis.',\n",
              " 'application honokiol preparation medicine inhibiting pd-l1 expressionthe invention belongs technical field medicines discloses application honokiol preparation medicine inhibiting pd-l1 expression. invention particularly discloses application honokiol pharmaceutically acceptable salts thereof preparation pd-l1 inhibitor. natural micromolecular compound honokiol pharmaceutically acceptable salts thereof provided invention inhibiting expression level pd-l1 protein dose manner inhibiting rna transcription level pd-l1; honokiol pharmaceutically acceptable salts thereof provided invention inhibiting proliferation tumor cells, significantly increasing number cd4<+>t cells cd8<+>t cells tumor infiltrating lymphocytes, effectively inhibiting volume increase transplanted tumors nude mice.',\n",
              " 'combination antibody-drug conjugate immune checkpoint inhibitora pharmaceutical composition therapeutic method antibody-drug conjugate immune checkpoint inhibitor administered combination, antibody-drug conjugate antibody-drug conjugate drug-linker represented formula (wherein represents connecting position antibody) conjugated antibody thioether bond; pharmaceutical composition therapeutic method treatment disease ameliorated antitumor immunity-activating effect antibody-drug conjugate included.',\n",
              " 'anti-hrs antibodies combination therapies treating cancersprovided antibodies specifically bind human histidyl-trna synthetase related therapeutic compositions methods treating cancer, including standalone therapies combination cancer immunotherapies, example, immune checkpoint modulators pd-1 inhibitors.',\n",
              " 'methods compositions identifying subject suffering cancer achieve response immune-checkpoint inhibitorthe present invention relates soluble cd27 biomarker predict reponse immune checkpoint inhibitor treatment. inventors worked cohorts patients identified soluble marker, cd27, present plasma patients renal cell cancer pre-treatment concentrations predict response anti-pd-1 / pd- l1. marker appears predictive marker response anti-pd1 / pd-l1 treatment, prognostic marker. indeed, associated survival patients metastatic renal cell cancer treated antiangiogenic agent. marker correlated conventional clinical markers severity classify patients metastatic renal cancer.',\n",
              " 'combination anti-pd-1 antibody anti-ctla-4 antibody preventing treating cancerdisclosed combination anti-pd-1 antibody targeting programmed death protein-1 (pd-1) antigen binding fragment antibody anti-ctla-4 antibody preparing medicament treating cancer, specifically hepatocellular carcinoma. disclosed pharmaceutical composition comprising anti-pd-1 antibody antigen binding fragment thereof anti-ctla-4 antibody complete medicinal kit.',\n",
              " 'engineered platelets nanogel internally loaded chemotherapeutic drugs externally carried immune checkpoint inhibitors preparation method application engineered plateletsthe invention discloses engineered platelets nanogel internally loaded chemotherapeutic drugs externally carried immune checkpoint inhibitors preparation method application engineered platelets, belongs technical field drugs. preparation method engineered platelets includes steps: crosslinking nanogel carried immune checkpoint inhibitor, extract purified platelets, loading chemotherapeutic nanogel platelets, like. engineered platelets deliver chemotherapeutic immune checkpoint inhibitor postoperative tumor remaining parts efficiently targeting damaged vascular endothelium, circulating tumor cells captured cleared high-affinity membrane adhesion receptor, engineered platelets activated situ surfaces tumor cells, chemotherapeutic immune checkpoint inhibitor released trigger t-cell-mediated anti-tumor immune response, tumor ablated, postoperative tumor recurrence metastasis effectively avoided.',\n",
              " \"combinations generating tumor-specific immunological memorycombinations bruton's tyrosine kinase (btk) inhibitors, e.g., l-((r)-3-(4-amino-3 -(4-phenoxyphenyl)- lh-pyrazolo[3,4-d]pyrimidin- 1 -yl)piperidin- 1 -yl)prop-2-en- 1 - one, immunomodulating agent, e.g., ctla-4 inhibitor, provided. provided methods inducing tumor-specific immunological memory cancer administering combinations bruton's tyrosine kinase (btk) inhibitors, e.g., l-((r)-3-(4- amino-3 -(4-phenoxyphenyl)- lh-pyrazolo[3,4-d]pyrimidin- 1 -yl)piperidin- 1 -yl)prop-2-en- 1 - one, immunomodulating agent.\",\n",
              " 'dendritic polymers complexed immune checkpoint inhibitors enhanced cancer immunotherapydescribed nanoparticle system including multivalent nanoparticle core plurality immune checkpoint inhibitors conjugated thereto. included pharmaceutical compositions methods making nanoparticle system. included immunotherapy methods including administering nanoparticle system subject thereof, human cancer patient.',\n",
              " 'antibodies methods depleting regulatory b10 cells combination immune checkpoint inhibitorsprovided methods involving combination therapy comprising administering individual thereof antibody preferentially depletes human b10 cells immune checkpoint inhibitor. antibodies methods provided.',\n",
              " 'multi-modal transfer learning framework predicting curative effect tumor immune checkpoint inhibitorthe invention discloses multimodal transfer learning-based method, device system predicting curative effect tumor immune checkpoint inhibitor application device system.',\n",
              " '8-methoxyobliquin compositon comprising 8-methoxyobliquin compound isolated helianthus tuberosus leaves meoh extraction preventing treating immune checkpoint inhibitorprovide pharmaceutical composition treating anticancer drug-resistant tumors immune checkpoint inhibitor effect safely immune checkpoint inhibitor chemical component ingredient toxicity side effects 8-methoxyobliquin separated above-ground part helianthus tuberosus, native domestic resource. composition present invention contributes treatment immune checkpoint inhibitors inhibiting expression inhibitory activity anti-programmed death-ligand 1 (pd-l1), enhancing activity cells inhibiting benign tumor activity.',\n",
              " 'compositions methods determining responsiveness immune checkpoint inhibitors (ici), increasing effectiveness ici, treating cancerdisclosed methods treating cancer administering immune checkpoint inhibitor modifying amount bacteria intestine subject.',\n",
              " 'combination therapy involving anti-cd39 antibodies anti-pd-1 anti-pd-l1 antibodiesprovided antibody combination therapy anti-cd39 antibody anti-pd-1 antibody and/or anti-pd-l1 antibody.',\n",
              " 'melanoma checkpoint inhibitor detection treatmentbiomarkers provided predicting irae response associated administration anti-ctla-4 antibodies (i.e. ipilumamb) antibodies disrupting pd-1/pd-l1 pathway (i.e. nivolumab pembrolizumab) treating melanoma. methods treatment incorporating biomarkers provided.',\n",
              " 'biomarkers predicting response patient cancer immune checkpoint inhibitorthe present invention relates biomarker predicting therapeutic responsiveness patients cancer immune checkpoint inhibitors. gene signatures gene markers aspect remarkably excellent predicting therapeutic responsiveness patients cancer immune-oncologic agents, patient group expected therapeutic effect selected receive appropriate treatment. also, possible reduce pain cost patient.',\n",
              " 'pharmaceutical combinations comprising kras g12c inhibitor kras g12c inhibitor treatment cancersit relates pharmaceutical combination comprising kras g12c inhibitor therapeutically active agents selected tno155 pd-1 inhibitor; pharmaceutical compositions comprising same; methods combinations compositions treatment prevention cancers.',\n",
              " 'composition immunotherapy liver cancer application thereofthe invention composition immunotherapy liver cancer application thereof. composition comprises liver tumor antigen immune checkpoint inhibitor, liver tumor antigen comprises antigen peptide, site-directed mutagenesis product antigen peptide full-length protein antigen peptide, antigen peptide comprises afp, cd133, cea, ezh2, epcam, gpc3, her2, hsp27, hsp90, magea3, magea4, mart1, ny-eso-1, muc1 tert; immune checkpoint inhibitor comprises components: anti-pd1, anti-pd-l1, anti-ctla4, anti-lag3, anti-tim3 anti-tigit, immune checkpoint inhibitor comprises components: anti-pd1, anti-pd-l1, anti-ctla4, anti-lag3, anti-tim3 anti-tigit composition provided invention comprises liver tumor antigen immune checkpoint inhibitor, liver tumor antigen protein peptide fragment thereof composition induce subject suffering liver cancer immunize generate corresponding antigen-specific cd8 + lymphocytes. combined immune checkpoint inhibitor, compound immunotherapy curative effect liver cancer.',\n",
              " 'chalcone containing substituted biphenyl application thereofthe invention relates chalcone containing substituted biphenyl application thereof. chalcone chemical structure shown formula (i) shown description; formula(i), r1 methoxy group, n-acetylethylenediamine group, piperazine group, acetyl piperazine group, ethyl piperazine group, isopropyl piperazine group, cyclopropyl piperazine group, 1-t-butoxycarbonyl-2-methylpiperazine group, cyclopropylmethyl piperazine group 1-(3-nitrophenyl)piperazine group, r2 hydrogen, fluorine methyl group, r3 hydrogen 1,4-dioxane group. chalcone containing substituted biphenyl inhibit mutual combination programmed cell death receptor 1/programmed cell death ligand 1 (pd1/pd-l1), applicable preparation pd1/pd-l1 inhibitors significant effect.',\n",
              " 'anti-ctla-4 antibody thereofthe present invention relates technical field antibody drugs, particular anti-ctla-4 antibody antigen-binding fragment thereof, anti-ctla-4/anti-pd-1 antibody antigen-binding fragment thereof, pharmaceutical composition containing anti-ctla-4 antibody antigen-binding fragment thereof anti-ctla-4/anti-pd-1 antibody antigen-binding fragment thereof, thereof. anti-ctla-4 antibody anti-ctla-4/anti-pd-1 antibody present invention significant anti-tumor activity preparation anti-tumor drugs.',\n",
              " 'bifunctional protein aiming vegf tgf-beta application bifunctional proteinthe invention relates field biological medicines, particularly bifunctional protein aiming vegf tgf-beta. bifunctional protein comprises anti-vegf monoclonal antibody capable specifically combined vegf antigen, connecting peptide linker tgf-beta rii extracellular domain polypeptide, anti-vegf monoclonal antibody connected tgf-beta rii extracellular domain polypeptide connecting peptide linker. bifunctional protein aiming vegf tgf-beta provided invention target tumor microenvironment high expression vegf reduce side effects tgf-beta inhibitor, bifunctional protein singly used, combined existing immunotherapy drugs pd-1/pd-l1 inhibitor, effectively improve therapeutic effect tumor diseases.',\n",
              " 'method improving pd-l1 detection sensitivity application thereofthe invention discloses method improving pd-l1 detection sensitivity application thereof, method comprises steps: carrying pd-l1 detection adopting immunohistochemical method, carrying glycoprotein denaturation antigen repair step, carrying deglycosylation treatment, terminating deglycosylation reaction, sealing sealing liquid, adding pd-l1 primary antibody corresponding glycosylation site, carrying immunohistochemical detection pd-l1. continuing subsequent detection step. method disclosed invention, pd-l1 signal intensity remarkably enhanced, clinical detection sensitivity specificity pd-l1 improved, favorable technical support provided detecting immune checkpoint pd-l1 guiding clinical treatment pd-1/pd-l1 inhibitor.',\n",
              " 'super dc expressing immune checkpoint inhibitors thereofthe present invention relates antigen presenting cells expressing immune checkpoint inhibitors thereof. particular, present invention antigen presenting cells secrete pd-1 binding molecules ctla-4 binding molecules contain coding sequences thereof. antigen presenting cell disclosed invention activate immature cells effectively stimulate effector function activated cells cancers.',\n",
              " 'application recombinant human endostatin adenovirus anti-pd-1 antibody anti-pd-l1 antibody preparation antitumor drugsthe invention belongs field biological medicines, particularly relates application recombinant human endostatin adenovirus anti-pd-1 antibody anti-pd-l1 antibody preparation antitumor drugs. technical problem solved invention provide medicine relatively anti-tumor effect. technical scheme solving technical problem, invention anti-tumor takes adenovirus encoding human endostatin anti-pd-1 antibody anti-pd-l1 antibody active ingredients. adenovirus coding human endostatin anti-pd-1 antibody anti-pd-l1 antibody jointly treating, growth tumors effectively inhibited, tumors fade relapse, obvious toxic side effects avoided; indicated combination anti-angiogenesis treatment adenovirus containing encoded human endostatin immunotherapy anti-pd-1 antibody anti-pd-l1 antibody effective method treating tumors, method application prospect.',\n",
              " 'rna vaccine immune checkpoint inhibitors combined anticancer therapythe present invention relates field biomedicine, particular field therapeutic nucleic acids. present invention combination rna encoding epitope immune checkpoint inhibitors. pharmaceutical composition, vaccine, kit-of-parts comprising combination provided. furthermore, present invention relates combination, (pharmaceutical) composition, vaccine kit-of-parts medicine, particular treatment and/or prophylaxis cancer, infectious diseases diseases disorders.',\n",
              " 'combination oncolytic virus immune checkpoint inhibitor tumor treatmentthe present application relates treatment tumors. attenuated strain oncolytic virus provided targeted mutation wild-type vesicular stomatitis virus matrix protein. oncolytic virus vaccine provided basis attenuated oncolytic virus strain insertion exogenous gene attenuated strain. combination oncolytic virus vaccine immune checkpoint inhibitor efficiently treat multiple classes tumors.',\n",
              " 'pharmaceutical composition treatment cancers inhibition metastasis comprising photothermal nanoparticle conjugated immune checkpoint inhibitor adjuvantthe present invention relates pharmaceutical composition treating cancer inhibiting cancer metastasis, comprises photothermal nanoparticles immune checkpoint inhibitor combined surface thereof immunomodulator (adjuvant) active components. composition present invention specifically accumulated tumor cells, exhibits significant effect photothermal therapy near-infrared irradiation, promotes differentiation dendritic cells, effect treating primary tumors metastatic tumors killed tumor cells, immune checkpoint inhibitor, immunomodulatory act endogenous vaccine photothermal therapy.',\n",
              " 'biomarker predicting adverse events tumor immune checkpoint blocking treatment application biomarkerthe invention discloses biomarker predicting adverse events tumor immune checkpoint blocking treatment application biomarker, relates field biomedicine. biomarker crtam gene, nucleotide sequence biomarker shown seq id no. 1. analysis discovers expression level crtam significantly positively correlated adverse events immune checkpoint blocking treatment, ligand cadm1 non-tumor tissue high expression crtam significantly interacts crtam + cells, finally, prediction value baseline crtam adverse events immune checkpoint blocking treatment verified melanoma immunotherapy queue. biomarker provided invention scientific basis early recognition immune checkpoints block treatment high-risk groups adverse events, brings clinical benefits tumor patients, important clinical significance.',\n",
              " 'methods cd40 activation immune checkpoint blockadeprovided methods compositions treating cancer individual comprising administering individual effective amount immune checkpoint inhibitor chimeric cd 154 polypeptide. provided methods enhanced immune function.',\n",
              " 'anti-pd-l1/anti-pd-1 natural antibody structure-like heterodimeric bispecific antibody preparation thereofprovided anti-pd-l1/anti-pd-1 natural antibody structure-like heterodimeric bispecific antibody preparation thereof. particular, provided highly stable heterodimeric anti-pd-l1/anti-pd-1 bispecific antibody characteristics natural igg mismatched heavy chain-light chain, preparation thereof. bispecific antibody bind target molecules effective treating complex disease.',\n",
              " 'combined medication zwitterionic capsular polysaccharide bacteroides fragilis immune checkpoint inhibitor treatment genitourinary tumorsdisclosed present invention combined medication zwitterionic capsular polysaccharide bacteroides fragilis immune checkpoint inhibitor prevention treatment genitourinary tumors. present invention, large number experiments prove combined medication capsular polysaccharide bacteroides fragilis, especially bacteroides fragilis zy-312 deposit number cgmcc no. 10685 immune checkpoint inhibitor enhance immunological reaction body tumors means regulating levels cells anti-tumor immune factors, achieving goal preventing treating genitourinary tumors.',\n",
              " 'application 1,3-bis(benzoyloxy)-4-(acetyl amino) benzene derivative thereofthe invention application 1,3-bis(benzoyloxy)-4-(acetyl amino) benzene derivative thereof inhibition pd-1/pd-l1 signal path. invention application 1,3-bis(benzoyloxy)-4-(acetyl amino) benzene derivative thereof pd-1/pd-l1 immune checkpoint inhibitor. invention application 1,3-bis(benzoyloxy)-4-(acetyl amino) benzene derivative thereof preparation pd-1/pd-l1 immune checkpoint inhibition medicines. 1,3-bis(benzoyloxy)-4-(acetyl amino) benzene derivative thereof simple structure, simple preparation method, rich sources excellent treatment effect.',\n",
              " 'chemotactic factor immune checkpoint inhibitor fusion expression protein production method application thereofthe invention discloses chemotactic factor immune checkpoint inhibitor fusion expression protein production method application thereof, relates field bioengineering. secretory fusion protein prepared invention, chemotactic factors cxcl9 cxcl10 immune checkpoint inhibitor pd-l1 nano antibody combined, foundation laid development tumor bacterium therapy. present invention, codon-optimized cxcl9 cxcl10 protein gene sequences, added signal peptide, connected pd-l1 nanometer antibody mmp-cleavable connexon, secretory expression cxcl9 cxcl10 achieved;',\n",
              " \"methods treating melanoma tebentafusp immune checkpoint inhibitorsthe present invention relates treatment melanoma patient, method includes administering patient suspected melanoma therapeutically effective amount tebentafusp; therapeutically effective amount immune checkpoint inhibitor. particular, patients metastatic melanoma refractory treatment anti-pd(l)1 inhibitor metastatic setting patient's melanoma relapsed treatment anti-pd(l)1 inhibitor.\",\n",
              " 'kmt2 family gene variation markers kit predicting immune checkpoint inhibitor therapy solid tumorthe invention relates field clinical molecular diagnostics, particular kmt2 family gene variation marker kit predicting immune checkpoint inhibitor therapy solid tumor. invention marker predicting sensitivity solid tumor patient immune checkpoint inhibitor therapy and/or predicting tumor mutation load degree solid tumor patient. marker comprises variant kmt2 family gene, kmt2 family gene selected kmt2a, kmt2c kmt2d. kmt2 family gene variation adopted invention independent prediction risk factor practical application, detection efficiency improved.',\n",
              " 'combination therapy treating cancer poxvirus expressing tumor antigen antagonist immune checkpoint inhibitorthe present disclosure encompasses therapies, compositions, methods treatment human cancer patient recombinant poxvirus encoding tumor-associated antigen combination agonists antagonists immune checkpoint inhibitors.',\n",
              " 'anti-ccr8 antibodies treatment cancerthe present invention isolated antibodies, monoclonal antibodies, specifically bind c-c motif chemokine receptor 8 (ccr8) expressed surface cell mediate depletion cell expressing ccr8 antibody dependent cytotoxicity (adcc). present invention methods treating subject afflicted cancer comprising administering subject therapeutically effective amount anti-ccr8 antibody single therapy combination anti-cancer agent, immune checkpoint inhibitor, anti-pd-1 anti-pd-l1 antibody.',\n",
              " 'combination braf inhibitor, talimogene laherparepvec, immune checkpoint inhibitor treatment cancer (melanoma)provided therapeutic regimen comprising braf inhibitor, talimogene laherparepvec, immune checkpoint inhibitor. embodiments, combination therapy disclosed treat solid malignant tumors.',\n",
              " 'predicting patient responsiveness immune checkpoint inhibitorsthe invention directed method predicting clinical response patient treatment cancer immune checkpoint pathway inhibitor, anti-ctla-4 anti-pd-1 antibody binding compound. aspect method comprises generating pre- post-treatment clonotype profiles, determining number clonotypes decrease frequency clonotype profiles, predicting lack responsiveness patient treatment number clonotypes decrease frequency greater predetermined value.',\n",
              " 'combination therapy treating cancer poxvirus expressing tumor antigen antagonist and/or agonist immune checkpoint inhibitorthe invention relates compositions, kits, methods cancer therapy recombinant poxviruses encoding tumor-associated antigen combination antagonists agonists immune checkpoint inhibitors.',\n",
              " 'application doxycycline preparing inhibiting myeloid-derived suppressor cellsthe invention application doxycycline preparing inhibiting myeloid-derived suppressor cells. doxycycline serve inhibitor mdsc inhibit generation recruitment activation body mdsc, increases content cd8t cells, improves immunosuppressive microenvironment body, improving immune regulation ability thebody, doxycycline suitable preparation anti-tumor drugs, suitable preparation drugs autoimmune diseases, infectious diseases, inflammatory-mediated tissue injuries like. addition, doxycycline work synergistically pd-1(programmed cell death protein-1, programmed death-1) inhibitor, enhance anti-tumor effect pd-1 inhibitor, prevent cytokine storms caused programmed cell death protein-1(pd-1) inhibitor treatment.',\n",
              " 'transdermal cold atmospheric plasma-mediated immune checkpoint blockade therapya cold atmospheric plasma (cap)-mediated icb therapy/delivery device disclosed employs patch microneedles deliver cap transdermally immune checkpoint inhibitor enhancing transdermal treatment efficacy. hollow-structured microneedle patch facilitate transportation cap skin, causing tumor cell death. release cancer antigens promotes maturation dendritic cells tumor-draining lymph nodes, subsequently initiating cell-mediated immune response. anti-pdl 1 antibody (apdl 1 ), immune checkpoint inhibitor (or immune checkpoint inhibitors), released microneedle patch (in embodiments) augments anti-tumor immunity. transdermal combinational cap icb therapy inhibits tumor growth primary tumors distant tumors, prolonged survival tumor-bearing mice. results translate species.',\n",
              " 'combination hdac inhibitor anti-pd-1 antibody treatment cancerto provide combination hdac inhibitor anti-pd-1 antibody treatment cancer.solution: described methods treatment cancer subject. particular, methods provided treatment non-small cell lung cancer melanoma combination entinostat anti-pd-1 antibody anti-pd-l1 antibody. aspect, anti pd-1 antibody pembrolizumab. aspect, cancer characterized overexpression pd-l1. aspect, cancer characterized low expression pd-l1.selected drawing:',\n",
              " 'cd274 rearrangements predictors response immune checkpoint inhibitor therapyprovided cd274 rearrangements, cd274 nucleic acid molecules, pd-l1 polypeptides, methods related detecting cd274 rearrangements, cd274 nucleic acid molecules, pd-l1 polypeptides cancer, methods treatment related thereto. detection cd274 rearrangements, cd274 nucleic acid molecules, pd-l1 polypeptides disclosure identify individuals benefit treatment anti-cancer therapy immune checkpoint inhibitor.',\n",
              " 'hybridoma comprising immune checkpoint inhibitor, preparation method same, applications thereofprovided present application hybridoma comprising immune checkpoint inhibitor cytokines, nucleic acid molecules encoding hybridoma, corresponding expression vector, host cell, method comprising preparation hybridoma. addition, provided present application method detecting activity hybridoma method hybridoma treating disease improving relieving discomfort.',\n",
              " 'prediction model curative efficacy immune checkpoint inhibitor primary liver cancer based body compositions construction method thereofthe invention discloses prediction model curative efficacy immune checkpoint inhibitors primary liver cancer based body compositions construction method thereof, belongs field biomedicine. construction method includes steps: s1, measuring body compositions patients primary liver cancer treated immune checkpoint inhibitors ct scanning, evaluating primary patients develop sarcopenia grouping; s2: evaluating influence sarcopenia survival progression-free survival patients; s3, evaluating influence total adipose tissue index survival patients; s4, evaluating effects different combinations muscle adipose tissue areas survival progression-free survival patients; s5: based influence results muscle adipose tissue areas survival progression-free survival, judging prognosis effect patients treated immune checkpoint inhibitors.',\n",
              " 'chemokine production promoter, therapeutic agent immune checkpoint inhibitor-resistant cancer, antitumor immunostimulatorto provide chemokine production promoter, therapeutic agent immune checkpoint inhibitor-resistant cancer, antitumor immunostimulator enhance antitumor immunity cancer microenvironment.solution: chemokine production promoter comprises saccharide derivative.selected drawing: figure 1',\n",
              " 'histone deacetylase inhibitors enhancing immunotherapiescompositions including combinations class histone deacetylase (hdac) inhibitors programmed cell death protein 1 (pd-1) inhibitors enhancing antitumor activity disclosed. disclosed methods administering compositions immunotherapies suppressing regulatory cells renal cell carcinoma.',\n",
              " 'method preparing pd-1/pd-l1 inhibitor aconitum gymnandrum maximthe present invention discloses active ingredient extracted aconitum gymnandrum maxim natural plant extraction method active ingredient. particularly active ingredient extracted aconitum gymnandrum maxim effectively block pd1-pdl1 combination remove, inhibit, reduce block pd1-pdl1 interaction subsequent action; pharmaceutical compositionof active ingredient pharmaceutical carrier effectively pd1-pdl1 inhibitor; pd1-pdl1 inhibitor applied anti-tumor related diseases, references provided clinical treatment schemes.',\n",
              " 'combination therapies treating cancer niraparib pd-1 inhibitorsthe present invention methods treatment cancer combination therapy agent inhibits programmed death-1 protein (pd-1) signaling agent inhibits poly[adp-ribose] polymerase (parp) signaling.',\n",
              " 'pd-1 inhibitor preparation method application thereofthe present invention relates compound represented formula i, racemates, stereoisomers, tautomers, isotope markers, nitrogen oxide, solvates, polymorphs, metabolites, esters, prodrugs pharmaceutically acceptable salts thereof, pharmaceutical composition containing compounds, preparation method medical compounds, structure formula shownin specification.',\n",
              " 'treatment cancer clever-1 inhibition combination pd-1/pd-l1 inhibitorthe invention relates agent capable binding clever-1 combination pd-1 and/or pd-l inhibitor treatment cancer.',\n",
              " 'construction method tumor immune checkpoint inhibitor therapy effectiveness evaluation model based dna methylation spectrumprovided dna methylation feature site screening method construction method tumor immune checkpoint inhibitor therapy effectiveness evaluation model based dna methylation spectrum.',\n",
              " 'method preparing pd-1/pd-l1 inhibitor stellera chamaejasme linn.the invention discloses active ingredient extracted natural plant stellera chamaejasme linn. extraction method. particularly, active ingredient extracted stellera chamaejasme linn. effectively block binding pd1-pdl1, pd1-pdl1 interaction subsequent effects eliminated, inhibited, reduced blocked, active ingredient pharmaceutical composition pharmaceutically acceptable carrier effectively pd1-pdl1 inhibitors, active ingredient pharmaceutical composition anti-tumor related diseases, reference provided clinical treatment programs.',\n",
              " 'porous hollow fiber membrane methods select immune checkpoint inhibitora porous hollow fiber membrane methods membrane select immune checkpoint inhibitor provided. membrane animal models immune system low-cost common mouse. host immune system unable attack cancer cells membrane animal study proves membrane system performed animals.',\n",
              " 'combination m6a rna methylase inhibitor immune checkpoint inhibitor treating tumorsa combination m6a rna methylase inhibitor immune checkpoint inhibitor treating tumors. combination therapy combination tumor immunotherapeutic agent stm2457 derivative thereof treating tumors comprising melanomas ovarian cancer. combination therapy anti-tumor drugs great significance temrs development clinical treatment melanomas ovarian cancer.',\n",
              " 'formulations human anti-pd-l1 antibodiesthis disclosure relates formulations compositions antibody directed human anti-pd-l1, durvalumab.',\n",
              " 'pd-l1 composition comprising pd-l1-inhibiting prodrug prevention treatment cancer본 발명은 암세포의 면역원성 세포사멸 및 세포에 대한 자가 인식 과정 억제를 유도하는 암 예방 또는 치료 약학 조성물에 관한 것으로서, epr(enhanced permeability retection) 효과를 통해 종양에 효과적으로 축적할 수 있으며, 암 전달 효율을 높여 정상조직에 대한 부작용은 최소화하면서 암을 효과적으로 예방 또는 치료할 수 있다.',\n",
              " 'treatment cancer combination comprising multi-tyrosine kinase inhibitor immune checkpoint inhibitordisclosed method prevention, delay progression treatment cancer subject, comprising administering subject thereof multi-tyrosine kinase inhibitor, n-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide pharmaceutically acceptable salt thereof, combination immune checkpoint inhibitor. also, disclosed pharmaceutical combination comprising multi-tyrosine kinase inhibitor, n-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide pharmaceutically acceptable salt thereof, combination immune checkpoint inhibitor thereof.',\n",
              " 'anti-tgfβ antibodies therapeutic agents treatment proliferative diseasestherapies tgfβ inhibitors, pd-1 inhibitors, and/or chemotherapeutic agents disclosed. drugs doses (including flat dosing) regimens treat prevent proliferative diseases solid tumors, including pancreatic colorectal cancers. combination thereof disclosed.',\n",
              " 'method predicting effect immune checkpoint inhibitorthe purpose present invention provide method predicting risk development severe interstitial pneumonia induced immune checkpoint inhibitor, achieve safe highly effective cancer immunotherapy. (a) number content ratio vδ2 + γδt cells peripheral blood mononuclear cells isolated subject, (b) number content ratio antigen-stimulated vδ2 + γδt cells peripheral blood mononuclear cells isolated subject, (c) number content ratio vδ2 + γδt cells peripheral blood cells isolated subject (d) number content ratio antigen-stimulated vδ2 + γδt cells peripheral blood cells isolated subject measured, risk development severe interstitial pneumonia predicted employing, measure, number content ratio.',\n",
              " 'combination therapy c-c chemokine receptor 4 (ccr4) antagonists immune checkpoint inhibitorsthe present disclosure drawn combination therapy c-c chemokine receptor 4 (ccr4) antagonist immune checkpoint inhibitors treatment cancer.',\n",
              " 'method preparing pd-1/pd-l1 inhibitor red chinese wolfberrythe invention discloses active component extracted natural plant, red chinese wolfberry extraction method active component. specifically, active component extracted red chinese wolfberry effectively block combination pd1-pdl1, pd1-pdl1 interaction subsequent effects pd1-pdl1 eliminated, inhibited, reduced blocked; active component pharmaceutical composition medicinal carrier effectively pd1-pdl1 inhibitors, inhibitors applied resisting tumor related diseases, provide reference clinical treatment scheme.',\n",
              " 'jujube processed product capable improving colon cancer and/or rectal cancer immunotherapy effects method thereofthe invention discloses jujube processed product capable improving colon cancer and/or rectal cancer immunotherapy effects method thereof. invention claims protection application jujube processed product preparation products intensive immunotherapy colon cancer and/or rectal cancer. invention claims protection application ofthe jujube processed product preparation products capable improving antitumor effects pd-1/pd-l1. invention claims protection application jujube processed product combination pd-1/pd-l1 inhibitor preparation products capable improving anti-tumor effects pd-1/pd-l1. jujube processed product method provided invention, tumor mc38 colon cancer mice significantly reduced compared control group treated pd-l1 alone.',\n",
              " 'cyclic small molecule compound preparation method application thereofthe invention relates field pharmacy, particularly cyclic small molecule compound preparation method application thereof, structure compound shown formula (i): # imgabs0 # formula (i), r1 selected hydrogen atom chlorine atom, relative positions amido bond connected ring oxymethyl ortho-position meta-position, selected 1, 2 3. cyclic small molecule compound disclosed invention structure, selectively act pd-1/pd-l1, shows pd-1/pd-l1 protein inhibitory activity; preparation high bioavailability, stable medicine, low toxicity capable orally; besides, compound convenient prepare low production cost, widely applied preparation pd-l1 inhibitors preparation drugs treating and/or preventing cancers.',\n",
              " 'prognosis evaluation combined treatment diffuse large b-cell lymphomathe invention belongs technical field biological medicine molecular biology, particularly relates prognosis evaluation combined treatment diffuse large b-cell lymphoma. invention determines pyroptosis closely related occurrence development diffuse large b-cell lymphoma time. based characteristics pyroptosis related genes diffuse large b-cell lymphoma, comprehensive prognosis model established, prognosis diffuse large b-cell lymphoma patient accurately predicted. furthermore, invention specifically verifies synergistic anti-tumor effect pd-l1 inhibitor bms1166 pyroptosis inhibitor dmxaa diffuse large b-cell lymphoma cells, indicates targeted pyroptosis combined immunotherapy possibly promising treatment method diffuse large b-cell lymphoma, targeted pyroptosis combined immunotherapy practical application value.',\n",
              " 'anti-tumor immune checkpoint blocking agentthe invention discloses anti-tumor immune checkpoint blocking agent. blocking agent comprises active ingredient, periplaneta americana refined product ii-3. characteristics ofthe blocking agent follows: culture bottle blocking agent comprises primary culture bottle, sealing cover arranged bottle opening located upper ofthe primary culture bottle; lower primary culture bottle connected secondary culture bottle; secondary culture bottle comprises bottle body, butt joint body butt joint groove; butt joint body arranged upper bottle body; butt joint groove arranged lower bottle body; sealing butt joint structure arranged hole located bottom butt joint groove; primary culture bottle secondary culture bottle structure; primary culture bottle connected withthe sealing cover threads. anti-tumor immune checkpoint blocking agent provided invention, sealing butt joint structure achieve sealed communication primary culture bottle secondary culture bottle; sealing ring achieve sealing butt joint position primary culture bottle secondary culture bottle; replacement rate culture solution increased degree.',\n",
              " 'pharmaceutical composition preventing treating cancer comprising naphthoquinone-based compound immune checkpoint inhibitor active ingredientsthe present invention pharmaceutical composition preventing treating cancer, comprising: naphthoquinone-based compound; selected immune checkpoint inhibitor immunogenic apoptosis inducer, active ingredients, exhibiting significantly higher anticancer effect case medication administered alone. accordingly, synergistic anticancer effect inhibiting growth metastasis cancer cells expected cancer cells anticancer effects insignificant conventional anticancer drugs administered alone. therefore, composition comprising naphthoquinone-based compound usefully preventing treating cancer immune checkpoint inhibitor and/or immunogenic apoptosis inducer.',\n",
              " 'application ilt4 egfr activated non-small cell lung cancer treatmentthe invention application ilt4 egfr activated non-small cell lung cancer treatment, belongs technical field biomedicine molecular biology. researches find ilt4 innon-small cell lung cancer cells activated induced egfr-akt/-erk1/2 signal channel express. ilt4 inhibits anti-tumor immunity collecting m2-like tams weakening cell functions, ilt4 blocking reverses tumor immunosuppression occurrence development. addition, ilt4 blocking enhance curative effect pd-l1 inhibitor egfr wild type nsclc, influence egfr mutant type nsclc. application determines mechanism ilt4-mediated tumor progression egfr activated nsclc, promising immunotherapy strategy patients, application practical application value.',\n",
              " 'pomalidomide derivative application thereofthe invention relates pomalidomide derivative. chemical structure pomalidomide derivative shown formula (i), formula (i), r1 phenyl 1, 4-benzodioxane,r2 chlorine bromine, r3 hydrogen 3-methylbenzonitrile group, x linking group selected ethylenediamine, propane diamine, butanediamine, pentanediamine, hexamethylenediamine,piperazine succinic acid, piperazine glutaric acid, piperazine diglycolic acid, ethylenediamine succinic acid, ethylenediamine glutaric acid, ethylenediamine diglycolic acid, propane diamine glutaricacid, butanediamine glutaric acid pentanediamine malonic acid. pomalidomide derivative disclosed invention inhibit mutual combination programmed cell death receptor 1/a programmed cell death ligand 1 (pd-1/pd-l1), preparing pd-1/pd-l1 inhibitor, remarkable effect.',\n",
              " 'ido activity marker tumor immune escape ido inhibitors means enhancing cells response antigen specific vaccinethe present invention compositions methods treating prostate cancer combination dna vaccine, pd-1 inhibitor ido inhibitor. further, methods measuring ido activity identify subpopulation subjects prostate cancer benefits treatment methods described provided.',\n",
              " 'application tet1 gene mutation predicting sensitivity colon cancer patient immune checkpoint inhibitor therapythe invention application tet1 gene mutation predicting sensitivity colon cancer patient immune checkpoint inhibitor (ici) therapy, application tet1 gene mutation predicting load degree tumor mutation colon cancer patient.',\n",
              " 'combined therapies activatable immune checkpoint inhibitors conjugated activatable antibodiesprovided compositions methods relating therapies combine conjugated activatable anti-cd 166 antibody activated specifically binds cd 166 activatable immune checkpoint inhibitor. provided compositions methods relating therapies combine activatable anti-immune checkpoint antibody activated specifically binds immune checkpoint conjugated activatable antibody, immune checkpoint mammalian pd-1 mammalian pd-l1.',\n",
              " 'oncolytic herpes simplex virus, combination immune checkpoint inhibitor, treatment canceran oncolytic herpes simplex virus disclosed method treating cancer, method comprising administering doses oncolytic herpes simplex virus effective induce th1 immune response subject, optionally administering therapeutically effective amount immune checkpoint inhibitor.',\n",
              " 'method treating cancer immune checkpoint inhibitor combination therapeutic agenta method provided treating cancer patient non-responsive treatment immune checkpoint inhibitor (ici) treating patient ici combination agent blocks activity dominant factor selected plurality host-driven resistance factors generated response treatment cancer patient ici, factors fold-change predictive non-favorable response cancer patient treatment ici.',\n",
              " 'application combination anti-pd-1 antibody anti-ctla-4 antibody preparation drugs treating kidney cancerthe invention relates application combination anti-pd1 antibody anti-ctla-4 antibody preparation medicine treating kidney cancer. combination comprises 1-4 mg/kg anti-pd-1 antibody 1-4 mg/kg anti-ctla-4 antibody.',\n",
              " 'lactobacillus paracasei strain enhancing therapeutic effect immune checkpoint inhibitor thereofprovided lactobacillus paracasei strain enhancing therapeutic effect immune checkpoint inhibitor thereof, strain deposit number cctcc no: 2020474. addition, strain recruit increase infiltration activation killer cd8 lymphocytes tumor cell tissue, promote therapeutic effect pd-1 antibody.',\n",
              " 'anti-pd-1 monoclonal antibody application thereofthe invention relates anti-pd-1 monoclonal antibody variable region sequence antibody belongs technical field biology. anti-pd-1 monoclonal antibody takes recombinant human pd-1 protein (rhepd-1) immunogen immunizing bal b/c mouse; spleen cells mouse fused myeloma cells sp2/0-ag14 obtain hybridoma cell line capable expressing anti-pd-1 antibody; cell line stably secrete single monoclonal antibody. anti-pd-1 monoclonal antibody, variable region nucleotide andamino acid sequences chain chain anti-pd-1 monoclonal antibody cloned time. anti-pd-1 monoclonal antibody provided invention specifically combined pd-1 combination pd1 pd-l1 blocked; functions cells recovered. anti-pd-1 monoclonal antibody immune checkpoint inhibitor treating cancer infectious diseases.',\n",
              " 'kinase activity signatures predicting response non-small cell lung cancer patients pd-1 pd-l1 immune checkpoint inhibitorsthe present invention relates method determining predicting response patient diagnosed non-small cell lung cancer pd-1 pd-l1 immune checkpoint inhibitor. present invention aims provide methods devices predicting response patient diagnosed non-small cell lung cancer pd-1 pd-l1 immune checkpoint inhibitor. specifically, present invention methods measuring kinase activity profile inhibition drugs thereto blood sample patient.',\n",
              " 'circrna profile predicting immunotherapy response cancer patientsdisclosed biomarkers, vitro methods, kits devices, predicting immunotherapy response anti-pd1 and/or anti-pd-l1 immune checkpoint inhibitors clinical benefit human subject metastatic cutaneous melanoma.',\n",
              " 'application coptis chinensis detoxification decoction preparation sensitizer tumor immune checkpoint blocking therapythe invention application coptis chinensis detoxification decoction preparation sensitizer tumor immune checkpoint blocking therapy, relates field traditional chinese medicines. application provided invention, lifetime immune checkpoint blocking therapy mice bearing melanoma remarkably prolonged; tumor volume mouse bearing melanoma reduced; infiltration immune cells tumor tissues melanoma-bearing mice improved; dendritic cell tlr7/8 pathway mouse-bearing melanoma tissues activated, secretion i-type interferon increased.',\n",
              " 'composition preventing treating cancer comprising vascular disrupting agent immune checkpoint inhibitorthe present disclosure composition preventing treating cancer comprising (s)-n-(4-(3-(1h-1,2,4-triazole-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazole-2-yl)-2-amino-3-methylbutanamide pharmaceutically acceptable salts thereof, immune checkpoint inhibitor. composition present disclosure achieves excellent cancer treatment effect.',\n",
              " 'combination tumor immunotherapyprovided methods treating cancer local administration cpg oligonucleotides (cpg odn) systemic administration checkpoint inhibitor anti-pd-1 antibody, anti-pd-l1 antibody, and/or anti-ctla-4 antibody. preferred embodiments, cpg odn selected based propensity induce high amounts interferon alpha (ifn-α) t-cell activation relative interleukin-10 (il-10) b-cell activation. embodiments, methods include pretreatment radiotherapy, potentiate combination immunotherapy.',\n",
              " 'compositions methods tumor immunotherapyprovided compositions methods treating cancer administration volumes cpg oligonucleotides (cpg odn) and, optionally, administration checkpoint inhibitor anti-pd-1 antibody, anti-pd-l1 antibody, and/or anti-ctla-4 antibody. preferred embodiments, cpg odn selected based propensity induce high amounts interferon alpha (ifn-a) t-cell activation relative interleukin-10 (il-10) b-cell activation. embodiments, methods include pretreatment radiotherapy, potentiate combination immunotherapy.',\n",
              " 'application pcdhgb1 mutation predicting sensitivity lung adenocarcinoma patients immune checkpoint inhibitor therapythe invention relates application pcdhgb1 mutation predicting sensitivity lung adenocarcinoma patients immune checkpoint inhibitor therapy predicting tumor mutation load, pd-l1 expression quantity, dna mismatch repair pathway gene mutation cd8 + cell infiltration degree tumors lung adenocarcinoma patients.',\n",
              " 'vivo controlled combination therapy treatment cancerdisclosed improved methods treatment brain cancer (such glioma/glioblastoma) ligand-inducible gene-switch controlled vivo expression immunomodulator (i.e., il-12) combination immunomodulators (i.e., immune cell check point inhibitor; e.g., pd-1 inhibitor pd-1 binder.',\n",
              " 'method treating cancer administration anti-pd-1 anti-pd-l1 therapeutic agent lymphatic devliery devicemethods, devices systems delivery anti-pd-1 anti-pd-l1 therapeutic agent lymphatic system treating cancer patient described.',\n",
              " 'device predicting treatment effect immune checkpoint blocking therapy application thereofthe invention device predicting treatment effect immune checkpoint blocking therapy application thereof, device comprises detection module detecting cd3 cxcl13 double-positive cells and/or cd8 cxcl13 double-positive cells sample, counting proportion cd3 cxcl13 double positive cells cd3 and/or proportion cd8 cxcl13 double positive cells cd8 cell; analysis module judging statistical result. proportion cd3 cxcl13 double positive cells cd3 cell and/or proportion cd8 cxcl13 double positive cells cd8 cell selected measurement standard, response condition sample immune checkpoint blocking therapy predicted, result accurate, applicability high.',\n",
              " 'aqueous anti-pd-l1 antibody formulationthe present invention relates anti-pd-l1 antibody formulation. particular, invention relates aqueous pharmaceutical formulation anti-pd-l antibody avelumab.',\n",
              " 'method predicting efficacy treatment lung cancer patient immune checkpoint inhibitorthis method predicting efficacy treatment lung cancer patient immune checkpoint inhibitor comprises: isolating exosomes biological sample derived lung cancer patient; determining amount expression protein present exosomes mass spectrometry. protein proteins selected group proteins shown tables 1-1 1-6.',\n",
              " 'prognosis prediction model evaluating primary liver cancer treatment combination immune checkpoint inhibitor lenvatinib, construction method applicationthe invention discloses prognosis prediction model evaluating primary liver cancer treatment combining immune checkpoint inhibitor lenvatinib, construction method application, belongs field bioinformatics analysis. risk assessment score prognosis prediction model obtained calculating sum scores different pathological indexes subjected correlation coefficient weight, risk assessment score prognosis prediction model predicting survival rate primary liver cancer treated combining immune checkpoint inhibitor lenvatinib. basis prior art, combination lenvatinib immunotherapy selected treatment schemes patients primary liver cancer; however, patients suitable scheme possibly exist clinically, invention prognosis model predicting treatment liver cancer patients combining immune checkpoint inhibitor lenvatinib, experiments show patients suitable treatment scheme screened out; scientific basis provided accurately evaluating treatment scheme treating primary liver cancer.',\n",
              " 'lgr4/rspo blocker anti-immune checkpoint inhibitor jointly tumor immunotherapydisclosed present invention lgr4/rspo blocker anti-immune checkpoint inhibitor jointly tumor immunotherapy, specifically disclosing product combination, comprising: (i) pharmaceutical composition, pharmaceutical composition comprising (a) active ingredient, active ingredient lgr4/rspo blocker, pharmaceutically acceptable carrier; (ii) pharmaceutical composition, pharmaceutical composition comprising (b) active ingredient, active ingredient inhibitor anti-immune checkpoint, immune checkpoint selected group: pd-1, pd-l1, ctla-4, tim3, tigit\\\\icos, lag3, ox40, cd47, vista, 4-1bb combination thereof; pharmaceutically acceptable carrier. present invention combines lgr4/rspo blocker anti-immune checkpoint inhibitor, effectively (i) treating tumors; (ii) inhibiting tumor growth; (iii) inhibiting antitumor activity tumor-associated macrophage cells tumor microenvironment; and/or (iv) increasing sensitivity tumors anti-immune checkpoint therapy.',\n",
              " 'methods treating cancer combination tucatinib anti-pd-1/anti-pd-l1 antibodythe invention methods treating solid tumors combination tucatinib, salt solvate thereof, anti-pd-1 antibody, antigen-binding fragment thereof. invention methods treating solid tumors combination tucatinib, salt solvate thereof, anti-pd-l1 antibody, antigen-binding fragment thereof.',\n",
              " 'method simultaneously determining concentrations anti-pd-1 antibody anti-pd-l1 antibody human serumthe invention belongs technical field medicine detection, discloses method simultaneously determining concentrations anti-pd-1 antibody anti-pd-l1 antibody human serum, method comprises steps: diluting anti-pd-1 antibody anti-pd-l1 antibody blank serum, preparing mixed standard curve working solution standard series concentrations; taking target protein neutralizing antibody concentration, diluting target protein neutralizing antibody carbonate coating solution, coating elisa plate, incubating, washing, patting dry, sealing; adding mixed standard curve working solution elisa plate, incubating, washing patting dry; adding hrp labeled secondary antibody, incubating, washing patting dry; adding tmb developing solution, incubating room temperature dark place, detecting value ending, fitting drawing obtain standard curve. concentration anti-pd-1 antibody concentration anti-pd-l1 antibody human serum measured time elisa method, antibody drugs captured detected analyzed coating target spot neutralizing antibody antibody drugs detected, detection sensitivity high, result accurate reliable.',\n",
              " 'synergistic tumor treatment il-2, therapeutic antibody, immune checkpoint blockerthe present invention method treating cancer combination il-2 (e.g., extended-pk il-2), therapeutic antibody fragment thereof, immune checkpoint blocker. methods invention treat broad range cancer types.',\n",
              " 'prediction method treatment effect combination anti-angiogenesis immune checkpoint inhibitorthe invention relates prediction method treatment effect combination anti-angiogenesis immune checkpoint inhibitor. method comprises steps: preparing curative effect evaluation data patient treated anti-angiogenesis combined immune checkpoint inhibitor; reading enhanced magnetic resonance imaging data patient treatment utilizing 3d medical image processing software, carrying focus range focus area sketching imaging data plurality related doctors, forming plurality feature sketching files enhanced magnetic resonance imaging sequence sketching information doctor; respectively extracting image omics characteristic parameters focus plurality sketching files pyradiomics packet; screening plurality obtained radiomics characteristic parameter files obtain effective characteristics, establishing prediction model screened characteristics, training verifying prediction model performing post-treatment curative effect prediction patient treatment assist clinical decision, screen effective crowds, improve curative effect relieve economic burden patient, avoid adverse reaction.',\n",
              " 'combination immunomodulatory agent pd-1-or pd-l1 checkpoint inhibitors treatment cancermethods treating cancer include administering therapeutically effective amount immunomodulatory agent interferon gamma 1b combination therapeutically effective amount pd-1 checkpoint inhibitor nivolumab pembrolizumab therapeutically effective amount pd-l1 checkpoint inhibitor.',\n",
              " 'small proteins application thereofthe present invention discloses small proteins application thereof. skeleton protein small protein mutant igg binding domain streptococcus g protein, small protein includes alpha helix beta folding, alpha helix penetrates region formed inclusion beta folding, key amino acid site capable binding pd-1protein distributed beta folding surface formed beta folding. small protein present invention high structural similarity pd-l1 protein inhibits pd-1/pd-l1 binding, potential pd-1/pd-l1 inhibitor, weak igg binding ability, long circulation time vivo, high structural stability, inhibit interaction pd-1/pd-l1. preparation method simple large-scale production application immunotherapy cancer.',\n",
              " 'application exosome mirna predicting immunotherapy effect non-small cell lung cancer patientthe invention relates technical field biological detection, particular application exosome mirna predicting immunotherapy effect non-small cell lung cancer patient. invention exosome mirna (micro ribonucleic acid) marker prognosis evaluation immunotherapy non-small cell lung cancer patient. exosome mirna marker selected mir-138-5p, mir-17-5p, mir-197-3p mir-21-5p. scientific reference provided pd-1/pd-l1 inhibitor immunotherapy prognosis tumors treatment. non-small cell lung cancer immunotherapy prognosis monitoring method developed based non-invasive detection technology, prognosis risk non-small cell lung cancer patient evaluated, prognosis condition patient predicted, treatment cost effectively reduced, method important application value.',\n",
              " 'preparation rabbit anti-human programmed death-ligand 1 (pd-l1) protein monoclonal antibody immunohistochemical thereofthe invention discloses rabbit anti-human programmed death-ligand 1 (pd-l1) protein monoclonal antibody specifically recognize pd-l1 protein expressed cell surface cell, stable performance high titers, cross reaction proteins cells medical basic research value. invention relates monoclonal antibody preparation immunohistochemical detection tool detecting pd-l1 protein. invention adopts immunohistochemical method detect expression pd-l1 onthe surfaces tumor cells, including melanoma, non-small cell lung cancer, bladder cancer, renal cancer, gastric cancer, colorectal cancer, prostate cancer, cervical cancer, breast cancer, toprovide scientific reference pd-1/pd-l1 inhibitors immunotherapy prognosis tumors effectively reduce treatment cost, detection hasrealizing important application value.',\n",
              " 'selective bcl-2 inhibitors combination anti-pd-1 anti-pd-l1 antibody treatment cancersthis invention pertains method treatment cancer subject comprising administering subject effective amount selective bcl-2 inhibitor prodrug pharmaceuticallyacceptable salt thereof combination effective amount anti-pd- 1 antibody anti-pd-l1 antibody.',\n",
              " 'immune adjuvant cancerthe present invention relates medicament treating cancer infectious disease, medicament comprising immune checkpoint blockade adjuvant composition. specifically, present invention relates medicament cancer infectious diseases, anti-pd-1 antibody anti-pd-l1 antibody combination nucleic acid adjuvant composed double-stranded rna single-stranded odn.',\n",
              " 'combination adoptive cell therapy chemotherapy acute myeloid leukemiadisclosed methods treatment cancers administering autologous tumor infiltrating lymphocytes optionally combination chemotherapeutic immunotherapeutic agents. methods include treating acute myeloid leukemia combination autologous tils-based adoptive cell therapy agents, pd-1 inhibitor hypomethylating agent. tils bioengineered modify expression function gene molecule interest.',\n",
              " 'pharmaceutical combinations comprising kras g12c inhibitor kras g12c inhibitor treatment cancersthe present invention relates pharmaceutical combination comprising kras g12c inhibitor therapeutically active agents selected shp2 inhibitor (e.g. tno155) pd-1 inhibitor; pharmaceutical compositions comprising same; methods combinations compositions treatment prevention cancer tumor, particular cancer tumor kras g12c mutated.',\n",
              " 'method treating cancer administration anti-pd-1 anti-pd-l1 therapeutic agent lymphatic microneedle delivery devicemethods, devices systems delivery anti-pd-1 anti-pd-l1 therapeutic agent lymphatic system treating cancer patient described.',\n",
              " 'irinotecan combination immune checkpoint inhibitor 5-fu preparation medicament treating tumor diseasesthe discloser relates irinotecan combination immune checkpoint inhibitor 5-fu preparation medicament treating tumor diseases. specifically, discloser relates irinotecan pharmacological salt combination pd-l1 antibody antigen binding fragment 5-fu preparation medicament treating tumor diseases.',\n",
              " 'methods pharmaceutical compositions treatment signet ring cell gastric cancerthe present disclosure relates methods pharmaceutical compositions treatment signet ring cell gastric cancer. present disclosure relates method treating signet ring cell gastric carcinoma subject thereof comprising administering subject therapeutically effective amount pd-1 inhibitor igf1 inhibitor.',\n",
              " 'silencing tgf-beta 1 cox2 treat cancer sirna delivered combination immune checkpoint inhibitorscertain pharmaceutical molecules compositions methods treating cancer provided. molecules small interfering rna (sirna) molecules inhibit tgf-beta 1 cox2 humans mammals combination immune checkpoint inhibitors treat cancer.',\n",
              " 'traditional chinese medicine composition improving treatment effect immune checkpoint inhibitor application traditional chinese medicine compositionthe invention belongs technical field traditional chinese medicine compositions, particularly relates traditional chinese medicine composition improving treatment effect immune checkpoint inhibitor application traditional chinese medicine composition. invention discloses traditional chinese medicine composition improving treatment effect immune checkpoint inhibitor. traditional chinese medicine composition prepared raw materials: 15-40 parts radix ranunculi ternati, 10-20 parts fried stiff silkworm, 15-40 parts herba sarcandrae, 10-20 parts edible tulip, 15-40 parts radix astragali, 10-20 parts bulbus fritillariae thunbergii, 10-20 parts rhizoma pinellinae praeparata, 10-20 parts lucid ganoderma, 15-40 parts radix glehniae 10-20 parts american ginseng. full-prescription medicine disclosed invention effects reducing phlegm resolving masses treat symptoms, tonifying lung kidney treat root treating symptoms root causes, effects ventilating lung reducing phlegm, detoxifying eliminating carbuncle, relieving cough asthma, tonifying qi lung. clinical tests prove formula specific traditional chinese medicine composition beneficial improving treatment effect immune checkpoint inhibitor, progression-free lifetime patient long 18 months.',\n",
              " 'methods compositions treating cancerdisclosed method treating cancer administering 8-cyclopentyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile immune checkpoint inhibitor. embodiments, immune checkpoint inhibitor anti-pd-1 antibody anti-ctla4 antibody. disclosed combinations 8-cyclopentyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile immune checkpoint inhibitor.',\n",
              " 'method treating cancer anti-pd-1 anti-ctla-4 antibody combinationdescribed method immunotherapy cancer patient, comprising administering patient antibody. particularly, provided method treating human subject afflicted cancer, comprising administering subject 4 doses combination 1 mg/kg anti-pd-1 antibody 3 mg/kg anti-ctla-4 antibody dosing frequency 3 weeks 4 doses, administering anti-pd-1 antibody dosage 3 mg/kg separately dosing frequency 2 weeks.',\n",
              " 'method establishing pd-1/ptx combined pd-1 resistance modelthe invention discloses method establishing pd-1/ptx combined pd-1 resistance model. belongs technical field medicine. invention discloses method establishing pd-1/ptx combined pd-1 resistance model, establishes pd-1 resistance primary cell line pd-1 combined ptx resistance cell line. present, pd-1 inhibitor combined therapies treating advanced cancers due fact patients response treatment pd-1 inhibitor, patients resistance treatment. therefore, exploration pd-1/ptx combined pd-1 resistance problem urgently needed solved field. invention method establishing pd-1/ptx combined pd-1 resistance model animal level establishing primary cell establish resistance primary cell line, beneficial research pd-1/ptx combined pd-1 resistance mechanism patient.',\n",
              " 'combination therapy immunotoxins checkpoint inhibitorsthe invention combination therapy immunotoxin checkpoint inhibitor. regional, tumor-targeted cytotoxin therapies, d2c7-immunotoxins (d2c7-it), specifically target destroy tumor cells, elicit immune events promote situ vaccine effects process. anti-tumor effect expanded immune checkpoint blocking, results long-term systemic immune response effectively eliminates tumor cells.',\n",
              " 'prediction response immune-modulatory therapiesthe present disclosure method treating cancer immune checkpoint blockade, selecting patients treatment immune checkpoint blockers, detecting tumors high levels t-lymphocytes low levels activation proliferation. embodiments tissue sample conventional biopsy. embodiments cancer non-small cell lung cancer.',\n",
              " 'biomarker evaluating efficacy cancer therapy immune checkpoint blockadethe present invention diagnostic agent evaluating efficacy cancer therapy immune checkpoint blockade. present invention diagnostic agent evaluating efficacy cancer therapy immune checkpoint blockade, diagnostic agent comprises means detecting, measuring quantifying expression level perforin. specific embodiment, determined subject responsive treatment immune checkpoint blockade expression level perforin start administration immune checkpoint blockade equal specific level.',\n",
              " 'cobmination hepatitis b virus (hbv) vaccines anti-pd-1 anti-pd-l1 antibodytherapeutic combinations hepatitis b virus (hbv) vaccines anti-pd-1 anti-pd-l1 antibody antigen-binding fragment thereof described. methods inducing immune response hbv treating hbv-induced disease, particularly individuals chronic hbv infection, disclosed therapeutic combinations described.',\n",
              " 'combination therapy involving antibodies claudin 18.2 immune checkpoint inhibitors treatment cancer.the present invention combination therapy comprising anti-claudin (cldn) 18.2 antibody immune checkpoint inhibitor effectively treating and/or preventing diseases associated cells expressing cldn18.2, including cancer diseases gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, cancer gallbladder metastases thereof.',\n",
              " \"tumor vaccine combining exosome immune checkpoint blocker preparation method thereofthe invention tumor vaccine combining exosome immune checkpoint blocker preparation method thereof. tumor vaccine takes exosome exo-ag dendritic cell activated bya specific tumor antigen ag carrier; apd-l1 modified tumor vaccine exo-ag-apd-l1 obtained taking phospholipid-polyethylene glycol-succinimide ester dspe-peg-nhs cross-linking agentand modifying surface exosome exo-ag pd-l1 antibody. dendritic cell exosome carrier realize efficient lymph node enrichment remarkable immune activation effect tumor vaccine, meanwhile, blocking immune checkpoint pathway, the'braking 'effect tumor vaccine immune response relieved effect greater achieved. dendritic cell exosome carrier effectively combined immune checkpoint blocker synergistically remove tumors prevent tumor metastasis recurrence.\",\n",
              " 'il-2rβ-selective agonists combination anti-ctla-4 antibody anti-pd-1 antibodyto provide method administering patient suffering cancer, method comprising steps of: (a) il-2rβ-activating amount long-acting, il-2rβ-selective agonist; (b) ctla-4 pathway-inhibiting amount anti-ctla-4 antibody pd-1 pathway-inhibiting amount anti-pd-1 antibody.solution: embodiments invention, method provided, method comprising steps administering cancer patient: (a) il-2rβ-activating amount long-acting, il-2rβ-selective agonist; (b) ctla-4 pathway-inhibiting amount anti-ctla-4 antibody pd-1 pathway-inhibiting amount anti-pd-1 antibody. clarity, regard sequence steps accordance method, indicated, method limited sequence steps, step (a) performed before, after, simultaneously step (b).selected drawing:',\n",
              " 'inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy combination immune checkpoint blocking agents solid tumorsthe invention relates inactivated nonreplicating modified vaccinia virus ankara (mva) monoimmunotherapy combination immune checkpoint blocking agents solid tumors. present disclosure relates infection-competent, nonreplicative inactivated modified vaccinia ankara (mva) immunotherapy, alone, combination immune checkpoint blocking agents treatment malignant solid tumors. particular embodiments relate inducing immune response subject diagnosed solid malignant tumor.',\n",
              " 'method system evaluating cardiotoxicity immune checkpoint inhibitor, devicethe invention method system evaluating cardiotoxicity immune checkpoint inhibitor, storage device. prior art, oncology department doctors surgeons determine risk cardiovascular disease complications, early clinical manifestations cvd easily ignored, adverse clinical events caused delayed treatment caused. purpose invention solve problem prior art. invention, risk assessment calculation method adopted assist non-cardiologist assess risk acardiovascular event, non-cardiologist helped quickly identify high-risk groups early stage, professional treatment suggestions sought cardiac specialist, theoccurrence cardiovascular event reduced, severity event reduced.',\n",
              " 'fgfr inhibitors fgfr-genetically altered cancers enhance patient response immune checkpoint inhibitors sequential treatment settingsembodiments present invention relate method treating cancer patient comprising administering immune checkpoint inhibitor patient, patient diagnosed fgfr-genetically altered cancer, pre-treated fgfr inhibitor, erdafitinib.',\n",
              " 'application pcsk9 inhibitor malignant tumor immunotherapythe invention relates application pcsk9 inhibitor malignant tumor immunotherapy. pcsk9 inhibitor effectively inhibit tumour. increasing expression immunocyte activation related gene, immunocyte activity enhanced pcsk9 inhibitor, tumour inhibited. invention reveals obvious effect combined application pcsk9 inhibitor pd-1 inhibitor increasing immunocyte activity tumour inhibition.',\n",
              " 'therapeutic combinations methods treating neoplasiathe disclosure features cxcr2 antagonist combination checkpoint inhibitor (e.g., anti-ctla-4 antibody anti-pd-l1 antibody) methods combination enhance anti-tumor activity subject.',\n",
              " 'antibody-drug conjugate combination immune checkpoint inhibitor treatment urothelial cancerprovided antibody-drug conjugate targeting her2 combination immune checkpoint inhibitor pd-1 antibody pd-l1 antibody, preparation medicine treating patients urothelial cancer, especially locally advanced metastatic urothelial cancer. compared treatment drugs alone, treatment combination marked synergistic effect significant therapeutic effect. addition, combination treatment efficacy patients low her2 ihc expression (1+).',\n",
              " 'methods treating cancer anti-pd-l1 antibodythe present disclosure relates methods, uses, kits related treating cancers administering anti-pd-l1 antibody (e.g., atezolizumab) patient. embodiments, anti-pd-l1 antibody administered 840 mg 2 weeks 1680 mg 4 weeks cycles.',\n",
              " '1,2,4-triazol-1,3,4-thiadiazole compounds application thereofthe invention discloses 1,2,4-triazol-1,3,4-thiadiazole compounds application thereof. 1,2,4-triazol-1,3,4-thiadiazole compounds structural formula represented formula shown specification. compounds provided invention regulating effect immune function dug candidates tumor immunotherapy synergistic agents nr2f6 inhibitors, tumor immunotherapy preparations pd-1 inhibitors.',\n",
              " 'binding molecules specific cd73 thereofthe present disclosure anti-cd73 binding molecules, e.g., antibodies antigen binding fragments thereof. provided pharmaceutical formulations comprising disclosed compositions, methods diagnosis treatment diseases associated cd73-expression, e.g., cancer. diseases treated, e.g., direct therapy anti-cd73 binding molecules disclosed (e.g., naked antibodies antibody-drug conjugates bind cd73), adjuvant therapy antigen-binding anticancer agents immune checkpoint inhibitors (e.g., anti-ctla-4 anti-pd-1 monoclonal antibodies), and/or combination therapies anti-cd73 molecules administered before, after, concurrently chemotherapy.',\n",
              " 'neoadjuvant cancer treatment immunotoxin checkpoint inhibitor combinationprovided method treating tumor individual neoadjuvant therapy, individual previously undergone resection tumor, method comprising administering immunotoxin immune checkpoint inhibitor immunotoxin, d2c7-immunotoxin (d2c7-it), resection tumor. method comprise administration immune checkpoint inhibitor resection.',\n",
              " 'genetically engineered tumor treatment exosome coupled immune checkpoint blocking antibodythe invention belongs technical field medicine, relates genetically engineered tumor treatment exosome coupled immune checkpoint blocking antibody application genetically engineered tumor treatment exosome treatment malignant solid tumors, tumor treatment exosome trigger cell mediated anti-tumor immune response, metastasis tumor blood pathways inhibited, primary tumors ablated, tumor treatment effect improved. postoperative tumor recurrence effectively avoided, long-term immune memory organism caused. tumor treatment exosome actla4 modified tumor treatment exosome obtained taking specific tumor antigen activated specific gene coded recombinant adenovirus transfected dendritic cell exosome carrier, taking biotin-streptavidin-biotin compound connecting arm modifying surface exosome actla4 antibody. genetically engineered tumor treatment exosome coupled immune checkpoint blocking antibody preparing anti-tumor anti-tumor metastasis drugs.',\n",
              " 'application flt3 gene mutation predicting sensitivity non-small cell lung cancer patient immune checkpoint inhibitor therapythe invention application flt3 gene mutation predicting sensitivity non-small cell lung cancer patient immune checkpoint inhibitor ici therapy application predicting degree tumor mutation burden non-small cell lung cancer patient.',\n",
              " 'composition preventing treating cancer, containing manassantin immune checkpoint inhibitor epithelial growth factor receptor inhibitorthe present invention pertains composition preventing and/or treating cancer, composition containing manassantin immune checkpoint inhibitor, manassantin epithelial growth factor receptor inhibitor, active ingredients. composition present invention expected effectively suppress, co-administration, proliferation, metastasis, relapse, resistance anticancer therapy solid cancers.',\n",
              " 'doxorubicin-monoamine oxidase inhibitor prodrug compound preparation method application thereofthe invention relates doxorubicin-monoamine oxidase inhibitor prodrug compound preparation method application thereof, doxorubicin isoniazide synthesized dox-inh ph response characteristic, doxorubicin-monoamine oxidase inhibitor prodrug compound plays role enhancing effect reducing toxicity. dox-inh effectively improves maximum tolerable dose adriamycin, premise ensuring anti-tumor effect high-dose dox, systematic toxicity caused high-dose adriamycin effectively improved, cardiotoxicity reduced. dox-inh releases inh, shh, tgf-beta il-6 signal factors emt process regulated inhibiting monoamine oxidase a, epithelial-mesenchymal transition inhibited, tumor metastasis inhibited. dox-inh realizes immune combination therapy based immune checkpoint maoa, effectively relieves immunosuppression, enhances immune response mice, shows synergistic anti-tumor effect combined small molecule pd-l1 inhibitor.',\n",
              " 'synergistic combined medicine treating advanced lung cancer combining anlotinib immune checkpoint inhibitorthe invention belongs technical field medicines, relates synergistic medicine anti-tumor medicine, particularly relates synergistic combined medicine treating advanced lung cancer combining anlotinib immune checkpoint inhibitor, particular synergistic medicine composition treating advanced lung cancer, composed immune checkpoint inhibitor including czodilithiumab (pd-1 pd-l1) anlotinib. random contrast research first-line treatment advanced lung cancer shows synergistic combined medicine disclosed invention effect treatment advanced lung cancer especially anti-tumor activity, objective remission rate (orr) reaches 72, 7%, disease control rate (dcr) reaches 100%, biomarker subgroups obtain high remission rates, survival-data pre-estimate 6-month progression-free survival (pfs) rate 93.8%; synergistic combined medicine treatment tolerance, unexpected toxicity observed, unexpected adverse event increased, synergistic combined medicine safety, beneficial first-line treatment intervention scheme advanced metastatic lung cancer.',\n",
              " 'application honokiol preparation medicine treating preventing capillary angiomathe invention belongs technical field biological medicines, particularly relates application honokiol, isomer thereof pharmaceutically acceptable salt thereof preparation medicine treating preventing capillary angioma. technical problem solved invention provide medicine eliminate hemangioma side effect pd-1 monoclonal antibody, affect anti-tumor effect pd-1 monoclonal antibody. therefore, invention application honokiol, isomer thereof pharmaceutically acceptable salt thereof preparation medicine treating preventing capillary angioma. invention proves honokiol liposome exert remarkable treatment effect hemangioma, particularly reactive capillary hyperplasia, beneficial reducing toxic side effects caused clinical treatment tumors pd-1 pd-l1 inhibitor, improves life quality tumor patients curative effect advanced tumor patients, wide application prospect. strategy provided comprehensive treatment tumors clinically.',\n",
              " 'il-4/il-13 pathway inhibitors enhanced efficacy treating cancerthe disclosure relates methods treating inhibiting growth tumor, methods include selecting administering subject thereof therapeutically effective amount il-4/il-13 pathway inhibitor therapeutically effective amount programmed death 1 (pd-1) inhibitor. embodiments, il-4/il-13 pathway inhibitor enhances anti-tumor efficacy pd-1 blockade.',\n",
              " 'combination therapy treat cancer comprising dendritic cells engineered overexpress p53 immune checkpoint inhibitora method disclosed treating small cell lung cancer (sclc) subject involves administering subject therapeutically effective amount dendritic cells engineered overexpress p53. embodiments, method involves administering subject therapeutically effective amount all-trans-retinoic acid (atra). method involve administering subject therapeutically effective amount immune checkpoint inhibitor.',\n",
              " 'pharmaceutical composition treating advanced breast cancerthe invention pharmaceutical composition treating advanced breast cancer, synergistic active ingredients including therapeutically effective amount pd-1/pd-l1 inhibitor, angiogenesis inhibitor microtubule inhibitor, application pharmaceutical composition. compared prior art, invention advantages: treatment scheme triple medicinal composition curative effect patient, pfs patient reaches 8.1 months, survival benefit patient obvious; traditional chinese medicine composition wide audiences suitable pd-l1 negative patients, analysis shows treatment effect scheme affected previous immunotherapy, treatment effect irrelevant immune typing, patient audiences expanded; traditional chinese medicine composition safe controllable, patients receiving treatment scheme free death caused treatment side effects, side effects comprise neutropenia, thrombocytopenia, transaminase increase, neutropenia like, side effects clinically accepted safe controllable.',\n",
              " 'inosine cancer immunotherapydisclosed formulations treatment cancer including inosine related compound combination immune checkpoint inhibitor including limited immune checkpoint inhibitor binding agents (including anti-ctla4, anti-pd1, anti-lag-3, anti-tim-3, anti-tigit, anti-cd47, anti-vista, anti-pd-l1 ), optionally including reinforcing agent boost immune response, including car-t, car-nk, tumor vaccine, oncolytic virus vaccine, tlr7/8 agonist, anti-cd47 il-2 receptor agonist optionally including pharmacologically immune-boosting active agents.',\n",
              " 'dosing administration activatable anti-ctla-4 antibody.the present invention methods dosing administration activatable anti-ctla-4 antibody, activatable ipilimumab.',\n",
              " 'combination therapyfield: medicine; oncology.substance: present group inventions relates medicine, oncology, concerns combination therapy lymphoma. this, phosphatidylinositol 3-kinase duvesilib inhibitor combination xp01 selinexor inhibitor combination checkpoint pd-1 inhibitor injected.effect: invention effective treatment lymphoma due synergetic antitumor effect combination components.35 cl, 2 ex, 1 tbl, 1 dwg',\n",
              " 'combined application arsenene nanometer material immune checkpoint inhibitor tumor treatmentthe invention combined application arsenene nanometer material immune checkpoint inhibitor tumor treatment, particularly relates technical field biological medicines. arsenene nanometer material pd-1 antibody combined inhibiting cervical cancer tumor, arsenene nanometer material activate immunoreaction body, arsenene nanometer material pd-1 antibody combined, tumor inhibition effect pd-1 antibody enhanced. invention takes arsenene auxiliary nano-medicine pd-1 antibody immunotherapy perform function efficiently inhibiting tumor.',\n",
              " \"cancer-specific trans-splicing ribozyme expressing immune checkpoint inhibitors thereofthe present invention relates cancer-specific trans-splicing ribozymes thereof. trans-splicing ribozyme present invention act normal tissue, specifically expressed cancer tissue, characteristics high safety excellent expression efficiency post-transcriptional level. moreover, target gene connected 3'exon ribozyme, entering body, ribozyme express cancer treatment gene immune checkpoint inhibitor, effectively cancer treatment.\",\n",
              " \"cancer-specific trans-splicing ribozyme expressing immune checkpoint inhibitor, thereorthe present disclosure relates cancer-specific trans-splicing ribozyme thereof. trans-splicing ribozyme act normal tissues specifically expressed cancer tissues, safety thereof high expression efficiency thereof excellent post-transcription level, target genes connected 3' exon ribozyme cancer therapeutic gene immune checkpoint inhibitor expressed applied vivo, present disclosure effectively cancer treatment.\",\n",
              " 'compositions comprising combination immune checkpoint inhibitor antibody-amatoxin conjugate cancer therapythe present application relates compositions comprising (a) immune checkpoint inhibitor (b) conjugate conjugate comprises (i) target binding moiety, (ii) amatoxin, (iii) optionally linker linking target binding moiety amatoxin. present application relates compositions treatment patients suffering cancer, pharmaceutical formulations comprising compositions additional excipients, methods making compositions.',\n",
              " 'combination therapy inhibitors human growth differentiation factor 15 (gdf-15) immune checkpoint blockersthe present invention relates inhibitors human growth differentiation factor 15 (gdf-15), combined inhibitors immune checkpoint blockers, treatment solid cancers.',\n",
              " 'anti-gitr/ctla-4 bispecific antibody, preparation method application thereofthe invention relates anti-gitr/ctla-4 bispecific antibody, preparation method application thereof, amino acid sequences light-chain bi-variable region bispecific antibody respectively represented seq id no.6 seq id no.10, amino acid sequences heavy-chain bi-variable region respectively represented seq id no.8 seq id no.12. bispecific antibody antagonizes ctla-4 inhibiting signal path cell activating gitr signal path treg cell, bispecific antibody relieves inhibiting signal effector cell enhances activities cd4+t cell cd+8t cell, eliminates inhibition effect treg cell effector cell, activating effector cell possible enhancing immune response reaction aiming tumor cell.',\n",
              " 'application arid1b gene variation prediction sensitivity lung adenocarcinoma patients immune checkpoint inhibitor therapythe invention relates field clinical molecular diagnostics, particular application arid1b gene variation prediction sensitivity lung adenocarcinoma patients immune checkpoint inhibitor therapy application prediction tumor mutation load degree lung adenocarcinoma patients. method beneficial simplify detection content, reduce detection cost patient shorten issuing time detection report, detection gene variation state reliable.',\n",
              " 'anti-ctla-4 antibodies enhanced adcc enhance immune response vaccinesthe present invention method enhancing immune response vaccine variant form anti-ctla-4 antibody enhanced adcc activity. variant anti-ctla-4 antibodies present invention comprise non-fucosylated ipilimumab (ipilimumab), method preparing same.',\n",
              " 'methods materials treating cancerthis document methods materials involved treating cancer. example, methods materials identifying mammal elevated level pd-1 + /cd11a high cd8 cells potential exert anti-cancer effects provided. addition, methods materials identifying mammal elevated level pd-1 + /cd11a high cd8 cells administering pd-1 inhibitor mammal provided.',\n",
              " 'cd40l-fc fusion polypeptides methods thereofprovided cd40l-fc fusion protein methods fusion protein treatment cancer comprising administering cd40l-fc fusion protein cd40l-fc fusion protein combination immune checkpoint inhibitors (e.g., anti-ctla4 antibody, anti-pd-l1 antibody).',\n",
              " 'cd40l-fc fusion polypeptides methods thereofprovided cd40l-fc fusion protein methods fusion protein treatment cancer comprising administering cd40l-fc fusion protein cd40l-fc fusion protein combination immune checkpoint inhibitors (e.g., anti-ctla4 antibody, anti-pd-l1 antibody).',\n",
              " 'biomarker predicting response anticancer agent thereofthe present disclosure describes biomarker predicting response anticancer agent immunotherapy, particularly, marker composition predicting response programmed cell death protein 1 (pd-1) inhibitor, pembrolizumab, includes genes selected group consisting armadillo repeat-containing x-linked protein 1 (armcx1; ncbi accession number: nm_016608), serine/threonine-protein kinase d1 (prkd1; ncbi accession number: nm_002742) tyrosine kinase 2 (tyk2; ncbi accession number: nm_003331) protein encoded gene, composition, kit information providing method predicting response anticancer agent. gene marker present disclosure utilizes formalin-fixed paraffin-embedded tissue derived patient analysis, separate sampling needed, analysis convenient.',\n",
              " 'method product predicting curative effect immune checkpoint inhibitor combined targeting therapy hepatobiliary tumor patientthe invention method product predicting curative effect immune checkpoint inhibitor combined targeting therapy hepatobiliary tumor patient. method comprises specific steps: s1, collecting peripheral blood sample hepatobiliary tumor patient, respectively extracting plasma free dna blood cell dna; s2, constructing gene library adopting plasma free dna blood cell dna; s3, capturing enriching targeted target genes gene library utilizing specific hybridization targeting sequence capture probe target region; targeted genes comprise calr, nr4a3, idh2, igf1r, etv6, stat3, nf2 ctcf; s4, respectively obtaining plasma free dna targeted sequencing data blood cell dna targeted sequencing data; s5, combination targeted sequencing data, analyzing copy number variation targeted gene plasma free dna targeted sequencing data; s6, predicting curative effect immune checkpoint inhibitor combined targeting therapy hepatobiliary tumor patient.',\n",
              " 'biomarkers determining response pd-1 blockade therapypd-l1 expression tumor cells prior treatment correlates highly response anti-pd-1 anti-pd-l1 therapy (e.g., nivolumab (bristol-myers squibb), pembrolizumab (merck)) anti-pd-l1 monotherapy (mpdl3280a (genentech/roche)). nonetheless, majority patients pd-li(+) tumors respond pd-1 pathway blockade. distinct gene profiles associated differential response treatment anti-pd-1 antibody patients pd-l1+ renal cell carcinoma identified. particular, strong up-regulation genes involved metabolic functions pathways found patients responding therapy. additionally, down-regulation genes involved cellular migration functions found group patients (non-responders). specific biomarkers stratify responders non-responders pd-1 pathway blocking drugs. additionally, biomarkers represent therapeutic targets anti-pd-1 combination therapy, companion diagnostic products combination therapies.',\n",
              " 'anti-ctla-4 pd-1 dual variable domain immunoglobulinthe invention discloses specific-binding pd-1 and/or ctla-4 dual variable domain immunoglobulin (dvd-ig) obtained modifying anti-pd-1 ctla-4 antibodies adopting molecular biology method. anti-pd-1 antibody variable domain intramolecular anti-ctla-4 antibody extramolecular, anti-pd-1 antibody variable domain extramolecular anti-ctla-4 antibody intramolecular, structures respectively combination characteristics pd-1 and/or ctla-4 molecules. anti-ctla-4 pd-1 dual variable domain immunoglobulin potential tumor treatment values.',\n",
              " 'hematopoietic stem cells combinatorial therapy immune checkpoint inhibitors cancerthe synergistic combination immune checkpoint blockade hematopoietic stem cell transplantation and/or hematopoietic stem cell mobilization yield synergistic effects disease therapy.',\n",
              " 'nanometer assembly based immune checkpoint inhibitor preparation method application nanometer assemblythe invention discloses nanometer assembly based immune checkpoint inhibitor preparation method application nanometer assembly. nanometer assembly comprises polymer, hyaluronic acid grafted chlorin pd-l1 monoclonal antibody, structural formula polymer shown description, number-average molar mass polymer 2000-6000, ratio 1:(8-15). nanometer assembly achieve integrated combination treatment enhancing enhance antigen presentation stage lymphocyte activation, proliferationand differentiation stage tumor removal stage.',\n",
              " \"- tumor-targeting trans-splicing ribozyme expressing immune checkpoint inhibitor thereofthe present invention relates cancer-specific trans-splicing ribozyme thereof. trans-splicing ribozyme, specifically expressed cancer tissue, expressed normal tissue, high safety, shows excellent gene expression efficiency post-transcriptional level. target gene linked 3' exon trans-splicing ribozyme, express cancer treatment genes immune checkpoint inhibitors introduced body. therefore, present invention effectively treat cancer.\",\n",
              " 'methods somatic hla-i loh predict response immune checkpoint inhibitor-treated patients lung cancerprovided methods related detecting loss heterozygosity (loh) human leukocyte antigen (hla) genes and/or tumor mutational burden (tmb), methods treatment related thereto. detection loh hla genes and/or tmb identify individuals benefit treatment immune checkpoint inhibitor.',\n",
              " 'low dose immune checkpoint blockade metastatic cancera method treating cancer comprising reducing autoimmune side effects administration anti-ctla-4 antibodies. invention methods low dose immune checkpoint (ic) treatment metastatic cancer delivering anti-ctla-4 anti-pd-1 antibodies cancer patients. methods provide il-2 stimulation activation cells tumor cells. invention methods daily cyclic high fever response (hyperthermia) il-2 therapy. methods provide treatment metastatic cancer unacceptable autoimmune side effects.',\n",
              " 'cancer treatment pd-1 pd-l1 inhibitor antibody-drug conjugates targeting claudin 18.2provided combination therapies include inhibitor pd-1 pd-l1 antibody-drug conjugate targeting claudin 18.2.',\n",
              " 'combinations dosing regimes treat rb-positive tumorsthis invention directed methods treating select rb-positive cancers rb- positive abnormal cellular proliferative disorders cdk4/6 inhibitors specific dosing combination alternation regimes. aspect, treatments select rb-positive cancers disclosed specific cdk4/6 inhibitors combination alternation chemotherapeutic, example, additional kinase inhibitor, pd-1 inhibitor, bcl-2 inhibitor, combination thereof.',\n",
              " 'combination therapy hepatocellular carcinomaprovided methods compositions combination therapy liver disorders hepatocellular carcinoma. provided method determining effectiveness therapy involving tyrosine kinase inhibitors sorafenib. method comprises determining status pd-1 cells, based change level pd-1 cells, determination effectiveness tyrosine kinase, indication combination therapy comprising lower dose tyrosine kinase inhibitor pd-1 inhibitor made.',\n",
              " 'targeting b cells enhance response immune checkpoint blockadeprovided methods identifying subject responder non-responder immune checkpoint blockade detecting b cell signature. provided methods treating cancer administering immune checkpoint blockade therapy subject identified b cell signature.',\n",
              " 'application pcdh11x mutation predicting sensitivity non-small cell lung cancer patient immune checkpoint inhibitor therapythe invention relates application pcdh11x mutation predicting sensitivity non-small cell lung cancer patient immune checkpoint inhibitor therapy, application pcdh11x mutation predicting tumor mutation load, dna mismatch repair pathway gene mutation in-tumor immune cell infiltration degree non-small cell lung cancer patient.',\n",
              " 'treatment breast cancer combination therapies comprising akt inhibitor, taxane, pd-l1 inhibitorprovided combination therapies comprising akt inhibitor, pd-l1 antibody, taxane treating mtnbc locally advanced tnbc.',\n",
              " 'combination therapies thereofthe present invention relates combination therapies treating cancer subject, methods thereof. combination therapies comprise (a) antibody, antigen-binding fragment thereof, specifically binds cd137 (b) immunotherapeutic agent, immunotherapeutic agent pd-1 inhibitor. invention relates pharmaceutical compositions comprising, of, methods using, kits comprising combination therapies invention. cancer solid tumour.',\n",
              " 'combination therapy prodrug immune checkpoint inhibitorthe present disclosure therapeutic methods treating cancer subject isopropyl (s)-2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate isopropyl (s)-2-((s)-6-acetamido-2-((3s,5s,7s)-adamantane-1-carboxamido)hexanamido)-6- diazo-5-oxohexanoate, (s)-2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5- oxohexanoic acid, immune checkpoint inhibitor. present disclosure intermittent dosing schedules isopropyl (s)-2-((s)-2-acetamido-3-(1h-indol-3- yl)propanamido)-6-diazo-5-oxohexanoate isopropyl (s)-2-((s)-6-acetamido-2-((3s,5s,7s)- adamantane-1-carboxamido)hexanamido)-6-diazo-5-oxohexanoate (s)-2-((s)-2-acetamido-3- (1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoic acid treatment cancer.',\n",
              " 'combination anti-ctla4 antibody diverse therapeutic regimens synergistic treatment proliferative diseasescompositions methods treatment prevention proliferative disorders comprising, inter alia, anti-ctla-4 agent, ipilimumab tremelimumab, combination chemotherapeutic agents, dasatinib, imatinib, paclitaxel, gemcitabine, cisplatin etoposide. particular, method treating cancer comprising administration anti-ctla-4 antibody gemcitabine.',\n",
              " 'combination lactobacillus plantarum strain strain-derived polysaccharide preventing treating tumorthe present invention relates combination lactobacillus plantarum imb19 strain and/or polysaccharides derived strain anticancer preventing treating tumors. lactobacillus plantarum imb19 strain polysaccharides derived strain present invention exhibit excellent ability stimulate cd8+t cell activity exhibit excellent regulatory (treg) cell inhibitory activity, stimulate improve antitumor immune response mechanisms increased macrophage infiltration cps tumors differentiation reprogramming macrophages inflammatory phenotype (m1). furthermore, strain polysaccharides significantly increase antitumor immune response administered combination anticancer drug, particularly immuno-anticancer pd-1 pd-l1 inhibitor (e.g., pd-1 antibody, pd-l1 antibody, like), exhibit remarkable tumor growth suppression effect compared case anticancer alone. therefore, present invention effectively prevent, relieve, treat tumors administration combination anticancer drugs.',\n",
              " 'pharmaceutical combinations sos1 inhibitors treating and/or preventing cancerthis disclosure relates pharmaceutical combinations treating and/or preventing cancer methods thereof. particularly, provided pharmaceutical combination comprising sos1 inhibitor additional active ingredient selected kras inhibitor kras g12c inhibitor kras g12d inhibitor, kras g13c inhibitor, pan kras inhibitor; egfr inhibitor; erk1/2 inhibitor; braf inhibitor; pan-raf inhibitor; mek inhibitor; akt inhibitor; shp2 inhibitor; protein arginine methyltransferases (prmts) inhibitor prmts inhibitor type 1 prmt inhibitor; pi3k inhibitor; cyclin -dependent kinase (cdk) inhibitor cdk4/6 inhibitor; fgfr inhibitor; c-met inhibitor; rtk inhibitor; non-receptor tyrosine kinase inhibitor; histone methyltransferases (hmts) inhibitor; dna methyltransferases (dnmts) inhibitor; focal adhesion kinase (fak) inhibitor; bcr-abl tyrosine kinase inhibitor; mtor inhibitor; pd1 inhibitor; pd-l1 inhibitor; ctla4 inhibitor; chemotherapeutic agents gemcitabine, doxorubicin, cisplatin, carboplatin, paclitaxel, docetaxel, topotecan, irinotecan temozolomide.',\n",
              " 'probiotic compound preparation capable improving intestinal micro-ecological performance enhancing treatment effect tumor immune checkpoint inhibitor application probiotic compound preparationthe invention discloses probiotic compound preparation capable improving intestinal microecological performance enhancing treatment effect tumor immune checkpoint inhibitor application probiotic compound preparation. probiotic compound preparation disclosed invention comprises types probiotics, bifidobacterium infantis, bifidobacterium longum bifidobacterium breve, meanwhile, pectin oligosaccharide prebiotics added. animal experiments show probiotic composition correct disorder intestinal flora tumor-bearing mice improve diversity composition flora, probiotic composition combined checkpoint inhibitor pd-1 significantly enhance curative effect rectal cancer mouse model; strains probiotic composition interact synergistically interact, probiotic composition effectively regulate intestinal flora, improve immune state body improve therapeutic effect immune checkpoint inhibitor tumors, adverse effect normal tissues organs, strategy immunotherapy tumors.',\n",
              " 'composition comprising combination immune checkpoint inhibitor antibody-amatoxin conjugate cancer therapythe present application relates composition comprising (a) immune checkpoint inhibitor (b) conjugate, conjugate comprising (i) target binding moiety, (ii) amatoxin, (iii) optionally linker connecting target binding moiety amatoxin. present application relates composition treating patient cancer, pharmaceutical formulation comprising composition additional excipients, methods producing composition.',\n",
              " 'application sms liver cancer diagnosis, prognosis immune checkpoint blocking treatment response predictionthe invention belongs technical field disease diagnosis, prognosis molecular biology, particularly relates application sms liver cancer diagnosis, prognosis immune checkpoint blocking treatment response prediction. researches find compared normal liver tissues, expression spermine synthetase (sms) hepatocellular carcinoma up-regulated; highly expressed sms related clinical pathological characteristics poor prognosis. addition, compared sms low expression group, total lifetime, disease-specific lifetime progression-free interval liver cancer patients sms high expression group shortened, overexpression sms indicates unfavorable result. meanwhile, overexpression sms influences immune cell infiltration patient hepatocellular carcinoma (hcc), immune checkpoint blocking (icb) reaction poor, curative effect hcc poor. conclusion, sms biomarker hcc clinical result diagnosis prediction, biomarker predicting icb treatment response.',\n",
              " 'ucp2 inducing agents treatment cancer resistant immune checkpoint blockadethe disclosure relates methods reducing resistance immune checkpoint blockade and/or treating cancer resistant immune checkpoint blockade therapy. methods present disclosure comprise administering subject uncoupling protein 2 (ucp2) inducing agent and/or immune checkpoint modulator.',\n",
              " 'treatment prostate cancer pap vaccine pd-1 inhibitor co-therapyprovided technology relating cancer treatment prevention particularly, exclusively, compositions methods related therapies prostate cancer.',\n",
              " 'application pd-1 inhibitor preparation medicine treating specific tumor subtypesthe invention relates field biological pharmacy, specifically, hand, relates application monoclonal antibody heavy-chain cdr sequences seq id no: 1, seq id no: 2 seq id no: 3 and/or light-chain cdr sequences seq id no: 4, seq id no: 5 seq id no: 6 antigen-binding fragment thereof preparation medicines treating specific solid tumor subtypes, cervical cancer subtypes, mesothelioma, lymphoma non-small cell lung cancer; hand, invention treatment method aiming solid tumor.',\n",
              " 'polypeptide micelle enhancing photoimmunotherapy based synergy tumor vessel normalization immune checkpoint blocking preparation application polypeptide micellethe invention belongs technical field biological medicine, particularly relates polypeptide micelle enhancing photoimmunotherapy based cooperation tumor blood vessel normalization immune checkpoint blocking preparation application polypeptide micelle. polypeptide (peg-rrrrrrrrrk (ce6)-llgplgvrg-atwlppr) hydrophobic compound subjected self-assembly adsorbed sipd-l1 electrostatic attraction form polypeptide micelle, polypeptide micelle enhancing photoimmunotherapy enhancing photoimmunotherapy based cooperation tumor blood vessel normalization immune checkpoint blocking. polypeptide comprises cation motif peptide fragment r9, mmp-2 substrate peptide fragment, anti-angiogenesis peptide fragment, photosensitizer ce6 peg, realize gene loading time, functions mmp-2 responsive degradation, blood vessel normalization, photoimmunotherapy icb function tumor area; immunosuppression microenvironment tumor area reversed tumor blood vessel normalization immune checkpoint blocking therapy, treatment effect photoimmunotherapy improved.',\n",
              " 'cross-species anti-latent tgf-β1 antibodies methods useto provide methods cross-species anti-latent tgf-β1 antibodies inhibit protease-mediated activation latent tgf-β1 inhibiting integrin-mediated activation latent tgf-β1, treatment fibrosis cancer.solution: provided pharmaceutical formulation treatment fibrosis cancer, comprising anti-latent tgf-β1 antibody specific sequence pharmaceutically acceptable carrier. preferably, anti-latent tgf-β1 antibody comprises modified igg1 fc region reduced effector function compared wild type igg1 fc region. anti-latent tgf-β1 antibody preferably combination immune checkpoint inhibitor anti-pd-1 antibody anti-pd-l1 antibody.selected drawing:',\n",
              " 'methods systems assessing proliferative potential resistance immune checkpoint blockadea method characterizing tumor response immune checkpoint blockade therapy, comprising: (i) obtaining tissue tumor; (ii) measuring, tissue, expression cell proliferation gene markers; (iii) determining, based measured expression cell proliferation gene markers, proliferation profile tumor; (iv) predicting, based determined proliferation profile, response tumor immune checkpoint blockade therapy; (v) determining, physician predicted response tumor immune checkpoint blockade therapy, therapy tumor.',\n",
              " 'pharmaceutical combination ep4 antagonist immune checkpoint inhibitors treatment tumoursthe present invention pharmaceutical combination comprising ep4 antagonist formula (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)cyclopropyl)-benzoic acid pharmaceutically acceptable salt thereof immune checkpoint inhibitor, preferably sodium salt (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)cyclopropyl) benzoic acid. polymorphic form sodium salt (r)-4-(1-(6-(4-(trifluoromethyl) benzyl)-6-azaspiro[2.5]octane-5-carboxamido)cyclopropyl)benzoate characterized powder xrd spectrum peaks values angle 2θ+0.2° 4.3, 5.0, 5.8, 6.4, 7.1, 8.3, 8.7, 12.8, 15.3, 15.9 described. combination polymorphic form described treatment tumours.',\n",
              " 'improved treatments advanced/metastatic cancers checkpoint inhibitor resistance resistance susceptibilitythis invention area improved therapeutic methods difficult treat locally advanced and/or metastatic cancers patients cancer advanced treated immune checkpoint inhibitor due development resistance inhibitory effects immune checkpoint inhibitor cancer susceptible development resistance effects immune checkpoint inhibitor. methods present invention particularly suitable select group hard-to-treat patients advanced/metastatic triple negative breast cancer (tnbc), recurrent metastatic non-small cell lung cancer (nsclc), advanced metastatic unresectable colorectal cancer locally advanced metastatic urothelial carcinoma, extended progression free survival (pfs) and/or increased survival (os) patient populations.',\n",
              " 'evs membrane protein marker predicting efficacy lung cancer immune combined chemotherapythe invention evs membrane protein marker predicting efficacy pd-1 inhibitor combined lung cancer immunity chemotherapy paclitaxel. evs membrane protein marker cd3, c-met, egfr, hif-1alpha pdgfra. evs membrane protein markers provided invention predicting efficacy lung cancer immune combined chemotherapy, patients low expression levels markers high treatment benefit probability roc lifetime.',\n",
              " 'dosage regimes anti-cd73 anti-entpd2 antibodies thereofthe invention generally relates dosage regimes anti-cluster differentiation 73 (cd73) antibodies and/or anti-ectoenzyme ectonucleoside triphosphate diphosphohydrolase 2 (entpd2) antibodies, methods treatment cancer subject, dosage regimes anti-cd73 antibodies treating cancer. invention generally relates dosage regimes combinations agents, combinations comprising anti-cd73 antibodies and/or anti-entpd2 antibodies pd-1 inhibitor, adenosine a2ar antagonist.',\n",
              " 'strong potentiation immune checkpoint blockade therapy cancer combination endoglin-targeting therapyprovided methods involve administering individual thereof immune checkpoint inhibitor monoclonal antibody (mab) antigen binding fragment thereof, mab fragment thereof binds specificity human endoglin. cancer patients, administration results inhibition tumor growth and/or inhibition metastasis, and/or prolongation life individual.',\n",
              " 'treatment pd-l1-negative melanoma anti-pd-1 antibody anti-ctla-4 antibodyto provide method treating melanoma.solution: method treating melanoma comprises: (i) identifying patient pd-l1-negative melanoma; (ii) administering patient (a) anti-pd-1 antibody antigen-binding portion thereof binds specifically human pd-1 (b) anti-ctla-4 antibody antigen-binding portion thereof binds specifically human ctla-4.selected drawing:',\n",
              " 'therapy malignant disease comprising inhibition human epididymal secretory protein e4 immune checkpoint inhibitorsprovided herein, inter alia, methods compositions directed suppressing tumor cell growth subject methods sensitizing proliferating cell treatment cytotoxic agent inhibiting expression he4 immune checkpoint inhibitors (icis). provided methods determining subject diagnosed cancer benefit immunotherapy methods determining subject cancer responding immunotherapy assessment levels he4 gene and/or protein expression.',\n",
              " 'bacteria, bacterial products immunoregulatory entities combination anti-ctla-4 and/or anti-pd-1 antibodies treat solid tumor malignanciesto provide methods kits treating solid tumors subject combination anti-ctla-4 and/or anti-pd-1 antibodies member group consisting bacteria, bacterial products, immunoregulatory entities.solution: particular embodiments, bacteria toxin-depleted, anaerobic bacteria, clostridium novyi-nt. aspect, invention method treating solid tumor subject, method comprising administering subject therapeutically effective amount antibody selected group consisting anti-ctla-4 antibody anti-pd-1 antibody combination member group consisting bacteria, bacterial products, immunoregulatory entities, treating solid tumor.selected drawing:',\n",
              " 'binding molecules specific claudin 18.2, compositons methods thereof, treatment cancer diseasescompositions methods making isolated binding molecules (e.g. antibodies) antigen-binding fragment thereof therapeutics treating and/or preventing diseases associated cells expressing claudin18.2, including tumor-related diseases gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, cancer gallbladder described. also, described pharmaceutical formulations comprising described compositions treatment diseases single agent (e.g., naked antibodies) adjuvant therapy antigen-binding anticancer agents immune checkpoint inhibitors (e.g., anti-ctla-4 anti-pd-1/pd-l1 monoclonal antibodies), and/or combination therapies anti-claudin18.2 antibodies administered before, after, concurrently chemotherapy.',\n",
              " 'application rnf43 gene variation prediction sensitivity solid tumor patient immune checkpoint inhibitor therapythe invention relates field clinical molecular diagnostics, particular application rnf43 gene variation prediction sensitivity solid tumor patients immune checkpointinhibitor therapy. application, rnf43 gene variation screened serve population biomarker predicting sensitivity solid tumor patients immune checkpoint inhibitor therapy, relative co-mutation gene combinations, prediction result accurate; rnf43 gene variation adopted application serve independent prediction risk factor practical application, detection efficiency improved.',\n",
              " 'method treating checkpoint inhibitors induced adverse eventsthe invention relates ctla4 agonist treating preventing adverse events patient treated immune checkpoint inhibitor.',\n",
              " 'composition preventing treating brain tumor high-glucose environment, comprising microorganism immune checkpoint inhibitor active ingredientsthe present invention relates composition preventing treating brain tumor high- glucose environment, comprising microorganism immune checkpoint inhibitor active ingredients. composition present invention exhibits beneficial effect suppressing brain tumor inducing change composition intestinal microflora, especially change composition desulfovibrionaceae family strain, high-glucose intake environment, brain tumor prevention, improvement, treatment agent.',\n",
              " '3-hydroxy-8-tigloyloxy-110-dehydroariglovin composition comprising extract jerusalem artichoke leaves 3-hydroxy-8-tigloyloxy-110-dehydroariglovin compounds isolated preventing treating immune checkpoint inhibitorthe present invention relates immune checkpoint inhibitor pharmaceutical composition containing helianthus tuberosus top part extract 3-hydroxy-8β-tigloyloxy-1,10-dehydroariglovin compound isolated active component. present invention pharmaceutical composition treating immune checkpoint inhibitor interferes interaction anti-programmed cell death protein 1 (pd-1) anti-programmed cell death-ligand 1 (pd-l1), proliferates activity cells, attacking infected tissues, benign tumors, deformed tissues human body, helpful enhancing immunity.',\n",
              " 'neoantigens targets immunotherapyimmune checkpoint inhibitors shown significant therapeutic responses tumors containing increased mutation-associated neoantigen load. observed emergence acquired resistance non-small cell lung cancer patients initially responsive immune checkpoint blockade. resistance occurred 4-11 months initiation immunotherapy clinical response therapeutic resistance associated changes cell clonality changes expression pd-l1. genomic analyses responsive resistant tumors patients identified loss 7 18 mutation-associated putative neoantigens resistant clones predicted high mhc binding affinity. neoantigen loss occurred elimination tumor subclones deletion chromosomal regions containing truncal alterations. analyses provide insights mechanisms evasion immune checkpoint blockade immune therapies target tumor neoantigens.',\n",
              " '- antibody-drug conjugate comprising immune checkpoint inhibitor exosome secretion inhibitor pharmaceutical composition comprising samethe present invention relates antibody-drug conjugate comprising exosome secretion inhibitor conjugated antibody inhibiting immune checkpoints, thereof treating cancer. antibody-drug conjugate present invention maintained form conjugated antibody normal tissue, releases reaching cancer microenvironment, inhibiting secretion cancer exosomes immunosuppression, exhibit high therapeutic efficacy significantly increase objective response rate immune checkpoint inhibitor.',\n",
              " 'pd-1 pd-l1 method selecting anti-pd-1 anti-pd-l1 antibodies alloimmunity xenoimmunitythe present invention relates method selecting anti-pd-1 anti-pd-l1 antibody rejection homogeneous objects rejection heterogeneous objects. present invention, antibody selected low costs method selecting antibody model simulating interaction pd-1 pd-l1 real cancer cell t-cell.',\n",
              " 'ipilimumab variant enhanced adccthe present invention anti-ctla-4 antibodies enhanced adcc activity, treating cancer. embodiment, anti-ctla-4 antibody ipilimumab, adcc activity enhanced introducing g236a, s239d, a330l i332e mutations (“gasdalie”) fc region heavy chain constant domain.',\n",
              " 'methods treating cancer anti-pd-1 antibodies combination anti-ctla-4 antibodiesthe present invention isolated monoclonal antibodies, particularly human monoclonal antibodies, specifically bind pd-1 high affinity. nucleic acid molecules encoding antibodies invention, expression vectors, host cells methods expressing antibodies invention provided. immunoconjugates, bispecific molecules pharmaceutical compositions comprising antibodies invention provided. invention methods detecting pd-1, methods treating diseases, including cancer infectious diseases, anti-pd-1 antibodies. present invention methods combination immunotherapy, combination anti-ctla-4 anti-pd-1 antibodies, treat hyperproliferative disease, cancer. invention methods altering adverse events related treatment antibodies individually.',\n",
              " 'methods treating tumors situ including intratumor injection cytotoxic particles immune checkpoint blockade therapydisclosed compositions, kits, methods treating cancer subject thereof. compositions, kits, methods treat tumor subject situ. compositions, kits, methods comprise utilize cytotoxic particles, immune checkpoint inhibitors, and/or t-cell stimulatory agents.',\n",
              " 'anti-cancer combination therapies comprising ctla-4 pd-1 blocking agentsanti-cancer combination therapies comprising ctla-4 blocking agent pd-1 blocking agent disclosed. particular, combination therapies disclosed ctla-4 blocking agent effector-silent anti-ctla-4 antibody effector-silent anti-ctla-4 antibody fragment pd-1 blocking agent anti- pd-1 anti-pd-l1 antibody, antibody fragment thereof.',\n",
              " 'pharmaceutical composition method preventing treating cancer combined anti-human fn14 antibody immune checkpoint inhibitorthe present invention addresses problem providing pharmaceutical composition preventing treating cancer pharmaceutical composition preventing treating steroid myopathy. provided are: pharmaceutical composition preventing treating cancer comprises anti fn14 antibody antigen-binding fragment thereof excipient, pharmaceutical composition combination immune checkpoint inhibitor; pharmaceutical composition preventing treating steroid myopathy comprises anti fn14 antibody antigen-binding fragment thereof excipient.',\n",
              " \"method reducing likelihood developing bladder colorectal cancer individual human beinga method treating individual suffering bladder cancer colorectal cancer employs crispr system selectively kill reduce numbers pathogenic bacteria individual individual administered immune checkpoint inhibitor. particular embodiments, pathogenic bacteria e. coli, pseudomonas aeruginosa klebsiella bacteria, checkpoint inhibitor selected group consisting nivolumab, pembrolizumab, pidilizumab, amp-224, amp-514, sti-a1110, tsr-042, rg-7446, bms-936559, medi-4736, msb-0020718c, aur-012 sti-a1010. embodiments include enhancing growth bacteria individual, bacteria including akkermansia, bacteroides, bifidobacterium, clostridium, enterococcus, fusobacterium, lactobacillus, propionibacterium, ruminococcus, veillonella, prevotella, escherichia streptococcus . embodiments include increasing levels roseburia and/or faecalibacterium prausnitzii , individual's gut microbiome.\",\n",
              " 'method treating individual suffering chronic infectious disease cancera method treating individual suffering chronic infectious disease cancer employs crispr system selectively kill reduce numbers pathogenic bacteria individual individual administered immune checkpoint inhibitor. particular embodiments, pathogenic bacteria e. coli, pseudomonas aeruginosa klebsiella bacteria, checkpoint inhibitor selected group consisting nivolumab, pembrolizumab, pidilizumab, amp-224, amp-514, sti-a1110, tsr-042, rg-7446, bms-936559, medi-4736, msb-0020718c, aur-012 sti-a1010. embodiments include enhancing growth bacteria individual, bacteria including akkermansia, bacteroides, bifidobacterium, clostridium, enterococcus, fusobacterium, coprococcus, lactobacillus, propionibacterium, ruminococcus, veillonella, prevotella, escherichia streptococcus . crispr system include cas9, cpf1 cas3, delivered bacteriophage.',\n",
              " 'screening method three-dimensional tumor slice model culture methodthe invention discloses screening method three-dimensional tumor slice model culture method, relates field biological medicine. three-dimensional tumor slice model culture method established, high-throughput screening drugs achieved combining label-free technology and/or cell apoptosis report substance delayed imaging method, efficient drugs specific cancer samples obtained week. immune components original tumors completely reserved three-dimensional tumor slice model culture, possible immune checkpoint blocking test successfully achieved immune checkpoint inhibitor. means technology, cheap, rapid simple platform provided anti-cancer discovery, accurate anti-cancer treatment accelerated.',\n",
              " 'tam reprogramming anticancer gel preparation method thereofthe invention relates tam reprogramming anticancer gel preparation method thereof. preparation method comprises steps: dispersing hsa powder deionized water prepare hsa precursor solution, filtering hsa precursor solution 0.2 [mu] nylon filter prepare sterile solution, uniformly mixing 6-dsa stock solution sterile solution prepare mixed solution; tam reprogramming anti-cancer gel prepared mixing tam reprogramming anti-cancer gel mixed solution, preparing hydrogel mixed solution, adding kn93 inhibitor pd-l1 inhibitor hydrogel, tam reprogramming anti-cancer gel prepared invention injectable hydrogel targeted tumor immune microenvironment enhance tumor immunotherapy inhibiting immunosuppressive cells reducing expression immunosuppressive molecules. tam reprogramming anticancer gel reprogramming tams tumor microenvironment differentiating tams m1-tams, tam reprogramming anticancer gel advantages biodegradability, excellent biocompatibility, safety, toxic side effect, simplicity convenience preparation, sustained release like.',\n",
              " 'method predicting immune-related adverse event immune checkpoint inhibitorthe present invention method obtaining data predicting onset adverse event due administration antibody selected anti-pd-1 antibody, anti-pd-l1 antibody, anti-ctla4 antibody, antigen-binding fragment thereof, method predicting onset adverse event. specifically, present invention method obtaining data predicting onset adverse event method predicting onset adverse event, comprising measuring level marker selected scd163 cxcl5 biological sample collected subject administered antibody drug.',\n",
              " 'targeted inhibitor enhancing brain glioma immunotherapy application thereofthe invention belongs technical field tumor immunity, relates targeted inhibitor enhancing glioma immunotherapy, particular inhibitor enhancing glioma immunotherapy interfering tumor cell wnt signal. targeted inhibitor enhancing brain glioma immunotherapy comprises active components: wnt/beta-catenin inhibitor immune checkpoint inhibitor. inhibitor disclosed invention improve response glioma patients immune checkpoint blocking treatment inhibiting proliferation migration tumor cells inducing cell anti-tumor immune effect tumor microenvironment immune infiltration. invention comprises application inhibitor. invention medicine method solving problem low response rate immune checkpoint antibody medicines brain glioma treatment.',\n",
              " 'method treatment neuroendocrine tumorsthe present invention relates methods treating cancers over-express somatostatin receptors, e.g. neuroendocrine tumors (net). particular, invention therapies based combination peptide receptor radionuclide therapeutic (prrt) agent immuno-oncology (i-o) therapeutic agents, i-o therapeutic agents selected group consisting lag-3 inhibitors, tim-3 inhibitors, gitr angonists, tgf-beta inhibitors, il15/il-15ra complex, selected pd-1 inhibitors.',\n",
              " 'combination pharmaceutical composition treatment methodprovided cancer treatment means reversible btk inhibitor immunity checkpoint inhibitor combined. example, provided pharmaceutical composition treating cancer btk inhibitor (i-a) anti pd-1 antibody combined.',\n",
              " 'method treatment neuroendocrine tumorsthe present invention relates methods treating cancers overexpress somatostatin receptors, e.g. neuroendocrine tumors (net). particular, invention therapies based combination peptide receptor radionuclide therapeutic (prrt) agent immuno-oncology (i-o) therapeutic agents, i-o therapeutic agents selected group consisting lag-3 inhibitors, tim-3 inhibitors, gitr angonists, tgf-β inhibitors, il15/il-15ra complex, selected pd-1 inhibitors.',\n",
              " 'dosing administration non-fucosylated anti-ctla-4 antibody monotherapythe present invention methods dosing administration non-fucosylated anti-ctla-4 antibodies, non-fucosylated ipilimumab, monotherapy, related compositions dosage forms.',\n",
              " 'dosage regimen anti-cd73 anti-entpd2 antibodies thereofthe present invention generally relates dosage regimens anti-cluster differentiation 73 (cd73) antibody and/or anti-extracellular enzyme extracellular nucleoside triphosphate diphosphohydrolase 2 (entpd2) antibody method treating cancer subject, dosage regimens anti-cd73 antibody treating cancer. present invention relates generally dosage regimens combinations agents, dosage regimens comprising combination anti-cd73 antibody and/or anti-entpd2 antibody pd-1 inhibitor adenosine a2ar antagonist.',\n",
              " 'method improving treatment immune checkpoint blockade therapythe present invention relates method determining subject cancer susceptible therapeutic benefit treatment immune checkpoint blockade therapy.',\n",
              " 'method treatment neuroendocrine tumorsthe present invention relates methods treating cancers overexpress somatostatin receptors, e.g. neuroendocrine tumors (net). particular, invention therapies based combination peptide receptor radionuclide therapeutic (prrt) agent immuno-oncology (i-o) therapeutic agents, i-o therapeutic agents selected group consisting lag-3 inhibitors, tim-3 inhibitors, gitr angonists, tgf-β inhibitors, il15/il-15ra complex, selected pd-1 inhibitors.',\n",
              " 'pharmaceutical composition possessing antitumour effect, method reducing pd-l1 inhibiting effect human t-cellsfield: medicine.substance: group inventions relates medicine concerns pharmaceutical composition exhibiting antitumour effect comprising effective number human t-cell populations, human t-cells include isolated nucleotide sequence comprising nucleotide sequence coding modified protein programmed death cell 1 (pd-1) nucleotide sequence encoding chimeric antigenic receptor (car), modified pd-1 car expressed form gene products separate polypeptides, modified pd-1 dominant-negative pd-1. group inventions relates method reducing inhibitory effect pd-l1 human t-cells, involving administering nucleotide sequence nucleotide sequence human t-cells. nucleotide sequence encodes modified pd-1, dominant-negative pd-1, nucleotide sequence encodes car.effect: group inventions reducing inhibitory effect pd-l1 t-cells.27 cl, 5 ex, 6 dwg, 3 tbl',\n",
              " 'anti-human immunosuppressive receptor lilrb4 monoclonal antibodies fragment thereof, immune-checkpoint inhibitors, therapeutic agents immune-checkpoint related diseases methods measuring human immunosuppressive receptor lilrb4to provide anti-human immunosuppressive receptor lilrb4 monoclonal antibodies fragment thereof, immune-checkpoint inhibitors, therapeutic agents immune-checkpoint related diseases methods determining human immunosuppressive receptor lilrb4.solution: disclosure anti-human immunosuppressive receptor lilrb4 monoclonal antibody fragment thereof specifically binds human immunosuppressive receptor lilrb4 inhibit binding fibronectin lilrb4. provided immune-checkpoint inhibitor comprising anti-human immunosuppressive receptor lilrb4 monoclonal antibody fragment thereof effective ingredient, therapeutic agent disease associated immune checkpoint, method determining human immunosuppressive receptor lilrb4 biological sample anti-human immunosuppressive receptor lilrb4 monoclonal antibody fragment thereof.selected drawing:',\n",
              " 'triple combination antibody therapiesthe present invention directed triple combination therapies anti-tigit antibodies, anti-pvrig antibodies, checkpoint inhibitors, including anti-pd-1 anti- pd-l1 antibodies.',\n",
              " 'cpg immunoconjugates cancer therapyapplicant discloses immunoconjugate, enables systemic targeted cpg class antibodies target tumor microenvironment. conjugation checkpoint inhibitors anti-pd-l1, anti-ctla-4, anti-lags anti-tim-3, anti-vista make “biobetter” reagents.',\n",
              " 'b cell characteristic detection kit predicting treatment reactivity solid tumor immune checkpoint blocking agentthe invention discloses b cell characteristic detection kit predicting therapeutic reactivity solid tumor immune checkpoint blocking agent. method disclosed invention, b cell characteristic genes related solid tumor immunotherapy curative effects screened applying lasso regression dichotomy logistic regression, influence b cell characteristic genes prediction model evaluated, b cell characteristic score (b cell sign) formed weighted calculation; verification plurality immunotherapy transcriptome databases, compound predicting survival benefits non-small cell lung cancer, bladder cancer, renal clear cell carcinoma, esophageal adenocarcinoma melanoma treated immune checkpoint blocking agent. compared existing immunotherapy prediction biomarker, method prediction efficiency stability, advantages easy convenient detect, high accuracy large patient benefit, application prospect.',\n",
              " 'dosing administration non-fucosylated anti-ctla-4 antibody monotherapythe present invention methods dosing administration non-fucosylated anti-ctla-4 antibodies, non-fucosylated ipilimumab, monotherapy, related compositions dosage forms.',\n",
              " 'antibody-drug conjugate comprising immune checkpoint inhibitor exosome secretion inhibitor, pharmaceutical composition comprising samethe present invention relates antibody-drug conjugate comprising exosome secretion inhibitor conjugated antibody inhibiting immune checkpoints, thereof treating cancer. antibody-drug conjugate present invention maintained, normal tissue, form conjugated antibody, releases reaching cancer microenvironment, inhibiting secretion cancer exosomes immunosuppression. thus, antibody-drug conjugate exhibits high therapeutic efficacy increase, remarkable degree, objective response rate immune checkpoint inhibitor.',\n",
              " 'oncolytic adenovirus checkpoint inhibitor combination therapythe present invention relates combination therapy oncolytic viruses, particularly oncolytic adenoviruses, checkpoint inhibitors treatment cancer, particularly combination comprising (a) oncolytic adenoviral vector encoding tumor necrosis factor alpha (tnfalpha) and/or interleukin-2 (il-2) transgene (b) immune checkpoint inhibitors treatment cancer.',\n",
              " 'predictive peripheral blood biomarker checkpoint inhibitorsto provide method identifying patients respond anti-pd-1 anti-pd-l1 antibody therapy.solution: present disclosure relates finding ratio circulating (i.e., peripheral blood) central memory cells circulating effector cells cancer patient predict tumor inflammatory milieu. addition, inflammatory milieu (\"hot tumor\") positive factor responding checkpoint inhibitors, e.g., pd-1 antagonists, assay peripheral blood predict response checkpoint inhibitor, e.g., antibody antigen-binding portion thereof specifically binds programmed death-1 (pd-1) receptor inhibits pd-1 activity, antibody antigen binding portion thereof binds specifically pd-1 ligand 1 (pd-l1) inhibits pd-l1 activity.selected drawing: figure 4d',\n",
              " 'nanoparticles targeting immune checkpoint blockade molecule photodynamic immunological multiple functions, method manufacturing nanoparticles targeting immune checkpoint blockade molecule photodynamic immunological multiple functionsa nanoparticles targeting immune checkpoint blockade molecule photodynamic immunological multiple functions manufacturing medication liver cancer. nanoparticles targeting immune checkpoint blockade molecule photodynamic immunological multiple functions administered subject need, nanoparticles targeting immune checkpoint blockade molecule photodynamic immunological multiple functions target cancer cell affected area subject. then, light wavelength 460-580 nm irradiated affected area subject 0.01-30 minutes, nanoparticles targeting immune checkpoint blockade molecule photodynamic immunological multiple functions produce free radicals, block specific interaction programmed cell-death protein 1 (pd-1) programmed cell-death ligand 1 (pd-l1).',\n",
              " 'hdac pd-1 pd-l1 pharmaceutical composition hdac inhibitor anti pd-1 antibody anti pd-l1 antibodythe present invention relates method killing cancer cells combination hdac inhibitor anti-pd-1 antibody anti-pd-l1 antibody. present invention, effectively affect survival period animals cancer, tumors, tumor-related disorders neoplastic diseases, inhibition proliferative cell growth associated neoplasia, neoplastic regression.',\n",
              " 'methods compositions cancer immunotherapyin embodiments present invention methods treatment mmr-proficient and/or microsatellite stable (mss) cancers enhancing immunogenicity mmr-proficient and/or microsatellite stable (mss) cancer cells, enhancing sensitivity mmr-proficient and/or microsatellite stable (mss) cancer cells immune checkpoint blockade, inducing mmr-deficient mutational signature mmr-proficient and/or microsatellite stable (mss) cancer cells, and/or increasing frequency missense indel mutations mmr-proficient and/or microsatellite stable (mss) cancer cells. embodiments methods involve administration combination temozolomide cisplatin, combination temozolomide, cisplatin immune checkpoint inhibitor, subject thereof.',\n",
              " 'application fgfr4 point mutation predicting sensitivity patients non-small cell lung cancer immune checkpoint inhibitor therapythe present invention relates field clinical molecular diagnostics particularly application fgfr4 point mutation predicting sensitivity patients non-small cell lung cancer immune checkpoint inhibitor therapy predicting degrees tumor mutation loads patients non-small cell lung cancer. method conducive simplifying content testing, reducing cost testing patients, speeding issuance time test reports. besides, detecting genetic mutations reliable.',\n",
              " 'method treating cancer composition comprising amlexanox immune modulatorto provide compositions methods treating cancer subject, methods comprising generating immune response individual inducing expression neoantigens surface abnormal (for example, proliferative) cells.solution: provided composition combination therapeutically effective amount checkpoint inhibitor selected group consisting anti-pd-1 antibody, anti-pd-l1 antibody, anti-ctla-4 antibody, anti-a2ar antibody, anti-kir antibody, anti-lag3 antibody, anti-b7-h3 antibody, combinations thereof, method treating cancer subject thereof, composition treating cancer subject thereof, comprising therapeutically effective amount amlexanox, cancer melanoma colon carcinoma.selected drawing: figure 4',\n",
              " 'biomarker predictive responsiveness anticancer agent thereofthe present invention relates biomarker predicting response anti-cancer immunotherapeutic agent, same. specifically, present invention relates marker composition predicting response pd-1 inhibitor, pembrolizumab, comprises genes selected group consisting armadillo repeat-containing x-linked protein 1 (armcx1), serine/threonine-protein kinase d1 (prkd1), tyrosine kinase 2 (tyk2), protein encoded genes; composition kit predicting response; method providing information predicting response. genetic marker present invention conducts analyses utilizing formalin-fixed paraffin-embedded tissues derived patient, eliminating separate sample collection, enables convenient analyses; predict advance response anti-cancer immunotherapeutic agent analyzing expression genes, provide information selecting optimal treatment. thus, genetic marker expected advantageously utilized clinical settings.',\n",
              " 'improved therapeutic index anti-immune checkpoint inhibitors combination therapy comprising phy906 extract, scutellaria baicalensis georgi (s) extract compound extractsthe present invention method treating melanoma cancers subject, method comprising administering subject thereof therapeutically effective amount herbal extract phy906 scutellaria baicalensis, fraction thereof active chemical present herbal extract fraction thereof, immune checkpoint inhibitors. embodiments, method comprises administering herbal extract, fraction thereof active chemical present herbal extract fraction thereof, herb selected group consisting glycyrrhiza uralensis, paeonia lactiflora , ziziphus jujuba . methods invention treating cancer melanoma, non-small cell lung cancer, renal cell carcinoma, liver cancer, colon cancer, urothelial bladder cancer pancreatic cancer. embodiments, administration herbal extracts invention counteract gastrointestinal side effects immune checkpoint inhibitors and/or increase therapeutic index cancer.',\n",
              " 'pharmacy applications combined immune checkpoint blockade medicines tumor vaccinesthe invention discloses applications combined immune checkpoint blockade medicines tumor vaccines preparing medicines treating cancer. immune checkpoint blockade medicines tumor vaccines combined prepare drug, treatment cancer combining immunization therapy methods realized, excellent treatment effects achieved single drugs achieved, growth tumor limited, finally, survival time patients prolonged.',\n",
              " 'application inpp4b gene mutation predicting sensitivity non-small cell lung cancer patients immune checkpoint inhibitor therapythe invention relates field clinical molecular diagnostics, particular, application inpp4b gene mutation predicting sensitivity non-small cell lung cancer patients immune checkpoint inhibitor therapy, application inpp4b gene mutation predicting degree tumor mutation burden non-small cell lung cancer patients. method beneficial simplifying detection content, reducing costs patient detection speeding issuance test report, detection gene mutation status reliable.',\n",
              " 'nucleic acid aptamer programmed death receptor-ligand 1 (pd-l1) application nucleic acid aptamerthe invention discloses nucleic acid aptamer programmed death receptor-ligand 1 (pd-l1) application nucleic acid aptamer, relates nucleic acid. nucleic acid aptamer withhigh specific recognition pd-l1 high affinity combination force pd-l1 provided. nucleic acid aptamer screened prepared means protein selex method based agarosemicrobead separation-flow cytometry analysis. nucleic acid aptamer advantages g basic groups abundant, stem-loop structure provided, synthesis marking easy, costis low, stability high, non-immunogenicity excellent; nucleic acid aptamer utilized achieve specific recognition pd-l1 proteins, tumor cell lines pd-l1 expression proteins exudates pd-l1 expression proteins excreted tumor cell lines, application nucleic acid aptamer field biochemical analysis detection verified, nucleic acid aptamer expected molecular recognition tool detecting expression level pd-l1 applied precise prediction dynamic monitoring treatment effect pd-1/pd-l1 inhibitors field clinical medical tumor immunity research.',\n",
              " 'anti-pd-l1 antibody thereofdisclosed anti-pd-l1 antibodies anti-pd-1 antibodies. antibody antigen-binding fragment specifically bind pd-l1 block interaction pd-1 pd-l1. antibody antigen-binding fragment immune system clear tumor cells, diagnosis prognosis tumor cancer.',\n",
              " 'cancer therapy combination oncolytic vaccinia virus immune checkpoint inhibitor, pharmaceutical composition combination medicine cancer therapythe present invention combination therapy genetically modified vaccinia virus (particularly oncolytic vaccinia virus) cancer therapy treating cancer, pharmaceutical composition combination kit therapy. specifically, invention therapy vaccinia virus containing polynucleotide encoding interleukin-7 (il-7) polynucleotide encoding interleukin-12 (il-12) combination immune checkpoint inhibitor, pharmaceutical composition combination kit therapy.',\n",
              " 'preparation method bionic multifunctional nano-drugthe invention discloses preparation method bionic multifunctional nano-drug. method comprises steps loading polyamino acid nano-core targeting regorafenib, coating polyamino acid nano-core erythrocyte membrane connected pd-l1 inhibitor (bms-202) targeting polypeptide group tcp-1 prepare bionic multifunctional nano-drug.the bionic multifunctional nano-drug multiple targeting properties: nano-drug advantage natural passive targeting enrichment (epr effect) nano-particles tumor tissues, plays active targeting role large intestine tumor cells inserting tcp-1 surface erythrocyte membrane; anti-tumor effect greatly enhanced multipletargeting effect; bms-202 acts pd-l1 surface tumor cell membrane, core endocytosed tumor cells continuously release regorafenib tumor cells, inhibition effect kinases cells achieved, multi-site effect tumor cells achieved; optimal ratio kinds amino acids enables drugloading capacity polyamino acid nano-core greatly enhanced.',\n",
              " 'anticancer maleimide derivatives immune checkpoint blockadea method treating cancer subject thereof described. method includes administering subject therapeutically effective amount maleimide derivative treating subject immune checkpoint blockade.',\n",
              " 'companion diagnostic biomarker composition companion diagnostic kit comprising samethe present invention relates biomarker composition companion diagnosis, kit companion diagnosis comprising same. specifically, present invention predicting therapeutic response immune checkpoint inhibitors pd-1 checkpoint inhibitor pd-l1 immune checkpoint inhibitor. present invention, addition companion diagnosis tissue cancer patients, effect predicting therapeutic response immune checkpoint inhibitors pd-1 immune checkpoint inhibitors pd-l1 immune checkpoint inhibitors proteomic analysis blood cancer patients. addition, present invention, advantage accuracy selecting reactive patient group shows effect chemotherapy immune checkpoint inhibitors pd-1 immune checkpoint inhibitor pd-l1 immune checkpoint inhibitor non-responding patient group show effect high.',\n",
              " 'combination viral superinfection therapy subthreshold doses nivolumab ipilimumab chronic hbv patientsthe present invention relates combination attenuated non-pathogenic avian double-stranded (ds) rna viral vector (ibdv) anti-pd-1 antibody and/or anti-ctla-4 antibody treating hepatitis b virus (hbv) infection.',\n",
              " 'sk1 biomarker predicting response immunecheckpoint inhibitorsimmune checkpoint inhibitors (ici) revolutionized therapy advanced cancer, patients respond treatment. however, efficacy effectiveness therapies varies greatly individual patients different tumour types. substantial unmet development biomarkers response ici, order identify, initiation treatment, patients experience response clinical benefit treatments. here, inventors analyzed sphk1 mrna tumor biopsies situ hybridization rnascope technology cohort 32 patients suffering metastatic melanoma. showed elevated expression sphk1, encoding sphingosine kinase 1 (sk1), produces oncometabolite sphingosine-1-phosphate (s1p) associated poor survival metastatic melanoma patients treated well-known immune-checkpoint inhibitor anti-pd-1 antibody. accordingly, present invention relates sk1 biomarker predicting response immune-checkpoint inhibitors.',\n",
              " 'combination anti-ctla4 antibody therapy regimens synergistic treatment proliferative diseasesproblem solved: provide compositions methods treatment prevention proliferative disorders.solution: present invention compounds contain anti-ctla-4 agent, ipilimumab tremelimumab, combination chemotherapeutic agent, dasatinib, paclitaxel, gemcitabine, cisplatin etoposide.',\n",
              " 'anti-human pd-l1 monoclonal antibody application thereofthe invention relates anti-human pd-l1 monoclonal antibody application thereof. anti-human pd-l1 monoclonal antibody effectively solve problem medication tumors, adopts technical scheme light chain sequence heavy chain sequence anti-pd-l1 monoclonal antibody shown seq id no: 1 seq id no: 2 sequence table respectively. anti-pd-l1 monoclonal antibody screened phage antibody library affinity human pd-l1 inhibit combination pd-l1 pd-1, anti-pd-l1 monoclonal antibody humanized serve immune checkpoint inhibitor, treatment solid tumors infectious diseases innovation antitumor drugs.',\n",
              " 'sk2 inhibitors combination immune checkpoint blockade therapy treatment cancerimmune checkpoint blockade therapy based inhibition tumor-mediated suppression anticancer immune responses. however, efficacy effectiveness therapy vary greatly individual patients different tumor types. substantial unmet identify targets enhance therapeutic efficacy immune checkpoint blockade therapy. s1p produced sphingosine kinases (i.e. sk1 sk2) catalyze phosphorylation sphingosine sip. sk2 inhibitors described suitable treatment cancer. role sk2 immune tumor microenvironment investigated. inventors showed genetic deletion sphk2 leads delay melanoma tumor growth increase tumor-infiltrating effector lymphocytes. particular increase tumor-infiltrating effector lymphocytes tumor associated decrease amount tumor-infiltrating myeloid-derived suppressor cells. moreover, combination sphk2 deficiency immune-checkpoint blockade leads tumor rejection increases survival rate. accordingly, present invention relates sk2 inhibitors combination immune checkpoint blockade therapy treatment cancer.',\n",
              " 'application bcas, pharmaceutical composition kit predicting curative effectthrough multi-queue clinical test, in-vitro branched chain amino acid adding experiment (including valine, leucine isoleucine, hereinafter referred bcaas) mouse in-vivo gastric servo experiment, found compared patient short treatment validity period (low response group) icis, concentration bcaas plasma patient long treatment validity period (high response group) treatment course higher; function cd8 + cell enhanced differentiation cd8 + cell memory cell influenced exogenously adding bcas; effectiveness anti-pd-1 antibody treating tumors effectively improved exogenously adding bcas mouse in-vivo experiment. results, application bcas preparation medicine enhancing immune checkpoint inhibitor, pharmaceutical composition kit predicting treatment effect immune checkpoint inhibitor summarized, creative contribution made treatment tumors immune checkpoint inhibitor.',\n",
              " 'anti-b7-h1 anti-ctla-4 antibodies treating non-small lung cancerthe present invention features methods treating lung cancer (e.g., nsclc) anti-pd-l1 antibody tremelimumab subject identified pd-l1 negative tumor.',\n",
              " 'immune checkpoint inhibitors combination anti-aging drugs preparation tumor treatment productsuse immune checkpoint inhibitors combination anti-aging drugs tumor treatment tumor treatment products disclosed, treatment strategy effective treatment tumors. therapeutic effect provided treatment icis combination anti-aging superior current treatment icis treatment alone, icis combination chemotherapy, etc. action process icis combination anti-aging drug, aging cells selectively removed, aging state immune system reversed. accordingly, inhibitory effect tumor immune micro-environment reduced, improving treatment effect solid tumors. based product provided present invention, strategies ideas provided improving clinical efficacy prognosis solid tumors.',\n",
              " 'compositions comprising anti-lag-3 antibody anti-lag-3 antibody anti-pd-1 anti-pd-l1 antibodythis pharmaceutical compositions comprise (i) anti-lag-3 antibody antigen binding fragment thereof (ii) anti-lag-3 antibody antigen binding fragment thereof anti-pd-1 antibody, anti-pd-l1 antibody, antigen binding fragment thereof. provided pharmaceutical compositions comprise buffering agent, stabilizing bulking agent, surfactant. disclosure vial, syringe, intravenous bag, kit comprises compositions, methods compositions.',\n",
              " 'gastric cancer immunotherapy curative effect prediction prognosis evaluation method application thereofthe invention relates technical field bioengineering, discloses gastric cancer immunotherapy curative effect prediction prognosis evaluation method application thereof, scheme: method comprises application substances jointly detecting expression quantities ldha pd-l1 gastric cancer immunotherapy curative effect prediction prognosis evaluation, application substances jointly detecting expression quantities ldha pd-l1 gastric cancer immunotherapy curative effect prediction prognosis evaluation. gastric cancer immunotherapy curative effect prediction prognosis evaluation content comprises contents: a1, preparing product prognosis evaluation gastric cancer patient; a2, preparing product predicting postoperative risk gastric cancer patient; a3, preparing product predicting total postoperative lifetime gastric cancer patient; a4, prognosis evaluation gastric cancer patients; a5, postoperative risk prediction gastric cancer patients; a6, predicting total postoperative lifetime gastric cancer patient. invention, ldha high table pd-l1cpslt used; 5 independent risk factor affecting pfs gastric cancer patient, ldha highly expressed pd-l1cpslt; survival time gastric cancer patient suffering pd-1 inhibitor shorter gastric cancer patient suffering pd-1 inhibitor treatment, combined detection expression levels ldha pd-l1 prognosis evaluation value gastric cancer immunotherapy patient.',\n",
              " 'combination anti-ctla4 antibody diverse therapeutic regimens synergistic treatment proliferative diseasescompositions methods disclosed treatment prevention proliferative disorders. compositions comprise inter alia anti-ctla-4 agent, e.g. ipilimumab tremelimumab combination chemotherapeutic agents dasatinib, imatinib, paclitaxel, gemcitabine, cisplatin etoposide.',\n",
              " \"microbial compositions improving efficacy anticancer treatments based immune checkpoint inhibitors and/or tyrosine kinase inhibitors markers responsiveness treatmentsthe invention pertains bacteria selected alistipes senegalensis, dorea longicatena eubacterium siraeum inducing immunostimulation patient combination anti-cancer immunotherapy immune checkpoint inhibitor (ici) and/or tyrosine kinase inhibitor (tki). invention relates methods assessing probability patient respond treatment ici and/or tki, based measuring relative abundances immunotolerant bacterial species ( clostridium hathewayi, clostridium clostridioforme clostridium boltae ) and/or immunostimulatory bacterial species ( akkermansia muciniphila, bacteroides salyersiae, alistipes senegalensis, dorea longicatena eubacterium siraeum ) patient's gut microbiota.\",\n",
              " 'application soluble tim3 immune checkpoint blocking treatment resistancethe invention application soluble tim3 immune checkpoint blocking treatment resistance, belongs technical field biological medicine molecular biology. invention, found soluble tim3 remarkably up-regulated nsclc responded pd-1 blocking treatment, shows relatively high serum level duct cancer, duct cancer reported relatively high resistance pd-1 blocking treatment. importantly, stim-3 found induce pd-1 antibody block treatment resistance icc mouse model, cell function inhibited ceacam1 dependency mode, tumor progression promoted. therefore, human stim-3 candidate biomarker tumor progression pd-1 blocking treatment resistance, mechanism tim-3 mediated immunosuppression pd-1 blocking treatment resistance tumor environment provided, human stim-3 practical application value.',\n",
              " 'companion diagnosis biomarker composition companion diagnosis kit containing samethe present invention relates companion diagnosis biomarker composition companion diagnosis kit containing and, particularly, companion diagnosis biomarker composition companion diagnosis kit containing same, composition predicting therapeutic response immune checkpoint inhibitor pd-1 immune checkpoint inhibitor pd-l1 immune checkpoint inhibitor. present invention perform companion diagnosis cancer patient tissues predict therapeutic response immune checkpoint inhibitor pd-1 immune checkpoint inhibitor pd-l1 immune checkpoint inhibitor analysis proteome cancer patient blood.',\n",
              " 'therapeutic agent cancer comprises combination il-18 molecule-targeting antibodya therapeutic agent cancer present invention contains, active ingredients, il-18 antibody selected group consisting anti-pd-l1 antibody, anti-pd-1 antibody, anti-pd-l2 antibody, anti-ctla-4 antibody, anti-cd25 antibody, anti-cd33 antibody anti-cd52 antibody.',\n",
              " 'compositions comprising tumor suppressor gene therapy immune checkpoint blockade treatment cancerprovided methods compositions treating cancer individual comprising administering individual effective amount immune checkpoint inhibitor p53 and/or mda-7 (il24) gene therapy. provided methods enhancing anti-tumor efficacy administering extracellular matrix-degrading protein. provided methods enhancing anti-tumor efficacy administering metronomic chemotherapy (for agents described above, 5fu+ctx+gm-csf) combination p53 and/or il24 gene therapy.',\n",
              " 'methods treating cancerthe present invention relates methods treating patients advanced forms cancer, metastatic melanoma non-small cell lung cancer, x4p-001 administered monotherapy combination immune checkpoint inhibitors, pembrolizumab. methods demonstrate surprising results, including regression disease, comparatively toxicity.',\n",
              " 'therapy combination preparation containing hemolytic streptococcus bacterial cellthe present invention cancer therapy characterized administering preparation containing hemolytic streptococcus bacterial cells therapeutic agent antineoplastic agent/ lymphangioma (for example, picibanil (registered trademark) etc.) combination immunity checkpoint inhibitor (for example, anti-pd-1 antibody etc.) and/or cxcr2 inhibitor.',\n",
              " 'methods treating tumorthe disclosure method treating subject afflicted tumor, e.g., derived non-small cell lung cancer (nsclc), comprising administering subject combination (a) chemotherapy, (b) anti-pd-1 antibody anti-pd-l1 antibody, (c) anti-ctla-4 antibody, chemotherapy administered period time standard.',\n",
              " 'egfr x cd28 multispecific antibodiesthe present invention multispecific antibodies bind egfr cd28 (egfrxcd28) anti-egfr antibodies. antibodies combined therapeutic agent anti-pd1 antibody. methods treating cancers (e.g., egfr-expressing cancer) administering antibodies (e.g., combinations thereof anti-pd1 ) provided. egfrxcd28 antibodies present invention embody tumor-targeted immunotherapeutic modality combined pd-1 inhibition. bispecific antibodies bind tumor-specific antigen (tsa) (egfr) arm co-stimulatory receptor, cd28, -cells arm. combination therapy pd-1 inhibitors specifically potentiated intra-tu cell activation, promoting effector memory-like cell phenotype systemic cytokine secretion variety syngeneic human tumor xenograft models. combining class cd28-co-stimulatory bispecific antibodies clinically validated anti-pd-1 treatment well-tolerated antibody therapy markedly enhanced anti-tumor efficacy.',\n",
              " 'therapeutic compositions, combinations, methods useto provide therapeutic compositions, combinations, methods use.solution: invention relates methods comprising step administering fak inhibitor immunotherapeutic agent anti-pd-1 anti-pd-l1, treatment abnormal cell growth, cancer, mammals, especially humans. invention discloses method treating human subject suffering disease disorder described (e.g., abnormal cell growth, e.g., cancer (e.g., cancer described herein)), comprising step administering fak inhibitor combination immunotherapeutic agent procedure (e.g., immunotherapeutic agent compound inhibits immune checkpoint blockade pathway).selected drawing:',\n",
              " 'method treating individuals cancer receiving cancer immunotherapythe methods described treating infections individuals cancer receiving cancer immunotherapy, preferably employing crispr system selectively kill reduce numbers pathogenic bacteria individual thereafter, administering immune checkpoint inhibitor thereto. particular embodiments, pathogenic bacteria e. coli, pseudomonas aeruginosa, klebsiella bacteria, staphylococcus aureus; streptoccocus; salmonella; shigella; mycobacterium tuberculosis; enterococcus; clostridium; neisseria gonnorrhoea; acinetobacter baumannii ; campylobacter bacteria checkpoint inhibitor selected group consisting nivolumab, pembrolizumab, pidilizumab, amp-224, amp-514, sti-a1110, tsr-042, rg-7446, bms-936559, medi-4736, msb-0020718c, aur-012 sti-a1010. embodiments include enhancing growth bacteria individual, bacteria including akkermansia, bacteroides, bifidobacterium, enterococcus, fusobacterium, coprococcus, lactobacillus, propionibacterium, ruminococcus, veillonella, prevotella , f. prausnitzii . crispr system include cas9, cpf1 cas3, delivered bacteriophage.',\n",
              " 'combination treatment treating cancer carrying kras g12c mutationsprovided methods treating cancer comprising kras g12c mutation patient comprising (a) administering patient therapeutically effective amount sotorasib 14 48 days (\"an induction period\\'\\'), (b) administering patient therapeutically effective amount sotorasib therapeutically effective amount anti-pd 1 antibody anti-pd-l1 antibody induction period duration combination period.',\n",
              " 'application chitotriase marker predicting curative effect immune checkpoint inhibitor lung cancerthe invention belongs technical field medicine, particularly relates application chitotriase (chit1) marker predicting curative effect immune checkpoint inhibitor (ici) lung cancer, particular application chit1 marker predicting curative effect ici lung cancer. application disclosed invention, chitotriase marker predicting curative effect ici lung cancer, compared currently common marker pd-l1, chitotriase predict progression-free lifetime (pfs) lung cancer patient ici treatment, disease progression risk lower; ici treatment effect accurately predicted applying liquid biopsy method, extracting peripheral blood lung cancer patient detected detecting concentration chitotriase peripheral blood serum patient invasive means operation puncture immunohistochemistry gene sequencing, method simple, convenient rapid, cost reduced.',\n",
              " 'humanized pd-l1 monoclonal antibody preparation method application thereofthe invention relates technical field biomedical engineering, particular anti-pd-l1 humanized rabbit monoclonal antibody, humanized rabbit anti-pd-l1 monoclonal antibody, discloses amino acid sequence humanized rabbit monoclonal antibody, corresponding expression vector, host cell capable expressing antibody, production method antibody. specially, anti-pd-l1 monoclonal antibody obtained humanized transformation rabbit immunized, high expression quantity mammalian cells, specially bound pd-l1 protein extracellular region, significant ability inhibiting ligand-receptor binding, blocks binding pd1 pd-l1, restores function cell. anti-pd-l1 humanized rabbit monoclonal antibody serve immune checkpoint inhibitor, especially treatment, prevention diagnosis pd-l1 related cases tumor.',\n",
              " 'kit predicting occurrence risk related pneumonia treated immune checkpoint inhibitor, system, storage medium application thereofthe invention kit predicting occurrence risk related pneumonia treated immune checkpoint inhibitor, system, computer readable storage medium application thereof, relates technical field medical diagnosis. kit comprises copd diagnostic tool, tumor cell pd-l1 expression state detection reagent baseline plasma il-8 level detection reagent. system comprises data acquisition module, risk assessment module output module. computer readable storage medium comprises program completing system. kit, system storage medium, cip occurrence risk predicted relatively high accuracy.',\n",
              " 'methods pharmaceutical compositions enhancing cd8+ cell-dependent immune responses subjects suffering cancertargeting immune checkpoints, programmed cell death 1 (pd1), improved survival cancer patients unleashing exhausted cd8+ t-cell restoring anti-tumor immune responses. patients, however, relapse refractory immune checkpoint blocking therapies. here, inventors show nrp1 recruited cytolytic synapse pd1+cd8+ t-cells, interacts enhances pd-1 activity. mice, cd8+ t-cell specific deletion nrp1 improves spontaneous anti pd1 antibody anti-tumor immune responses. likewise, human metastatic melanoma, expression nrp1 tumor infiltrating cd8+ t-cells predicts poor outcome patients treated anti-pd1 (e.g. pembrolizumab). finally, combination anti-nrpl anti-pd1 antibodies synergistic human, specifically cd8+ t-cells anti-tumor response. therapeutic inhibition nrp1 combined immune checkpoint inhibitor (e.g. anti-pd1 antibody) efficiently repress tumor growth human cancer. present invention relates multispecific antibodies comprising binding site specifically binds immune checkpoint molecule (e.g. pd-1), binding site specifically binds nrp-1. present invention relates population cells engineered express chimeric antigen receptor (car) expression nrp-1 cells repressed.',\n",
              " 'methods treating cancerthe present invention relates methods treating patients advanced forms cancer, unresectable metastatic renal cell carcinoma kidney cancer, x4p-001 pharmaceutically acceptable salt thereof administered monotherapy combination immune checkpoint inhibitor, nivolumab. methods demonstrate surprising results, including regression disease, comparatively toxicity.',\n",
              " 'methods overcoming resistance immune checkpoint inhibitorsprovided methods bmp7 levels marker selection patients, non-small cell lung cancer patients, clinically respond combination therapy comprising bmp7 inhibitor immune checkpoint therapy, anti-pd1 therapy and/or anti-ctla-4 therapy. provided methods treating selected patients combination bmp7 inhibitor immune checkpoint therapy.',\n",
              " 'adjuvant compositions comprising fucoidan ecklonia cavafor active ingredientthe present invention relates adjuvant composition comprising fucoidan ecklonia cava active ingredient. administration fucoidan ecklonia cava nasal cavity increases number dendritic cells lymphatic gland activity dendritic cells raises activity nk cells cells, bringing excellent effects cancer immunotherapy. administration combination anti-pd-l1 antibody immune checkpoint inhibitors found excellent anticancer effects single administration anti-pd-l1 antibody completely inhibit metastasis cancer vivo. accordingly, fucoidan ecklonia cava provided adjuvant concomitant treating cancer.',\n",
              " 'bihaptenized autologous vaccines thereofin embodiments, methods treating cancer, including metastatic cancers, cancers resistant immune checkpoint inhibitor therapy, cancers respond immune checkpoint inhibitor therapy acquired resistance immune checkpoint inhibitor therapy disclosed.',\n",
              " 'bihaptenized autologous vaccines thereofin embodiments, methods treating cervical cancer, including cervical cancers resistant immune checkpoint inhibitor therapy, cervical cancers respond immune checkpoint inhibitor therapy acquired resistance immune checkpoint inhibitor therapy disclosed.',\n",
              " 'dosing treatment anti-tigit anti-pd-l1 antagonist antibodiesthe invention methods dosing treatment cancers. particular, provided methods, compositions, uses, kits treating subjects cancer administering anti-tigit antagonist antibody (e.g., anti-tig antagonist antibody disclosed herein, e.g., tiragolumab) pd-1 axis binding antagonist (e.g., anti-pd-l1 antagonist antibody (e.g., atezolizumab)).',\n",
              " 'combined anti-pld-1 anti-ctla-4 antibodies treating non-small lung cancera method treating lung cancer (e.g., non-small cell lung cancer) anti-pd-l1 antibody (medi4736), combination anti-ctla4 antibody (tremelimumab), patient identified polynucleotide marker ifngamma.',\n",
              " 'carrier-pd-l1 binding agent compositions treating cancersa nanoparticle composition treatment cancer expresses pd-l1, nanoparticles comprises albumin, anti-pd-l1 antibody, paclitaxel, nanoparticles capable binding pd-l1; antibodies comprise avelumab, durvalumab, bms 936559 (mdx1105); nanoparticle composition administration pd-1 immunotherapy.',\n",
              " 'formulation curcumin anti-pd-1 antibodyto provide therapeutic agent cancer higher therapeutic effect. therapeutic agent cancer, containing: selected group consisting curcumin derivative thereof; selected group consisting anti-pd-1 antibody, anti-pd-l1 antibody, anti-pd-l2 antibody combination.',\n",
              " 'treatment cytokine encoding rnathe present disclosure relates methods compositions inducing immune response subject comprising co-administering subject rna encoding peptides proteins vaccination rna encoding il-2 attached pharmacokinetic modifying group and/or rna encoding il-7 attached pharmacokinetic modifying group. vaccine particularly effective immune checkpoint inhibitor anti-pd-l1 antibody administered. present disclosure relates methods involving target-specific delivery cytokine target organ targettissue.',\n",
              " 'combinations comprising cd8+ cell enhancer, immune checkpoint inhibitor radiotherapy targeted abscopal effects treatment cancerprovided methods compositions treating cancer individual enhances efficacy localized therapy site administration concurrently transforming efficacy systemic efficacy. method comprise inducing cd8+ cell response memory cd8+ cell response local therapy administered, administering individual effective amount combined tumor suppressor therapy immune checkpoint inhibitor treatment induce increased cd8+ cell response memory cd8+ cell response radiation therapy. provided methods enhancing anti-tumor efficacy administering agents described combination cancer therapies.',\n",
              " 'compositions including therapeutic antibodies and/or checkpoint inhibitor integrin activating compoundpharmaceutical compositions including integrin activating compounds capable enhancing anti-tumor activity therapeutic antibodies, immune checkpoint inhibitors, mixtures thereof.',\n",
              " 'methods predicting response patient treatment pd-1 pd-l1 immune checkpoint inhibitorthe present invention methods predicting response patient immune checkpoint inhibitor (ici), treatment programmed cell death-1 (pd-1) programmed death-ligand 1 (pd-l1) ici, comprising steps of: (a) measuring kinase activity kinases independently selected families kinases selected group consisting of: vegfr pdgfr family kinases; src family kinases; syk family kinases; tam family kinases; jaka family kinases; alk family kinases, blood sample obtained patient, providing kinase activity profile blood sample; (b) predicting kinase activity profile response patient treatment pd-1 pd-l1 ici, kits predicting response patient ici treatment pd-1 pd-l1 ici.',\n",
              " 'combination cancer immunotherapy pentaaza macrocyclic ring complexa method treating cancer mammalian subject afflicted cancer, includes administering subject immune checkpoint inhibitor, administering subject pentaaza macrocyclic ring complex corresponding formula (i) below, prior to, concomitantly with, administration immune checkpoint inhibitor, increase response cancer immune checkpoint inhibitor.',\n",
              " 'combination cancer immunotherapy pentaaza macrocyclic ring complexa method treating cancer mammalian subject afflicted cancer, includes administering subject immune checkpoint inhibitor, administering subject pentaaza macrocyclic ring complex corresponding formula (i) below, prior to, concomitantly with, administration immune checkpoint inhibitor, increase response cancer immune checkpoint inhibitor.',\n",
              " 'triple pharmaceutical combination comprising dabrafenib, erk inhibitor raf inhibitor pd-1 inhibitor.the present invention relates pharmaceutical combination comprising dabrafenib, erk-inhibitor raf inhibitor; pharmaceutical compositions comprising same; methods combinations compositions treatment prevention conditions mapk pathway inhibition beneficial, example, treatment cancers.',\n",
              " 'combination cancer immunotherapy pentaaza macrocyclic ring complexa method treating cancer mammalian subject afflicted cancer, includes administering subject immune checkpoint inhibitor, administering subject pentaaza macrocyclic ring complex corresponding formula (i) below, prior to, concomitantly with, administration immune checkpoint inhibitor, increase response cancer immune checkpoint inhibitor.',\n",
              " 'methods compositions comprising viral gene therapy immune checkpoint inhibitor treatment prevention cancer infectious diseasesprovided methods compositions treating cancer individual comprising administering individual effective amount immune checkpoint inhibitor viral composition comprising viruses engineered comprise n1l gene deletion, matrix-degrading protein gene, adenoviral death protein (adp) gene, and/or cytochrome p450 gene. provided methods compositions treating cancer individual comprising administering individual effective amount viral composition comprising viruses engineered comprise n1l gene deletion, matrix-degrading protein gene, adenoviral death protein (adp) gene, and/or cytochrome p450 gene. provided methods enhancing antitumor efficacy administering agents described combination cancer therapies.',\n",
              " 'methods treating cancer anti-pd-1 antibodiesthe present invention relates methods treating cancer patient comprising administering pd-1 antagonist, e.g., anti-pd-1 antibody antigen binding fragment thereof (e.g. pembrolizumab), specific amounts patient weeks. embodiments, amount anti-pd-1 antibody antigen binding fragment thereof 400 mg. embodiments, pd-1 antagonist pembrolizumab, antigen binding fragment thereof. provided compositions kits comprising dosage anti-pd-1 antibody, antigen-binding fragment thereof, thereof treating cancer.',\n",
              " 'methods compositions cancer treatment treatment selectionin aspects, disclosure methods treating cancer infection. aspects, disclosure methods enhancing efficacy treatment immune checkpoint inhibitor. embodiments methods comprise administering complement inhibitor immune checkpoint inhibitor subject cancer infection. aspects, disclosure methods identifying subject appropriate candidate treatment immune checkpoint inhibitor. aspects, disclosure methods identifying subject appropriate candidate treatment immune checkpoint inhibitor complement inhibitor. embodiments methods comprise determining subject appropriate candidate treatment immune checkpoint inhibitor complement inhibitor based assay complement system biomarker subject sample obtained subject.',\n",
              " 'programmed cell death (pd-1) inhibitor therapy patients pd-1-expressing cancersdescribed biomarkers comprising mtor, pi3k/akt, mapk/erk signaling pathway members cap-dependent translation initiation factors enable monitoring predicting responses pd-1 pathway blockade patients afflicted cancers characterized pd-1 expression.',\n",
              " 'benzo heterocyclic compound pharmaceutical compositionto provide pharmaceutical composition treating preventing cancer related pd-l1, septic fever sepsis shock.solution: provided pharmaceutical composition including benzoxazole derivative expressed formula (i), composition preferably administered combination anticancer agent, immunity check point inhibitor anti pd-l1 antibody, anti pd-1 antibody, anti ctla-4 antibody.selected drawing: figure 3',\n",
              " 'methods predicting immune checkpoint blockade efficacy multiple cancer typesthe present disclosure relates generally methods, devices, systems accurately predicting efficacy immune checkpoint blockade therapy multiple cancer types.',\n",
              " 'dosing treatment anti-tigit anti-pd-l1 antagonist antibodiesthe invention methods dosing treatment cancers. particular, provided methods, compositions, uses, kits treating subjects cancer administering anti-tig antagonist antibody (e.g., anti-tig antagonist antibody disclosed herein, e.g., tiragolumab) pd-1 axis binding antagonist (e.g., anti-pd-l1 antagonist antibody (e.g., atezolizumab)).',\n",
              " 'bispecific checkpoint inhibitor antibodiesthe present invention directed heterodimeric anti-pd-1 x anti-ctla-4. provided nucleic acid compositions encode antibodies, expression vector compositions include nucleic acids, host cells include expression vector compositions.',\n",
              " 'anti-pd-l1 antibodythe present application anti-pd-l1 antibody. invention nucleic acid molecule coding anti-pd-l1 antibody, expression vector expressing anti-pd-l1 antibody, host cell. invention method producing anti-pd-l1 antibody application anti-pd-l1 antibody.',\n",
              " 'anti-pd-1 checkpoint inhibitor antibodies block binding pd-l1 pd-1the present invention concerns compositions methods anti-pd-1 antibodies comprising cdr sequences corresponding seq id no:1 seq id no:6. preferably antibody humanized antibody comprising variable region amino acid sequences seq id no: 9 seq id no:10. antibodies treat cancer administered standard anti-cancer therapy. methods comprise administering anti-pd-1 antibody antigen-binding fragment thereof combination therapeutic agents antibody-drug conjugates, interferons (preferably interferon-α), and/or checkpoint inhibitor antibodies.',\n",
              " 'therapeutic combinations comprising agonists ferroptosis treating proliferative disordersthe invention based finding ferroptosis mediated cell death results local recruitment immune cells concomitant sensitization tumour tissue tumour cells cell-mediated immune response results synergistic therapeutic effects proliferative diseases. inducing supporting ferroptosis, inhibition key regulators, shown tumour cells sensitized immune checkpoint inhibition, improved myeloid cell recruitment blocked. hence, enhanced recruitment immune cells ferroptosis harnessed antitumour response immune checkpoint inhibition and/or suppression local recruitment immune suppressive cell fractions. invention combinatorial approaches treat proliferative disorders, preferably solid cancers characterized resistance immune checkpoint inhibition, observed hepatocellular carcinoma. invention pertains medical application ferroptosis induction ferroptosis agonists combination immune checkpoint inhibition - inhibition pd-1/pd-l1 axis - treatment prevention proliferative disorders. invention compounds compositions indicated medical approaches.',\n",
              " 'combinations macrolide compounds immune checkpoint inhibitorsthe present invention combination immune stimulating macrolides checkpoint inhibitors. combinations synergistic effects treating viral diseases cancer.',\n",
              " 'increasing responses checkpoint inhibitors extracorporeal apheresisthe invention means, methods, compositions matter enhancing tumor response checkpoint inhibitors. embodiment, invention teaches utilization extracorporeal apheresis, specifically removal tumor derived, tumor microenvironment derived immunological “blocking factors”. embodiment invention removal soluble tnf-alpha receptors (stnf-rs) means augmenting efficacy immune checkpoint inhibitors. specific embodiment removal stnf-rs utilized enhance efficacy inhibitors pd-1/pd-l1 pathway, and/or cd28/ctla-4 pathway.',\n",
              " 'situ thiol-maleimide crosslinked hydrogel immune checkpoint blockade deliverydisclosed hydrogel compositions deliver therapeutic agents, including therapeutic proteins, patients thereof. embodiment, therapeutic agent immune checkpoint blockade antibody, hydrogel thermoresponsive polymer crosslinked hydrophilic polymer.',\n",
              " 'progastrin biomarker immunotherapymethods selecting patients responsive immune checkpoint inhibitors disclosed. methods treating cancer patients immune checkpoint inhibitor provided.',\n",
              " 'treatment lag-3 positive tumors.the invention method treating tumor human patient comprising (i) identifying patient lag-3 positive tumor (ii) administering patient pd-1 pathway inhibitor, combination pd1 pathway inhibitor immune checkpoint inhibitor, combination lag-3 inhibitor pd-1 pathway inhibitor, anti-ctla4 antibody. embodiments, method comprises identifying patient lag-3 positive pd-l1 positive tumor. embodiments, lag-3 inhibitor anti-lag-3 antibody pd-1 pathway inhibitor anti-pd-1 antibody. methods invention improve response rates treatment pd-1 pathway inhibitor, combination pd1 pathway inhibitor immune checkpoint inhibitor, combination lag-3 inhibitor pd-1 pathway inhibitor.',\n",
              " 'biomarker predicting sensitivity lung adenocarcinoma patient immunotherapy, application devicethe present invention relates biomarker predicting sensitivity lung adenocarcinoma patients immune checkpoint inhibitor therapy, comprises mutant cell differentiation regulatory gene selected zfhx3 ptprd genes, mutant missense mutation and/or nonsense mutation. biomarker predicting sensitivity lung adenocarcinoma patient immune checkpoint inhibitor therapy significant correlation tmb value, biomarker predicting sensitivity lung adenocarcinoma patient immune checkpoint inhibitor therapy, accurately screen benefitting immune checkpoint inhibitor therapy, detection cost reduced.',\n",
              " 'construction application animal model blocking il-8 combined anti-pd-1 antibody treat gastric cancerthe invention belongs technical field animal model construction, particularly relates construction application animal model blocking treatment gastric cancer combining il-8 anti-pd-1 antibody. human pbmcs adopted immunodeficient mouse ncg body, cxcr1/2 knocked-out human gastric cancer cells (hgc-27) subcutaneously injected, gastric cancer patient-derived mesenchymal stem cells (gcmscs) supernatant acts, major humanization realized animal model body, human pbmcs closer real human in-vivo environment, effect human il-8 anti-pd-1 immunotherapy favorably researched. method applied development preclinical evaluation products il-8 signal channel blocker combined immune checkpoint blocking (icb) treatment, effects improving tumor immune microenvironment improving gastric cancer treatment prognosis achieved.',\n",
              " 'methods compositions tusc2-immunotherapyfield: medicine; pharmaceutics.substance: group inventions relates field medicine pharmaceutics, namely, method treatment malignant neoplasm individual, method includes conducting tusc2 therapy individual, immune checkpoint inhibitor injected injected individual, additionally including injection immune checkpoint inhibitor individual, immune checkpoint inhibitor contains anti-pd1 antibody; set treatment malignant neoplasm containing therapeutic agent tusc2 immune checkpoint inhibitor, anti-pd1 antibody; composition treatment malignant neoplasm containing therapeutic tusc2 immune checkpoint inhibitor, anti-pd1 antibody, amount therapeutically effective treatment malignant neoplasm.effect: group inventions synergetic effect combined therapy malignant neoplasms.38 cl, 40 dwg, 2',\n",
              " 'method manufacturing immune checkpoint blockade particles immune checkpoint blockade particlesa method manufacturing immune checkpoint blockade particles includes mixing plurality functional monomers, template peptide solvent form molecularly imprinted polymer embedding template peptide polymerizing plurality functional monomers solvent. plurality recognition sites corresponding template peptide formed surface molecularly imprinted polymer. template peptide surface molecularly imprinted polymer removed. moreover, template peptide includes amino acid sequence set seq id no: 1, 2, 3, 5, 6 7. accordingly, immune particle block specific interaction programmed cell-death protein 1 (pd-1) programmed cell-death ligand 1 (pd-l1), applied immunotherapy.',\n",
              " 'combinations irs/stat3 dual modulators anti pd-1/pd-l1 antibodies treating cancerthe present invention relates treatment cancer combination therapy comprising dual modulator insulin receptor substrate (irs) signal transducer activator transcription 3 (stat3), combination antibody programmed cell death 1 (pd-1) protein, anti-programmed cell death protein 1 ligand (pd-l1) antibody, combination thereof. combination re-sensitize tumor develop developed resistance anti-pd-1 and/or anti-pd-l1 antibody, enhancing response tumor anti-pd-1 and/or anti-pd-l1 antibody, converting non-responding tumors responders and/or blocking tumor progression.',\n",
              " 'methods including geometric network analysis selecting patients high grade serous carcinoma ovary treated immune checkpoint blockade therapythe present disclosure gene network curvature-based methods, devices, systems determining patient suffering diagnosed ovarian cancer benefit immune checkpoint inhibitor therapy. network curvature-based methods disclosed based copy number alterations (cnas) gene level provide integrated measure variability cancer gene networks ovarian cancer patients.',\n",
              " 'combination therapy pd-l1 negative tumorsa method treatment comprising administering anti-pd-l1 (programmed death ligand 1, b7-h1 cd274) antibody anti-ctla4 (cytotoxic lymphocyte antigen-4 cd152) antibody, antigen binding fragments thereof, patient identified lung cancer negative pd-l1. preferably anti-pd-l1 antibody medi4736 (durvalumab) ctla4 antibody tremelimumab. lung cancer preferably non-small cell lung cancer (nsclc) selected group consisting squamous cell carcinoma, adenocarcinoma, large cell carcinoma, adenosquamous carcinoma sarcomatoid carcinoma. preferably method comprises administering 1mg/kg 20mg/kg medi4736 1mg/kg 10mg/kg tremelimumab antigen binding fragments thereof patient identified lung cancer negative pd-l1.',\n",
              " 'methods predicting treatment outcome checkpoint inhibitors cancerdescribed methods selecting treatment for, optionally treating, subject tumor methods determining subject tumor benefit immunotherapy treatment. methods disclosed include long non-coding rna, and/or ribonucleoprotein, biomarkers patient response immunotherapy treatment, immune checkpoint inhibitor.',\n",
              " 'combination anti-kir antibodies anti-pd-1 antibodies treat cancerprovided anti-kir antibody antibody selected anti-pd-1 antibodies, anti-pd-l1 antibodies anti-pd-l2 antibodies treating cancer (e.g., advanced refractory solid tumors hematological malignancies).',\n",
              " 'anti-pd-1 checkpoint inhibitor antibodies block binding pd-l1 pd-1the present invention concerns compositions methods anti-pd-1 antibodies comprising cdr sequences corresponding seq id no:1 seq id no:6. preferably antibody humanized antibody comprising variable region amino acid sequences seq id no: 9 seq id no:10. antibodies treat cancer administered standard anti-cancer therapy. methods comprise administering anti-pd-1 antibody antigen-binding fragment thereof combination therapeutic agents antibody-drug conjugates, interferons (preferably interferon-α), and/or checkpoint inhibitor antibodies.',\n",
              " 'methods treating immune related ocular disordersdisclosed method treating ophthalmic inflammatory conditions subject providing immune checkpoints inhibitors subject. disclosed combinations immune checkpoint inhibitors comprising enhanced therapeutic efficiency.',\n",
              " 'compositions plinabulin thereofdisclosed compositions methods preventing and/or treating reducing immunotherapy mediated adverse events administering plinabulin combination immune checkpoint inhibitors. embodiments relate treatment immunotherapy related inflammation administering plinabulin combination immune checkpoint inhibitors. embodiments relate treatment psoriasis and/or inflammation administering plinabulin combination immune checkpoint inhibitors.',\n",
              " 'combination local systemic immunomodulative therapies enhanced treatment cancerproblem solved: provide method treatment malignant melanoma, primary metastatic liver cancer, therapeutically effective amount intralesional chemoablative pharmaceutical composition, combination therapeutically effective amount systemic immunomodulatory anticancer agent.solution: intralesional chemoablative pharmaceutical composition, rose bengal like, systemic immunomodulatory anticancer agent, anti-ctla-4 antibody, anti-pd-l1 antibody, anti-pd-1 antibody like.selected drawing:',\n",
              " 'fak inhibitor combination thereofa deuterated compound represented formula (i) optical isomer, tautomer, pharmaceutically acceptable salt, prodrug, hydrate, solvate thereof. compared compound deuteration, deuterated compound shows pharmacokinetics, higher maximum plasma concentration, higher exposure, longer half-life, excellent metabolic performance. moreover, deuterated compound effectively inhibit fak activity, application prospect preparation fak inhibitors and/or drugs treating cancer. addition, deuterated compound combination anti-cancer (such pd-1 inhibitor) achieve synergistic effect, significantly improving tumor suppression effect, providing choice clinical cancer treatment. (i)',\n",
              " 'compositions methods combination treatment cancerthe present invention relates combination therapy compositions methods combination therapy treatment cancer. present invention discloses composition comprising: (i) effective amount programmed cell death protein-1 (pd-1) inhibitor capable blocking pd-1 pathway, partially recovering function cells, enabling cells continue killing tumor cells; (ii) effective amount glucosylceramide synthetase (gcs) inhibitor capable enhancing activity immune system; immunosuppressive agent administered intravenously intravenous dosage form, gcs inhibitor administered orally oral dosage form. tumor growth effectively inhibited composition combined treatment method disclosed invention.',\n",
              " 'composition immunotherapy liver cancer application thereofthe invention composition immunotherapy liver cancer, composition comprises monoclonal antibody immune checkpoint inhibitor, monoclonal antibody secreted phosphoprotein spp1, immune checkpoint inhibitor pd-1. composition immunotherapy liver cancer formed combining phosphoprotein spp1 secreted monoclonal antibody immune checkpoint inhibitor pd-1, compared single immune checkpoint inhibitor, composition destroy tumor immune barrier tib structure, significantly increase killer cd8 + lymphocytes slow tumor growth proliferation capacity. combined composition immunotherapy curative effect liver cancer, great significance clinical treatment liver cancer.',\n",
              " 'antitumor effect potentiatorprovided means activating immune response tumor immunotherapy immune checkpoint inhibitor used. immune-checkpoint-inhibitor antitumor effect potentiator probiotics prebiotics active ingredients.',\n",
              " 'anti-pd-l1 antibody preparationprovided anti-pd-l1 antibody preparation, including anti-pd-l1 antibody, buffer solution sodium chloride, added sugars and/or sugar alcohols. provided anti-pd-l1 antibody preparation preparation drugs preventing and/or treating and/or adjuvant treating and/or diagnosing tumor anemia.',\n",
              " 'anti-pd-l1 antibodyanti-pd-l1 antibody present invention anti-pd-l1 antibody capable repeated administration animals rat. anti-pd-l1 antibody comprising (a) light chain comprising light chain variable region containing cdr1 amino acid sequence qsllysenqkdy (seq id no: 37), cdr2 amino acid sequence cdr3 amino acid sequence gqylvypft (seq id no: 38) light chain stant region antibody animal rat; (b) heavy chain comprising heavy chain variable region containing cdr1 amino acid sequence gytftsnf (seq id no: 39), cdr2 amino acid sequence iypeygnt (seq id no: 40) cdr3 amino acid sequence aseeavislvy (seq id no: 41) heavy chain constant region antibody animal rat. pharmaceutical composition comprising anti-pd-l1 antibody active ingredient. method preparing anti-pd-l1 antibody provided. [fig. 10]',\n",
              " 'methods predicting anti ctla-4 response recurrence cancerprovided methods predicting patient respond administration anti-ctla-4 antibody treatment cancer melanoma. methods include predicting patient suffering melanoma, increased response administration anti-cti-a-4 antibody ipilimumab, based elevated level ctla-4 receptors patient, elevated level proliferation patient immune cells treatment cell activator? ipilimumab, and/or elevated level proliferation healthy donor t-cells treatment t-cell activator patient sera. furthermore, methods predicting recurrence melanoma survival rate, based ctla-4 receptor levels proliferation levels t-cells described herein.',\n",
              " 'composition treating breast cancer application thereofthe invention composition treating breast cancer. composition comprises aurora kinase inhibitor immune checkpoint inhibitor. composition provided invention, aurora kinase inhibitor immune checkpoint inhibitor combined treat breast cancer, especially triple-negative breast cancer; curative effect remarkable thanthat utilizing aurora kinase inhibitor immune checkpoint inhibitor treat breast cancer respectively; inhibitors obvious synergistic effect.',\n",
              " 'anti-mertk antibodies treating cancerthis disclosure isolated antibodies bind specifically mertk expressed surface cell inhibit efferocytosis mertk-expressing cell. disclosure methods treating subject afflicted cancer comprising administering subject therapeutically effective amount anti-mertk antibody monotherapy combination checkpoint inhibitor, anti-pd-1 anti-pd-l1 antibody.',\n",
              " 'methods making tolerogenic dendritic cellsthe disclosure features lipid nanoparticle (lnp) compositions comprising immune checkpoint inhibitor molecules thereof. lnp compositions present disclosure comprise mrna therapeutics encoding immune checkpoint inhibitor polypeptides,',\n",
              " 'neural stem cell-mediated cancer treatmentprovided methods compositions treating cancer combination neural stem cells (nscs) oncolytic virus combination oncolytic virotherapy immune modulation. method entails administrating subject pharmaceutical composition comprising combination nscs oncolytic virus, and/or nscs packaged immunomodulatory viruses expressing immunity checkpoint inhibitors, including adaptive immunity checkpoint inhibitors innate immunity checkpoint inhibitors. immunity checkpoint inhibitors include shrnas immunity checkpoint proteins. cancer includes limited primary, recurrent, metastatic brain cancer, breast cancer, head neck cancer, bladder cancer, ovarian cancer, uterine cancer, prostate cancer, skin cancer, lung cancer, colorectal cancer.',\n",
              " 'yeast-brachyury immunotherapeutic compositionsdiscloses immunotherapeutic composition comrpising yeast vehicle, brachyury antigen agent selected group consisting immunotherapeutic virus-based vaccine, cytokine, t-cell co-stimulator, immunomodulator, cd40, anti-ctla-4 antibody, anti-pd-1, anti-pd-l1, anti-pd-l2 manufacture medicament treating cancer. discloses recombinant nucleic acid molecule encoding fusion protein comprising brachyury antigen.',\n",
              " 'combination therapy anti-il-8 antibodies anti-pd-1 antibodies treating cancerprovided methods clinical treatment tumors (e.g., advanced solid tumors) patients anti-il-8 antibody combination anti-pd-1 and, optionally, anti-ctla-4 antibody.',\n",
              " 'anti-pd-l1 antibodiesanti-pd-l1 antibodies present disclosure relates antibodies antigen-binding fragments thereof bind pd-l1, methods antibodies antigen-binding fragments. example, present invention humanized anti-pd-l1 antibodies methods thereof. figure 1',\n",
              " 'anti-tumor polypeptide blood detection antibody kit thereofthe invention discloses anti-tumor polypeptide, artificially synthesized polypeptide designed computer aided design composed 55 amino acids. optimization process ofthe anti-tumor polypeptide, conventional polypeptide design strategy selectively replacing adding deleting amino acids adopted, amino acid side chain reconstruction strategy combined design idea, ideal polypeptide structure obtained large extent. anti-tumor polypeptide disclosed invention short peptide chain, obtainedby conventional fmoc solid-phase synthesis pd-1 inhibitor relatively high inhibition activity tumors. basis anti-tumor polypeptide, monoclonal antibody akit obtained detect content anti-tumor polypeptide blood development process.',\n",
              " 'compositions methods modulating anti-tumor immunitythe present invention methods treating cancer combination therapy cdk4/6 inhibitors immune checkpoint inhibition.',\n",
              " 'anti-ctla-4 antibodies depleting ctla-4-positive cellsdescribed anti-ctla-4 antibody molecules nucleotide sequences expression vectors, viruses, encoding antibody molecules. antibody molecules treg depleting antibody molecules, improved depleting effect ctla-4 positive cells, tregs, compared ipilimumab. described antibody molecules nucleotide sequences viruses medicine, treatment cancer, solid tumours.',\n",
              " 'treatment cancer tg02.the present disclosure therapeutic methods treating cancer patient tg02 therapeutic agent, e.g., tg02 immune checkpoint inhibitor, tg02 cox-2 inhibitor, tg02 immune checkpoint inhibitor cox-2 inhibitor.',\n",
              " 'multi-target complex loaded liposome drug-loaded platform containing applicationdisclosed present invention multi-target complex loaded liposome drug-loaded platform containing application. multi-target complex loaded liposome contains: stimulator interferon genes (sting) agonist, immune checkpoint inhibitor, ectonucleotide pyrophosphatase/phosphodiesterase (enpp1) inhibitor, liposome; immune checkpoint inhibitor targets different immune checkpoint epitopes; mass ratio sting agonist enpp1 inhibitor 10:(2.5-10) 10:10; mass ratio sting agonist immune checkpoint inhibitor 10:(2.5-100) 10:100. multi-target complex loaded liposome present invention co-loads sting agonist, enpp1 inhibitor, immune checkpoint inhibitor, antitumor activity multi-target complex improved.',\n",
              " 'anti-tumor polypeptide blood detection elisa kit thereofthe invention discloses anti-tumor polypeptide, artificially synthesized polypeptide designed computer aided design composed 72 amino acids. optimization process ofthe anti-tumor polypeptide, conventional polypeptide design strategy selectively replacing adding deleting amino acids adopted, amino acid side chain reconstruction strategy combined design idea, ideal polypeptide structure obtained large extent. anti-tumor polypeptide disclosed invention short peptide chain, obtainedby conventional fmoc solid-phase synthesis pd-1 inhibitor relatively high inhibition activity tumors. basis anti-tumor polypeptide, monoclonal antibody elisa kit obtained detect content anti-tumor polypeptide blood development process.',\n",
              " 'treatment cancer tg02the present disclosure therapeutic methods treating cancer patient tg02 therapeutic agent, e.g., tg02 immune checkpoint inhibitor, tg02 cox-2 inhibitor, tg02 immune checkpoint inhibitor cox-2 inhibitor.',\n",
              " 'anti-tumor polypeptide blood detection antibody kit samethe invention discloses anti-tumor polypeptide, computer-aided designed artificially synthesized polypeptide consisting 51 amino acids. anti-tumor polypeptide optimizationprocess, conventional polypeptide design strategy amino acid selective substitution addition deletion adopted, amino acid side chain modification strategy incorporated design concept, obtain desired polypeptide structure greater extent. anti-tumor polypeptide short peptide chain, obtained solid phase synthesis conventional fmoc method, pd-1 inhibitor, inhibitory activity tumors. further, monoclonal antibody kit obtained basis anti-tumor polypeptides, detecting content anti-tumor polypeptides blood development.',\n",
              " 'compositions methods modulating anti-tumor immunitythe present invention methods treating cancer combination therapy cdk4/6 inhibitors immune checkpoint inhibition.',\n",
              " 'anti-pd-l1 antibodiesthe present invention relates anti-pd-l1 antibodies, bispecific antibodies containing domain specificity pd-l1, immunocytokines comprising anti-pd-l1 antibody fused cytokine, il-2. present invention methods treatment, pharmaceutical compositions comprising antibodies, bispecific antibodies immunocytokines.',\n",
              " 'ceacam5 adc–anti-pd1/pd-l1 combination therapyprovided methods combination treatment cancer antibody-drug conjugate (adc) targeting ceacam5 anti-pd-1 antibody anti-pd-l1 antibody, optionally platinum-containing agent cisplatin carboplatin pemetrexed. embodiments adc tusamitamab ravtansine. embodiments anti-pd-1 antibody pembrolizumab. embodiments, cancer nonsquamous non-small cell lung cancer (nsq nsclc). embodiments, cancer advanced metastatic nsq nsclc.',\n",
              " 'ipilimumab variants enhanced specificity binding low phthe present disclosure variant forms anti-ctla-4 antibodies, ipilimumab, preferentially bind ctla-4 low ph. antibody variants exhibit preferential activity tumor microenvironment, enhanced ratio anti-tumor response side-effects, enhanced therapeutic index.',\n",
              " 'peptides peptidomimetics combination cell activating and/or checkpoint inhibiting agents cancer treatmentthis invention compounds including peptides peptidomimetics treat cell proliferative disorders, associated benign malignant tumor cells, combinations cisplatin carboplatin, immune checkpoint inhibitors. invention compounds combinations inhibit cell growth, treat tumor cancer.',\n",
              " 'glutamine antagonists thereofglutamine antagonists treating oncological, immunological, neurological diseases disclosed. disclosed methods treating oncological, immunological, infectious neurological disease disorder, method comprising administering subject treatment thereof therapeutically effective amount glutamine antagonist disclosure pharmaceutical composition thereof. disclosed methods enhancing effects immune checkpoint inhibitor, enabling subject respond immune checkpoint inhibitor, enabling toxicity dose number treatments immune checkpoint inhibitor reduced, comprising administering subject treatment thereof therapeutically effective amount glutamine antagonist disclosure pharmaceutical composition thereof, immune checkpoint inhibitor. disclosed methods treating oncological, immunological, infectious neurological disease disorder refractory checkpoint inhibitor therapy, method comprising administering subject thereof, refractory disease disorder, therapeutically effective amount glutamine antagonist disclosure pharmaceutical composition thereof.',\n",
              " 'anti-pd-l1 antibodiesthe present invention relates anti-pd-l1 antibodies, bispecific antibodies containing domain specificity pd-l1, immunocytokines comprising anti-pd-l1 antibody fused cytokine, il-2. present invention methods treatment, pharmaceutical compositions comprising antibodies, bispecific antibodies immunocytokines.',\n",
              " 'pharmaceutical anti-pd-1(cd279) antibodiesthe present disclosure relates pharmaceutical composition containing cdr defined anti-pd-1 antibodies. antibodies directed extracellular part pd-1. derived humanized antibodies tested binding activities compared nivolumab.',\n",
              " 'treatment her2 negative, mammaprint high risk 2 breast cancer.the invention relates parp inhibitor, immune checkpoint inhibitor, combination thereof, medicament. invention relates kit parts pharmaceutical composition comprising parp inhibitor immune checkpoint inhibitor, preferably method treating breast cancer.',\n",
              " 'construction method application prediction model non-small cell lung cancer immune checkpoint inhibition treatment effect based organ metastasis spectrumthe invention relates field biomedicine, particular construction method application prediction model non-small cell lung cancer immune checkpoint inhibition treatment effect based organ metastasis spectrum. construction method comprises steps: evaluating comparing influence different baseline transfer organs oak queue pfs patients attezumab group docetaxel group, prediction effect transfer organ spectrum different pd-l1 expression level stratification atezumab group docetaxel group oak queue, different transfer organ types numbers attezumab group docetaxel group pd-l1 positive oak queue; establishing scoring system metscore based organ transfer spectrum, performing multivariable cox proportional risk regression, predicting clinical result ici treatment calculating total score prognosis effect prediction effect. immunotherapy prediction prognosis effects metastatic organ spectrum advanced nsclc patient described, clinical decisions tumor immunotherapy patients facilitated, understanding metastatic organ specificity anti-tumor immunity improved.',\n",
              " 'anti-b7-h1 anti-ctla-4 antibodies treating non-small cell lung cancerthe invention relates anti-b7-h1 anti-ctla-4 antibodies treating non-small cell lung cancer. provided methods treating non-small cell lung cancers comprising administering effective amount medi4736 antigen-binding fragment thereof tremelimumab antigen- binding fragment thereof.',\n",
              " 'anti-pd-l1 antibodies variantsprovided anti-pd-l1 antibodies, variants, mutants, antigen binding fragments thereof. provided isolated nucleic acid molecules encode anti-pd-l1 antibodies, variants, mutants, antigen binding fragments thereof, related expression vectors, host cells. provided methods making anti-pd-l1 antibodies, variants, mutants, antigen binding fragments thereof. provided related pharmaceutical compositions methods treat subjects.',\n",
              " 'gastric cancer patient prognosis biomarker application thereofthe invention relates application prognosis biomarker gastric cancer patient preparation detection tool prognosis immune checkpoint inhibitor treatment response gastric cancer patient, biomarker comprises cg06804210, cg19410791 cg12606911, prognosis gastric cancer patient immune checkpoint inhibitor treatment response detected analyzing methylation level biomarker. prognosis gastric cancer patient immune checkpoint inhibitor treatment response evaluated. correlation methylation levels methylation sites cg06804210, cg19410791 cg12606911 cd8a gene prognosis gastric cancer patient immune microenvironment gastric cancer tumor environment discovered time, methylation sites biomarkers evaluating prognosis gastric cancer patient treatment response immune checkpoint inhibitor based discovery. compound important value treatment gastric cancer patients.',\n",
              " 'information providing method predicting occur autoimmune encephalitisthe present invention relates information providing method predicting autoimmune encephalitis occurrence possibility, side effect atezolizumab, comprises: step confirming hla genotype blood sample isolated individual; step determining genotype hla-b*27:05 hla-c*01:02, possibility developing encephalitis higher hla genotypes. present invention, immune checkpoint inhibitor determined advance.',\n",
              " 'substituted biphenyl compound preparation method, application pharmaceutical composition thereofthe invention discloses immune checkpoint inhibitor substituted biphenyl compound capable blocking pd-1/pd-l1 signal path preparation method, application pharmaceutical composition immune checkpoint inhibitor substituted biphenyl compound, compound shown formula i, pharmaceutically acceptable salt, racemate, optical isomer solvent compound compound. compound structure, orally taken, overcomes defects treatment resistance monoclonal antibody immune checkpoint inhibitors, simple prepare small molecule inhibitor, convenient industrial production.',\n",
              " 'hif-1-alpha inhibitors cancer immunotherapythe present invention relates hypoxia-inducible factor (hif) inhibitors cancer immunotherapy. specifically, disclosure methods treating cancer subject cancer immunotherapy, comprising administering hif-1a inhibitor subject cancer immunotherapeutic agent subject, hif-1a inhibitor comprising echinomycin, cancer immunotherapeutic agent comprising anti-ctla-4 antibody including ipilimumab tremelimumab.',\n",
              " 'anti-pd-1 antibody treatment patients colorectal cancerthis disclosure methods treating tumor derived colorectal cancer exhibiting high degree microsatellite instability subject comprising administering subject anti-pd-1 antibody. embodiments, method comprises administering anti-ctla-4 antibody. embodiments, colorectal cancer rectal cancer, colon cancer, combination thereof.',\n",
              " 'combination therapy biomarker indicating efficacy thereofthe present disclosure method treating microsatellite stable cancer patient specific combination medical agents composition combination therefor. specific combinations medical agents include combination cancer stem cell inhibitor (e.g., napabucasin) immune checkpoint inhibitor (e.g., pembrolizumab). mss patient selected determining patient patient characteristics. aspect disclosure method predicting responsiveness patient cancer treatment based patient characteristics.',\n",
              " 'systems methods identifying responders non-responders immune checkpoint blockade therapytechniques determining subject respond immune checkpoint blockade therapy. techniques include obtaining expression data subject, expression data determine subject expression levels genes selected set predictor genes consisting braf, acvr1b, mprip, prkag1, stx2, agpat3, fyn, cmip, robo4, rab40c, haus8, snap23, snx6, acvr1b, mprip, cops3, nlrx1, elac2, mon1b, arf3, arpin, spryd3, fli1, tirap, gse1, polr3k, pigo, mfhas1, npipa1, dph6, erlin2, ces2, lhfp, naif1, alcam, syne1, spint1, smtn, slca46a1, sap25, wisp2, tstd1, nlrx1, npipa1, hist1h2ac, fut8, fabp4, erbb2, tuba1a, xage1e, serpinf1, rai14, sirpa, mt1x, nek3, tgfb3, usp13, hla-drb4, igf2, mical1; determining, determined expression levels statistical model trained expression data indicating expression levels plurality genes plurality subjects, subject respond immune checkpoint blockade therapy.',\n",
              " 'combination therapy anti-pvrig antibodies formulations anti-pd-1 antibodies.the present invention directed combination treatments anti-pvrig antibodies anti-pd-1 antibodies, particular nivolumab, stable liquid pharmaceutical formulations thereof.',\n",
              " 'combinations anti human cd39 antibody, anti human pd-1 antibody, chemotherapy gastric cancerprovided dosing combination therapies cd39 antibody, pd-1 antibody, folfox capox gastric cancer. immune checkpoint inhibitors revolutionized cancer treatment paradigm. agents modulate tumor microenvironment aspects immune system overcome immune suppression tumor elicits host immune system. anti-pd-1/programmed cell death ligand-1 (pd-l1 ) agents target immunosuppressive pathways shown beneficial numerous tumor types.',\n",
              " 'anti–ctla-4 antibodythe present disclosure anti–ctla-4 antibody production method usage method anti–ctla-4 antibody. present disclosure nucleic acid codes anti–ctla-4 antibody host cells include nucleic acid. present disclosure polypeptide includes mutant fc region includes amino acid modification parent fc region production method usage method polypeptide.',\n",
              " 'near-infrared (nir) photoimmunotherapy (pit) treatment cancers anti-cd25 antibody-phthalocyanine dye conjugate anti-pd1 antibodythe present disclosure relates near-infrared (nir) photoimmunotherapy (pit) treating subject cancer, cancer comprising tumor primary tumor, metastatic tumor cells and/or invasive tumor cells. method includes administering subject targeting molecule binds cd25 conjugated phthalocyanine dye, ir700, administering immune checkpoint inhibitor anti pd-1 antibody, illuminating tumor primary tumor wavelength light suitable activation phthalocyanine dye.',\n",
              " 'pharmazeutical combination (treg depleting agent, checkpoint inhibitor, tlr9 agonist) treatment cancerthe present disclosure relates pharmaceutical combination, comprising components: a) regulatory cell (treg) -depleting agent, b) toll-like receptor 9 (tlr9) agonist, c) immune checkpoint inhibitors, treatment cancer humans non-human mammals.',\n",
              " 'immunotherapy combination therapy comprising immunotoxinprovided combination method combination therapy treat tumor individual. immunotoxin immunostimulator administered individual, immunotoxin comprises single chain variable region antibody fused pe38 truncated pseudomonas exotoxin, immunostimulator comprises anti-cd40 agonist antibody. combination comprise checkpoint inhibitor comprising anti-pd- 1 antibody anti-pd-l1 antibody.',\n",
              " 'peptides peptidomimetics combination cell activating and/or checkpoint inhibiting agents cancer treatmentthis invention compounds including peptides peptidomimetics treat cell proliferative disorders, associated benign malignant tumor cells, combinations cell activating agents and/or immune checkpoint inhibitors peptides peptidimimetics. invention compounds combinations inhibit cell growth, treat tumor cancer.',\n",
              " 'compositions thereofthe invention composition application thereof, composition comprises heparan sulfate analogue shown formula (i), salt thereof immune checkpoint inhibitor, immune checkpoint inhibitor comprises pd-1 pd-l1. invention, heparan sulfate analogue shown formula (i) salt thereof combined immune checkpoint inhibitor use, heparan sulfate analogue salt thereof interact influence play synergistic effect, growth tumors inhibited, effective therapy provided treatment tumors, especially treatment liver cancer.',\n",
              " 'combination therapy treatment prevention tumoursthe present invention relates combination therapy tumours comprising administration epoxytiglianc compound immune checkpoint inhibitor. particular embodiments, method treating tumour and/or treating preventing bystander tumours therapy. pharmaceutical compositions kits containing epoxytigliane compounds immune checkpoint inhibitors described.',\n",
              " 'evaluating method pharmacological actions immune checkpoint inhibitors, calculating method, evaluating apparatus, calculating apparatus, evaluating program, calculating program, recording medium, evaluating system, terminal apparatusan evaluating method includes evaluating step evaluating pharmacological action immune checkpoint inhibitor subject evaluated, (i) concentration value metabolite glu, arg, orn, cit, his, val, phe, tyr, met, pro, asn, leu, lys, thr, ile, gln, ala, ser, a-aba, trp, gly, antha, hantha, hiaa, hkyn, htrp, iaa, ila, kyn, kyna, nfkyn, np, pa, qa, serot, xa blood subject evaluated, (ii) value formula calculated concentration value formula including explanatory variable substituted concentration value.',\n",
              " 'preparation application tumor immune microenvironment regulating agentthe invention tumor immune microenvironment regulating agent consists components: protective agent crushed poecilobdella manillensis. protective agent comprises components: 5% skimmed milk powder, cane sugar, vitamin c, propolis glycerol. further, ratios raw material protective agent, i.e., mass volume ratios raw material normal saline, respectively that: ratio skimmed mild powder 5%, ratio cane sugar 3%, ratio vitamin 0.5%, ratio propolis 0.1% ratio glycerol 8%. invention, positive immunization driven regulating controlling tumor immune microenvironment, i.e., infiltration ratios cd8-positive t-lymphocytes (cd8+t) natural killer cells (nk) tumor microenvironment increased, m1 type tumor immune macrophages (tam) inhibited enhance sensitivity anti-tumor effect immune checkpoint inhibitor (ici) drugs pembrolizumab, nivolumab like, improve response rate (orr) ici solid tumor treatment.',\n",
              " 'innate immune checkpoint modulatorsprovided compositions methods modulating myeloid cell-mediated killing cancer cells modulating activity myeloid cell immune checkpoint inhibitors. provided methods screening modulators myeloid cell-mediated killing cancer cells modulators myeloid cell immune checkpoint inhibitors.',\n",
              " 'composition preventing treating cancer comprising bifidobacterium longum rapo (kctc13773bp)the present invention relates composition preventing treating cancer comprising bifidobacterium longum rapo (kctc13773bp), immune checkpoint inhibitors (immune anticancer drugs), side effects immune checkpoint inhibitors reduced effect promoted, resulting excellent effect preventing treating cancer.',\n",
              " 'anti-tumor medicine composition based immune checkpoint blocking application anti-tumor medicine compositionthe invention discloses anti-tumor pharmaceutical composition based immune checkpoint blocking application thereof, anti-tumor pharmaceutical composition comprises paroxetine hydrochloride cell enhancer, cell enhancer vitamin thymosin. series in-vivo in-vitro experiments, found time cannabidiol paroxetine hydrochloride effectively reduce pd-l1 expression tumor cell membranes, pd-1/pd-l1 signal channel blocked, effect cells killing tumor cells enhanced; cell enhancer added basis improve number activity cells, enhance killing ability cells immunosuppression relieved, greatly improve anti-tumor effect medicine. components cannabidiol, paroxetine hydrochloride, vitamin thymosin pharmaceutical composition play synergistic role, anti-tumor effect improved.',\n",
              " 'culture medium culturing cd90posi cells, culturing method cd90posi cells culture mediumthe invention belongs technical field cell culture, specifically relates culture medium culturing cd90posi cells, culturing method cd90posi cells culture medium. cd90posi cell culture medium provided invention, cell growth inhibitor composed pd-1 inhibitor matrine weight ratio 7:3, mutation inhibitor composed apine mushroom extract acanthopanax senticosus extract weight ratio 3:2 added basic culture medium dmem/f-12. cd90posi cells cultured three-dimensional culturemethod. culture medium provided invention culture cd90posi cells, advantages: cells easy aggregate clusters, culture speed easy control, time, activity cells ensured culture process, problem cells continue undergo mutations culture process appear.',\n",
              " \"quantitative scoring hla diversitysystems methods quantifying hla diversity solid tissue circulating tumor dna sample anticipates patient's response immune checkpoint inhibition therapy disclosed.\",\n",
              " 'methods pharmaceutical composition treatment cancerthe present invention relates methods pharmaceutical composition treatment cancer. particular, present invention relates method enhancing potency immune checkpoint inhibitor administered subject part treatment regimen cancer, method comprising: administering pharmaceutically effective amount tnfα blocking agent subject combination immune checkpoint inhibitor.',\n",
              " 'anti-tumor polypeptide monoclonal antibody elisa kit thereofthe invention discloses anti-tumor polypeptide. anti-tumor polypeptide polypeptide consisting 81 amino acids artificially synthesized computer-aided design. optimization process anti-tumor polypeptide, conventional polypeptide design strategy amino acid selective substitution addition deletion adopted, amino acid side chain modification strategy incorporated design concept obtain desired polypeptide structure greater extent. anti-tumor polypeptide short peptide length obtained solid phase synthesis conventional fmoc method. anti-tumor polypeptide pd-1 inhibitor, inhibitory activity tumors. further, monoclonal antibody elisakit obtained basis anti-tumor polypeptide, detecting content anti-tumor polypeptide blood development process.',\n",
              " 'anti-ctla-4 antibody thereofthe present invention relates anti-ctla-4 antibody and, specifically, anti-ctla-4 antibody multi-specific antibody designed basis anti-ctla-4 antibody. identified anti-ctla-4 antibody present invention exhibits excellent binding ctla-4 remarkably reduces tumor size animal models. addition, multi-specific antibody designed basis anti-ctla-4 antibody exhibits excellent binding antigen 4-1bb, effectively inhibit tumors. therefore, anti-ctla-4 antibody multi-specific antibody designed basis anti-ctla-4 antibody, present invention, effectively prevention treatment tumors cancer inflammatory diseases interest.',\n",
              " 'combination therapies inhibition ttk protein kinaseprovided methods treating cancer effective amount compound represented formula pharmaceutically acceptable salt thereof effective amount immune checkpoint inhibitor. provided compositions comprising compound represented formula shown pharmaceutically acceptable salt thereof immune checkpoint inhibitor.',\n",
              " 'combination therapies inhibition polo-like kinase 4provided methods treating cancer effective amount compound represented formula: pharmaceutically acceptable salt thereof effective amount immune checkpoint inhibitor. provided compositions comprising compound represented formula shown pharmaceutically acceptable salt thereof immune checkpoint inhibitor.',\n",
              " 'anti-pd-l1/vegf fusion proteinan anti-pd-l1/vegf fusion protein provided comprises anti-pd-l1 antibody, peptide linker d2 domain vegfr1, n-terminal d2 domain vegfr1 connected c-terminal anti-pd-l1 antibody heavy chain peptide linker l. fusion protein provided invention potential treating pd-l1 vegf activity related diseases.',\n",
              " 'enhanced immunotherapy cancer targeted transcriptional modulatorsthe present invention relates combination signal transducer activator transcription 3 (stat3) activity inhibitor; immune checkpoint inhibitor treating preventing hyperproliferative disorder subject. preferably, sta3 activity inhibitor pyrimethamine atovaquone, immune checkpoint inhibitor anti-pd1 antibody. preferably, hyperproliferative disorder glioma glioblastoma.',\n",
              " 'application plant host expressing pd-1 antibody and/or pd-l1 antibodyprovided application plant host expressing pd-1 antibody and/or pd-l1 antibody, plant, lettuce, effective expression platform preparing recombinant proteins, simple effective agrobacterium-mediated vacuum infiltration method expressing pd-1 monoclonal antibody (keytruda, pembrolizumab) pd-l1 monoclonal antibody (atezolizumab).',\n",
              " 'biomarkers hyperprogressive disease therapy response immunotherapythe invention relates field diagnostics guide cancer immunotherapy. specifically, invention method determining likelihood hyperprogression and/or progressive disease cancer cells response immunotherapy, immune checkpoint inhibitor treatment. furthermore, invention method determining likelihood positive response immunotherapy, immune checkpoint inhibitor treatment.',\n",
              " 'compositions containing tucaresol analogsdisclosed compositions including compound formula (i) treating cancer. embodiments relate methods treating cancer co-administering compound formula (i) immune checkpoint inhibitor subject thereof, particular, combinations tucaresol immune checkpoint inhibitors pd-l1, pd-l2, ctla-4. embodiments relate methods treating cancer co-administering compound formula (i) plinabulin subject thereof. embodiments relate methods providing co-stimulation t-cell activation cancer co-administering compound formula (i), immune checkpoint inhibitor.',\n",
              " 'anti-pd-l1 antibody application thereofthe invention anti-pd-l1 antibody antigen binding fragment thereof preparation method application anti-pd-l1 antibody antigen binding fragment thereof. invention nucleic acid coding anti-pd-l1 antibody antigen binding fragment thereof, vector containing nucleic acid, cell containing vector, detection method pd-l1. anti-pd-l1 antibody antigen binding fragment thereof disclosed invention advantages strong specificity high affinity, treating diseases related pd-l1 expression detecting pd-l1 expression level.',\n",
              " 'methods assessing treating cancer subjects dysregulated lymphatic systems combination vegfr-3 pd-1 pd-l1 inhibitorsprovided method determining cancer treatment immune modulating therapy subject thereof. method comprises assessing lymphatic system subject dysregulated. lymphatic system dysregulated, treatment lymphatic system determined therapeutic amount immune modulating therapy administered treat cancer subject. alternatively, lymphatic system dysregulated, immune modulating therapy selected treat cancer subject, immune modulating therapy independent immune-cell priming, antigen trafficking, antigen presentation, combination thereof. subject treated cancer accordingly.',\n",
              " 'radiomics-based treatment decision support lung cancertwo major treatment strategies employed fighting non-small cell lung cancer (nsclc) tyrosine kinase inhibitors (tkis) immune checkpoint inhibitors (icis). choice strategy based heterogeneous biomarkers expressed lung tumor tissue. major challenge molecular testing biomarkers insufficiency biopsy specimens patients advanced nsclc. disclosed method predicting response immune-checkpoint blockade immunotherapy. method generally involves imaging subject positron emission tomography 2-deoxy-2-[fluorine-18] fluoro-d-glucose integrated computed tomography produce 18 f-fdg pet/ct images tumor, analyzing images pet, ct, kulbek leibler divergence statistical (kld) features or, alternatively deep leaning neural networks; generating radiomic signature identified features network characteristics; computing radiomic score based radiomic signature predictive responsiveness icis tkis.',\n",
              " 'anti-tumor composition based immune checkpoint blockage application thereofthe invention anti-tumor composition based immune checkpoint blockage application thereof. biological mechanism composition tumor treatment process demonstrated. anti-tumor composition comprises immune checkpoint inhibitor macrophage reaction blocker. anti-tumor composition anti-tumor effect; immune checkpoint inhibitor macrophage reaction blocker remove different tumor promoting factors respectively, synergistic effect realized combination immune checkpoint inhibitor macrophage reaction blocker, tumor growth effectively restrained. thus, composition broad clinical application prospects.',\n",
              " 'co-expression secretory anti-immune checkpoint antibody, intracellular immune checkpoint inhibiting molecule tegfr molecule application thereofthe invention expression vector, lentivirus, transgenic cell, secretory antibody therapeutic composition treating cancer. expression vector carries nucleic acid molecules: (a) nucleic acid molecule, encoding secretory immune checkpoint inhibiting molecule fragment; (b) nucleic acid molecule, silencing intracellular immune checkpoint optionally carrying nucleic acid molecule, nucleic acid molecule encoding non-functional egfr. expressionvector embodiment invention introduced receptor cells, secretory anti-immune checkpoint antibody efficiently expressed receptor cells secreted cells,meanwhile, immune checkpoint molecules receptor cells specifically silenced, immune escape mechanism mediated immune checkpoint repressed. expression vector embodiment invention introduced receptor cells, lymphocytes, proliferation capacity effect function lymphocytes enhanced, specific killing tumor cells stronger effective.',\n",
              " 'combination therapy colorectal carcinomathe invention method treating colorectal carcinoma combination anti- lag-3 antibody anti-pd-1 anti-pd-li antibody. aspects, combination comprises 480 mg antibody as, example, 480 mg anti-lag-3 antibody (e.g, relatlimab) 480 mg anti-pd-1 antibody (e.g, nivolumab). aspects, colorectal carcinoma unresectable, advanced, metastatic, including, example, microsatellite stable high microsatellite instable colorectal carcinoma.',\n",
              " 'anti-pd-l1 antibodiesanti-pd-l1 antibodies disclosed. disclosed pharmaceutical compositions comprising antibodies, methods same.',\n",
              " 'anti-ctla-4 antibodyproblem solved: anti-ctla-4(cytotoxic lymphocyte antigen-4) antibody pharmaceutical composition. solution: human anti-ctla-4 antibody antibody amino acid sequence anti-ctla-4 antibody, especially antibody 3.1.1, 4.1.1, 4.8.1, 4.10.2, 4.13.1, 4.4.3, 6.1.1, 11.2.1, 11.6.1, 11.7.1, 12.3.1.1 12.9.1.1, treating specific cancers.',\n",
              " 'combination ezh2 inhibitor checkpoint therapy treatment cancerprovided methods treating cancer comprising administering ezh2 inhibitor combined immune checkpoint inhibitor. provided methods depleting regulatory cells (tregs) subject comprising administering ezh2 inhibitor subject. provided pharmaceutical compositions comprising cpi- 1205 immune checkpoint inhibitor.',\n",
              " 'cancer treatment method drugthe invention composition, composition, medical device treating, preventing preventing cancer tumor relapse. present invention composition, composition, medical device, treating, preventing, preventing recurrence cancer tumor, comprise immune checkpoint inhibitor dendritic cell direct activator mechanism. embodiment, present invention provides: cancer treatment method immunotherapy; cancer treatment method; cancer treatment method expect excellent treatment effect treatment performed administration immune checkpoint inhibitor treatment improving sensitivity immune checkpoint inhibitor combination cancer treatment.',\n",
              " 'method treating cancer immunomodulationdisclosed method treating, preventing ameliorating tumor growth administering therapeutic agent selectively inhibits dipeptidyl peptidases, including fibroblast activating protein dipeptidyl peptidases 8/9, combination immune checkpoint inhibitor. methods specifically disclose combination tarlastat immune checkpoint inhibitor, pharmaceutical compositions thereof, methods preparing compositions.',\n",
              " 'pharmaceutical composition treatment triple-negative breast cancerthe present invention relates pharmaceutical composition treatment triple-negative breast cancer, immune checkpoint inhibitor administered combination radiation therapy, treatment immune checkpoint inhibitor radiation therapy alone, therapeutic effect triple-negative breast cancer enhanced, abscopal effect achieved.',\n",
              " 'pharmaceutical composition liposome preparation regulating epigenetic immune checkpointsthe invention belongs technical field anti-tumor pharmacy, discloses pharmaceutical composition liposome preparation regulating epigenetic immune checkpoints. preparation comprises pharmaceutical composition liposome loading pharmaceutical composition, pharmaceutical composition comprises epigenetic regulator immune checkpoint inhibitor; pharmaceutical composition liposome preparation regulate tumor immunogenicity and/or inhibit tumor growth and/or inhibit tumor metastasis. epigenetic regulator immune checkpoint inhibitor loaded lipidosome, correspondingly obtained lipidosome preparation efficiently encapsulate epigenetic regulator immune checkpoint inhibitor, targeted tumors released sustained controlled release manner, particularly tumor immune combined therapy.',\n",
              " 'pd-1 antagonist anti-ccr2 antibody treatment cancerthe present disclosure relates methods treatment cancers administering anti-pd-1 antagonists combination anti-ccr2 antibodies. preferred embodiment, plozalizumab (also mln1202) combination pembrolizumab (also keytruda) treat non-small cell lung cancer humanized nsg mice.',\n",
              " 'enhancing t-cell function treating t-cell dysfunctional disorder combination lsd inhibitor pd1 binding antagonistthe present invention relates composition enhancing t-cell function treating t-cell dysfunctional disorder, composition comprising, consisting consisting essentially lysine specific demethylase (lsd) inhibitor (which mao inhibitor phenelzine) programmed cell death protein- 1 (pd-1) binding antagonist (which antibody, preferably nivolumab, pembrolizumab, lambrolizumab pidilizumab).',\n",
              " 'methods anti-tumor therapythe disclosure methods treating tumor subject thereof comprising administering subject combination effective dose vector comprising fas-chimera gene operably linked endothelial cell-specific promoter effective dose immune checkpoint inhibitor. aspects disclosure, immune checkpoint inhibitor pd-1 antagonist pd-l1 antagonist.',\n",
              " 'methods modulating immune responsethe present disclosure methods modulating immune response individual. present disclosure methods treatment. present disclosure methods comprising administering multimeric polypeptide (syntac) immune checkpoint inhibitor individual. present disclosure methods comprising administering multimeric polypeptide (syntac) individual undergoing treatment immune checkpoint inhibitor.',\n",
              " 'dosing regimens anti-ilt4 antibody combination anti-pd-1 antibody treating cancerprovided dosing regimens anti-immunoglobulin-like transcript 4 (anti-ilt4) antibody treating cancer. provided dosing regimens treating cancer combination anti-ilt4 antibody agent ( e.g. , pd-1 antagonist, anti-pd-1 antibody anti-pd-l1 antibody).',\n",
              " 'anti-pd-l1 antibody thereofthe present invention relates anti-pd-l1 antibody thereof. specifically, present invention relates anti-pd-l1 antibody, antigen-binding fragment antibody, useof antibody diagnosing treating cancer, predicting prognosis.',\n",
              " 'approach treatment cancer immunomodulation talabostatthe present invention discloses method treating, preventing ameliorating tumor growth administering therapeutic agent selectively inhibits dipeptidyl peptidase including fibroblast activation protein dipeptidyl peptidase 8/9 combination immune checkpoint inhibitor. method specifically discloses talabostat combination immune checkpoint inhibitor, pharmaceutical composition process preparing composition.',\n",
              " 'combination therapies treating disease innate immunity modifier ox40 agonistthe present disclosure method treating cancer comprising administering selective dipeptidyl peptidase inhibitor ox40 agonist immune checkpoint inhibitors subject cancer. present disclosure pharmaceutical compositions treating cancer comprising selective dipeptidyl peptidase inhibitor ox40 agonist immune checkpoint inhibitors.',\n",
              " 'pharmaceutical combination method regulation tumor microenvironment immunotherapythe present invention relates method removing immune suppression tumor microenvironment stimulating immune system cancer cells, comprising administering combination hdac inhibitor nsaid combination immune checkpoint inhibitor patient. combination pharmaceutical combination immune checkpoint inhibitor present invention significantly eradicate tumors increase survival rate 70 80%.',\n",
              " 'anti-pd-l1 antibody functional fragment application thereofthe invention belongs field biomedicine discloses aspects including anti-pd-l1 antibody functional fragment thereof, nucleic acid molecule, expression vector,a host cell, preparation method anti-pd-l1 antibody functional fragment thereof, immunoconjugate pharmaceutical composition thereof application anti-pd-l1 antibodyor functional fragment thereof preparation drugs treating cell dysfunctional diseases. nucleic acid molecule encoding anti-pd-l1 antibody functional fragmentthereof, expression vector expressing anti-pd-l1 antibody functional fragment thereof, immunoconjugate comprises anti-pd-l1 antibody functional fragmentthereof.',\n",
              " 'method predicting sensitivity patients nsclc (non-small cell lung cancer) immunotherapiesthe invention discloses method predicting sensitivity patients cancer (non-small cell lung cancer) immunotherapies, immunotherapy immune checkpoint inhibitor, kmt2c tp53 genes biomarkers, discloses application reagent, detects biomarkers specifically, preparation kits predict sensitivity patients acancer (non-small cell lung cancer) immunotherapies, immunotherapy immune checkpoint inhibitor. combinatory consideration tp53 kmt2c gene mutation states herein, groups sensitive icis (immune checkpoint inhibitors) predicted accurately patients nsclc (non-small cell lung cancer), blind medication avoided, economy ici therapy isimproved.',\n",
              " 'anti-pd-l1 diabodies thereofprovided anti-pd-l1 diabodies, imaging agents, methods kits determination distribution expression levels pd-l1 individual disease condition. anti-pd-l1 diabody agents, methods treating diseases disorders provided.',\n",
              " 'composition treating non-small cell lung cancer preparation thereofthe invention relates composition treating non-small cell lung cancer preparation thereof, belongs field drugs. composition comprises immune checkpoint inhibitor parishin compound, weight ratio immune checkpoint inhibitor parishin compound 1:(0.1-1). invention relevant preparation andapplication composition.',\n",
              " 'baseline serum autoantibodies predicting recurrence toxicity immune checkpoint blockade cancer patientsprovided compositions methods determining baseline serum autoantibodies (autoabs) patient selection treatment immune checkpoint blockade agents promote avoidance development severe immune related adverse events (iraes). treatments include administering anti-cancer agents predicted toxicity selected patients, administering agents reduce predicted toxicity selected patients.',\n",
              " 'medicament treating and/or preventing cancerthe present invention relates medicament treating and/or preventing cancer, particular, non-treatment-resistant cancer combination immune checkpoint inhibitor, contains, active ingredient, selected group consisting antibodies specific il-34, derivatives thereof, inhibitory nucleic acids il-34 immune checkpoint inhibitor.',\n",
              " 'recombinant anti-pd-l1 monoclonal antibodythe invention discloses recombinant anti-pd-l1 monoclonal antibody, relates technical field biological medicines, providing effective treatment medicine patients advanced metastatic cancers, particular patients ineffective drug-resistant treatment existing anti-pd-l1 medicine. complementarity determining region antibodyhas sequences shown seq id no: 1 seq id no: 6. compared existing anti-pd-l1 drug, antibody unique binding epitope, affinity human pd-l1 tumorinhibition effect.',\n",
              " 'anti-pd-l1 antibodies fusion proteins thereofthe invention relates generally anti-pd-l1 antibodies, recombinant sialidase anti-pd-l1 immunoglobulin antigen-binding domain fusion proteins. invention antibody conjugates including sialidase anti-pd-l1 antibody portion thereof. invention relates methods antibodies, sialidase fusion proteins, antibody conjugates treating cancer.',\n",
              " 'cd4/il-2 biomarker.this invention pertains cd4/il-2 biomarker predicts response treatment immune checkpoint inhibitors. invention pertains treatment patient tumor determined negative cd4/il-2 biomarker. provided kit determining cd4/il biomarker predicts response treatment immune checkpoint inhibitors.',\n",
              " 'triple combination therapy enhancing cancer cell killing cancers low immunogenicitydisclosed composition methods treating condition enhanced immunogenicity desired. embodiments disclosed relate compositions comprising t-cell activator and/or proliferator, immune checkpoint inhibitor, fpps inhibitor. embodiments relate methods treating cancer co-administering plinabulin, immune checkpoint inhibitor, fpps inhibitor subject thereof.',\n",
              " 'predictive marker sensitivity immune checkpoint blockade prostate cancer cancer typesthe present invention relates vitro method identifying and/or selecting subjects suffering cancer affected microsatellite instability-like (msi-like) cancer and/or responsive immune checkpoint blockade (icb) therapy, kit computer program enabling identification and/or selection. method involves determining expression levels signature markers cd11b (itgam) and/or cd11c (itgax).',\n",
              " 'anti-pd-l1 antibody application thereofthe invention discloses anti-pd-l1 antibody application thereof, relates field antibodies, anti-pd-l1 antibody capable specifically combined pd-l1 functional fragment thereof, cdrs anti-pd-l1 antibody selected (1)-(14); present invention, antibody functional fragment thereof specifically block combination pd-1 pd-l1, block inhibitory effect lymphocytes, immune escape mechanism tumors blocked, growth local tumors effectively inhibited, approach provided prevention treatment tumors.',\n",
              " 'anti-pd-l1 antibodies antibody-drug conjugates.provided anti-pd-l1 antibodies antibody-drug conjugates methods anti-pd-l1 antibodies antibody-drug conjugates treat cancer.',\n",
              " 'combination therapies including cell-antigen couplers checkpoint inhibitors treating cancermethods treating cancer subjects thereof administering combination therapy including (a) cell expressing cell antigen coupler (tac) polypeptide (i) antigen-binding domain binds target antigen, (ii) antigen-binding domain binds protein associated tcr complex, (iii) cell receptor signaling domain polypeptide; (b) immune checkpoint inhibitor provided.',\n",
              " 'pharmaceutical composition containing papaverine derivative thereof applicationthe invention belongs field biological medicine, particularly relates pharmaceutical composition containing papaverine derivative thereof application pharmaceutical composition. specifically, invention pharmaceutical composition treating cancer, pharmaceutical composition contains anoxia inhibitor immune checkpoint inhibitor. hypoxia inhibitor immune checkpoint inhibitor combined use, synergistic effect generated, inhibition tumor volume improved.',\n",
              " 'anti-ctla-4 antibody fusion protein preparationthe invention relates anti-ctla-4 antibody fusion protein preparation specifically, invention anti-ctla-4 antibody composition, composition comprises anti-ctla-4 monoclonal antibody, surfactant, buffer solution stabilizer. composition provided invention improve stability anti-ctla-4 antibody.',\n",
              " 'anti-pd-l1 antibodiesaspects invention include isolated anti-pd-l1 antibodies, compositions containing antibodies, methods treatment diseases conditions mediated pd-l1 signaling.',\n",
              " 'agents treating cancersdisclosed agent treating cancer combination immunotherapeutic agent, immune checkpoint inhibitor. present disclosure, botulinum toxin composition comprising cancer treatment agent combination immunotherapeutic agent, example, immune checkpoint inhibitor. object present disclosure provide composition treating cancer combination immunotherapeutic agent, comprising botulinum toxin active ingredient.',\n",
              " 'nanodrug composites preparation method therof samethe present invention immune checkpoint inhibitor-nano-photosensitizer complex comprising: nano-photosensitizer comprising photosensitizer coupled biodegradable polymer support; polyethylene glycol bound nano-photosensitizer; extracellular enzyme-sensitive peptides bound nano-photosensitizer; immune checkpoint inhibitor bound extracellular enzyme-sensitive polymer. present invention biomarker diagnosis treatment cancer.',\n",
              " 'agents treating cancersdisclosed agent treating cancer combination immunotherapeutic agent, immune checkpoint inhibitor. present disclosure, botulinum toxin composition comprising cancer treatment agent combination immunotherapeutic agent, example, immune checkpoint inhibitor. object present disclosure provide composition treating cancer combination immunotherapeutic agent, comprising botulinum toxin active ingredient.',\n",
              " 'anti-cd47/anti-pd-l1 antibody application thereofthe invention relates technical field antibody drugs particularly relates anti-cd47/anti-pd-l1 antibody, pharmaceutical composition containing anti-cd47/anti-pd-l1 antibody application anti-cd47/anti-pd-l1 antibody. anti-cd47/anti-pd-l1 antibody disclosed invention remarkable anti-tumor activity, obvious erythrocyte toxicity applied preparation antitumor drugs.',\n",
              " 'anti-pd - l1 human antibody application thereofthe present invention relates anti-pd - l1 human antibody application thereof, particular, human antibody capable specifically binding pd-l1 screened yeast display technology, affinity antibody improved affinity maturation. anti-pd - l1 human antibody specificity, high affinity stability, cell activation effect enhanced binding activated cell, anti-pd - l1 human antibody significant tumor growth inhibition effect. present invention relates application anti-pd - l1 human antibody diagnosis treatment pd-l1-associated tumors.',\n",
              " 'anti-ctla-4 nanobody medicine composition application anti-ctla-4 nanobody medicine compositionthe invention relates anti-ctla-4 nanobody medicine composition application anti-ctla-4 nanobody medicine composition. provided anti-ctla-4 nanobody selected following: (1) cdr1 shown kyiysnyc, cdr2 shown iytggsnt cdr3 shown aatsrrwcsslekqvfgy; (2) conservative amino acid substitution comparedwith (1). provided anti-ctla-4 nanobody high binding capacity extracellular segment ctla-4 tumor diagnosis treatment.',\n",
              " 'combination bispecific fusion protein anti-her2 antibody tumor therapythe present disclosure immune checkpoint inhibitor combination her2 inhibitor preparation medicament treating tumor subject thereof, pharmaceutical composition comprising effective amount immune checkpoint inhibitor effective amount her2 inhibitor optionally comprising pharmaceutically acceptable excipient, pharmaceutical composition preparation medicament treating tumor subject thereof.',\n",
              " 'anti-pd-l1 antibodiesaspects invention include isolated anti-pd-l1 antibodies, compositions containing antibodies, methods treatment diseases conditions mediated pd-l1 signaling.',\n",
              " 'methods treating tumorthe disclosure method treating subject afflicted tumor derived non-small cell lung cancer (nsclc) comprising administering subject therapeutically effective amount (a) anti- pd-1 antibody antigen-binding portion thereof anti-pd-l1 antibody antigen-binding portion thereof (b) anti-ctla-4 antibody antigen binding portion thereof, tumor high tumor mutation burden (tmb) status. tmb status determined sequencing nucleic acids tumor identifying genomic alteration, e.g., somatic nonsynonymous mutation, sequenced nucleic acids.',\n",
              " ...]"
            ]
          },
          "metadata": {},
          "execution_count": 100
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "UK9v8v9iSZKh",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "ac24f0db-f14f-49ed-eb5b-263df7f92099"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "def lemmatization (texts, allowed_postags=['NOUN','ADJ','VERB']):\n",
        "    texts_out = []\n",
        "    for text in texts:\n",
        "        doc = nlp(text)\n",
        "        new_text = []\n",
        "        for token in doc:\n",
        "            if token.pos_ in allowed_postags:\n",
        "                new_text.append (token.lemma_)\n",
        "        final = \" \".join(new_text)\n",
        "        texts_out.append (final)\n",
        "    return (texts_out)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "UiT1-qgKSZNY",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "2fb2aa65-0236-47f5-9e5c-19b0205593ce"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "txt = lemmatization (txt)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "PDzd9JvsiwXt",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "98dee3ce-2ad2-407e-fc35-303c7d3f0580"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "# Tokenization\n",
        "def tokenize (texts):\n",
        "    tokens = [word for word in nltk.word_tokenize(texts) if len(word) > 2]\n",
        "    return tokens"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "k8L0qBHdiwYz",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "e3e8458b-e65d-4594-c6a8-c4ee15781ab7"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "tok = []\n",
        "for item in txt:\n",
        "  tok.append (tokenize (item))"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from sklearn.feature_extraction.text import TfidfVectorizer\n",
        "\n",
        "# ... [your previous code to create the set 's' of stopwords] ...\n",
        "\n",
        "# Using the set 's' as stopwords for TfidfVectorizer\n",
        "vectorizer_tf = TfidfVectorizer(tokenizer=tokenize, stop_words=list(s), max_df=0.75, min_df=50, use_idf=False, norm=None)\n"
      ],
      "metadata": {
        "id": "oBVugd5VijJS",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "30af965b-84be-4e16-be7b-53104db58488"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "j8C04E9eiwck",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "9809f758-d8df-4d3e-f34b-9183446fddf9"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "#vectorizer_tf = TfidfVectorizer (tokenizer=tokenize, stop_words='english', max_df=0.75, min_df=50,  use_idf=False, norm=None) #max_features=10000,"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "yV59G7XQGGng",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "764c11d8-f076-479a-e51d-4aba86340be2"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#df"
      ],
      "metadata": {
        "id": "pVXNaQzIMZ6k",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "ac194799-1d67-41c5-9a8f-119cb24926a5"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "QEVoazI2iwjV",
        "outputId": "6b4aeafa-9e30-4a77-9a03-7a2b7b50b739"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/feature_extraction/text.py:528: UserWarning: The parameter 'token_pattern' will not be used since 'tokenizer' is not None'\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/feature_extraction/text.py:409: UserWarning: Your stop_words may be inconsistent with your preprocessing. Tokenizing the stop words generated tokens [\"'ll\", \"'re\", \"'ve\", 'aldiz', 'baizik', 'bukatzeko', 'edota', 'eze', 'ezpabere', 'ezpada', 'ezperen', 'gainera', 'gainerontzean', 'guztiz', 'hainbestez', 'horra', \"n't\", 'onların', 'ordea', 'osterantzean', 'sha', 'агар-чи', 'аз-баски', 'афташ', 'бале', 'баҳри', 'болои', 'валекин', 'вақте', 'вуҷуди', 'гар', 'гарчанде', 'даме', 'карда', 'кошки', 'куя', 'магар', 'майлаш', 'модоме', 'нияти', 'онан', 'оре', 'рӯи', 'сар', 'тразе', 'хом', 'хуб', 'чаро', 'чунон', 'шарте', 'қадар', 'ҳай-ҳай', 'ҳамин', 'ҳатто', 'ҳой-ҳой', 'ҳол', 'ҳолате', 'ӯим', 'באיזו', 'במקום', 'בשעה', 'הסיבה', 'לאיזו', 'למקום', 'מאיזו', 'מידה', 'מקום', 'סיבה', 'שבגללה', 'שבו', 'תכלית', 'أفعل', 'أفعله', 'انفك', 'برح', 'سيما', 'ἀλλ'] not in stop_words.\n",
            "  warnings.warn(\n"
          ]
        }
      ],
      "source": [
        "df1 = pd.DataFrame(data={'Text':txt})\n",
        "tf_vectors = vectorizer_tf.fit_transform (df1['Text'])"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#data.to_frame()"
      ],
      "metadata": {
        "id": "hDGmlg_ZPHi2",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "0aaca3b2-5985-40b3-d86a-0e1b6721ebdf"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df1"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 479
        },
        "id": "ssM423WKO_ud",
        "outputId": "6b8376e7-cf26-48d8-cce1-6bc1b9a01d97"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                                   Text\n",
              "0     combination comprise inhibitor ctla-4 inhibito...\n",
              "1     treatment solid present invention relate metho...\n",
              "2     combination agonist immune checkpoint inhibito...\n",
              "3     inhibitor combination immune checkpoint inhibi...\n",
              "4     method predict treatment outcome select subjec...\n",
              "...                                                 ...\n",
              "3315  combination therapy treat brain cancerprovide ...\n",
              "3316  method treat metastatic castration resistant p...\n",
              "3317  method confirm constitutional mismatch repair ...\n",
              "3318  nucleic acid sequence encode chimeric antigen ...\n",
              "3319  aminopyrazolo[1,5 compound therapeutic usethe ...\n",
              "\n",
              "[3320 rows x 1 columns]"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-45312e93-f6c3-4e41-bf63-3953f4bfcb14\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>combination comprise inhibitor ctla-4 inhibito...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>treatment solid present invention relate metho...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>combination agonist immune checkpoint inhibito...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>inhibitor combination immune checkpoint inhibi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>method predict treatment outcome select subjec...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3315</th>\n",
              "      <td>combination therapy treat brain cancerprovide ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3316</th>\n",
              "      <td>method treat metastatic castration resistant p...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3317</th>\n",
              "      <td>method confirm constitutional mismatch repair ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3318</th>\n",
              "      <td>nucleic acid sequence encode chimeric antigen ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3319</th>\n",
              "      <td>aminopyrazolo[1,5 compound therapeutic usethe ...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>3320 rows × 1 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-45312e93-f6c3-4e41-bf63-3953f4bfcb14')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-45312e93-f6c3-4e41-bf63-3953f4bfcb14 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-45312e93-f6c3-4e41-bf63-3953f4bfcb14');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-606a8ae3-4b24-4ffc-b579-0a2831589a42\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-606a8ae3-4b24-4ffc-b579-0a2831589a42')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-606a8ae3-4b24-4ffc-b579-0a2831589a42 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_72af3529-1537-4245-a13d-ba262fb8e752\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df1')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_72af3529-1537-4245-a13d-ba262fb8e752 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df1');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 110
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "R9lXQcfWiwlA",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "747cf317-937a-4114-a94e-dd75bb7989c5"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "import pickle\n",
        "with open('/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/vectorizer_tf_immune_checkpoint.pk', 'wb') as f:\n",
        "     pickle.dump(vectorizer_tf, f)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "twrDwj6Ciwph",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "b75e7400-3d35-440f-8553-fa73e11527ef"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "import scipy.sparse\n",
        "scipy.sparse.save_npz('/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/tf_vectors_immune_checkpoint.npz', tf_vectors)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "C3lUbC4Gj5ju",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "de11a6ce-36f3-450c-b7b0-46b6d4787968"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "# Save this model with 20 topics:\n",
        "import pickle\n",
        "with open(\"/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/vectorizer_tf_immune_checkpoint.pk\",\"rb\") as f:\n",
        "    vectorizer_tf = pickle.load (f)\n",
        "\n",
        "import scipy.sparse\n",
        "tf_vectors = scipy.sparse.load_npz('/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/tf_vectors_immune_checkpoint.npz')"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "-u4KGmmSYyEo",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "9333d27d-fa1d-4210-d28b-90bf1a3429ac"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "fIjl8SpElpzg"
      },
      "source": [
        "# Finding the Best Number of Topics"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "yu-J05OOj5k-",
        "outputId": "b60ffc59-2472-4a3f-a9d6-5f03207f557a"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting tmtoolkit\n",
            "  Downloading tmtoolkit-0.12.0-py3-none-any.whl (10.5 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m10.5/10.5 MB\u001b[0m \u001b[31m41.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: numpy<2.0,>=1.23.0 in /usr/local/lib/python3.10/dist-packages (from tmtoolkit) (1.23.5)\n",
            "Requirement already satisfied: scipy<2.0,>=1.7.0 in /usr/local/lib/python3.10/dist-packages (from tmtoolkit) (1.11.4)\n",
            "Collecting globre<0.2,>=0.1.5 (from tmtoolkit)\n",
            "  Downloading globre-0.1.5.tar.gz (20 kB)\n",
            "  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: pandas<3.0,>=1.4.0 in /usr/local/lib/python3.10/dist-packages (from tmtoolkit) (1.5.3)\n",
            "Requirement already satisfied: xlrd>=2.0.0 in /usr/local/lib/python3.10/dist-packages (from tmtoolkit) (2.0.1)\n",
            "Requirement already satisfied: openpyxl<4.0,>=3.0.0 in /usr/local/lib/python3.10/dist-packages (from tmtoolkit) (3.1.2)\n",
            "Requirement already satisfied: matplotlib<4.0,>=3.5.0 in /usr/local/lib/python3.10/dist-packages (from tmtoolkit) (3.7.1)\n",
            "Requirement already satisfied: bidict<1.0,>=0.21.0 in /usr/local/lib/python3.10/dist-packages (from tmtoolkit) (0.22.1)\n",
            "Requirement already satisfied: wheel<1.0,>=0.40 in /usr/local/lib/python3.10/dist-packages (from tmtoolkit) (0.42.0)\n",
            "Requirement already satisfied: contourpy>=1.0.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib<4.0,>=3.5.0->tmtoolkit) (1.2.0)\n",
            "Requirement already satisfied: cycler>=0.10 in /usr/local/lib/python3.10/dist-packages (from matplotlib<4.0,>=3.5.0->tmtoolkit) (0.12.1)\n",
            "Requirement already satisfied: fonttools>=4.22.0 in /usr/local/lib/python3.10/dist-packages (from matplotlib<4.0,>=3.5.0->tmtoolkit) (4.47.2)\n",
            "Requirement already satisfied: kiwisolver>=1.0.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib<4.0,>=3.5.0->tmtoolkit) (1.4.5)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from matplotlib<4.0,>=3.5.0->tmtoolkit) (23.2)\n",
            "Requirement already satisfied: pillow>=6.2.0 in /usr/local/lib/python3.10/dist-packages (from matplotlib<4.0,>=3.5.0->tmtoolkit) (9.4.0)\n",
            "Requirement already satisfied: pyparsing>=2.3.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib<4.0,>=3.5.0->tmtoolkit) (3.1.1)\n",
            "Requirement already satisfied: python-dateutil>=2.7 in /usr/local/lib/python3.10/dist-packages (from matplotlib<4.0,>=3.5.0->tmtoolkit) (2.8.2)\n",
            "Requirement already satisfied: et-xmlfile in /usr/local/lib/python3.10/dist-packages (from openpyxl<4.0,>=3.0.0->tmtoolkit) (1.1.0)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.10/dist-packages (from pandas<3.0,>=1.4.0->tmtoolkit) (2023.4)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.10/dist-packages (from python-dateutil>=2.7->matplotlib<4.0,>=3.5.0->tmtoolkit) (1.16.0)\n",
            "Building wheels for collected packages: globre\n",
            "  Building wheel for globre (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for globre: filename=globre-0.1.5-py3-none-any.whl size=19545 sha256=78efadab197bd74a7325dab1f7142d40b7e75c54b77a011e9c11a5f6dd9d72d8\n",
            "  Stored in directory: /root/.cache/pip/wheels/e6/c5/26/0d27e07d567b3b4e63a618efff19a2cdbab636ac1295d20206\n",
            "Successfully built globre\n",
            "Installing collected packages: globre, tmtoolkit\n",
            "Successfully installed globre-0.1.5 tmtoolkit-0.12.0\n"
          ]
        }
      ],
      "source": [
        "!pip install tmtoolkit"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "pJO2fZUIluMQ"
      },
      "outputs": [],
      "source": [
        "import tmtoolkit\n",
        "from tmtoolkit.topicmod.evaluate import metric_coherence_gensim\n",
        "from statistics import mean\n",
        "from sklearn.metrics import jaccard_score"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "import matplotlib.pyplot as plt\n",
        "from sklearn import decomposition\n",
        "from sklearn.metrics import jaccard_score\n",
        "import numpy as np\n",
        "\n",
        "# Assuming tf_vectors, vectorizer_tf, and tok are defined earlier in your code\n",
        "\n",
        "results = pd.DataFrame(columns=['num_topic', 'Coherence', 'Jaccard', 'Perplexity'])\n",
        "\n",
        "for topic_num in range(5, 40):\n",
        "    lda = decomposition.LatentDirichletAllocation(n_components=topic_num, learning_method='online', learning_offset=50, n_jobs=-1, random_state=111)\n",
        "\n",
        "    w1 = lda.fit_transform(tf_vectors)\n",
        "    ppx = lda.perplexity(w1, sub_sampling=False)\n",
        "    coh = mean(metric_coherence_gensim(measure='c_v', top_n=30, topic_word_distrib=lda.components_, vocab=np.array([x for x in vectorizer_tf.vocabulary_.keys()]), texts=tok))\n",
        "\n",
        "    l = len(lda.components_)\n",
        "    n = 0\n",
        "    js = 0\n",
        "    for i in range(0, l-1):\n",
        "        topic1 = [1 if x > 1 else 0 for x in lda.components_[i]]\n",
        "        for j in range(i+1, l):\n",
        "            topic2 = [1 if x > 1 else 0 for x in lda.components_[j]]\n",
        "            js += jaccard_score(topic1, topic2)\n",
        "            n += 1\n",
        "    js /= n\n",
        "\n",
        "    results = results.append({'num_topic': topic_num,\n",
        "                              'Coherence': coh,\n",
        "                              'Jaccard': js,\n",
        "                              'Perplexity': ppx\n",
        "                              }, ignore_index=True)\n",
        "\n",
        "# Print the DataFrame\n",
        "print(results)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RyT5RyKSmeAA",
        "outputId": "33be8019-6884-464c-8d39-613faf6a5bd3"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "    num_topic  Coherence   Jaccard    Perplexity\n",
            "0         5.0   0.233793  0.522706  3.020319e+03\n",
            "1         6.0   0.224470  0.466513  4.284272e+03\n",
            "2         7.0   0.232352  0.424811  5.466691e+03\n",
            "3         8.0   0.239453  0.385870  9.391458e+03\n",
            "4         9.0   0.245046  0.361034  1.144520e+04\n",
            "5        10.0   0.236070  0.347538  1.554066e+04\n",
            "6        11.0   0.256159  0.328151  1.910195e+04\n",
            "7        12.0   0.244499  0.289092  2.245736e+04\n",
            "8        13.0   0.237013  0.239965  2.259150e+04\n",
            "9        14.0   0.250724  0.215418  2.686251e+04\n",
            "10       15.0   0.237168  0.219967  6.159225e+04\n",
            "11       16.0   0.224814  0.171728  4.140085e+04\n",
            "12       17.0   0.254382  0.156399  6.839104e+04\n",
            "13       18.0   0.234195  0.163149  8.812494e+04\n",
            "14       19.0   0.242225  0.162634  1.329427e+05\n",
            "15       20.0   0.234603  0.119614  7.446315e+04\n",
            "16       21.0   0.235512  0.139559  1.160721e+05\n",
            "17       22.0   0.239375  0.124811  1.990188e+05\n",
            "18       23.0   0.238978  0.148492  1.747401e+05\n",
            "19       24.0   0.226202  0.126409  1.603775e+05\n",
            "20       25.0   0.243121  0.136815  2.029082e+05\n",
            "21       26.0   0.238927  0.101624  1.674437e+05\n",
            "22       27.0   0.233194  0.116684  1.889073e+05\n",
            "23       28.0   0.242030  0.098149  2.274506e+05\n",
            "24       29.0   0.241641  0.108958  4.834251e+05\n",
            "25       30.0   0.244457  0.100077  4.231311e+05\n",
            "26       31.0   0.252025  0.093374  6.568158e+05\n",
            "27       32.0   0.248182  0.077251  4.281901e+05\n",
            "28       33.0   0.239118  0.085775  5.862850e+05\n",
            "29       34.0   0.238530  0.077686  6.933176e+05\n",
            "30       35.0   0.240777  0.078404  1.033692e+06\n",
            "31       36.0   0.241545  0.069342  1.113654e+06\n",
            "32       37.0   0.232524  0.073643  1.581096e+06\n",
            "33       38.0   0.246977  0.067305  1.268384e+06\n",
            "34       39.0   0.237670  0.059201  6.791653e+05\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Jaccard is ill-defined and being set to 0.0 due to no true or predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "<ipython-input-44-5b4d08bf0ff7>:29: FutureWarning: The frame.append method is deprecated and will be removed from pandas in a future version. Use pandas.concat instead.\n",
            "  results = results.append({'num_topic': topic_num,\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Print the DataFrame\n",
        "print(results)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "DUSKdz8jpZ8A",
        "outputId": "f0143373-ffb7-45bd-b26d-0d1d2abfc43d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "    num_topic  Coherence   Jaccard    Perplexity\n",
            "0         5.0   0.233793  0.522706  3.020319e+03\n",
            "1         6.0   0.224470  0.466513  4.284272e+03\n",
            "2         7.0   0.232352  0.424811  5.466691e+03\n",
            "3         8.0   0.239453  0.385870  9.391458e+03\n",
            "4         9.0   0.245046  0.361034  1.144520e+04\n",
            "5        10.0   0.236070  0.347538  1.554066e+04\n",
            "6        11.0   0.256159  0.328151  1.910195e+04\n",
            "7        12.0   0.244499  0.289092  2.245736e+04\n",
            "8        13.0   0.237013  0.239965  2.259150e+04\n",
            "9        14.0   0.250724  0.215418  2.686251e+04\n",
            "10       15.0   0.237168  0.219967  6.159225e+04\n",
            "11       16.0   0.224814  0.171728  4.140085e+04\n",
            "12       17.0   0.254382  0.156399  6.839104e+04\n",
            "13       18.0   0.234195  0.163149  8.812494e+04\n",
            "14       19.0   0.242225  0.162634  1.329427e+05\n",
            "15       20.0   0.234603  0.119614  7.446315e+04\n",
            "16       21.0   0.235512  0.139559  1.160721e+05\n",
            "17       22.0   0.239375  0.124811  1.990188e+05\n",
            "18       23.0   0.238978  0.148492  1.747401e+05\n",
            "19       24.0   0.226202  0.126409  1.603775e+05\n",
            "20       25.0   0.243121  0.136815  2.029082e+05\n",
            "21       26.0   0.238927  0.101624  1.674437e+05\n",
            "22       27.0   0.233194  0.116684  1.889073e+05\n",
            "23       28.0   0.242030  0.098149  2.274506e+05\n",
            "24       29.0   0.241641  0.108958  4.834251e+05\n",
            "25       30.0   0.244457  0.100077  4.231311e+05\n",
            "26       31.0   0.252025  0.093374  6.568158e+05\n",
            "27       32.0   0.248182  0.077251  4.281901e+05\n",
            "28       33.0   0.239118  0.085775  5.862850e+05\n",
            "29       34.0   0.238530  0.077686  6.933176e+05\n",
            "30       35.0   0.240777  0.078404  1.033692e+06\n",
            "31       36.0   0.241545  0.069342  1.113654e+06\n",
            "32       37.0   0.232524  0.073643  1.581096e+06\n",
            "33       38.0   0.246977  0.067305  1.268384e+06\n",
            "34       39.0   0.237670  0.059201  6.791653e+05\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Plotting\n",
        "fig, ax1 = plt.subplots(figsize=(10, 6))\n",
        "\n",
        "# Plot Coherence and Jaccard on the primary y-axis\n",
        "ax1.plot(results['num_topic'], results['Coherence'], label='Coherence', color='blue')\n",
        "ax1.plot(results['num_topic'], results['Jaccard'], label='Jaccard', color='green')\n",
        "ax1.set_xlabel('Number of Topics')\n",
        "ax1.set_ylabel('Coherence & Jaccard Scores')\n",
        "\n",
        "# Create a second y-axis for Perplexity\n",
        "ax2 = ax1.twinx()\n",
        "ax2.plot(results['num_topic'], results['Perplexity'], label='Perplexity', color='red')\n",
        "ax2.set_ylabel('Perplexity')\n",
        "\n",
        "# Adding legends\n",
        "ax1.legend(loc='upper left')\n",
        "ax2.legend(loc='upper right')\n",
        "\n",
        "plt.title('LDA Model Metrics with Dual Axis for Perplexity')\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 564
        },
        "id": "3Hd7fvvurWno",
        "outputId": "2e7ac4fe-c279-4a97-de47-fa12f293b39f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 2 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Plotting\n",
        "plt.figure(figsize=(10, 6))\n",
        "plt.plot(results['num_topic'], results['Coherence'], label='Coherence')\n",
        "#plt.plot(results['num_topic'], results['Jaccard'], label='Jaccard')\n",
        "#plt.plot(results['num_topic'], results['Perplexity'], label='Perplexity')\n",
        "plt.xlabel('Number of Topics')\n",
        "plt.ylabel('Scores')\n",
        "plt.title('LDA Model Metrics')\n",
        "plt.grid(True)\n",
        "plt.legend()\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 564
        },
        "id": "xrmsfoTLmgE9",
        "outputId": "eaaddfe5-b69b-4b2d-d254-158295f581b7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "\n",
        "\n",
        "```\n",
        "coh0 = 0\n",
        "js0 = 100\n",
        "ppx0 = 100\n",
        "num = 1\n",
        "for topic_num in range (5, 100):\n",
        "  lda = decomposition.LatentDirichletAllocation (n_components=topic_num, learning_method='online', learning_offset=50, n_jobs=-1, random_state=111)\n",
        "  # n_components is the number of topics\n",
        "\n",
        "  w1 = lda.fit_transform (tf_vectors)\n",
        "  #h1 = lda.components_\n",
        "\n",
        "  ppx = lda.perplexity(w1,  sub_sampling=False)\n",
        "\n",
        "  coh = mean (metric_coherence_gensim(measure='c_v', top_n=30, topic_word_distrib=lda.components_, vocab=np.array([x for x in vectorizer_tf.vocabulary_.keys()]), texts=tok))\n",
        "\n",
        "  l = len (lda.components_)\n",
        "  n = 0\n",
        "  js = 0\n",
        "  for i in range(0, l-1):\n",
        "    topic1 = [1 if x>1 else 0 for x in lda.components_[i]]\n",
        "    for j in range(i+1, l):\n",
        "      topic2 = [1 if x>1 else 0 for x in lda.components_[j]]\n",
        "      js += jaccard_score (topic1, topic2)\n",
        "      n += 1\n",
        "  js /= n\n",
        "\n",
        "  if js > js0 and coh < coh0 and ppx > ppx0:\n",
        "    pass\n",
        "  else:\n",
        "    num = topic_num\n",
        "    js0 = js\n",
        "    coh0 = coh\n",
        "    ppx0 = ppx\n",
        "\n",
        "  print ('num_topic: ', topic_num, 'Coherence: ', coh, 'Jaccard: ', js, 'Perplexity: ', ppx)\n",
        "#print ('BEST: ', 'num_topic: ', num, 'Coherence: ', coh0, 'Jaccard: ', js0, 'Perplexity: ', ppx0)\n",
        "```\n",
        "\n"
      ],
      "metadata": {
        "id": "ztfoj_Amr5DY"
      }
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "TjQeTwLknCwD"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "tAk1XHTrluNz"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "source": [
        "#XXXXXXXXXXXXXXXXXXXXXXXXX"
      ],
      "metadata": {
        "id": "9msD2lVNDZHy"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "vTL6wrYHmLoX"
      },
      "source": [
        "# Topic Modeling"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "\n",
        "def get_smallest_topic_with_max_metric(df, metric):\n",
        "    # Find the max value in the metric column\n",
        "    max_value = df[metric].max()\n",
        "\n",
        "    # Filter the DataFrame for rows with this max value\n",
        "    df_max_value = df[df[metric] == max_value]\n",
        "\n",
        "    # Get the smallest 'num_topic' in these rows\n",
        "    topic_num = df_max_value['num_topic'].min()\n",
        "\n",
        "    return topic_num\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "YXHjYS1Meuyg",
        "outputId": "9bf93724-a08b-4aa2-8255-960d529b8af4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "n_topics = int(get_smallest_topic_with_max_metric(results, 'Coherence'))\n",
        "\n",
        "n_topics"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "bfTofRYmeyg-",
        "outputId": "dee205ad-538e-4f1e-cd69-d3cf72b4c8ba"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "11"
            ]
          },
          "metadata": {},
          "execution_count": 121
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "jmnWjExZluXG",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "5948003a-f806-4c3b-ee94-5bc03ea7e4e2"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "lda = decomposition.LatentDirichletAllocation (n_components=n_topics, learning_method='online', learning_offset=50, n_jobs=-1, random_state=111)\n",
        "# n_components is the number of topics\n",
        "\n",
        "w1 = lda.fit_transform (tf_vectors)\n",
        "h1 = lda.components_"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "91PQhE4TluZI",
        "outputId": "c356eb8e-a0b3-4f6e-cc50-7af813eee114"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "import pickle\n",
        "with open(f\"/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/lda_immune_checkpoint_{n_topics}.pk\",\"wb\") as f1:\n",
        "    pickle.dump (lda, f1)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "TTughGF6luck",
        "outputId": "2c5df8cd-6370-4063-ec63-972f732c7659"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "import pickle\n",
        "lda = decomposition.LatentDirichletAllocation (n_components=n_topics, learning_method='online', learning_offset=50, n_jobs=-1, random_state=111)\n",
        "with open(f\"/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/lda_immune_checkpoint_{n_topics}.pk\",\"rb\") as f1:\n",
        "    lda = pickle.load (f1)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "JGyDq4fpj5os",
        "outputId": "b967cf9e-f4c1-4fb4-af7b-e816306257de"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "#pyLDAvis.enable_notebook()\n",
        "#pyLDAvis.sklearn.prepare(lda, tf_vectors, vectorizer_tf, mds='tsne')"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "WIs07MaqhJsG"
      },
      "source": [
        "What did I do to make this work?\n",
        "\n",
        "I installed pyLDAvis, but didn't import it!\n",
        "\n",
        "I went to usr/local/lib/python3.10/dist-packages/pyLDAvis/sklearn.py\n",
        "and changed get_feature_names() to get_feature_names_out()\n",
        "\n",
        "saved it!\n",
        "Then imported pyLDAvis and pyLDAvis.sklearn"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "f5j2MPpArouO",
        "outputId": "1f2e694a-38cf-40ee-cebe-14cce505ee4a"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "w1 = lda.transform (tf_vectors)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "KyVJSp5XrpAE",
        "outputId": "e6f488c9-e92b-4cd9-abec-384192004d81"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(3320, 11)"
            ]
          },
          "metadata": {},
          "execution_count": 127
        }
      ],
      "source": [
        "w1.shape"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "0Hq85-fp1nLl",
        "outputId": "4b07173b-450c-43aa-e41f-bd17556ea7a8"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "-2VMWHDNtO_v",
        "outputId": "06878a88-b3e6-4896-84ce-ed3a4396e12e"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "text = []\n",
        "topic = []\n",
        "probabilit = []\n",
        "for i in range(len(idx)):\n",
        "  text.append (str(data[idx[i]]))\n",
        "  t = np.argmax (w1[i,:])\n",
        "  topic.append (t)\n",
        "  probabilit.append (w1[i,t])\n",
        "probabilities = pd.DataFrame (data= {'Text':text,'Topic':topic,'Probability':probabilit})"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "0lbr7iWjFPbp",
        "outputId": "2253c2de-2ca9-460c-c203-79d6abd0e95e",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "6skxozvjtPgQ",
        "outputId": "d2af8806-32ca-4e02-d7d5-af8af674b5b4"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Topic: Number:\n",
            "topic 0      75\n",
            "topic 1      222\n",
            "topic 2      92\n",
            "topic 3      57\n",
            "topic 4      419\n",
            "topic 5      280\n",
            "topic 6      582\n",
            "topic 7      721\n",
            "topic 8      328\n",
            "topic 9      192\n",
            "topic 10      352\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "print('Topic:','Number:')\n",
        "for i in range(n_topics):\n",
        "  print('topic',i,'    ',list(probabilities['Topic']).count(i))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "kqzUegLQtJlC",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "5f280f82-58c9-44c0-d80c-b22aaa200fe0"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "PUi5wtePiGJj",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "5b8d04c4-e337-441b-c421-609c81494ee1"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ],
      "source": [
        "# topic similarity matrix"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "## jaccard_similarity"
      ],
      "metadata": {
        "id": "Eg8JjxNC64lW",
        "outputId": "d38c99a7-611c-47f7-e7db-fefbb3d0316a",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "from sklearn.decomposition import LatentDirichletAllocation\n",
        "\n",
        "def jaccard_similarity(vector1, vector2, threshold=0.01):\n",
        "    set1 = set(np.where(vector1 > threshold)[0])\n",
        "    set2 = set(np.where(vector2 > threshold)[0])\n",
        "    intersection = len(set1.intersection(set2))\n",
        "    union = len(set1) + len(set2) - intersection\n",
        "    if union == 0:\n",
        "        return 0\n",
        "    else:\n",
        "        return intersection / union\n",
        "\n",
        "\n",
        "# Assuming lda is your trained LDA model\n",
        "# Normalize the topic-word distribution\n",
        "topic_word_distributions = lda.components_ / lda.components_.sum(axis=1)[:, np.newaxis]\n",
        "\n",
        "# Number of topics\n",
        "n_topics = lda.components_.shape[0]\n",
        "\n",
        "# Create Jaccard Similarity matrix\n",
        "jaccard_similarity_matrix = np.zeros((n_topics, n_topics))\n",
        "\n",
        "for i in range(n_topics):\n",
        "    for j in range(n_topics):\n",
        "        jaccard_similarity_matrix[i, j] = jaccard_similarity(topic_word_distributions[i, :], topic_word_distributions[j, :], threshold=0.01)\n",
        "\n",
        "\n",
        "# Plot Heatmap\n",
        "plt.figure(figsize=(25, 15))\n",
        "sns.set(font_scale=1)\n",
        "sns.heatmap(\n",
        "    jaccard_similarity_matrix,\n",
        "    annot=True,\n",
        "    fmt=\".2f\",\n",
        "    cmap=\"coolwarm\",\n",
        "    cbar=True,\n",
        "    square=True,\n",
        "    annot_kws={\"size\": 12}\n",
        ")\n",
        "plt.title(\"Topic Similarity Matrix based on Jaccard Similarity\")\n",
        "plt.xlabel(\"Topic ID\")\n",
        "plt.ylabel(\"Topic ID\")\n",
        "\n",
        "# Save the figure\n",
        "plt.savefig(f'/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/topic_similarity_matrix_jaccard_immune_checkpoint.png', dpi=600)\n",
        "\n",
        "plt.show()\n"
      ],
      "metadata": {
        "id": "fz7xdnxM64nf",
        "outputId": "da25b438-ead1-4ca9-af03-874c36bfdd9f",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 2500x1500 with 2 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "from scipy.cluster.hierarchy import linkage, dendrogram\n",
        "from sklearn.decomposition import LatentDirichletAllocation\n",
        "\n",
        "# Define Jaccard Similarity function\n",
        "def jaccard_similarity(vector1, vector2, threshold=0.01):\n",
        "    set1 = set(np.where(vector1 > threshold)[0])\n",
        "    set2 = set(np.where(vector2 > threshold)[0])\n",
        "    intersection = len(set1.intersection(set2))\n",
        "    union = len(set1) + len(set2) - intersection\n",
        "    if union == 0:\n",
        "        return 0\n",
        "    else:\n",
        "        return intersection / union\n",
        "\n",
        "\n",
        "# Assuming lda is your trained LDA model\n",
        "n_topics = lda.components_.shape[0]\n",
        "topic_word_distributions = lda.components_ / lda.components_.sum(axis=1)[:, np.newaxis]\n",
        "\n",
        "# Create Jaccard Similarity matrix\n",
        "jaccard_similarity_matrix = np.zeros((n_topics, n_topics))\n",
        "\n",
        "for i in range(n_topics):\n",
        "    for j in range(n_topics):\n",
        "        jaccard_similarity_matrix[i, j] = jaccard_similarity(topic_word_distributions[i, :], topic_word_distributions[j, :], threshold=0.01)\n",
        "\n",
        "# Perform hierarchical clustering\n",
        "linkage_matrix = linkage(1 - jaccard_similarity_matrix, method=\"average\")\n",
        "\n",
        "# Plot the dendrogram\n",
        "plt.figure(figsize=(15, 10))\n",
        "dendrogram(linkage_matrix, color_threshold=0.5)\n",
        "plt.title(\"Hierarchical Clustering of Topics based on Jaccard Similarity\")\n",
        "plt.xlabel(\"Topic ID\")\n",
        "plt.ylabel(\"Distance\")\n",
        "plt.tight_layout()\n",
        "\n",
        "# Save the figure in high resolution\n",
        "plt.savefig(f'/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/topic_clustering_dendrogram_jaccard_immune_checkpoint.png', dpi=600)\n",
        "\n",
        "plt.show()\n"
      ],
      "metadata": {
        "id": "_2_uZVPx64p_",
        "outputId": "ef151baf-2c79-48de-b112-0555933ed8b8",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 958
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n",
            "<ipython-input-133-c8adf837f1e1>:31: ClusterWarning: scipy.cluster: The symmetric non-negative hollow observation matrix looks suspiciously like an uncondensed distance matrix\n",
            "  linkage_matrix = linkage(1 - jaccard_similarity_matrix, method=\"average\")\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1500x1000 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "3BlZF26d64tk",
        "outputId": "e8b18c68-140f-4b68-d3ef-20f7c2e96d2b",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "JwOEdWbk644g",
        "outputId": "49914d4e-245c-4293-b109-78a752dadb8a",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# get_top_keywords"
      ],
      "metadata": {
        "id": "YLvp3I17jJcJ",
        "outputId": "87a27c0b-71f9-49c5-9cda-7658e2863995",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def get_top_keywords(lda_model, vectorizer, n_words=50):\n",
        "    terms = vectorizer.get_feature_names_out()\n",
        "    topic_keywords = []\n",
        "\n",
        "    for topic_idx, topic in enumerate(lda.components_):\n",
        "        top_keywords_idx = topic.argsort()[::-1][:n_words]\n",
        "        top_keywords = [(terms[i], topic[i]) for i in top_keywords_idx]\n",
        "        topic_keywords.append(top_keywords)\n",
        "\n",
        "    return topic_keywords\n",
        "\n",
        "top_keywords = get_top_keywords(lda, vectorizer_tf, n_words=50)\n",
        "\n",
        "# To display the topics with their keywords and scores\n",
        "with open(f\"/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/top_keywords_immune_checkpoint.txt\", \"w\") as f:\n",
        "    for idx, keywords in enumerate(top_keywords):\n",
        "        f.write(f\"Topic {idx}:\\n\")\n",
        "        print(f\"Topic {idx}:\")\n",
        "        for word, score in keywords:\n",
        "            f.write(f\"{word}, \")\n",
        "            print(f\"{word}\", end=\", \")\n",
        "        f.write(\"\\n\\n\")\n",
        "        print(\"\\n\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "QbvhB8uijJhu",
        "outputId": "bcaf6bd7-4afb-4f6b-c44b-61a36be90924"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Topic 0:\n",
            "acid, molecule, sequence, amino, polypeptide, nucleic, invention, encode, death, ligand, method, protein, comprise, show, formulation, derivative, present, stable, composition, cell, pharmaceutical, program, vector, host, programmed, bind, region, disclosure, disclose, contain, relate, application, functional, produce, receptor, include, small, make, chain, capable, inhibit, interaction, structure, consist, provide, disease, production, select, construct, modify, \n",
            "\n",
            "Topic 1:\n",
            "composition, pharmaceutical, inhibitor, immune, checkpoint, comprise, cancer, invention, present, treat, active, anticancer, relate, effect, treatment, anti, tumor, combination, prevent, ingredient, contain, component, combine, provide, type, prevention, inhibit, exhibit, administration, increase, kit, carrier, include, product, excellent, colorectal, form, enhance, antibody, synergistic, activity, method, formulation, growth, extracellular, receptor, administer, inhibition, pd1, therapy, \n",
            "\n",
            "Topic 2:\n",
            "gene, lung, cell, peptide, tumor, cancer, detection, detect, patient, application, invention, mutation, prognosis, small, expression, kit, relate, predict, sensitivity, immunotherapy, carcinoma, immune, blood, molecular, target, disclose, inhibitor, clinical, extracellular, high, checkpoint, solid, field, level, diagnosis, treatment, construct, model, prediction, base, result, condition, load, strategy, particular, diagnostic, value, tissue, sequence, time, \n",
            "\n",
            "Topic 3:\n",
            "method, liver, obtain, step, sample, cancer, subject, model, comprise, screen, high, solution, tumor, low, effect, immunotherapy, carry, prediction, disclose, determine, provide, perform, curative, datum, material, level, base, biological, product, suitable, process, treatment, mouse, identify, tissue, expression, patient, result, select, control, reaction, measure, specific, value, cost, test, simple, analysis, inhibitor, invention, \n",
            "\n",
            "Topic 4:\n",
            "combination, agent, inhibitor, cancer, checkpoint, therapy, treatment, immune, present, therapeutic, invention, relate, treat, comprise, method, agonist, group, vaccine, conjugate, include, solid, select, particular, anti, immunotherapeutic, consist, tumor, tumour, chemotherapeutic, administration, nanoparticle, immunotherapy, provide, delivery, ctla-4, describe, prevent, prevention, adjuvant, target, regimen, malignant, administer, induce, human, associate, chemotherapy, disclosure, disclose, specific, \n",
            "\n",
            "Topic 5:\n",
            "cell, immune, checkpoint, method, protein, target, enhance, receptor, composition, inhibitor, cancer, express, tumor, antigen, response, comprise, provide, car, chimeric, signal, therapy, effector, expression, specific, therapeutic, activate, induce, include, engineer, associate, inhibit, activation, derive, fusion, present, combination, activity, mediate, vector, modify, invention, obtain, dendritic, surface, death, function, vaccine, immunity, treatment, virus, \n",
            "\n",
            "Topic 6:\n",
            "cancer, method, treat, subject, administer, comprise, combination, treatment, inhibitor, effective, amount, disclosure, therapy, composition, patient, anti, antagonist, tumor, include, embodiment, provide, cell, present, antibody, checkpoint, pd-1, lung, breast, bind, melanoma, dose, aspect, small, pembrolizumab, carcinoma, reduce, metastatic, receptor, pancreatic, kit, inhibit, growth, resistant, program, administration, relate, identify, death, immune, negative, \n",
            "\n",
            "Topic 7:\n",
            "antibody, anti, pd-1, bind, invention, fragment, antigen, monoclonal, protein, ctla-4, comprise, bispecific, relate, human, chain, present, method, domain, region, fusion, provide, antibodie, treat, application, disease, variable, heavy, single, recombinant, affinity, humanize, light, high, activity, target, block, preparation, contain, expression, sequence, portion, treatment, disclosure, specific, particular, cell, conjugate, combination, specificity, pd1, \n",
            "\n",
            "Topic 8:\n",
            "immune, checkpoint, patient, inhibitor, treatment, method, cancer, predict, response, biomarker, invention, therapy, relate, marker, base, virus, block, oncolytic, system, individual, present, provide, determine, expression, immunotherapy, identify, tumor, efficacy, gene, level, effect, sample, benefit, blood, blockade, clinical, analysis, adverse, resistance, advanced, melanoma, select, kit, improve, therapeutic, pd1, respond, disclose, suffer, cell, \n",
            "\n",
            "Topic 9:\n",
            "compound, inhibitor, cancer, salt, disease, acceptable, combination, treat, formula, invention, relate, preparation, method, treatment, kinase, disorder, pharmaceutical, application, present, composition, derivative, activity, disclose, tyrosine, medicament, show, infectious, comprise, prevent, represent, immune, nivolumab, inhibitory, autoimmune, checkpoint, form, proliferative, describe, interaction, include, particular, breast, contain, pd-1, inhibition, structure, provide, condition, tumor, small, \n",
            "\n",
            "Topic 10:\n",
            "tumor, application, effect, preparation, cell, invention, combine, anti, medicine, treatment, immune, improve, inhibit, disclose, inhibitor, immunotherapy, field, target, prepare, nano, enhance, block, reduce, technical, belong, promote, growth, function, microenvironment, relate, synergistic, high, expression, system, lymphocyte, increase, achieve, body, inhibition, side, time, cancer, prospect, mouse, antibody, biological, compare, form, treat, show, \n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "PSupvnq1fIvW",
        "outputId": "d838b46b-2ae8-449e-ae1f-becf0ff47321"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Emergent topics"
      ],
      "metadata": {
        "id": "XOHiCtECjJnK",
        "outputId": "ae3f4296-c289-4172-b786-03d68d300873",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from wordcloud import WordCloud\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "\n",
        "# Word Clouds for topics\n",
        "def plot_wordcloud(lda, topic_id, ax, n_words=50):\n",
        "    terms = vectorizer_tf.get_feature_names_out()\n",
        "    word_probs = {terms[i]: prob for i, prob in enumerate(lda.components_[topic_id])}\n",
        "    wc = WordCloud(background_color='white', max_words=n_words).generate_from_frequencies(word_probs)\n",
        "    ax.imshow(wc, interpolation='bilinear')\n",
        "    ax.axis('off')\n",
        "    ax.set_title(f\"Topic {topic_id}\", fontweight='bold')  # Bold title for each subplot\n",
        "\n",
        "# Assuming n_topics to be the number of topics you've chosen\n",
        "n_topics = n_topics  # Make sure this matches the number of topics in lda_model\n",
        "\n",
        "# Calculate the number of rows needed\n",
        "n_rows = int(np.ceil(n_topics / 5))\n",
        "\n",
        "fig, axes = plt.subplots(n_rows, 5, figsize=(20, 4 * n_rows))\n",
        "\n",
        "# Flatten the array and truncate it to match the number of topics\n",
        "axes_flat = axes.flatten()[:n_topics]\n",
        "\n",
        "for ax, topic_id in zip(axes_flat, range(n_topics)):\n",
        "    plot_wordcloud(lda, topic_id, ax)\n",
        "\n",
        "# Remove extra subplots\n",
        "for idx in range(n_topics, len(axes.flatten())):\n",
        "    fig.delaxes(axes.flatten()[idx])\n",
        "\n",
        "plt.suptitle(\"Word Clouds for LDA Topics\", fontweight='bold')  # Bold main title\n",
        "plt.tight_layout()\n",
        "plt.savefig(f'/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/wordclouds_immune_checkpoint.png', dpi=600)  # Use raw string for path\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 762
        },
        "id": "QWyTazRCjJp-",
        "outputId": "bd51a678-8579-493c-b4cb-9d707c4d07eb"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 2000x1200 with 11 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "t4jXPXETjJ_z",
        "outputId": "aaa308cd-a6a1-4add-8dc8-b2583b505c95",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Attach Discovered Topic Labels to Original scholar publications"
      ],
      "metadata": {
        "id": "TQt994bCjKCg",
        "outputId": "b1a172ad-b378-47f6-eb2c-3bf413ab0b31",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "final_topics = lda.transform(tf_vectors)\n",
        "final_topics.shape"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "mYbNmPEnjKF_",
        "outputId": "9a59c75d-0763-4408-c3b8-9eb7f480803f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(3320, 11)"
            ]
          },
          "metadata": {},
          "execution_count": 139
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_filtered[\"Topic N°\"] = final_topics.argmax(axis=1)\n",
        "df_filtered.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 779
        },
        "id": "qbPdazntuHNg",
        "outputId": "37cf9f54-d0e0-4bff-cc2f-0e2cfdf9177f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                      # Jurisdiction Kind        Display Key  \\\n",
              "Lens ID             Publication Year                                           \n",
              "197-733-628-711-768 2021              1           TW    A     TW 202114659 A   \n",
              "023-616-950-865-48X 2022              2           WO   A1  WO 2022/056572 A1   \n",
              "094-569-953-648-612 2021              3           CN    A     CN 112512579 A   \n",
              "143-969-408-220-424 2021              4           CN    A     CN 112512580 A   \n",
              "194-887-353-832-386 2019              5           WO   A8  WO 2019/156568 A8   \n",
              "\n",
              "                                     Publication Date Application Number  \\\n",
              "Lens ID             Publication Year                                       \n",
              "197-733-628-711-768 2021                   2021-04-16     TW 109133847 A   \n",
              "023-616-950-865-48X 2022                   2022-03-24   AU 2020/050994 W   \n",
              "094-569-953-648-612 2021                   2021-03-16  CN 201980049832 A   \n",
              "143-969-408-220-424 2021                   2021-03-16  CN 201980049896 A   \n",
              "194-887-353-832-386 2019                   2019-10-03    NL 2019050092 W   \n",
              "\n",
              "                                     Application Date  \\\n",
              "Lens ID             Publication Year                    \n",
              "197-733-628-711-768 2021                   2020-09-29   \n",
              "023-616-950-865-48X 2022                   2020-09-18   \n",
              "094-569-953-648-612 2021                   2019-09-27   \n",
              "143-969-408-220-424 2021                   2019-09-27   \n",
              "194-887-353-832-386 2019                   2019-02-12   \n",
              "\n",
              "                                                                       Priority Numbers  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                  EP 19201152 A   \n",
              "023-616-950-865-48X 2022                                               AU 2020/050994 W   \n",
              "094-569-953-648-612 2021              CN 201811147946 A;;CN 201910467950 A;;CN 20191...   \n",
              "143-969-408-220-424 2021              CN 201811149357 A;;CN 201811547685 A;;CN 20191...   \n",
              "194-887-353-832-386 2019                                                   NL 2020422 A   \n",
              "\n",
              "                                     Earliest Priority Date  \\\n",
              "Lens ID             Publication Year                          \n",
              "197-733-628-711-768 2021                         2019-10-02   \n",
              "023-616-950-865-48X 2022                         2020-09-18   \n",
              "094-569-953-648-612 2021                         2018-09-29   \n",
              "143-969-408-220-424 2021                         2018-09-29   \n",
              "194-887-353-832-386 2019                         2018-02-12   \n",
              "\n",
              "                                                                                  Title  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              Combination comprising HDAC inhibitor, CTLA-4 ...   \n",
              "023-616-950-865-48X 2022                                     TREATMENT OF SOLID TUMOURS   \n",
              "094-569-953-648-612 2021              USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...   \n",
              "143-969-408-220-424 2021              USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...   \n",
              "194-887-353-832-386 2019              METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...   \n",
              "\n",
              "                                                                               Abstract  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              The invention relates to medical uses of an HD...   \n",
              "023-616-950-865-48X 2022              The present invention relates to a method for ...   \n",
              "094-569-953-648-612 2021              Use of a combination of a TLR agonist and an i...   \n",
              "143-969-408-220-424 2021              Disclosed is the use of an EZH2 inhibitor in c...   \n",
              "194-887-353-832-386 2019              The present invention relates to the field of ...   \n",
              "\n",
              "                                                                             Applicants  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                         4SC AG   \n",
              "023-616-950-865-48X 2022                        OLIVIA NEWTON JOHN CANCER RES INSTITUTE   \n",
              "094-569-953-648-612 2021              JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "143-969-408-220-424 2021              JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "194-887-353-832-386 2019              STICHTING HET NEDERLANDS KANKER INST ANTONI VA...   \n",
              "\n",
              "                                                                              Inventors  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                   HAMM SVETLANA;;HERMANN FRANK   \n",
              "023-616-950-865-48X 2022              POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER   \n",
              "094-569-953-648-612 2021              JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...   \n",
              "143-969-408-220-424 2021              ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...   \n",
              "194-887-353-832-386 2019              SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...   \n",
              "\n",
              "                                     Owners  \\\n",
              "Lens ID             Publication Year          \n",
              "197-733-628-711-768 2021                NaN   \n",
              "023-616-950-865-48X 2022                NaN   \n",
              "094-569-953-648-612 2021                NaN   \n",
              "143-969-408-220-424 2021                NaN   \n",
              "194-887-353-832-386 2019                NaN   \n",
              "\n",
              "                                                                       URL  \\\n",
              "Lens ID             Publication Year                                         \n",
              "197-733-628-711-768 2021              https://lens.org/197-733-628-711-768   \n",
              "023-616-950-865-48X 2022              https://lens.org/023-616-950-865-48X   \n",
              "094-569-953-648-612 2021              https://lens.org/094-569-953-648-612   \n",
              "143-969-408-220-424 2021              https://lens.org/143-969-408-220-424   \n",
              "194-887-353-832-386 2019              https://lens.org/194-887-353-832-386   \n",
              "\n",
              "                                            Document Type Has Full Text  \\\n",
              "Lens ID             Publication Year                                      \n",
              "197-733-628-711-768 2021               Patent of Addition            no   \n",
              "023-616-950-865-48X 2022               Patent Application           yes   \n",
              "094-569-953-648-612 2021               Patent Application            no   \n",
              "143-969-408-220-424 2021               Patent Application            no   \n",
              "194-887-353-832-386 2019              Amended Application           yes   \n",
              "\n",
              "                                      Cites Patent Count  \\\n",
              "Lens ID             Publication Year                       \n",
              "197-733-628-711-768 2021                               0   \n",
              "023-616-950-865-48X 2022                               3   \n",
              "094-569-953-648-612 2021                               3   \n",
              "143-969-408-220-424 2021                               2   \n",
              "194-887-353-832-386 2019                               0   \n",
              "\n",
              "                                      Cited by Patent Count  \\\n",
              "Lens ID             Publication Year                          \n",
              "197-733-628-711-768 2021                                  0   \n",
              "023-616-950-865-48X 2022                                  0   \n",
              "094-569-953-648-612 2021                                  0   \n",
              "143-969-408-220-424 2021                                  1   \n",
              "194-887-353-832-386 2019                                  0   \n",
              "\n",
              "                                      Simple Family Size  \\\n",
              "Lens ID             Publication Year                       \n",
              "197-733-628-711-768 2021                               2   \n",
              "023-616-950-865-48X 2022                               1   \n",
              "094-569-953-648-612 2021                               3   \n",
              "143-969-408-220-424 2021                               3   \n",
              "194-887-353-832-386 2019                               3   \n",
              "\n",
              "                                      Extended Family Size  Sequence Count  \\\n",
              "Lens ID             Publication Year                                         \n",
              "197-733-628-711-768 2021                                 2               0   \n",
              "023-616-950-865-48X 2022                                 2               0   \n",
              "094-569-953-648-612 2021                                 3               0   \n",
              "143-969-408-220-424 2021                                 3               0   \n",
              "194-887-353-832-386 2019                                 3               0   \n",
              "\n",
              "                                                                    CPC Classifications  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                              A61K45/06;;A61P35/00;;A61K31/4155   \n",
              "023-616-950-865-48X 2022              A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...   \n",
              "094-569-953-648-612 2021                  A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04   \n",
              "143-969-408-220-424 2021              A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...   \n",
              "194-887-353-832-386 2019                                   G01N33/57423;;G01N2333/70532   \n",
              "\n",
              "                                                                   IPCR Classifications  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                  A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00   \n",
              "023-616-950-865-48X 2022              A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...   \n",
              "094-569-953-648-612 2021                  A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04   \n",
              "143-969-408-220-424 2021              A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...   \n",
              "194-887-353-832-386 2019                                                     G01N33/574   \n",
              "\n",
              "                                     US Classifications  NPL Citation Count  \\\n",
              "Lens ID             Publication Year                                          \n",
              "197-733-628-711-768 2021                            NaN                   0   \n",
              "023-616-950-865-48X 2022                            NaN                   2   \n",
              "094-569-953-648-612 2021                            NaN                   0   \n",
              "143-969-408-220-424 2021                            NaN                   0   \n",
              "194-887-353-832-386 2019                            NaN                   0   \n",
              "\n",
              "                                      NPL Resolved Citation Count  \\\n",
              "Lens ID             Publication Year                                \n",
              "197-733-628-711-768 2021                                        0   \n",
              "023-616-950-865-48X 2022                                        2   \n",
              "094-569-953-648-612 2021                                        0   \n",
              "143-969-408-220-424 2021                                        0   \n",
              "194-887-353-832-386 2019                                        0   \n",
              "\n",
              "                                                       NPL Resolved Lens ID(s)  \\\n",
              "Lens ID             Publication Year                                             \n",
              "197-733-628-711-768 2021                                                   NaN   \n",
              "023-616-950-865-48X 2022              011-457-792-548-92X;;048-229-382-653-004   \n",
              "094-569-953-648-612 2021                                                   NaN   \n",
              "143-969-408-220-424 2021                                                   NaN   \n",
              "194-887-353-832-386 2019                                                   NaN   \n",
              "\n",
              "                                                            NPL Resolved External ID(s)  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022              29955905;;10.1007/s00018-018-2863-3;;pmc638240...   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "\n",
              "                                                                          NPL Citations  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022              YU, G.-T. ET AL.: \"Inhibition of SRC family ki...   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "\n",
              "                                     Legal Status  \\\n",
              "Lens ID             Publication Year                \n",
              "197-733-628-711-768 2021                  PENDING   \n",
              "023-616-950-865-48X 2022                  PENDING   \n",
              "094-569-953-648-612 2021                  PENDING   \n",
              "143-969-408-220-424 2021                  PENDING   \n",
              "194-887-353-832-386 2019                  PENDING   \n",
              "\n",
              "                                                                           Cleaned_Text  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              combination comprising hdac inhibitor, ctla-4 ...   \n",
              "023-616-950-865-48X 2022              treatment solid tumoursthe present invention r...   \n",
              "094-569-953-648-612 2021              combination tlr agonist immune checkpoint inhi...   \n",
              "143-969-408-220-424 2021              ezh2 inhibitor combination immune checkpoint i...   \n",
              "194-887-353-832-386 2019              methods predicting treatment outcome and/or se...   \n",
              "\n",
              "                                      Topic N°  \n",
              "Lens ID             Publication Year            \n",
              "197-733-628-711-768 2021                     4  \n",
              "023-616-950-865-48X 2022                     6  \n",
              "094-569-953-648-612 2021                     4  \n",
              "143-969-408-220-424 2021                     4  \n",
              "194-887-353-832-386 2019                     4  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-cccb5fb0-c043-4734-bee7-56c79a9b5dbb\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th>#</th>\n",
              "      <th>Jurisdiction</th>\n",
              "      <th>Kind</th>\n",
              "      <th>Display Key</th>\n",
              "      <th>Publication Date</th>\n",
              "      <th>Application Number</th>\n",
              "      <th>Application Date</th>\n",
              "      <th>Priority Numbers</th>\n",
              "      <th>Earliest Priority Date</th>\n",
              "      <th>Title</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Applicants</th>\n",
              "      <th>Inventors</th>\n",
              "      <th>Owners</th>\n",
              "      <th>URL</th>\n",
              "      <th>Document Type</th>\n",
              "      <th>Has Full Text</th>\n",
              "      <th>Cites Patent Count</th>\n",
              "      <th>Cited by Patent Count</th>\n",
              "      <th>Simple Family Size</th>\n",
              "      <th>Extended Family Size</th>\n",
              "      <th>Sequence Count</th>\n",
              "      <th>CPC Classifications</th>\n",
              "      <th>IPCR Classifications</th>\n",
              "      <th>US Classifications</th>\n",
              "      <th>NPL Citation Count</th>\n",
              "      <th>NPL Resolved Citation Count</th>\n",
              "      <th>NPL Resolved Lens ID(s)</th>\n",
              "      <th>NPL Resolved External ID(s)</th>\n",
              "      <th>NPL Citations</th>\n",
              "      <th>Legal Status</th>\n",
              "      <th>Cleaned_Text</th>\n",
              "      <th>Topic N°</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Lens ID</th>\n",
              "      <th>Publication Year</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>197-733-628-711-768</th>\n",
              "      <th>2021</th>\n",
              "      <td>1</td>\n",
              "      <td>TW</td>\n",
              "      <td>A</td>\n",
              "      <td>TW 202114659 A</td>\n",
              "      <td>2021-04-16</td>\n",
              "      <td>TW 109133847 A</td>\n",
              "      <td>2020-09-29</td>\n",
              "      <td>EP 19201152 A</td>\n",
              "      <td>2019-10-02</td>\n",
              "      <td>Combination comprising HDAC inhibitor, CTLA-4 ...</td>\n",
              "      <td>The invention relates to medical uses of an HD...</td>\n",
              "      <td>4SC AG</td>\n",
              "      <td>HAMM SVETLANA;;HERMANN FRANK</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/197-733-628-711-768</td>\n",
              "      <td>Patent of Addition</td>\n",
              "      <td>no</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K45/06;;A61P35/00;;A61K31/4155</td>\n",
              "      <td>A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>combination comprising hdac inhibitor, ctla-4 ...</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>023-616-950-865-48X</th>\n",
              "      <th>2022</th>\n",
              "      <td>2</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2022/056572 A1</td>\n",
              "      <td>2022-03-24</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>TREATMENT OF SOLID TUMOURS</td>\n",
              "      <td>The present invention relates to a method for ...</td>\n",
              "      <td>OLIVIA NEWTON JOHN CANCER RES INSTITUTE</td>\n",
              "      <td>POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/023-616-950-865-48X</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...</td>\n",
              "      <td>A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>011-457-792-548-92X;;048-229-382-653-004</td>\n",
              "      <td>29955905;;10.1007/s00018-018-2863-3;;pmc638240...</td>\n",
              "      <td>YU, G.-T. ET AL.: \"Inhibition of SRC family ki...</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>treatment solid tumoursthe present invention r...</td>\n",
              "      <td>6</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>094-569-953-648-612</th>\n",
              "      <th>2021</th>\n",
              "      <td>3</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512579 A</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>CN 201980049832 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811147946 A;;CN 201910467950 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...</td>\n",
              "      <td>Use of a combination of a TLR agonist and an i...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/094-569-953-648-612</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04</td>\n",
              "      <td>A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>combination tlr agonist immune checkpoint inhi...</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143-969-408-220-424</th>\n",
              "      <th>2021</th>\n",
              "      <td>4</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512580 A</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>CN 201980049896 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811149357 A;;CN 201811547685 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...</td>\n",
              "      <td>Disclosed is the use of an EZH2 inhibitor in c...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/143-969-408-220-424</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...</td>\n",
              "      <td>A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>ezh2 inhibitor combination immune checkpoint i...</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>194-887-353-832-386</th>\n",
              "      <th>2019</th>\n",
              "      <td>5</td>\n",
              "      <td>WO</td>\n",
              "      <td>A8</td>\n",
              "      <td>WO 2019/156568 A8</td>\n",
              "      <td>2019-10-03</td>\n",
              "      <td>NL 2019050092 W</td>\n",
              "      <td>2019-02-12</td>\n",
              "      <td>NL 2020422 A</td>\n",
              "      <td>2018-02-12</td>\n",
              "      <td>METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...</td>\n",
              "      <td>The present invention relates to the field of ...</td>\n",
              "      <td>STICHTING HET NEDERLANDS KANKER INST ANTONI VA...</td>\n",
              "      <td>SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/194-887-353-832-386</td>\n",
              "      <td>Amended Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>G01N33/57423;;G01N2333/70532</td>\n",
              "      <td>G01N33/574</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>methods predicting treatment outcome and/or se...</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-cccb5fb0-c043-4734-bee7-56c79a9b5dbb')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-cccb5fb0-c043-4734-bee7-56c79a9b5dbb button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-cccb5fb0-c043-4734-bee7-56c79a9b5dbb');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-eb06d7a2-eb23-4f2e-8763-dbbb30d70b59\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-eb06d7a2-eb23-4f2e-8763-dbbb30d70b59')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-eb06d7a2-eb23-4f2e-8763-dbbb30d70b59 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 140
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Save data to CSV and Pickle formats\n",
        "df_filtered.to_csv(f'/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/topic_probability_immune_checkpoint.csv', index=False)\n",
        "df_filtered.to_pickle(f'/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/topic_probability_immune_checkpoint.pkl')\n",
        "\n",
        "df_filtered.head()"
      ],
      "metadata": {
        "id": "wgl1pPqUvSsH",
        "outputId": "2d299a56-9a39-43b3-ab80-db04a9aa113c",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 779
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                      # Jurisdiction Kind        Display Key  \\\n",
              "Lens ID             Publication Year                                           \n",
              "197-733-628-711-768 2021              1           TW    A     TW 202114659 A   \n",
              "023-616-950-865-48X 2022              2           WO   A1  WO 2022/056572 A1   \n",
              "094-569-953-648-612 2021              3           CN    A     CN 112512579 A   \n",
              "143-969-408-220-424 2021              4           CN    A     CN 112512580 A   \n",
              "194-887-353-832-386 2019              5           WO   A8  WO 2019/156568 A8   \n",
              "\n",
              "                                     Publication Date Application Number  \\\n",
              "Lens ID             Publication Year                                       \n",
              "197-733-628-711-768 2021                   2021-04-16     TW 109133847 A   \n",
              "023-616-950-865-48X 2022                   2022-03-24   AU 2020/050994 W   \n",
              "094-569-953-648-612 2021                   2021-03-16  CN 201980049832 A   \n",
              "143-969-408-220-424 2021                   2021-03-16  CN 201980049896 A   \n",
              "194-887-353-832-386 2019                   2019-10-03    NL 2019050092 W   \n",
              "\n",
              "                                     Application Date  \\\n",
              "Lens ID             Publication Year                    \n",
              "197-733-628-711-768 2021                   2020-09-29   \n",
              "023-616-950-865-48X 2022                   2020-09-18   \n",
              "094-569-953-648-612 2021                   2019-09-27   \n",
              "143-969-408-220-424 2021                   2019-09-27   \n",
              "194-887-353-832-386 2019                   2019-02-12   \n",
              "\n",
              "                                                                       Priority Numbers  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                  EP 19201152 A   \n",
              "023-616-950-865-48X 2022                                               AU 2020/050994 W   \n",
              "094-569-953-648-612 2021              CN 201811147946 A;;CN 201910467950 A;;CN 20191...   \n",
              "143-969-408-220-424 2021              CN 201811149357 A;;CN 201811547685 A;;CN 20191...   \n",
              "194-887-353-832-386 2019                                                   NL 2020422 A   \n",
              "\n",
              "                                     Earliest Priority Date  \\\n",
              "Lens ID             Publication Year                          \n",
              "197-733-628-711-768 2021                         2019-10-02   \n",
              "023-616-950-865-48X 2022                         2020-09-18   \n",
              "094-569-953-648-612 2021                         2018-09-29   \n",
              "143-969-408-220-424 2021                         2018-09-29   \n",
              "194-887-353-832-386 2019                         2018-02-12   \n",
              "\n",
              "                                                                                  Title  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              Combination comprising HDAC inhibitor, CTLA-4 ...   \n",
              "023-616-950-865-48X 2022                                     TREATMENT OF SOLID TUMOURS   \n",
              "094-569-953-648-612 2021              USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...   \n",
              "143-969-408-220-424 2021              USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...   \n",
              "194-887-353-832-386 2019              METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...   \n",
              "\n",
              "                                                                               Abstract  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              The invention relates to medical uses of an HD...   \n",
              "023-616-950-865-48X 2022              The present invention relates to a method for ...   \n",
              "094-569-953-648-612 2021              Use of a combination of a TLR agonist and an i...   \n",
              "143-969-408-220-424 2021              Disclosed is the use of an EZH2 inhibitor in c...   \n",
              "194-887-353-832-386 2019              The present invention relates to the field of ...   \n",
              "\n",
              "                                                                             Applicants  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                         4SC AG   \n",
              "023-616-950-865-48X 2022                        OLIVIA NEWTON JOHN CANCER RES INSTITUTE   \n",
              "094-569-953-648-612 2021              JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "143-969-408-220-424 2021              JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...   \n",
              "194-887-353-832-386 2019              STICHTING HET NEDERLANDS KANKER INST ANTONI VA...   \n",
              "\n",
              "                                                                              Inventors  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                   HAMM SVETLANA;;HERMANN FRANK   \n",
              "023-616-950-865-48X 2022              POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER   \n",
              "094-569-953-648-612 2021              JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...   \n",
              "143-969-408-220-424 2021              ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...   \n",
              "194-887-353-832-386 2019              SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...   \n",
              "\n",
              "                                     Owners  \\\n",
              "Lens ID             Publication Year          \n",
              "197-733-628-711-768 2021                NaN   \n",
              "023-616-950-865-48X 2022                NaN   \n",
              "094-569-953-648-612 2021                NaN   \n",
              "143-969-408-220-424 2021                NaN   \n",
              "194-887-353-832-386 2019                NaN   \n",
              "\n",
              "                                                                       URL  \\\n",
              "Lens ID             Publication Year                                         \n",
              "197-733-628-711-768 2021              https://lens.org/197-733-628-711-768   \n",
              "023-616-950-865-48X 2022              https://lens.org/023-616-950-865-48X   \n",
              "094-569-953-648-612 2021              https://lens.org/094-569-953-648-612   \n",
              "143-969-408-220-424 2021              https://lens.org/143-969-408-220-424   \n",
              "194-887-353-832-386 2019              https://lens.org/194-887-353-832-386   \n",
              "\n",
              "                                            Document Type Has Full Text  \\\n",
              "Lens ID             Publication Year                                      \n",
              "197-733-628-711-768 2021               Patent of Addition            no   \n",
              "023-616-950-865-48X 2022               Patent Application           yes   \n",
              "094-569-953-648-612 2021               Patent Application            no   \n",
              "143-969-408-220-424 2021               Patent Application            no   \n",
              "194-887-353-832-386 2019              Amended Application           yes   \n",
              "\n",
              "                                      Cites Patent Count  \\\n",
              "Lens ID             Publication Year                       \n",
              "197-733-628-711-768 2021                               0   \n",
              "023-616-950-865-48X 2022                               3   \n",
              "094-569-953-648-612 2021                               3   \n",
              "143-969-408-220-424 2021                               2   \n",
              "194-887-353-832-386 2019                               0   \n",
              "\n",
              "                                      Cited by Patent Count  \\\n",
              "Lens ID             Publication Year                          \n",
              "197-733-628-711-768 2021                                  0   \n",
              "023-616-950-865-48X 2022                                  0   \n",
              "094-569-953-648-612 2021                                  0   \n",
              "143-969-408-220-424 2021                                  1   \n",
              "194-887-353-832-386 2019                                  0   \n",
              "\n",
              "                                      Simple Family Size  \\\n",
              "Lens ID             Publication Year                       \n",
              "197-733-628-711-768 2021                               2   \n",
              "023-616-950-865-48X 2022                               1   \n",
              "094-569-953-648-612 2021                               3   \n",
              "143-969-408-220-424 2021                               3   \n",
              "194-887-353-832-386 2019                               3   \n",
              "\n",
              "                                      Extended Family Size  Sequence Count  \\\n",
              "Lens ID             Publication Year                                         \n",
              "197-733-628-711-768 2021                                 2               0   \n",
              "023-616-950-865-48X 2022                                 2               0   \n",
              "094-569-953-648-612 2021                                 3               0   \n",
              "143-969-408-220-424 2021                                 3               0   \n",
              "194-887-353-832-386 2019                                 3               0   \n",
              "\n",
              "                                                                    CPC Classifications  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                              A61K45/06;;A61P35/00;;A61K31/4155   \n",
              "023-616-950-865-48X 2022              A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...   \n",
              "094-569-953-648-612 2021                  A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04   \n",
              "143-969-408-220-424 2021              A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...   \n",
              "194-887-353-832-386 2019                                   G01N33/57423;;G01N2333/70532   \n",
              "\n",
              "                                                                   IPCR Classifications  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                  A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00   \n",
              "023-616-950-865-48X 2022              A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...   \n",
              "094-569-953-648-612 2021                  A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04   \n",
              "143-969-408-220-424 2021              A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...   \n",
              "194-887-353-832-386 2019                                                     G01N33/574   \n",
              "\n",
              "                                     US Classifications  NPL Citation Count  \\\n",
              "Lens ID             Publication Year                                          \n",
              "197-733-628-711-768 2021                            NaN                   0   \n",
              "023-616-950-865-48X 2022                            NaN                   2   \n",
              "094-569-953-648-612 2021                            NaN                   0   \n",
              "143-969-408-220-424 2021                            NaN                   0   \n",
              "194-887-353-832-386 2019                            NaN                   0   \n",
              "\n",
              "                                      NPL Resolved Citation Count  \\\n",
              "Lens ID             Publication Year                                \n",
              "197-733-628-711-768 2021                                        0   \n",
              "023-616-950-865-48X 2022                                        2   \n",
              "094-569-953-648-612 2021                                        0   \n",
              "143-969-408-220-424 2021                                        0   \n",
              "194-887-353-832-386 2019                                        0   \n",
              "\n",
              "                                                       NPL Resolved Lens ID(s)  \\\n",
              "Lens ID             Publication Year                                             \n",
              "197-733-628-711-768 2021                                                   NaN   \n",
              "023-616-950-865-48X 2022              011-457-792-548-92X;;048-229-382-653-004   \n",
              "094-569-953-648-612 2021                                                   NaN   \n",
              "143-969-408-220-424 2021                                                   NaN   \n",
              "194-887-353-832-386 2019                                                   NaN   \n",
              "\n",
              "                                                            NPL Resolved External ID(s)  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022              29955905;;10.1007/s00018-018-2863-3;;pmc638240...   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "\n",
              "                                                                          NPL Citations  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021                                                            NaN   \n",
              "023-616-950-865-48X 2022              YU, G.-T. ET AL.: \"Inhibition of SRC family ki...   \n",
              "094-569-953-648-612 2021                                                            NaN   \n",
              "143-969-408-220-424 2021                                                            NaN   \n",
              "194-887-353-832-386 2019                                                            NaN   \n",
              "\n",
              "                                     Legal Status  \\\n",
              "Lens ID             Publication Year                \n",
              "197-733-628-711-768 2021                  PENDING   \n",
              "023-616-950-865-48X 2022                  PENDING   \n",
              "094-569-953-648-612 2021                  PENDING   \n",
              "143-969-408-220-424 2021                  PENDING   \n",
              "194-887-353-832-386 2019                  PENDING   \n",
              "\n",
              "                                                                           Cleaned_Text  \\\n",
              "Lens ID             Publication Year                                                      \n",
              "197-733-628-711-768 2021              combination comprising hdac inhibitor, ctla-4 ...   \n",
              "023-616-950-865-48X 2022              treatment solid tumoursthe present invention r...   \n",
              "094-569-953-648-612 2021              combination tlr agonist immune checkpoint inhi...   \n",
              "143-969-408-220-424 2021              ezh2 inhibitor combination immune checkpoint i...   \n",
              "194-887-353-832-386 2019              methods predicting treatment outcome and/or se...   \n",
              "\n",
              "                                      Topic N°  \n",
              "Lens ID             Publication Year            \n",
              "197-733-628-711-768 2021                     4  \n",
              "023-616-950-865-48X 2022                     6  \n",
              "094-569-953-648-612 2021                     4  \n",
              "143-969-408-220-424 2021                     4  \n",
              "194-887-353-832-386 2019                     4  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-fb298e39-4317-43cb-ac71-8a4db6ec767a\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th>#</th>\n",
              "      <th>Jurisdiction</th>\n",
              "      <th>Kind</th>\n",
              "      <th>Display Key</th>\n",
              "      <th>Publication Date</th>\n",
              "      <th>Application Number</th>\n",
              "      <th>Application Date</th>\n",
              "      <th>Priority Numbers</th>\n",
              "      <th>Earliest Priority Date</th>\n",
              "      <th>Title</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Applicants</th>\n",
              "      <th>Inventors</th>\n",
              "      <th>Owners</th>\n",
              "      <th>URL</th>\n",
              "      <th>Document Type</th>\n",
              "      <th>Has Full Text</th>\n",
              "      <th>Cites Patent Count</th>\n",
              "      <th>Cited by Patent Count</th>\n",
              "      <th>Simple Family Size</th>\n",
              "      <th>Extended Family Size</th>\n",
              "      <th>Sequence Count</th>\n",
              "      <th>CPC Classifications</th>\n",
              "      <th>IPCR Classifications</th>\n",
              "      <th>US Classifications</th>\n",
              "      <th>NPL Citation Count</th>\n",
              "      <th>NPL Resolved Citation Count</th>\n",
              "      <th>NPL Resolved Lens ID(s)</th>\n",
              "      <th>NPL Resolved External ID(s)</th>\n",
              "      <th>NPL Citations</th>\n",
              "      <th>Legal Status</th>\n",
              "      <th>Cleaned_Text</th>\n",
              "      <th>Topic N°</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Lens ID</th>\n",
              "      <th>Publication Year</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>197-733-628-711-768</th>\n",
              "      <th>2021</th>\n",
              "      <td>1</td>\n",
              "      <td>TW</td>\n",
              "      <td>A</td>\n",
              "      <td>TW 202114659 A</td>\n",
              "      <td>2021-04-16</td>\n",
              "      <td>TW 109133847 A</td>\n",
              "      <td>2020-09-29</td>\n",
              "      <td>EP 19201152 A</td>\n",
              "      <td>2019-10-02</td>\n",
              "      <td>Combination comprising HDAC inhibitor, CTLA-4 ...</td>\n",
              "      <td>The invention relates to medical uses of an HD...</td>\n",
              "      <td>4SC AG</td>\n",
              "      <td>HAMM SVETLANA;;HERMANN FRANK</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/197-733-628-711-768</td>\n",
              "      <td>Patent of Addition</td>\n",
              "      <td>no</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K45/06;;A61P35/00;;A61K31/4155</td>\n",
              "      <td>A61K31/4155;;A61K39/395;;A61K45/06;;A61P35/00</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>combination comprising hdac inhibitor, ctla-4 ...</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>023-616-950-865-48X</th>\n",
              "      <th>2022</th>\n",
              "      <td>2</td>\n",
              "      <td>WO</td>\n",
              "      <td>A1</td>\n",
              "      <td>WO 2022/056572 A1</td>\n",
              "      <td>2022-03-24</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>AU 2020/050994 W</td>\n",
              "      <td>2020-09-18</td>\n",
              "      <td>TREATMENT OF SOLID TUMOURS</td>\n",
              "      <td>The present invention relates to a method for ...</td>\n",
              "      <td>OLIVIA NEWTON JOHN CANCER RES INSTITUTE</td>\n",
              "      <td>POH ASHLEIGH REN-YI;;ERNST MATTHIAS ROBERT WALTER</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/023-616-950-865-48X</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/506;;A61K2300/00;;A61K31/519;;A61K9/001...</td>\n",
              "      <td>A61K31/506;;A61K31/519;;A61K39/395;;A61P35/00;...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>011-457-792-548-92X;;048-229-382-653-004</td>\n",
              "      <td>29955905;;10.1007/s00018-018-2863-3;;pmc638240...</td>\n",
              "      <td>YU, G.-T. ET AL.: \"Inhibition of SRC family ki...</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>treatment solid tumoursthe present invention r...</td>\n",
              "      <td>6</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>094-569-953-648-612</th>\n",
              "      <th>2021</th>\n",
              "      <td>3</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512579 A</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>CN 201980049832 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811147946 A;;CN 201910467950 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF COMBINATION OF TLR AGONIST AND IMMUNE C...</td>\n",
              "      <td>Use of a combination of a TLR agonist and an i...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>JIANG JIAHUA;;YANG CHANGYONG;;LIAO CHENG;;ZHAN...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/094-569-953-648-612</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K39/395;;A61P35/00;;A61K31/395;;C07D471/04</td>\n",
              "      <td>A61K39/395;;A61K31/395;;A61P35/00;;C07D471/04</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>combination tlr agonist immune checkpoint inhi...</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143-969-408-220-424</th>\n",
              "      <th>2021</th>\n",
              "      <td>4</td>\n",
              "      <td>CN</td>\n",
              "      <td>A</td>\n",
              "      <td>CN 112512580 A</td>\n",
              "      <td>2021-03-16</td>\n",
              "      <td>CN 201980049896 A</td>\n",
              "      <td>2019-09-27</td>\n",
              "      <td>CN 201811149357 A;;CN 201811547685 A;;CN 20191...</td>\n",
              "      <td>2018-09-29</td>\n",
              "      <td>USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMU...</td>\n",
              "      <td>Disclosed is the use of an EZH2 inhibitor in c...</td>\n",
              "      <td>JIANGSU HENGRUI MEDICINE CO;;SUZHOU SHENGDIYA ...</td>\n",
              "      <td>ZHANG LAN;;JIANG JIAHUA;;LIAO CHENG;;ZHANG LIA...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/143-969-408-220-424</td>\n",
              "      <td>Patent Application</td>\n",
              "      <td>no</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>A61K31/4433;;A61K31/4545;;A61K31/496;;A61K31/5...</td>\n",
              "      <td>A61K39/395;;A61K31/4433;;A61K31/4545;;A61K31/4...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>ezh2 inhibitor combination immune checkpoint i...</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>194-887-353-832-386</th>\n",
              "      <th>2019</th>\n",
              "      <td>5</td>\n",
              "      <td>WO</td>\n",
              "      <td>A8</td>\n",
              "      <td>WO 2019/156568 A8</td>\n",
              "      <td>2019-10-03</td>\n",
              "      <td>NL 2019050092 W</td>\n",
              "      <td>2019-02-12</td>\n",
              "      <td>NL 2020422 A</td>\n",
              "      <td>2018-02-12</td>\n",
              "      <td>METHODS FOR PREDICTING TREATMENT OUTCOME AND/O...</td>\n",
              "      <td>The present invention relates to the field of ...</td>\n",
              "      <td>STICHTING HET NEDERLANDS KANKER INST ANTONI VA...</td>\n",
              "      <td>SCHUMACHER ANTONIUS NICOLAAS MARIA;;ZIPPELIUS ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>https://lens.org/194-887-353-832-386</td>\n",
              "      <td>Amended Application</td>\n",
              "      <td>yes</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>G01N33/57423;;G01N2333/70532</td>\n",
              "      <td>G01N33/574</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PENDING</td>\n",
              "      <td>methods predicting treatment outcome and/or se...</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-fb298e39-4317-43cb-ac71-8a4db6ec767a')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-fb298e39-4317-43cb-ac71-8a4db6ec767a button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-fb298e39-4317-43cb-ac71-8a4db6ec767a');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-0c4872fc-cf86-40de-be4f-aae5fcb12f83\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-0c4872fc-cf86-40de-be4f-aae5fcb12f83')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-0c4872fc-cf86-40de-be4f-aae5fcb12f83 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 141
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_filtered['Topic N°'].value_counts()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "w2YM_CRFuSL2",
        "outputId": "8329d77d-abdf-4dff-f9c8-8509e8d9b144"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "7     721\n",
              "6     582\n",
              "4     419\n",
              "10    352\n",
              "8     328\n",
              "5     280\n",
              "1     222\n",
              "9     192\n",
              "2      92\n",
              "0      75\n",
              "3      57\n",
              "Name: Topic N°, dtype: int64"
            ]
          },
          "metadata": {},
          "execution_count": 142
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "b8FNvESuuHRW",
        "outputId": "e7d57faf-a11c-4d8b-8010-5f7734b486aa",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Frequency Counting"
      ],
      "metadata": {
        "id": "523ItiHxuHU0",
        "outputId": "6fbb0ac8-356b-4f43-b060-d3499e64a20c",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Step 1: Group data by 'Publication Year' and 'topic', then count occurrences\n",
        "topic_counts_by_year = df_filtered.reset_index().groupby(['Publication Year', 'Topic N°']).size().unstack(fill_value=0)\n",
        "\n",
        "# Step 2: Calculate the total count of each topic\n",
        "total_counts = topic_counts_by_year.sum()\n",
        "\n",
        "# Step 3: Sort columns by total count\n",
        "sorted_columns = total_counts.sort_values(ascending=False).index\n",
        "topic_counts_by_year = topic_counts_by_year[sorted_columns]\n",
        "\n",
        "# Step 4: Add a row with the total count of each topic\n",
        "topic_counts_by_year.loc['Total'] = total_counts.loc[sorted_columns]\n",
        "\n",
        "# Save the DataFrame to CSV and pickle files\n",
        "topic_counts_by_year.to_csv(f'/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/topic_counts_by_year_immune_checkpoint.csv')\n",
        "topic_counts_by_year.to_pickle(f'/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/topic_counts_by_year_immune_checkpoint.pkl')\n",
        "\n",
        "# This will give you a DataFrame where each row is a year (plus a 'Total' row at the bottom),\n",
        "# and each column is the count of documents associated with a topic for that year (and the total count).\n",
        "\n",
        "# Display the updated DataFrame\n",
        "topic_counts_by_year"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 889
        },
        "id": "bH7Nrjr1uHZL",
        "outputId": "d088c403-1c8a-43dd-f367-87cb93786b9c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Topic N°           7    6    4    10   8    5    1    9   2   0   3 \n",
              "Publication Year                                                    \n",
              "1999                0    0    1    0    0    2    0    0   0   0   0\n",
              "2000                0    0    0    0    0    0    1    0   0   0   0\n",
              "2002                1    0    0    0    1    0    0    0   0   0   0\n",
              "2005                0    1    0    0    0    0    0    0   0   0   0\n",
              "2006                1    1    0    0    0    1    0    0   0   0   0\n",
              "2007                2    0    1    0    1    0    0    0   0   0   0\n",
              "2008                1    1    1    0    1    0    0    0   0   0   0\n",
              "2009                1    0    2    2    1    0    0    1   0   0   0\n",
              "2010                2    0    1    0    0    1    1    0   0   1   0\n",
              "2011                4    1    0    0    0    2    0    0   0   0   1\n",
              "2012                1    0    2    0    3    0    0    0   0   0   0\n",
              "2013                4    1    3    1    3    1    1    2   0   0   0\n",
              "2014                3    2    2    2    1    2    0    0   0   0   2\n",
              "2015                7    5    2    1    4    2    1    0   1   1   2\n",
              "2016               17   12   10    5    7    1    2    6   2   5   0\n",
              "2017               42   28   24   10    6   13    2    6   0   2   4\n",
              "2018               39   29   30   10   12   25    7    9   4   6   2\n",
              "2019               84   55   31   30   27   35   13   15   6  13   2\n",
              "2020               89   77   46   39   45   39   30   29  20   9   7\n",
              "2021              121  114   52   51   56   42   51   33  21  10  11\n",
              "2022              139  107   97   86   84   45   49   41  15   9  12\n",
              "2023              156  141  110  115   75   67   63   46  23  17  13\n",
              "2024                7    7    4    0    1    2    1    4   0   2   1\n",
              "Total             721  582  419  352  328  280  222  192  92  75  57"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-def640d1-c3ca-47da-9196-d35f21373184\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th>Topic N°</th>\n",
              "      <th>7</th>\n",
              "      <th>6</th>\n",
              "      <th>4</th>\n",
              "      <th>10</th>\n",
              "      <th>8</th>\n",
              "      <th>5</th>\n",
              "      <th>1</th>\n",
              "      <th>9</th>\n",
              "      <th>2</th>\n",
              "      <th>0</th>\n",
              "      <th>3</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Publication Year</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1999</th>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2000</th>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2002</th>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2005</th>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2006</th>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2007</th>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2008</th>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2009</th>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2010</th>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2011</th>\n",
              "      <td>4</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2012</th>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>3</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2013</th>\n",
              "      <td>4</td>\n",
              "      <td>1</td>\n",
              "      <td>3</td>\n",
              "      <td>1</td>\n",
              "      <td>3</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2014</th>\n",
              "      <td>3</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2015</th>\n",
              "      <td>7</td>\n",
              "      <td>5</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>4</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2016</th>\n",
              "      <td>17</td>\n",
              "      <td>12</td>\n",
              "      <td>10</td>\n",
              "      <td>5</td>\n",
              "      <td>7</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>6</td>\n",
              "      <td>2</td>\n",
              "      <td>5</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2017</th>\n",
              "      <td>42</td>\n",
              "      <td>28</td>\n",
              "      <td>24</td>\n",
              "      <td>10</td>\n",
              "      <td>6</td>\n",
              "      <td>13</td>\n",
              "      <td>2</td>\n",
              "      <td>6</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2018</th>\n",
              "      <td>39</td>\n",
              "      <td>29</td>\n",
              "      <td>30</td>\n",
              "      <td>10</td>\n",
              "      <td>12</td>\n",
              "      <td>25</td>\n",
              "      <td>7</td>\n",
              "      <td>9</td>\n",
              "      <td>4</td>\n",
              "      <td>6</td>\n",
              "      <td>2</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2019</th>\n",
              "      <td>84</td>\n",
              "      <td>55</td>\n",
              "      <td>31</td>\n",
              "      <td>30</td>\n",
              "      <td>27</td>\n",
              "      <td>35</td>\n",
              "      <td>13</td>\n",
              "      <td>15</td>\n",
              "      <td>6</td>\n",
              "      <td>13</td>\n",
              "      <td>2</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2020</th>\n",
              "      <td>89</td>\n",
              "      <td>77</td>\n",
              "      <td>46</td>\n",
              "      <td>39</td>\n",
              "      <td>45</td>\n",
              "      <td>39</td>\n",
              "      <td>30</td>\n",
              "      <td>29</td>\n",
              "      <td>20</td>\n",
              "      <td>9</td>\n",
              "      <td>7</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2021</th>\n",
              "      <td>121</td>\n",
              "      <td>114</td>\n",
              "      <td>52</td>\n",
              "      <td>51</td>\n",
              "      <td>56</td>\n",
              "      <td>42</td>\n",
              "      <td>51</td>\n",
              "      <td>33</td>\n",
              "      <td>21</td>\n",
              "      <td>10</td>\n",
              "      <td>11</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2022</th>\n",
              "      <td>139</td>\n",
              "      <td>107</td>\n",
              "      <td>97</td>\n",
              "      <td>86</td>\n",
              "      <td>84</td>\n",
              "      <td>45</td>\n",
              "      <td>49</td>\n",
              "      <td>41</td>\n",
              "      <td>15</td>\n",
              "      <td>9</td>\n",
              "      <td>12</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2023</th>\n",
              "      <td>156</td>\n",
              "      <td>141</td>\n",
              "      <td>110</td>\n",
              "      <td>115</td>\n",
              "      <td>75</td>\n",
              "      <td>67</td>\n",
              "      <td>63</td>\n",
              "      <td>46</td>\n",
              "      <td>23</td>\n",
              "      <td>17</td>\n",
              "      <td>13</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2024</th>\n",
              "      <td>7</td>\n",
              "      <td>7</td>\n",
              "      <td>4</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "      <td>4</td>\n",
              "      <td>0</td>\n",
              "      <td>2</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Total</th>\n",
              "      <td>721</td>\n",
              "      <td>582</td>\n",
              "      <td>419</td>\n",
              "      <td>352</td>\n",
              "      <td>328</td>\n",
              "      <td>280</td>\n",
              "      <td>222</td>\n",
              "      <td>192</td>\n",
              "      <td>92</td>\n",
              "      <td>75</td>\n",
              "      <td>57</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-def640d1-c3ca-47da-9196-d35f21373184')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-def640d1-c3ca-47da-9196-d35f21373184 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-def640d1-c3ca-47da-9196-d35f21373184');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-38b561cd-2976-4b01-86ba-1b85605b07a7\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-38b561cd-2976-4b01-86ba-1b85605b07a7')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-38b561cd-2976-4b01-86ba-1b85605b07a7 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_fc907412-93ba-484e-9133-423dd9c6ee0e\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('topic_counts_by_year')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_fc907412-93ba-484e-9133-423dd9c6ee0e button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('topic_counts_by_year');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 144
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "topic_counts_by_year.shape"
      ],
      "metadata": {
        "id": "CJD35-VmvEt_",
        "outputId": "7ca08b3b-34a2-43f5-8c34-6fea66c80644",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(24, 11)"
            ]
          },
          "metadata": {},
          "execution_count": 145
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Evolution Curve for Each Topic"
      ],
      "metadata": {
        "id": "NoSWY_VxvEeB",
        "outputId": "9509e32e-bd83-4759-92bc-c92217f5d5f5",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import matplotlib.pyplot as plt\n",
        "import pandas as pd\n",
        "\n",
        "# Read the DataFrame from the CSV file (assuming it's stored as 'topic_counts_by_year.csv')\n",
        "# Replace this line with your actual data if it's not in a CSV\n",
        "#topic_counts_by_year = pd.read_csv('topic_counts_by_year.csv', index_col='Publication Year')\n",
        "\n",
        "# Remove the 'Total' row if it exists\n",
        "if 'Total' in topic_counts_by_year.index:\n",
        "    topic_counts_by_year = topic_counts_by_year.drop(index=['Total'])\n",
        "\n",
        "# Sort columns by topic name\n",
        "topic_counts_by_year = topic_counts_by_year.sort_index(axis=1)\n",
        "\n",
        "# Define the number of topics (make sure this matches your data)\n",
        "n_topics = len(topic_counts_by_year.columns)\n",
        "\n",
        "# Calculate the number of rows needed for subplots\n",
        "n_rows = (n_topics + 4) // 5  # +4 for rounding up\n",
        "\n",
        "# Create a grid of subplots\n",
        "fig, axes = plt.subplots(n_rows, 5, figsize=(20, n_rows * 3.5))\n",
        "\n",
        "# Flatten the array to easily iterate over it\n",
        "axes_flat = axes.flatten()\n",
        "\n",
        "# Loop through each topic and plot its curve on a separate subplot\n",
        "for i, topic in enumerate(topic_counts_by_year.columns):\n",
        "    axes_flat[i].plot(\n",
        "        topic_counts_by_year.index,\n",
        "        topic_counts_by_year[topic]\n",
        "    )\n",
        "    axes_flat[i].set_title(f'Topic {topic}')\n",
        "    axes_flat[i].set_xlabel('Year')\n",
        "    axes_flat[i].set_ylabel('Frequency')\n",
        "    axes_flat[i].grid(True, which='both', linestyle='--', linewidth=0.5)\n",
        "\n",
        "# Remove extra subplots\n",
        "for i in range(n_topics, len(axes_flat)):\n",
        "    fig.delaxes(axes_flat[i])\n",
        "\n",
        "# Add a main title for the entire figure\n",
        "fig.suptitle('Evolution Curve for Each Topic', fontsize=16, fontweight='bold')\n",
        "\n",
        "# Save the figure\n",
        "plt.tight_layout(rect=[0, 0, 1, 0.96])  # Make room for the main title\n",
        "plt.savefig(f'/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/topic_evolution_curves_subplot_ordered_immune_checkpoint.png', dpi=600)\n",
        "\n",
        "# Show the figure\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 733
        },
        "id": "3GptximmvEAS",
        "outputId": "d86316bf-2290-4364-c1ae-892ef7cb231e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 2000x1050 with 11 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "g_30fTTfuHc2",
        "outputId": "a0da94d0-1945-4777-9e9e-1402bc67586d",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Temporal Heatmaps: Display how topic proportions change over time."
      ],
      "metadata": {
        "id": "5NFfs0DfyENS",
        "outputId": "6fe45455-5212-417f-bc7b-a7d7e7c9b255",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import matplotlib.pyplot as plt\n",
        "import pandas as pd\n",
        "import seaborn as sns\n",
        "\n",
        "# Assume you already have topic_counts_by_year DataFrame\n",
        "\n",
        "# Remove the 'Total' row if it exists\n",
        "if 'Total' in topic_counts_by_year.index:\n",
        "    topic_counts_by_year = topic_counts_by_year.drop(index=['Total'])\n",
        "\n",
        "# Sort columns by topic name\n",
        "topic_counts_by_year = topic_counts_by_year.sort_index(axis=1)\n",
        "\n",
        "# Calculate the total count for each year (row-wise sum)\n",
        "total_counts_by_year = topic_counts_by_year.sum(axis=1)\n",
        "\n",
        "# Normalize frequencies to get proportions\n",
        "proportions_by_year = topic_counts_by_year.divide(total_counts_by_year, axis=0)\n",
        "\n",
        "# Create the heatmap\n",
        "plt.figure(figsize=(25, 10))\n",
        "sns.heatmap(proportions_by_year.fillna(0), annot=True, cmap=\"coolwarm\", cbar=True, xticklabels=True, yticklabels=True)\n",
        "\n",
        "# Add labels and title\n",
        "plt.title('Temporal Heatmap of Topic Proportions')\n",
        "plt.xlabel('Topics')\n",
        "plt.ylabel('Publication Year')\n",
        "\n",
        "# Save the figure\n",
        "plt.tight_layout()\n",
        "plt.savefig(f\"/content/drive/Othercomputers/My laptop/D:/PROJECT/YORK UNIVERSITY/Immune checkpoint /data_preprocesse/temporal_heatmap_topic_proportions_immune_checkpoint.png\")  # Save the plot to a PNG file\n",
        "\n",
        "# Show the plot\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 643
        },
        "id": "mQsuGEqMyEPw",
        "outputId": "2cf622cf-b413-4c2a-9965-5f860220c90d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 2500x1000 with 2 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "vP4BEzb7yESP",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "45f6e313-7c98-4b7c-e3b1-6893103c298a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "nIrPnpeayEVy",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "0ef630ab-eddb-490f-aa6d-4107ba3f139f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py:283: DeprecationWarning: `should_run_async` will not call `transform_cell` automatically in the future. Please pass the result to `transformed_cell` argument and any exception that happen during thetransform in `preprocessing_exc_tuple` in IPython 7.17 and above.\n",
            "  and should_run_async(code)\n"
          ]
        }
      ]
    }
  ],
  "metadata": {
    "colab": {
      "provenance": [],
      "toc_visible": true,
      "include_colab_link": true
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}